Our O
results O
indicate O
a O
strong O
BC200 B-RNA
presence O
in O
both O
the O
normal O
brains O
and O
NAD O
affected O
neocortices O
, O
but O
a O
70 O
per O
cent O
reduction O
in O
BC200 B-RNA
signal O
strength O
in O
AD B-Disease
afflicted O
brains O
. O

The O
increased O
expression O
of O
Rb B-RNA
and O
p53 B-RNA
RNA O
was O
observed O
in O
a O
majority O
of O
colorectal B-Disease
cancers I-Disease
in O
comparison O
to O
adjacent O
normal O
mucosa O
and O
is O
accompanied O
by O
proportional O
increase O
in O
the O
expression O
of O
histone O
H3 O
gene O
. O

The O
correlation O
of O
chromosomal O
loss O
in O
17p O
on O
the O
cytogenetic O
and O
molecular O
level O
along O
with O
p53 B-RNA
mRNA O
expression O
and O
DNA O
sequence O
data O
indicate O
that O
genetic O
alterations O
in O
p53 B-RNA
could O
be O
a O
feature O
of O
malignant B-Disease
mesotheliomas I-Disease
and O
may O
reveal O
an O
important O
role O
of O
asbestos O
fibers O
in O
tumor O
suppressor O
gene O
inactivation O
. O

It O
is O
reexpressed O
in O
a O
number O
of O
tumors O
including O
bladder B-Disease
carcinoma I-Disease
, O
demonstrating O
that O
H19 B-RNA
RNA O
is O
an O
oncofetal O
RNA O
. O

Prominent O
expression O
of O
H19 B-RNA
was O
found O
in O
placental O
site O
trophoblastic B-Disease
tumor I-Disease
and O
gestational B-Disease
choriocarcinoma I-Disease
. O

Immunostaining O
of O
p53 B-RNA
is O
associated O
with O
the O
malignant O
phenotype O
, O
but O
does O
not O
correlate O
with O
the O
biological O
behavior O
of O
human O
endometrial B-Disease
carcinoma I-Disease
. O

Loss O
of O
imprinting O
( O
LOI O
) O
of O
the O
endogenous O
gene O
H19 B-RNA
was O
frequently O
found O
in O
lung B-Disease
cancer I-Disease
and O
chorio B-Disease
- I-Disease
carcinoma I-Disease
, O
common O
adulthood O
cancers O
. O

High O
incidence O
of O
loss O
of O
heterozygosity O
and O
abnormal O
imprinting O
of O
H19 B-RNA
and O
IGF2 B-RNA
genes O
in O
invasive B-Disease
cervical I-Disease
carcinomas I-Disease
. O

We O
analyzed O
p53 B-RNA
sequence O
and O
c O
- O
myc O
and O
p53 B-RNA
mRNA O
expression O
in O
26 O
metastases O
and O
4 O
advanced O
primaries O
of O
human O
colorectal B-Disease
cancer I-Disease
. O

The O
biallelic O
expression O
of O
H19 B-RNA
was O
only O
partial O
in O
two O
medulloblastomas B-Disease
, O
however O
, O
with O
one O
allele O
being O
significantly O
weaker O
than O
the O
other O
. O

Inactivation O
of O
the O
p53 B-RNA
function O
in O
colorectal B-Disease
cancers I-Disease
involves O
at O
least O
two O
distinct O
mechanisms O
, O
including O
p53 B-RNA
overexpression O
and O
/ O
or O
mutation O
. O

Choriocarcinomas B-Disease
were O
characterized O
by O
a O
low O
expression O
of O
IGF2 B-RNA
and O
a O
high O
expression O
of O
H19 B-RNA
with O
the O
transcripts O
being O
apparently O
intact O
in O
size O
. O

All O
4 O
informative O
testicular B-Disease
germ I-Disease
cell I-Disease
tumors I-Disease
showed O
LOI O
for O
the O
H19 B-RNA
gene O
. O

Here O
we O
show O
that O
the O
expression O
of O
the O
H19 B-RNA
gene O
is O
significantly O
suppressed O
with O
respect O
to O
normal O
muscle O
tissue O
in O
13 O
out O
of O
15 O
rhabdomyosarcomas B-Disease
with O
embryonal O
histology O
( O
ERMS O
) O
and O
in O
three O
out O
of O
11 O
rhabdomyosarcomas B-Disease
classified O
as O
alveolar O
subtype O
( O
ARMS O
) O
. O

XIST B-RNA
was O
expressed O
at O
a O
higher O
level O
in O
parenchyma O
with O
carcinoma O
in O
situ O
, O
the O
precursor O
lesion O
of O
seminomas B-Disease
and O
nonseminomas O
. O

Low O
frequency O
hTR B-RNA
expression O
was O
also O
associated O
with O
adenocarcinoma B-Disease
of I-Disease
the I-Disease
breast I-Disease
( O
13 O
% O
) O
, O
and O
ovary O
( O
17 O
% O
) O
. O

Differentiated O
tissues O
within O
ovarian B-Disease
germ I-Disease
cell I-Disease
tumours I-Disease
and O
in O
testicular B-Disease
teratomas I-Disease
lacked O
detectable O
hTR B-RNA
expression O
. O

Unlike O
WT O
, O
loss O
of O
imprinting O
( O
LOI O
) O
of O
IGF2 B-RNA
in O
HCC B-Disease
was O
not O
linked O
to O
down O
- O
regulation O
of O
H19 B-RNA
expression O
, O
but O
rather O
associated O
with O
coexpression O
for O
H19 B-RNA
and O
IGF2 B-RNA
. O

Thus O
, O
Hl9 O
and O
IGF2 B-RNA
expression O
can O
be O
uncoupled O
in O
tumors O
with O
LOI O
. O

Overexpression O
of O
hTR B-RNA
due O
to O
stem O
cell O
hyperplasia O
is O
an O
early O
event O
of O
carcinogenesis B-Disease
of I-Disease
the I-Disease
stomach I-Disease
. O

In O
72 O
. O
5 O
% O
of O
studied O
breast B-Disease
adenocarcinomas I-Disease
an O
overall O
H19 B-RNA
gene O
expression O
is O
increased O
when O
compared O
with O
healthy O
tissues O
. O

aHIF B-RNA
is O
specifically O
overexpressed O
in O
all O
nonpapillary B-Disease
clear I-Disease
- I-Disease
cell I-Disease
renal I-Disease
carcinomas I-Disease
examined O
, O
but O
not O
in O
the O
papillary O
renal O
carcinomas O
examined O
, O
aHIF B-RNA
is O
overexpressed O
in O
an O
established O
nonpapillary O
renal O
carcinoma O
cell O
line O
under O
both O
normoxic O
( O
i O
. O
e O
. O
, O
normal O
aerobic O
) O
and O
hypoxic O
conditions O
. O

The O
differences O
in O
p53 B-RNA
protein O
and O
/ O
or O
mRNA O
contents O
reflect O
corresponding O
differences O
in O
the O
pathogenetic O
importance O
of O
p53 B-RNA
alterations O
in O
these O
types O
of O
adrenal B-Disease
tumors I-Disease
. O

The O
incidence O
of O
WIT B-RNA
- I-RNA
1 I-RNA
methylation O
in O
primary O
refractory O
AML B-Disease
was O
significantly O
higher O
than O
that O
noted O
in O
chemosensitive O
AML B-Disease
( O
P O
= O
0 O
. O
18 O
) O
. O

The O
highest O
levels O
of O
hTR B-RNA
expression O
were O
found O
predomintly O
in O
ovarian B-Disease
carcinomas I-Disease
. O

H19 B-RNA
is O
expressed O
in O
the O
majority O
of O
serous B-Disease
epithelial I-Disease
tumors I-Disease
. O

Changes O
in O
the O
expression O
of O
sra B-RNA
- O
related O
molecules O
occur O
during O
breast B-Disease
tumor I-Disease
progression O
. O

Upregulation O
of O
hTR B-RNA
expression O
detected O
by O
ISH O
assay O
may O
be O
a O
useful O
marker O
or O
tool O
for O
the O
early O
detection O
of O
gastric B-Disease
cancer I-Disease
. O

These O
data O
suggest O
that O
loss O
of O
imprinting O
at O
the O
IGF2 B-RNA
and O
H19 B-RNA
loci O
play O
a O
role O
in O
the O
oncogenesis O
of O
head B-Disease
and I-Disease
neck I-Disease
carcinoma I-Disease
. O

In O
situ O
hybridisation O
visualised O
a O
moderate O
to O
high O
upregulation O
of O
hTR B-RNA
in O
the O
melanoma B-Disease
cells O
but O
not O
in O
the O
admixed O
reactive O
cells O
. O

PEG8 B-RNA
/ I-RNA
IGF2AS I-RNA
and O
IGF2 B-RNA
were O
found O
to O
be O
overexpressed O
in O
Wilms B-Disease
' I-Disease
tumor I-Disease
samples O
, O
at O
levels O
over O
ten O
and O
a O
hundred O
times O
higher O
than O
that O
in O
normal O
kidney O
tissues O
neighboring O
the O
tumors O
, O
respectively O
. O

These O
results O
indicate O
that O
modulation O
of O
the O
imprinting O
status O
of O
IGF2 B-RNA
and O
H19 B-RNA
may O
play O
an O
important O
role O
for O
the O
development O
of O
meningiomas B-Disease
. O

Altogether O
, O
these O
observations O
indicate O
that O
DISC1 B-RNA
and O
DISC2 B-RNA
should O
be O
considered O
formal O
candidate O
genes O
for O
susceptibility O
to O
psychiatric B-Disease
illness I-Disease
. O

We O
have O
recently O
identified O
a O
minimally O
deleted O
region O
encompassing O
parts O
of O
two O
adjacent O
genes O
, O
termed O
LEU1 B-RNA
and O
LEU2 B-RNA
( O
leukemia O
- O
associated O
genes O
1 O
and O
2 O
) O
, O
frequently O
deleted O
in O
B B-Disease
- I-Disease
cell I-Disease
chronic I-Disease
lymphocytic I-Disease
leukemia I-Disease
. O

These O
results O
suggest O
that O
LOI O
of O
LIT1 B-RNA
is O
frequently O
observed O
in O
colorectal B-Disease
cancer I-Disease
and O
may O
be O
a O
useful O
marker O
for O
diagnosis O
of O
colorectal B-Disease
cancer I-Disease
. O

The O
expression O
of O
hTR B-RNA
is O
a O
prevailing O
event O
in O
lung O
cancer O
and O
therefore O
can O
be O
used O
as O
an O
indicator O
of O
lung B-Disease
maligncy I-Disease
. O

NAG B-RNA
- I-RNA
7 I-RNA
is O
a O
novel O
gene O
downregulated O
in O
human O
nasopharyngeal B-Disease
carcinoma I-Disease
. O

Telomerase O
activity O
, O
hTR B-RNA
expression O
and O
hTRT B-RNA
/ I-RNA
hEST2 I-RNA
are O
frequently O
detected O
at O
higher O
levels O
in O
NSCLC B-Disease
than O
the O
pericancerous O
normal O
tissues O
. O

Interestingly O
, O
this O
protein O
accumulates O
in O
many O
cancerous O
tissues O
, O
such O
as O
breast B-Disease
carcinomas I-Disease
in O
which O
we O
have O
also O
demonstrated O
an O
overexpression O
of O
the O
H19 B-RNA
gene O
. O

The O
results O
suggest O
that O
hTR B-RNA
might O
indirectly O
reflect O
the O
telomerase O
activity O
, O
and O
be O
used O
as O
a O
new O
marker O
for O
diagnosis O
of O
malignt O
melanoma B-Disease
and O
metastasis O
prediction O
. O

Expression O
of O
the O
DD3 B-RNA
( O
PCA3 O
) O
gene O
is O
a O
very O
sensitive O
and O
specific O
marker O
for O
the O
detection O
of O
prostate B-Disease
tumor I-Disease
cells O
in O
a O
high O
background O
of O
normal O
( O
prostate O
) O
cells O
. O

M41 B-RNA
mRNA O
is O
expressed O
at O
a O
statistically O
significantly O
higher O
level O
in O
human O
breast B-Disease
cancer I-Disease
specimens O
than O
in O
normal O
human O
breast O
and O
benign O
lesions O
. O

An O
overload O
of O
H19 B-RNA
transcript O
is O
associated O
with O
cells O
exhibiting O
higher O
tumorigenic O
phenotypes O
and O
therefore O
we O
conclude O
that O
the O
H19 B-RNA
gene O
has O
oncogenic O
properties O
in O
breast O
epithelial O
cells O
. O

The O
clinical O
relevance O
of O
this O
observation O
is O
demonstrated O
by O
the O
strong O
association O
between O
XIST B-RNA
RNA O
levels O
and O
disease O
- O
free O
periods O
of O
ovarian B-Disease
cancer I-Disease
patients O
in O
a O
group O
of O
21 O
ovarian B-Disease
cancer I-Disease
cases O
with O
Taxol O
in O
the O
therapeutic O
regiments O
. O

Our O
results O
demonstrate O
that O
full O
- O
length O
SRA B-RNA
- O
RNAs O
likely O
to O
encode O
stable O
proteins O
are O
widely O
expressed O
in O
breast B-Disease
cancer I-Disease
cell O
lines O
. O

LOI O
, O
deregulation O
of O
IGF2 B-RNA
promoters O
, O
and O
the O
altered O
expression O
levels O
of O
IGF2 B-RNA
and O
H19 B-RNA
genes O
might O
be O
associated O
with O
the O
progression O
of O
GTD B-Disease
. O

Reduced O
expression O
of O
H19 B-RNA
in O
bone O
marrow O
cells O
from O
chronic B-Disease
myeloproliferative I-Disease
disorders I-Disease
. O

Tmevpg1 O
( O
IFNG B-RNA
- I-RNA
AS1 I-RNA
) O
is O
another O
lncRNA O
that O
may O
be O
involved O
in O
MS B-Disease
. O

Prostate B-Disease
tumors I-Disease
showed O
a O
66 O
- O
fold O
up O
- O
regulation O
of O
DD3 B-RNA
( O
PCA3 O
) O
( O
median O
158 O
. O
4 O
. O
10 O
( O
5 O
) O
copies O
/ O
microg O
tissue O
RNA O
) O
when O
compared O
to O
benign O
prostate O
tissue O
( O
median O
2 O
. O
4 O
. O
10 O
( O
5 O
) O
copies O
/ O
microg O
tissue O
RNA O
) O
. O

This O
up O
- O
regulation O
was O
found O
in O
more O
than O
95 O
% O
of O
prostate B-Disease
cancer I-Disease
specimens O
studied O
. O

aHIF B-RNA
transcript O
expression O
was O
associated O
with O
poor O
disease O
- O
free O
survival O
in O
univariate O
( O
P O
= O
0 O
. O
38 O
) O
and O
multivariate O
( O
P O
= O
0 O
. O
16 O
) O
analysis O
in O
this O
series O
of O
high O
- O
risk O
primary O
breast B-Disease
carcinomas I-Disease
. O

High O
expression O
of O
precursor O
microRNA B-RNA
- I-RNA
155 I-RNA
/ O
BIC B-RNA
RNA I-RNA
in O
children O
with O
Burkitt B-Disease
lymphoma I-Disease
. O

CASC2 B-RNA
, O
in O
a O
region O
of O
common O
allelic O
loss O
at O
chromosome O
10q26 O
is O
a O
novel O
candidate O
gene O
in O
human O
endometrial B-Disease
cancer I-Disease
. O

As O
a O
result O
, O
we O
identified O
a O
novel O
gene O
, O
designated O
Chromosome O
13 O
open O
reading O
frame O
25 O
( O
C13orf25 B-RNA
) O
, O
which O
was O
overexpressed O
in O
B O
- O
cell O
lymphoma O
cell O
lineand O
diffuse B-Disease
large I-Disease
B I-Disease
- I-Disease
cell I-Disease
lymphoma I-Disease
patients O
with O
13q31 O
- O
q32 O
amplifications O
. O

Reduced O
expression O
of O
the O
let B-RNA
- I-RNA
7 I-RNA
microRNAs O
in O
human O
lung B-Disease
cancers I-Disease
in O
association O
with O
shortened O
postoperative O
survival O
. O

Our O
results O
indicate O
that O
H19 B-RNA
expression O
in O
epithelial O
cells O
of O
endometrial O
hyperplasia O
and O
cancer O
merits O
further O
investigation O
and O
could O
be O
useful O
as O
a O
complementary O
histopathologic O
and O
prognostic O
marker O
among O
other O
modalities O
in O
endometrial B-Disease
cancer I-Disease
. O

We O
here O
report O
that O
BC200 B-RNA
RNA O
is O
expressed O
at O
high O
levels O
in O
invasive B-Disease
carcinomas I-Disease
of I-Disease
the I-Disease
breast I-Disease
. O

Measurement O
of O
lncRNA O
PCA3 B-RNA
in O
patient O
urine O
samples O
has O
been O
shown O
to O
allow O
more O
sensitive O
and O
specific O
diagnosis O
of O
prostate B-Disease
cancer I-Disease
than O
the O
widely O
used O
marker O
prostate O
- O
specific O
antigen O
( O
PSA O
) O
. O

P53 B-RNA
is O
frequently O
mutated O
in O
many O
cancers O
including O
human O
head B-Disease
and I-Disease
neck I-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
and O
pancreatic B-Disease
cancer I-Disease
. O

SNPs O
in O
the O
promoter O
of O
a O
B O
cell O
- O
specific O
antisense O
transcript O
, O
SAS B-RNA
- I-RNA
ZFAT I-RNA
( O
ZFAT O
- O
AS1 O
) O
, O
determine O
susceptibility O
to O
autoimmune B-Disease
thyroid I-Disease
disease I-Disease
. O

DISC2 B-RNA
is O
a O
likely O
susceptibility O
locus O
for O
both O
schizophrenia B-Disease
and O
affective B-Disease
disorders I-Disease
. O

Thus O
, O
miR B-RNA
- I-RNA
375 I-RNA
is O
a O
regulator O
of O
insulin O
secretion O
and O
may O
thereby O
constitute O
a O
novel O
pharmacological O
target O
for O
the O
treatment O
of O
diabetes B-Disease
. O

The O
human O
H19 B-RNA
gene O
is O
frequently O
overexpressed O
in O
myometrium O
and O
stroma O
during O
pathological B-Disease
endometrial I-Disease
proliferative I-Disease
events O
. O

miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
are O
expressed O
at O
lower O
levels O
in O
pituitary B-Disease
adenomas I-Disease
as O
compared O
to O
normal O
pituitary O
tissue O
. O

miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
down O
- O
regulation O
in O
pituitary B-Disease
adenomas I-Disease
. O

G72 B-RNA
/ O
G30 B-RNA
( O
DAOA O
- O
AS1 O
) O
are O
important O
candidate O
genes O
for O
explaining O
schizophrenia B-Disease
in O
the O
Han O
Chinese O
population O
. O

We O
found O
that O
imbalances O
in O
levels O
of O
IGF2 B-RNA
and O
H19 B-RNA
transcripts O
were O
correlated O
with O
advanced O
tumor O
stage O
and O
poor O
outcome O
in O
HCC B-Disease
patients O
. O

Clinical O
isolates O
of O
several O
types O
of O
B B-Disease
cell I-Disease
lymphomas I-Disease
, O
including O
diffuse O
large O
B O
cell O
lymphoma O
( O
DLBCL O
) O
, O
have O
10 O
- O
to O
30 O
- O
fold O
higher O
copy O
numbers O
of O
miR B-RNA
- I-RNA
155 I-RNA
than O
do O
normal O
circulating O
b O
cells O
. O

We O
show O
that O
the O
microRNA O
miR B-RNA
- I-RNA
155 I-RNA
can O
be O
processed O
from O
sequences O
present O
in O
BIC B-RNA
RNA O
, O
a O
spliced O
and O
polyadenylated O
but O
non O
- O
protein O
- O
coding O
RNA O
that O
accumulates O
in O
lymphoma B-Disease
cells O
. O

PRINS B-RNA
is O
a O
psoriasis B-Disease
susceptibility O
- O
related O
noncoding O
RNA O
gene O
. O

Down O
- O
regulation O
of O
7SL B-RNA
RNA O
expression O
and O
impairment O
of O
vesicular O
protein O
transport O
pathways O
by O
Leishmania B-Disease
infection I-Disease
of I-Disease
macrophages I-Disease
. O

This O
clearly O
supports O
the O
H19 B-RNA
oncogenic O
function O
in O
breast B-Disease
tumor I-Disease
genesis O
. O

BIC B-RNA
and O
miR B-RNA
- I-RNA
155 I-RNA
are O
highly O
expressed O
in O
Hodgkin B-Disease
, O
primary B-Disease
mediastinal I-Disease
and O
diffuse B-Disease
large I-Disease
B I-Disease
cell I-Disease
lymphomas I-Disease
. O

In O
animal O
models O
, O
deregulation O
of O
the O
DSCR1 B-RNA
and O
DYRK1A B-RNA
genes O
act O
synergistically O
to O
prevent O
nuclear O
occupancy O
of O
NFATc O
transcription O
factors O
leading O
to O
reduced O
NFATc O
activity O
and O
to O
many O
features O
of O
DS B-Disease
, O
suggesting O
a O
potential O
link O
between O
NRON B-RNA
activity O
and O
DS B-Disease
pathophysiology O
. O

The O
presence O
of O
both O
coding O
SRA B-RNA
rna O
and O
its O
corresponding O
srap O
modifies O
the O
activity O
of O
estrogen O
receptor O
in O
breast B-Disease
cancer I-Disease
cells O
and O
that O
SRAP O
could O
be O
a O
new O
clinical O
marker O
for O
breast B-Disease
cancer I-Disease
. O

Lack O
of O
BIC B-RNA
and O
microRNA O
miR B-RNA
- I-RNA
155 I-RNA
expression O
in O
primary O
cases O
of O
Burkitt B-Disease
lymphoma I-Disease
. O

Both O
miR B-RNA
- I-RNA
18 I-RNA
and O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
3p I-RNA
showed O
overexpression O
with O
patterns O
quite O
similar O
to O
those O
of O
miR B-RNA
- I-RNA
20 I-RNA
and O
miR B-RNA
- I-RNA
19a I-RNA
, O
indicating O
overexpression O
of O
the O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
in O
lung B-Disease
cancer I-Disease
cell O
lines O

We O
detected O
the O
metastasis O
- O
associated O
lung O
adenocarcinoma O
transcript O
1 O
( O
MALAT B-RNA
- I-RNA
1 I-RNA
) O
gene O
as O
one O
of O
the O
major O
genes O
upregulated O
in O
ESS B-Disease
. O

The O
results O
of O
this O
study O
indicate O
potential O
utility O
of O
the O
hTERT B-RNA
mRNA O
and O
DD3 B-RNA
mRNA O
as O
diagnostic O
but O
not O
prognostic O
biomarkers O
for O
PCa B-Disease
. O

A O
genetic O
screen O
implicates O
miRNA B-RNA
- I-RNA
372 I-RNA
and O
miRNA B-RNA
- I-RNA
373 I-RNA
as O
oncogenes O
in O
testicular B-Disease
germ I-Disease
cell I-Disease
tumors I-Disease
. O

MiR O
- O
21 O
, O
miR B-RNA
- I-RNA
141 I-RNA
, O
and O
miR B-RNA
- I-RNA
200b I-RNA
were O
highly O
over O
- O
expressed O
in O
malignant B-Disease
cholangiocytes I-Disease
. O

Involvement O
of O
microRNA B-RNA
- I-RNA
451 I-RNA
in O
resistance O
of O
the O
MCF O
- O
7 O
breast B-Disease
cancer I-Disease
cells O
to O
chemotherapeutic O
drug O
doxorubicin O
. O

miR B-RNA
- I-RNA
181 I-RNA
expression O
is O
decreased O
inTPA O
- O
induced O
differentiation O
of O
human O
promyelocytic B-Disease
leukemia I-Disease
cells O
. O

The O
analysis O
by O
several O
bioinformatics O
algorithms O
of O
colorectal B-Disease
tumours I-Disease
and O
adjacent O
non O
- O
neoplastic O
tissues O
from O
patients O
and O
colorectal O
cancer O
cell O
lines O
allowed O
identifying O
a O
group O
of O
13 O
miRNA O
whose O
expression O
is O
significantly O
altered O
in O
this O
tumor O
. O

The O
most O
significantly O
deregulated O
miRNA O
being O
miR B-RNA
- I-RNA
31 I-RNA
, O
miR B-RNA
- I-RNA
96 I-RNA
, O
miR B-RNA
- I-RNA
133b I-RNA
, O
miR B-RNA
- I-RNA
135b I-RNA
, O
miR B-RNA
- I-RNA
145 I-RNA
, O
and O
miR B-RNA
- I-RNA
183 I-RNA
. O

UCA1 B-RNA
is O
a O
very O
sensitive O
and O
specific O
unique O
marker O
for O
bladder B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
204 I-RNA
is O
primarily O
expressed O
in O
insulinomas B-Disease
and O
correlates O
with O
immunohistochemical O
expression O
of O
insulin O
. O

Later O
on O
, O
deletion O
of O
mir B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
and O
mir B-RNA
- I-RNA
15a I-RNA
deletion O
were O
also O
identified O
in O
epithelial O
tumors O
, O
such O
as O
pituitary B-Disease
adenomas I-Disease
, O
ovarian O
and O
breast B-Disease
cancer I-Disease
. O

mir B-RNA
- I-RNA
21 I-RNA
upregulated O
in O
glioblastoma B-Disease
and O
associated O
with O
antiapoptosis O
upregulated O
in O
breast B-Disease
cancer I-Disease
( O
Iorio O
et O
al O
. O
, O
2005 O
) O
, O
and O
in O
a O
signature O
for O
solid O
cancers O
( O
Volinia O
et O
al O
. O
, O
2006 O
) O
. O

Upregulated O
mir O
- O
221 O
/ O
222 O
in O
papillary B-Disease
thyroid I-Disease
cancer I-Disease

These O
data O
demonstrate O
that O
OncomiR B-RNA
- I-RNA
1 I-RNA
accelerates O
lymphoma B-Disease
and O
promotes O
a O
more O
disseminated O
disease O
. O

miR B-RNA
- I-RNA
23a I-RNA
, O
miR B-RNA
- I-RNA
23b I-RNA
, O
miR B-RNA
- I-RNA
24 I-RNA
, O
miR B-RNA
- I-RNA
195 I-RNA
, O
and O
miR B-RNA
- I-RNA
214 I-RNA
, O
all O
of O
which O
were O
up O
- O
regulated O
during O
cardiac B-Disease
hypertrophy I-Disease
, O
appeared O
to O
be O
capable O
of O
inducing O
hypertrophic O
growth O
in O
vitro O
. O

We O
recently O
demonstrated O
that O
a O
polycistronic O
cluster O
of O
miRNAs O
, O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
, O
is O
oncogenic O
in O
a O
mouse O
model O
for O
Burkitt B-Disease
' I-Disease
s I-Disease
lymphoma I-Disease
. O

This O
region O
encodes O
miRNA B-RNA
- I-RNA
199a I-RNA
- I-RNA
1 I-RNA
( O
19p13 O
. O
2 O
) O
, O
whose O
expression O
levels O
are O
lower O
in O
HCC B-Disease
compared O
to O
nontumor O
liver O
[ O
59 O
] O
and O
is O
deleted O
in O
several O
other O
tumor O
types O
. O

P53 B-RNA
variant O
mrnas O
are O
expressed O
in O
both O
normal O
oral O
stratified O
epithelium O
and O
SCCHN B-Disease
. O

Nevertheless O
, O
these O
results O
demonstrate O
a O
highly O
specific O
up O
- O
regulation O
of O
HULC B-RNA
RNA O
expression O
levels O
in O
HCC B-Disease

MicroRNA B-RNA
- I-RNA
34a I-RNA
functions O
as O
a O
potential O
tumor O
suppressor O
by O
inducing O
apoptosis O
in O
neuroblastoma B-Disease
cells O
. O

The O
micro O
- O
ribonucleic O
acid O
( O
miRNA O
) O
miR B-RNA
- I-RNA
206 I-RNA
targets O
the O
human O
estrogen O
receptor O
- O
alpha O
( O
ERalpha O
) O
and O
represses O
ERalpha O
messenger O
RNA O
and O
protein O
expression O
in O
breast B-Disease
cancer I-Disease
cell O
lines O
. O

Both O
approaches O
show O
that O
miR B-RNA
- I-RNA
21 I-RNA
and O
miR B-RNA
- I-RNA
155 I-RNA
are O
dramatically O
overexpressed O
in O
patients O
with O
CLL B-Disease
, O
although O
the O
corresponding O
genomic O
loci O
are O
not O
amplified O
. O

miR B-RNA
- I-RNA
150 I-RNA
and O
miR B-RNA
- I-RNA
92 I-RNA
are O
also O
significantly O
deregulated O
in O
patients O
with O
CLL B-Disease
. O

Human O
miR B-RNA
- I-RNA
127 I-RNA
is O
embedded O
in O
a O
CpG O
island O
and O
is O
silenced O
in O
several O
human O
cancers O
including O
bladder O
, O
prostate O
and O
colon B-Disease
cancer I-Disease
and O
has O
been O
suggested O
to O
play O
a O
role O
as O
a O
possible O
tumour O
suppressor O
gene O
. O

These O
include O
miR B-RNA
- I-RNA
200b I-RNA
and O
miR B-RNA
- I-RNA
141 I-RNA
which O
have O
been O
shown O
to O
be O
highly O
overexpressed O
in O
malignant O
cholangiocytes O
and O
in O
colon B-Disease
carcinoma I-Disease
. O

The O
high O
specificity O
and O
informative O
rate O
suggest O
that O
the O
PCA3 B-RNA
assay O
could O
have O
an O
important O
role O
in O
prostate B-Disease
cancer I-Disease
diagnosis O
. O

Identification O
of O
PVT1 B-RNA
( O
rs2720709 O
, O
A O
> O
G O
) O
as O
a O
candidate O
gene O
for O
end B-Disease
- I-Disease
stage I-Disease
renal I-Disease
disease I-Disease
in O
type O
2 O
diabetes O
using O
a O
pooling O
- O
based O
genome O
- O
wide O
single O
nucleotide O
polymorphism O
association O
study O
. O

These O
data O
strongly O
indicate O
that O
miR B-RNA
- I-RNA
1 I-RNA
is O
an O
arrhythmogenic B-Disease
or O
proarrhythmic O
factor O
that O
is O
detrimental O
to O
the O
ischemic O
heart O
. O

Delivery O
of O
miR B-RNA
- I-RNA
1 I-RNA
into O
healthy O
hearts O
was O
also O
arrhythmogenic B-Disease
. O

The O
mir B-RNA
- I-RNA
17 I-RNA
cluster O
is O
also O
overexpressed O
in O
human O
lung B-Disease
cancer I-Disease
. O

A O
mutation O
in O
the O
3 O
' O
UTR O
of O
the O
SLITRK1 B-RNA
gene O
which O
is O
associated O
with O
Tourette B-Disease
' I-Disease
s I-Disease
syndrome I-Disease
was O
found O
to O
enhance O
repression O
of O
the O
SLITRK O
mRNA O
by O
miR B-RNA
- I-RNA
189 I-RNA
, O
presumably O
preventing O
SLITRK1 B-RNA
' O
s O
promotion O
of O
dendritic O
growth O
. O

DLBCL O
cases O
over O
- O
expressed O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
155 I-RNA
and O
miR B-RNA
- I-RNA
221 I-RNA
by O
an O
average O
of O
9 O
. O
3 O
, O
4 O
. O
6 O
and O
2 O
. O
3 O
- O
fold O
respectively O
compared O
to O
normal O
peripheral O
blood O
B O
cells O
. O

Ectopically O
raising O
miR B-RNA
- I-RNA
21 I-RNA
expression O
in O
myeloma B-Disease
cells O
in O
the O
absence O
of O
IL O
- O
6 O
significantly O
reduced O
their O
apoptosis O
levels O
. O

PVT1 B-RNA
is O
frequently O
involved O
in O
the O
translocations O
occurring O
in O
variant O
Burkitt B-Disease
' I-Disease
s I-Disease
lymphomas I-Disease
and O
murine O
plasmacytomas B-Disease
. O

miR B-RNA
- I-RNA
124 I-RNA
and O
miR B-RNA
- I-RNA
137 I-RNA
inhibit O
proliferation O
of O
glioblastoma B-Disease
multiforme I-Disease
cells O
and O
induce O
differentiation O
of O
brain O
tumor O
stem O
cells O
. O

Modulating O
miR B-RNA
- I-RNA
21 I-RNA
expression O
via O
antisense O
- O
mediated O
depletion O
( O
knockdown O
) O
had O
a O
significant O
negative O
effect O
on O
cardiomyocyte B-Disease
hypertrophy I-Disease
. O

The O
loss O
- O
of O
- O
function O
of O
miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
in O
CLL B-Disease
, O
and O
perhaps O
other O
cancers O
as O
well O
, O
may O
contribute O
to O
malignant O
transformation O
by O
upregulating O
Bcl2 O
thereby O
preventing O
apoptosis O
. O

MiR B-RNA
- I-RNA
21 I-RNA
is O
found O
to O
be O
highly O
expressed O
in O
numerous O
cancers O
like O
breast B-Disease
cancer I-Disease
, O
and O
glioblastoma B-Disease
and O
pancreatic B-Disease
cancer I-Disease
. O

Recently O
Meng O
et O
al O
. O
showed O
that O
miR B-RNA
- I-RNA
21 I-RNA
is O
also O
overexpressed O
in O
malignant B-Disease
cholangiocarcinomas I-Disease
, O
a O
highly O
chemoresistant O
cancer O
type O
, O
knockdown O
of O
miR B-RNA
- I-RNA
21 I-RNA
sensitised O
cholangiocarcinoma O
cell O
lines O
for O
treatment O
with O
gemcitabin O
, O
whereas O
transfection O
of O
non O
- O
malignant O
cholangiocytes O
with O
precursor O
miR B-RNA
- I-RNA
21 I-RNA
made O
cells O
more O
resistant O
to O
gemcitabin O
. O

Characterized O
mechanism O
of O
alpha O
- O
mangostin O
- O
induced O
cell O
death O
: O
caspase O
- O
independent O
apoptosis O
with O
release O
of O
endonuclease O
- O
G O
from O
mitochondria O
and O
increased O
miR B-RNA
- I-RNA
143 I-RNA
expression O
in O
human O
colorectal B-Disease
cancer I-Disease
DLD O
- O
1 O
cells O
. O

BC200 B-RNA
RNA O
was O
significantly O
up O
- O
regulated O
in O
AD B-Disease
brains O
, O
in O
comparison O
with O
age O
- O
matched O
normal O
brains O
. O

miR B-RNA
- I-RNA
221 I-RNA
and O
miR B-RNA
- I-RNA
222 I-RNA
expression O
affects O
the O
proliferation O
potential O
of O
human O
prostate B-Disease
carcinoma I-Disease
cell O
lines O
by O
targeting O
p27Kip1 B-RNA
. O

The O
c13orf25 B-RNA
/ O
miR B-RNA
- I-RNA
17 I-RNA
cluster O
, O
which O
is O
responsible O
for O
13q31 O
- O
q32 O
amplification O
in O
malignant B-Disease
lymphoma I-Disease
, O
contains O
the O
microRNA O
- O
17 O
- O
18 O
- O
19 O
- O
20 O
- O
92 O
polycistron O
. O

MicroRNA B-RNA
- I-RNA
497 I-RNA
is O
a O
potential O
prognostic O
marker O
in O
human O
cervical B-Disease
cancer I-Disease
and O
functions O
as O
a O
tumor O
suppressor O
by O
targeting O
the O
insulin O
- O
like O
growth O
factor O
1 O
receptor O

miR B-RNA
- I-RNA
21 I-RNA
was O
significantly O
up O
- O
regulated O
both O
psoriasis B-Disease
( O
p O
< O
0 O
. O
1 O
) O
and O
atopic B-Disease
eczema I-Disease
( O
p O
< O
0 O
. O
1 O
) O
as O
compared O
with O
healthy O
skin O
. O

Interestingly O
, O
high O
levels O
of O
miR B-RNA
- I-RNA
221 I-RNA
& I-RNA
222 I-RNA
appear O
in O
glioblastomas B-Disease
and O
correlate O
with O
low O
levels O
of O
p27 O
( O
Kip1 O
) O
protein O
. O

Overexpression O
of O
micro O
ribonucleic O
acid O
29 O
, O
highly O
up O
- O
regulated O
in O
diabetic B-Disease
rats O
, O
leads O
to O
insulin O
resistance O
in O
3T3 O
- O
L1 O
adipocytes O
. O

Since O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
155 I-RNA
is O
on O
chromosome O
21 O
, O
we O
hypothesize O
that O
the O
observed O
lower B-Disease
blood I-Disease
pressure I-Disease
in O
trisomy O
21 O
is O
partially O
caused O
by O
the O
overexpression O
of O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
155 I-RNA
leading O
to O
allele O
- O
specific O
underexpression O
of O
AGTR1 B-RNA
. O

The O
published O
literature O
dealing O
with O
these O
two O
faces O
of O
the O
sra B-RNA
gene O
products O
and O
underscores O
the O
relevance O
of O
this O
bifaceted O
system O
to O
breast B-Disease
cancer I-Disease
development O
. O

Regulation O
of O
p27Kip1 B-RNA
by O
miRNA B-RNA
221 I-RNA
/ O
222 O
in O
glioblastoma B-Disease
. O

Hypoxia O
upregulates O
the O
level O
of O
H19 B-RNA
RNA O
. O

Ablations O
of O
tumorigenicity O
of O
HCC B-Disease
and O
bladder B-Disease
carcinomas I-Disease
in O
vivo O
are O
seen O
by O
H19 B-RNA
knockdown O
which O
also O
significantly O
abrogates O
anchorage O
- O
independent O
growth O
after O
hypoxia O
recovery O
, O
while O
ectopic O
H19 B-RNA
expression O
enhances O
tumorigenic O
potential O
of O
carcinoma O
cells O
in O
vivo O
. O

These O
results O
suggest O
an O
active O
role O
for O
miR B-RNA
- I-RNA
133 I-RNA
in O
the O
inhibition O
of O
cardiac B-Disease
hypertrophy I-Disease
. O

These O
data O
strongly O
indicate O
that O
miR B-RNA
- I-RNA
1 I-RNA
is O
an O
arrhythmogenic B-Disease
or O
proarrhythmic O
factor O
that O
is O
detrimental O
to O
the O
ischemic O
heart O
. O

Delivery O
of O
miR B-RNA
- I-RNA
1 I-RNA
into O
healthy O
hearts O
was O
also O
arrhythmogenic B-Disease
. O

Importantly O
, O
miR B-RNA
- I-RNA
34b I-RNA
and O
miR B-RNA
- I-RNA
34c I-RNA
cooperate O
in O
suppressing O
proliferation O
and O
soft O
- O
agar O
colony O
formation O
of O
neoplastic B-Disease
epithelial I-Disease
ovarian I-Disease
cells O
, O
in O
agreement O
with O
the O
partially O
overlapping O
spectrum O
of O
their O
predicted O
targets O
. O

Human O
micro O
- O
RNAs O
miR B-RNA
- I-RNA
223 I-RNA
, O
miR B-RNA
- I-RNA
26b I-RNA
, O
miR B-RNA
- I-RNA
221 I-RNA
, O
miR B-RNA
- I-RNA
103 I-RNA
- I-RNA
1 I-RNA
, O
miR B-RNA
- I-RNA
185 I-RNA
, O
miR B-RNA
- I-RNA
23b I-RNA
, O
miR B-RNA
- I-RNA
203 I-RNA
, O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
, O
miR B-RNA
- I-RNA
23a I-RNA
, O
and O
miR B-RNA
- I-RNA
205 I-RNA
were O
significantly O
up O
- O
regulated O
in O
bladder O
cancers O
( O
P O
< O
0 O
. O
5 O
) O
compared O
to O
normal O
bladder O
mucosa O
. O

Micro B-RNA
RNA I-RNA
145 I-RNA
targets O
the O
insulin O
receptor O
substrate O
- O
1 O
and O
inhibits O
the O
growth O
of O
colon B-Disease
cancer I-Disease
cells O
. O

Previously O
, O
we O
identified O
HLA B-RNA
- I-RNA
G I-RNA
as O
an O
asthma B-Disease
- O
susceptibility O
gene O
and O
discovered O
that O
the O
risk O
of O
asthma B-Disease
in O
a O
child O
was O
determined O
by O
both O
the O
child O
' O
s O
HLA B-RNA
- I-RNA
G I-RNA
genotype O
and O
the O
mother O
' O
s O
affection O
status O
. O

The O
activity O
of O
pluc O
- O
HLAG O
- O
G O
in O
the O
presence O
of O
each O
of O
the O
three O
miRNAs O
was O
significantly O
lower O
than O
those O
of O
pluc O
- O
HLAG O
- O
C O
and O
pluc O
- O
HLA B-RNA
- I-RNA
G I-RNA
- O
Del O
. O

Tumor O
- O
suppressive O
miR B-RNA
- I-RNA
34a I-RNA
induces O
senescence O
- O
like O
growth O
arrest O
through O
modulation O
of O
the O
E2F O
pathway O
in O
human O
colon B-Disease
cancer I-Disease
cells O
. O

mir O
- O
29 O
family O
( O
29a O
, O
b O
, O
c O
) O
reverts O
aberrant O
methylation O
in O
lung B-Disease
cancer I-Disease
by O
targeting O
DNA O
methyltransferases O
3A O
and O
3B O
. O

down O
- O
regulated O
of O
microRNAs B-RNA
- I-RNA
143 I-RNA
and O
- O
145 O
in O
B B-Disease
- I-Disease
cell I-Disease
malignancies I-Disease
. O

Tumour O
invasion O
and O
metastasis O
initiated O
by O
microRNA B-RNA
- I-RNA
10b I-RNA
in O
breast B-Disease
cancer I-Disease
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
knockdown O
disrupts O
glioma O
growth O
in O
vivo O
and O
displays O
synergistic O
cytotoxicity O
with O
neural O
precursor O
cell O
delivered O
S O
- O
TRAIL O
in O
human O
gliomas B-Disease
. O

Our O
results O
reveal O
the O
efficacy O
of O
miR B-RNA
- I-RNA
21 I-RNA
antagonism O
in O
murine O
glioma B-Disease
models O
and O
implicate O
miR B-RNA
- I-RNA
21 I-RNA
as O
a O
target O
for O
therapeutic O
intervention O
. O

Tumor O
protein O
53 O
- O
induced O
nuclear O
protein O
1 O
expression O
is O
repressed O
by O
miR B-RNA
- I-RNA
155 I-RNA
, O
and O
its O
restoration O
inhibits O
pancreatic B-Disease
tumor I-Disease
development O
. O

The O
disruption O
of O
the O
DISC O
genomic O
locus O
, O
which O
encodes O
both O
the O
DISC1 B-RNA
protein O
- O
coding O
gene O
and O
the O
DISC2 B-RNA
lncRNA O
, O
has O
been O
linked O
in O
a O
number O
of O
genetic O
analysis O
to O
the O
risk O
of O
developing O
schizophrenia B-Disease
, O
schizophrenia B-Disease
, O
bipolar B-Disease
disorder I-Disease
, O
major B-Disease
depression I-Disease
, O
and O
autistic B-Disease
spectrum I-Disease
disorders I-Disease
. O

In O
most O
Wilms B-Disease
' I-Disease
tumors I-Disease
, O
all O
WT1 B-RNA
- I-RNA
AS I-RNA
spliceoforms O
were O
overexpressed O
relative O
to O
normal O
kidney O
and O
at O
comparable O
levels O
to O
fetal O
kidney O
. O

MicroRNA O
let B-RNA
- I-RNA
7a I-RNA
down O
- O
regulates O
MYC B-RNA
and O
reverts O
MYC B-RNA
- O
induced O
growth O
in O
Burkitt B-Disease
lymphoma I-Disease
cells O
. O

MYCN B-RNA
regulates O
oncogenic O
MicroRNAs O
in O
neuroblastoma B-Disease
. O

Detection O
of O
let B-RNA
- I-RNA
7a I-RNA
microRNA O
by O
real O
- O
time O
PCR O
in O
colorectal B-Disease
cancer I-Disease
: O
a O
single O
- O
centre O
experience O
from O
China O
. O

The O
overexpression O
of O
miR B-RNA
- I-RNA
21 I-RNA
was O
recognized O
in O
malignant B-Disease
brain I-Disease
tumours I-Disease
, O
and O
knockdown O
of O
this O
miRNA O
in O
cultured O
glioblastoma O
cells O
resulted O
in O
caspase O
activation O
and O
apoptosis O
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
( O
miR O
- O
21 O
) O
post O
- O
transcriptionally O
downregulates O
tumor O
suppressor O
Pdcd4 B-RNA
and O
stimulates O
invasion O
, O
intravasation O
and O
metastasis O
in O
colorectal B-Disease
cancer I-Disease
. O

spine O
morphology O
in O
patients O
with O
Fragile B-Disease
- I-Disease
X I-Disease
mental I-Disease
retardation I-Disease
syndrome I-Disease
( O
FXS O
) O
is O
not O
dissimilar O
from O
the O
spine O
structure O
observed O
on O
miR B-RNA
- I-RNA
134 I-RNA
overexpression O
or O
in O
neurons O
deficient O
for O
the O
miR B-RNA
- I-RNA
134 I-RNA
target O
Limk1 O
. O

We O
also O
show O
that O
LAMB3 B-RNA
expression O
is O
increased O
in O
the O
presence O
of O
the O
HPV B-RNA
- I-RNA
16 I-RNA
E6 O
oncogene O
and O
this O
effect O
is O
mediated O
through O
miR B-RNA
- I-RNA
218 I-RNA
. O

These O
findings O
may O
contribute O
to O
a O
better O
understanding O
of O
the O
molecular O
mechanisms O
involved O
in O
cervical B-Disease
carcinogenesis I-Disease
. O

The O
oncogenic O
microRNA B-RNA
- I-RNA
27a I-RNA
targets O
genes O
that O
regulate O
specificity O
protein O
transcription O
factors O
and O
the O
G2 O
- O
M O
checkpoint O
in O
MDA O
- O
MB O
- O
231 O
breast B-Disease
cancer I-Disease
cells O
. O

An O
androgen O
- O
regulated O
miRNA O
suppresses O
Bak1 B-RNA
expression O
and O
induces O
androgen O
- O
independent O
growth O
of O
prostate B-Disease
cancer I-Disease
cells O
. O

Among O
them O
, O
miR B-RNA
- I-RNA
128a I-RNA
and O
- O
128b O
are O
significantly O
overexpressed O
, O
whereas O
let O
- O
7b O
and O
miR O
- O
223 O
are O
significantly O
down O
- O
regulated O
in O
ALL B-Disease
compared O
with O
AML O
. O

Among O
them O
, O
miR O
- O
128a O
and O
- O
128b O
are O
significantly O
overexpressed O
, O
whereas O
let B-RNA
- I-RNA
7b I-RNA
and O
miR B-RNA
- I-RNA
223 I-RNA
are O
significantly O
down O
- O
regulated O
in O
ALL B-Disease
compared O
with O
AML O
. O

mir O
- O
29a O
, O
mir O
- O
124a O
, O
mir B-RNA
- I-RNA
132 I-RNA
and O
mir O
- O
330 O
could O
be O
detected O
, O
Comparison O
of O
human O
WT O
and O
HD B-Disease
individuals O
shows O
that O
significant O
differences O
in O
miRNA O
levels O
exist O
: O
mir B-RNA
- I-RNA
132 I-RNA
levels O
were O
significantly O
lower O
in O
the O
HD B-Disease
samples O
, O
indicating O
that O
this O
miRNA O
is O
down O
- O
regulated O
in O
HD B-Disease
. O

In O
contrast O
, O
mir B-RNA
- I-RNA
29a I-RNA
and O
mir B-RNA
- I-RNA
330 I-RNA
were O
significantly O
higher O
in O
HD B-Disease
samples O
. O

Loss O
of O
mir B-RNA
- I-RNA
146a I-RNA
function O
in O
hormone B-Disease
- I-Disease
refractory I-Disease
prostate I-Disease
cancer I-Disease
. O

Ectopic O
expression O
of O
miR B-RNA
- I-RNA
126 I-RNA
* I-RNA
, O
an O
intronic O
product O
of O
the O
vascular O
endothelial O
EGF O
- O
like O
7 O
gene O
, O
regulates O
prostein O
translation O
and O
invasiveness O
of O
prostate B-Disease
cancer I-Disease
LNCaP O
cells O
. O

Altered O
expression O
of O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
31 I-RNA
, O
miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
is O
related O
to O
clinicopathologic O
features O
of O
colorectal B-Disease
cancer I-Disease
. O

Here O
, O
we O
show O
that O
several O
miRNAs O
are O
altered O
in O
human O
ovarian B-Disease
cancer I-Disease
, O
with O
the O
most O
significantly O
deregulated O
miRNAs O
being O
miR B-RNA
- I-RNA
214 I-RNA
, O
miR B-RNA
- I-RNA
199a I-RNA
* I-RNA
, O
miR B-RNA
- I-RNA
200a I-RNA
, O
miR B-RNA
- I-RNA
100 I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
, O
and O
let B-RNA
- I-RNA
7 I-RNA
cluster O
. O

down O
- O
regulated O
of O
miR B-RNA
- I-RNA
138 I-RNA
is O
associated O
with O
overexpression O
of O
human O
telomerase O
reverse O
transcriptase O
protein O
in O
human B-Disease
anaplastic I-Disease
thyroid I-Disease
carcinoma I-Disease
cell O
lines O
. O

The O
expression O
of O
microRNA O
miR B-RNA
- I-RNA
107 I-RNA
decreases O
early O
in O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
and O
may O
accelerate O
disease O
progression O
through O
regulation O
of O
beta O
- O
site O
amyloid O
precursor O
protein O
- O
cleaving O
enzyme O
1 O
. O

Variation O
in O
the O
miRNA B-RNA
- I-RNA
433 I-RNA
binding O
site O
of O
FGF20 B-RNA
confers O
risk O
for O
Parkinson B-Disease
disease I-Disease
by O
overexpression O
of O
alpha O
- O
synuclein O
. O

Of O
these O
, O
miR O
rno B-RNA
- I-RNA
mir I-RNA
- I-RNA
290 I-RNA
, O
rno B-RNA
- I-RNA
mir I-RNA
- I-RNA
292 I-RNA
, O
rno B-RNA
- I-RNA
mir I-RNA
- I-RNA
5p I-RNA
, O
rno B-RNA
- I-RNA
mir I-RNA
- I-RNA
327 I-RNA
, O
and O
rno B-RNA
- I-RNA
mir I-RNA
- I-RNA
494 I-RNA
were O
identified O
as O
the O
highly O
expressed O
miRNAs O
in O
the O
ischemic B-Disease
brain I-Disease
. O

Epigenetic O
silencing O
of O
the O
intronic O
microRNA O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
342 I-RNA
and O
its O
host O
gene O
EVL O
in O
colorectal B-Disease
cancer I-Disease
. O

hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
210 I-RNA
Is O
induced O
by O
hypoxia O
and O
is O
an O
independent O
prognostic O
factor O
in O
breast B-Disease
cancer I-Disease
. O

MicroRNA B-RNA
- I-RNA
137 I-RNA
targets O
microphthalmia O
- O
associated O
transcription O
factor O
in O
melanoma B-Disease
cell O
lines O
. O

Profiling O
microRNA O
expression O
in O
hepatocellular B-Disease
carcinoma I-Disease
reveals O
microRNA B-RNA
- I-RNA
224 I-RNA
up O
- O
regulation O
and O
apoptosis O
inhibitor O
- O
5 O
as O
a O
microRNA B-RNA
- I-RNA
224 I-RNA
- O
specific O
target O
. O

MicroRNA O
let B-RNA
- I-RNA
7b I-RNA
targets O
important O
cell O
cycle O
molecules O
in O
malignant O
melanoma B-Disease
cells O
and O
interferes O
with O
anchorage O
- O
independent O
growth O
. O

This O
study O
provides O
the O
first O
description O
of O
increased O
expression O
of O
miRNA O
miR B-RNA
- I-RNA
155 I-RNA
and O
miR B-RNA
- I-RNA
146a I-RNA
in O
RA B-Disease
. O

MicroRNA B-RNA
29c I-RNA
is O
down O
- O
regulated O
in O
nasopharyngeal O
carcinomas O
, O
up O
- O
regulating O
mRNAs O
encoding O
extracellular O
matrix O
proteins O
. O

We O
confirm O
that O
the O
presence O
of O
the O
ALT O
phenotype O
is O
associated O
with O
poor O
prognosis O
and O
in O
addition O
, O
for O
the O
first O
time O
, O
we O
show O
a O
direct O
association O
between O
hTR B-RNA
expression O
and O
poor O
prognosis O
in O
liposarcoma B-Disease
patients O
. O

Oncogenic O
role O
of O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster I-RNA
in O
anaplastic B-Disease
thyroid I-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
96 I-RNA
was O
overexpressed O
in O
HBV B-Disease
tumors I-Disease
, O
and O
miR O
- O
126 O
* O
was O
down O
- O
regulated O
in O
alcohol O
- O
related O
hepatocellular O
carcinoma O
. O

miR O
- O
96 O
was O
overexpressed O
in O
HBV O
tumors O
, O
and O
miR B-RNA
- I-RNA
126 I-RNA
* I-RNA
was O
down O
- O
regulated O
in O
alcohol B-Disease
- I-Disease
related I-Disease
hepatocellular I-Disease
carcinoma I-Disease
. O

This O
study O
shows O
that O
miR B-RNA
- I-RNA
146 I-RNA
is O
expressed O
in O
RA B-Disease
synovial O
tissue O
and O
that O
its O
expression O
is O
induced O
by O
stimulation O
with O
TNFalpha O
and O
IL O
- O
1beta O
. O

miR B-RNA
- I-RNA
15b I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
modulate O
multidrug O
resistance O
by O
targeting O
BCL2 O
in O
human O
gastric B-Disease
cancer I-Disease
cells O
. O

Overexpression O
of O
miR B-RNA
- I-RNA
184 I-RNA
might O
play O
an O
oncogenic O
role O
in O
the O
antiapoptotic O
and O
proliferative O
processes O
of O
tongue B-Disease
SCC I-Disease
. O

Down O
- O
regulation O
of O
miR B-RNA
- I-RNA
1 I-RNA
/ O
miR B-RNA
- I-RNA
133 I-RNA
contributes O
to O
re O
- O
expression O
of O
pacemaker O
channel O
genes O
HCN2 O
and O
HCN4 O
in O
hypertrophic B-Disease
heart I-Disease
. O

Truncation O
in O
CCND1 B-RNA
mRNA O
alters O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
regulation O
in O
mantle B-Disease
cell I-Disease
lymphoma I-Disease
. O

we O
have O
shown O
that O
miR B-RNA
- I-RNA
203 I-RNA
can O
regulate O
DeltaNp63 O
levels O
upon O
genotoxic O
damage O
in O
head B-Disease
and I-Disease
neck I-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
cells O
, O
thus O
controlling O
cell O
survival O
. O

RT O
- O
PCR O
analysis O
indicated O
that O
UCA1 B-RNA
is O
an O
embryonic O
development O
and O
bladder B-Disease
cancer I-Disease
- O
associated O
RNA O
. O

A O
functional O
screen O
identifies O
miR B-RNA
- I-RNA
34a I-RNA
as O
a O
candidate O
neuroblastoma B-Disease
tumor I-Disease
suppressor O
gene O
. O

Our O
results O
suggest O
that O
miR B-RNA
- I-RNA
34b I-RNA
/ O
c O
and O
BTG4 B-RNA
are O
novel O
tumor O
suppressors O
in O
CRC B-Disease
and O
that O
the O
miR B-RNA
- I-RNA
34b I-RNA
/ O
c O
CpG O
island O
, O
which O
bidirectionally O
regulates O
miR B-RNA
- I-RNA
34b I-RNA
/ O
c O
and O
BTG4 B-RNA
, O
is O
a O
frequent O
target O
of O
epigenetic O
silencing O
in O
CRC B-Disease
. O

Deregulated O
expression O
of O
miR B-RNA
- I-RNA
106a I-RNA
predicts O
survival O
in O
human O
colon B-Disease
cancer I-Disease
patients O
. O

Microinjecting O
fragments O
of O
either O
the O
coding O
region O
or O
the O
related O
microRNA O
miR B-RNA
- I-RNA
1 I-RNA
led O
to O
high O
levels O
of O
expression O
of O
homologous O
RNA O
, O
resulting O
in O
an O
epigenetic O
defect O
, O
cardiac B-Disease
hypertrophy I-Disease
, O
whose O
efficient O
hereditary O
transmission O
correlated O
with O
the O
presence O
of O
miR B-RNA
- I-RNA
1 I-RNA
in O
the O
sperm O
nucleus O
. O

Liver O
- O
specific O
microRNA O
miR B-RNA
- I-RNA
122 I-RNA
enhances O
the O
replication O
of O
hepatitis B-Disease
C I-Disease
virus O
in O
nonhepatic O
cells O
. O

MicroRNA B-RNA
- I-RNA
223 I-RNA
is O
commonly O
reproessed O
in O
hepatocellular B-Disease
carcinoma I-Disease
and O
potentiates O
expression O
of O
Stathmin1 O
. O

In O
leukaemic O
cell O
lines O
PLZF B-RNA
overexpression O
downmodulated O
miR B-RNA
- I-RNA
146a I-RNA
and O
upregulated O
CXCR4 B-RNA
protein O
, O
whereas O
PLZF B-RNA
knockdown O
induced O
the O
opposite O
effects O
. O

MicroRNA B-RNA
21 I-RNA
promotes O
glioma B-Disease
invasion O
by O
targeting O
matrix O
metalloproteinase O
regulators O
. O

MicroRNA B-RNA
- I-RNA
126 I-RNA
inhibits O
invasion O
in O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
carcinoma I-Disease
cell O
lines O
. O

However O
, O
loss O
of O
MEG3 B-RNA
expression O
occurs O
only O
in O
nonfunctioning O
pituitary B-Disease
adenomas I-Disease
of O
a O
gonadotroph O
origin O
. O

miR B-RNA
- I-RNA
135b I-RNA
: O
miR O
- O
135 O
family O
: O
Regulation O
of O
the O
adenomatous B-Disease
polyposis I-Disease
coli O
gene O
. O

And O
the O
most O
promising O
marker O
for O
PCa B-Disease
diagnosis O
was O
positive O
PCA3 B-RNA
detection O
associated O
with O
serum O
PSA O
levels O
. O

We O
also O
discovered O
that O
miR B-RNA
- I-RNA
93 I-RNA
, O
miR B-RNA
- I-RNA
106b I-RNA
, O
and O
miR B-RNA
- I-RNA
375 I-RNA
, O
which O
are O
known O
to O
be O
frequently O
overexpressed O
in O
prostate B-Disease
cancer I-Disease
patients O
, O
cooperatively O
down O
- O
regulate O
CIC O
levels O
to O
promote O
cancer O
progression O
. O

Integrin O
beta O
3 O
expression O
is O
regulated O
by O
let B-RNA
- I-RNA
7a I-RNA
miRNA O
in O
malignant O
melanoma B-Disease
. O

miR B-RNA
- I-RNA
122 I-RNA
targets O
an O
anti O
- O
apoptotic O
gene O
, O
Bcl O
- O
w O
, O
in O
human O
hepatocellular B-Disease
carcinoma I-Disease
cell O
lines O
. O

miR B-RNA
- I-RNA
146a I-RNA
: O
A O
functional O
polymorphism O
( O
rs2910164 O
) O
in O
the O
miR B-RNA
- I-RNA
146a I-RNA
gene O
is O
associated O
with O
the O
risk O
for O
hepatocellular B-Disease
carcinoma I-Disease
. O

Interestingly O
, O
miR B-RNA
- I-RNA
26a I-RNA
was O
also O
found O
to O
be O
deregulated O
in O
primary O
human O
Burkitt B-Disease
lymphoma I-Disease
samples O
, O
thereby O
probably O
being O
of O
clinical O
relevance O
. O

MicroRNA B-RNA
- I-RNA
377 I-RNA
is O
up O
- O
regulated O
and O
can O
lead O
to O
increased O
fibronectin O
production O
in O
diabetic B-Disease
nephropathy I-Disease
. O

miR B-RNA
- I-RNA
217 I-RNA
: O
biomarkers O
improved O
the O
ability O
to O
distinguish O
between O
healthy O
tissue O
, O
PDAC B-Disease
, O
and O
chronic B-Disease
pancreatitis I-Disease
. O

Common O
variation O
in O
the O
miR B-RNA
- I-RNA
659 I-RNA
binding O
- O
site O
of O
GRN O
is O
a O
major O
risk O
factor O
for O
TDP43 O
- O
positive O
frontotemporal B-Disease
dementia I-Disease
. O

Up O
- O
regulation O
of O
micro O
- O
RNA O
- O
221 O
( O
miRNA B-RNA
- I-RNA
221 I-RNA
; O
chr O
Xp11 O
. O
3 O
) O
and O
caspase B-RNA
- I-RNA
3 I-RNA
accompanies O
down O
- O
regulation O
of O
the O
survivin O
- O
1 O
homolog O
BIRC1 O
( O
NAIP O
) O
in O
glioblastoma B-Disease
multiforme I-Disease
( O
GBM O
) O
. O

Megakaryocytic O
Expression O
of O
miRNA B-RNA
10a I-RNA
, O
17 O
- O
5p O
, O
20a O
and O
126 O
in O
Philadelphia B-Disease
Chromosome I-Disease
- I-Disease
Negative I-Disease
Myeloproliferative I-Disease
Neoplasm I-Disease
. O

decreased O
expression O
in O
c B-RNA
- I-RNA
Myc I-RNA
induced O
mouse O
mammary B-Disease
tumors I-Disease
. O

MicroRNA B-RNA
- I-RNA
27a I-RNA
functions O
as O
an O
oncogene O
in O
gastric B-Disease
adenocarcinoma I-Disease
by O
targeting O
prohibitin O
. O

These O
data O
suggest O
that O
miR B-RNA
- I-RNA
155 I-RNA
may O
play O
an O
important O
role O
in O
TGF O
- O
beta O
- O
induced O
EMT O
and O
cell O
migration O
and O
invasion O
by O
targeting O
RhoA O
and O
indicate O
that O
it O
is O
a O
potential O
therapeutic O
target O
for O
breast B-Disease
cancer I-Disease
intervention O
. O

miR B-RNA
- I-RNA
21 I-RNA
plays O
a O
pivotal O
role O
in O
gastric B-Disease
cancer I-Disease
pathogenesis O
and O
progression O
. O

miR B-RNA
- I-RNA
21 I-RNA
/ O
miR B-RNA
- I-RNA
205 I-RNA
expression O
ratio O
that O
has O
the O
ability O
to O
distinguish O
between O
invasive O
and O
noninvasive B-Disease
bladder I-Disease
tumors I-Disease
. O

An O
NF O
- O
kB O
- O
sensitive O
microRNA B-RNA
- I-RNA
146a I-RNA
- O
mediated O
inflammatory O
circuit O
in O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
and O
in O
stressed O
human O
brain O
cells O
. O

These O
results O
indicate O
for O
the O
first O
time O
that O
hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
34b I-RNA
may O
influence O
c O
- O
Myc O
expression O
in O
Burkitt B-Disease
lymphoma I-Disease
as O
the O
more O
common O
aberrant O
control O
exercised O
by O
the O
immunoglobulin O
enhancer O
locus O
. O

tumor O
suppressor O
miR B-RNA
- I-RNA
34 I-RNA
inhibits O
human O
p53 O
- O
mutant O
gastric B-Disease
cancer I-Disease
tumorspheres O
. O

miR B-RNA
- I-RNA
143 I-RNA
: O
Up O
- O
regulated O
expression O
of O
microRNA B-RNA
- I-RNA
143 I-RNA
in O
association O
with O
obesity B-Disease
in O
adipose O
. O

MicroRNA B-RNA
- I-RNA
128 I-RNA
inhibits O
glioma B-Disease
cells O
proliferation O
by O
targeting O
transcription O
factor O
E2F3a O
. O

Taken O
together O
, O
our O
study O
demonstrates O
that O
miR B-RNA
- I-RNA
128 I-RNA
can O
inhibit O
proliferation O
of O
glioma B-Disease
cells O
through O
one O
of O
its O
targets O
, O
E2F3a O
. O

We O
found O
underexpression O
of O
miR B-RNA
- I-RNA
145 I-RNA
( O
2 O
. O
0 O
- O
foldP O
= O
0 O
. O
4 O
) O
, O
miR B-RNA
- I-RNA
21 I-RNA
( O
2 O
. O
4 O
- O
foldP O
= O
0 O
. O
4 O
) O
, O
miR B-RNA
- I-RNA
141 I-RNA
( O
2 O
. O
6 O
- O
foldP O
= O
0 O
. O
2 O
) O
, O
let B-RNA
- I-RNA
7a I-RNA
( O
3 O
. O
3 O
- O
foldP O
= O
0 O
. O
3 O
) O
, O
miR B-RNA
- I-RNA
150 I-RNA
( O
3 O
. O
8 O
- O
foldP O
= O
0 O
. O
4 O
) O
, O
miR B-RNA
- I-RNA
15a I-RNA
( O
4 O
. O
5 O
- O
foldP O
= O
0 O
. O
3 O
) O
, O
miR B-RNA
- I-RNA
16 I-RNA
( O
5 O
. O
0 O
- O
foldP O
= O
0 O
. O
4 O
) O
, O
and O
miR B-RNA
- I-RNA
143 I-RNA
( O
6 O
. O
4 O
- O
foldP O
= O
0 O
. O
4 O
) O
in O
ACTH O
- O
secreting O
pituitary B-Disease
tumors I-Disease
when O
compared O
to O
normal O
pituitary O
tissues O
. O

We O
demonstrated O
by O
quantitative O
RT O
- O
PCR O
an O
active O
XIST B-RNA
RNA O
expression O
in O
blood O
lymphocytes O
from O
Klinefelter B-Disease
patients O
, O
comparable O
to O
that O
observed O
in O
control O
females O
and O
over O
30 O
, O
0 O
- O
fold O
greater O
than O
in O
control O
males O
. O

A O
SNP O
in O
a O
let B-RNA
- I-RNA
7 I-RNA
microRNA O
complementary O
site O
in O
the O
KRAS B-RNA
3 O
' O
untranslated O
region O
increases O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
risk O
. O

The O
miR B-RNA
- I-RNA
15a I-RNA
- O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
cluster O
controls O
prostate B-Disease
cancer I-Disease
by O
targeting O
multiple O
oncogenic O
activities O
. O

High O
miR B-RNA
- I-RNA
21 I-RNA
expression O
in O
breast B-Disease
cancer I-Disease
associated O
with O
poor O
disease O
- O
free O
survival O
in O
early O
stage O
disease O
and O
high O
TGF O
- O
beta1 O
. O

miR B-RNA
- I-RNA
15a I-RNA
: O
MicroRNA15a B-RNA
modulates O
expression O
of O
the O
cell O
- O
cycle O
regulator O
Cdc25A O
and O
affects O
hepatic B-Disease
cystogenesis I-Disease
. O

Glioma B-Disease
cells O
and O
angiogenic O
growth O
factors O
elevate O
the O
level O
of O
miR B-RNA
- I-RNA
296 I-RNA
in O
primary O
human O
brain O
microvascular O
endothelial O
cells O
in O
culture O
. O

In O
particular O
, O
the O
inhibition O
of O
miRNA B-RNA
- I-RNA
221 I-RNA
and O
- O
222 O
, O
which O
are O
abnormally O
expressed O
in O
melanoma B-Disease
and O
favor O
the O
induction O
of O
the O
malignant O
phenotype O
by O
downregulating O
c O
- O
KIT O
receptor O
and O
p27Kip O
, O
might O
in O
the O
future O
represent O
an O
efficient O
treatment O
for O
translation O
into O
the O
clinical O
setting O
. O

miR B-RNA
- I-RNA
34a I-RNA
inhibits O
migration O
and O
invasion O
by O
down O
- O
regulation O
of O
c O
- O
Met O
expression O
in O
human O
hepatocellular B-Disease
carcinoma I-Disease
cells O
. O

A O
microarray O
experiment O
was O
carried O
out O
to O
compare O
glioblastoma O
with O
adjacent O
brain O
. O

Among O
several O
differentially O
expressed O
miRs O
, O
we O
found O
that O
miR B-RNA
- I-RNA
128 I-RNA
was O
strongly O
down O
- O
regulated O
in O
glioblastomas B-Disease
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
down O
- O
regulates O
the O
expression O
of O
tumor O
suppressor O
PDCD4 O
in O
human O
glioblastoma B-Disease
cell O
T98G O
. O

microRNA B-RNA
- I-RNA
122 I-RNA
stimulates O
translation O
of O
hepatitis B-Disease
C I-Disease
virus O
RNA O
. O

MicroRNA B-RNA
- I-RNA
34a I-RNA
inhibits O
uveal O
melanoma B-Disease
cell O
proliferation O
and O
migration O
through O
downregulation O
of O
c O
- O
Met O
. O

Blockage O
of O
miR B-RNA
- I-RNA
205 I-RNA
activity O
with O
an O
antagomir O
or O
via O
ectopic O
expression O
of O
miR O
- O
184 O
could O
be O
novel O
therapeutic O
approaches O
for O
treating O
aggressive O
SCCs B-Disease
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
contributes O
to O
myocardial B-Disease
disease I-Disease
by O
stimulating O
MAP O
kinase O
signalling O
in O
fibroblasts O
. O

Epigenetic O
mutations O
of O
the O
imprinted O
IGF2 B-RNA
- O
H19 B-RNA
domain O
in O
Silver B-Disease
- I-Disease
Russell I-Disease
syndrome I-Disease
. O

Down O
- O
regulation O
of O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
10a I-RNA
in O
chronic B-Disease
myeloid I-Disease
leukemia I-Disease
CD34 O
+ O
cells O
increases O
USF2 O
- O
mediated O
cell O
growth O
. O

Of O
those O
, O
the O
miR B-RNA
- I-RNA
205 I-RNA
, O
miR B-RNA
- I-RNA
449 I-RNA
, O
and O
miR B-RNA
- I-RNA
429 I-RNA
were O
greatly O
enriched O
; O
in O
contrast O
the O
miR O
- O
204 O
, O
miR O
- O
99b O
, O
and O
miR O
- O
193b O
were O
greatly O
downregulated O
in O
adenocarcinoma B-Disease
tissues O
. O

Of O
those O
, O
the O
miR O
- O
205 O
, O
miR O
- O
449 O
, O
and O
miR O
- O
429 O
were O
greatly O
enriched O
; O
in O
contrast O
the O
miR B-RNA
- I-RNA
204 I-RNA
, O
miR B-RNA
- I-RNA
99b I-RNA
, O
and O
miR B-RNA
- I-RNA
193b I-RNA
were O
greatly O
downregulated O
in O
adenocarcinoma B-Disease
tissues O
. O

Specific O
activation O
of O
microRNA106b B-RNA
enables O
the O
p73 O
apoptotic O
response O
in O
chronic B-Disease
lymphocytic I-Disease
leukemia I-Disease
by O
targeting O
the O
ubiquitin O
ligase O
, O
Itch O
for O
degradation O
. O

The O
inhibition O
of O
the O
highly O
expressed O
miR B-RNA
- I-RNA
221 I-RNA
and O
miR B-RNA
- I-RNA
222 I-RNA
impairs O
the O
growth O
of O
prostate B-Disease
carcinoma I-Disease
xenografts O
in O
mice O
. O

MiR B-RNA
- I-RNA
9 I-RNA
and O
miR B-RNA
- I-RNA
9 I-RNA
* I-RNA
, O
which O
decreased O
early O
in O
HD B-Disease
. O

Decreased O
levels O
of O
microRNA O
miR B-RNA
- I-RNA
122 I-RNA
in O
individuals O
with O
hepatitis B-Disease
C I-Disease
responding O
poorly O
to O
interferon O
therapy O
. O

MiRNA O
expression O
in O
urothelial B-Disease
carcinomas I-Disease
: O
Important O
roles O
of O
miR B-RNA
- I-RNA
10a I-RNA
, O
miR B-RNA
- I-RNA
222 I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
, O
miR B-RNA
- I-RNA
7 I-RNA
and O
miR B-RNA
- I-RNA
452 I-RNA
for O
tumor O
stage O
and O
metastasis O
, O
and O
frequent O
homozygous O
losses O
of O
miR B-RNA
- I-RNA
31 I-RNA
. O

These O
data O
strongly O
indicate O
that O
miR B-RNA
- I-RNA
1 I-RNA
is O
an O
arrhythmogenic B-Disease
or O
proarrhythmic O
factor O
that O
is O
detrimental O
to O
the O
ischemic O
heart O
. O

Delivery O
of O
miR B-RNA
- I-RNA
1 I-RNA
into O
healthy O
hearts O
was O
also O
arrhythmogenic B-Disease
. O

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR B-RNA
- I-RNA
101 I-RNA
- I-RNA
1 I-RNA
is O
significantly O
associated O
with O
development O
of O
liver B-Disease
cirrhosis I-Disease
and O
hepatocellular B-Disease
carcinoma I-Disease
occurrence O
. O

MicroRNA B-RNA
- I-RNA
15b I-RNA
regulates O
cell O
cycle O
progression O
by O
targeting O
cyclins O
in O
glioma B-Disease
cells O
. O

Taken O
together O
, O
our O
findings O
indicate O
that O
miR B-RNA
- I-RNA
15b I-RNA
regulates O
cell O
cycle O
progression O
in O
glioma B-Disease
cells O
by O
targeting O
cell O
cycle O
- O
related O
molecules O
. O

MicroRNAs B-RNA
373 I-RNA
and O
520c O
Are O
Downregulated O
in O
Prostate B-Disease
Cancer I-Disease
, O
Suppress O
CD44 O
. O

The O
majority O
of O
miRNAs O
exhibiting O
altered O
expression O
in O
primary O
human O
HNSCC B-Disease
tumors I-Disease
( O
including O
miR B-RNA
- I-RNA
1 I-RNA
, O
miR B-RNA
- I-RNA
133a I-RNA
, O
miR B-RNA
- I-RNA
205 I-RNA
, O
and O
let B-RNA
- I-RNA
7d I-RNA
) O
show O
lower O
expression O
levels O
relative O
to O
normal O
adjacent O
tissue O
. O

In O
contrast O
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
21 I-RNA
is O
frequently O
overexpressed O
in O
human O
HNSCC B-Disease
tumors I-Disease
. O

miR B-RNA
- I-RNA
146 I-RNA
: O
Breast O
cancer O
metastasis O
suppressor O
1 O
up O
- O
regulates O
miR B-RNA
- I-RNA
146 I-RNA
, O
which O
suppresses O
breast B-Disease
cancer I-Disease
metastasis O
. O

Prognostic O
value O
of O
miR B-RNA
- I-RNA
16 I-RNA
expression O
in O
childhood B-Disease
acute I-Disease
lymphoblastic I-Disease
leukemia I-Disease
relationships O
to O
normal O
and O
malignant O
lymphocyte O
proliferation O
. O

High O
levels O
of O
miR B-RNA
- I-RNA
106a I-RNA
were O
associated O
with O
small O
- O
cell O
lung O
cancer O
( O
p O
= O
0 O
. O
31 O
) O
, O
and O
high O
levels O
of O
miR B-RNA
- I-RNA
19a I-RNA
with O
advanced O
NSCLC B-Disease
( O
p O
= O
0 O
. O
8 O
) O
. O

upregulated O
, O
The O
expression O
levels O
of O
miR B-RNA
- I-RNA
21 I-RNA
were O
correlated O
with O
PTEN B-RNA
and O
commonly O
used O
clinicopathologic O
features O
of O
breast B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
5p I-RNA
: O
were O
repressed O
, O
overexpression O
can O
inhibitu O
lung B-Disease
cancer I-Disease
growth O
. O

miR B-RNA
- I-RNA
205 I-RNA
Exerts O
tumor O
- O
suppressive O
functions O
in O
human O
prostate B-Disease
through O
down O
- O
regulation O
of O
protein O
kinase O
Cepsilon O
. O

miR B-RNA
- I-RNA
449a I-RNA
targets O
HDAC O
- O
1 O
and O
induces O
growth O
arrest O
in O
prostate B-Disease
cancer I-Disease
. O

Expression O
of O
both O
miR B-RNA
- I-RNA
346 I-RNA
and O
GRID1 B-RNA
is O
lower O
in O
SZ B-Disease
patients O
than O
that O
in O
normal O
controls O
. O

miR B-RNA
- I-RNA
221 I-RNA
/ O
222 B-RNA
target O
p27Kip1 O
in O
Marek B-Disease
' I-Disease
s I-Disease
disease I-Disease
virus O
- O
transformed O
tumour O
cell O
line O
MSB O
- O
1 O
. O

Taken O
together O
, O
our O
findings O
suggest O
that O
miR B-RNA
- I-RNA
146b I-RNA
is O
involved O
in O
glioma B-Disease
cell O
migration O
and O
invasion O
by O
targeting O
MMPs O
, O
and O
implicate O
miR B-RNA
- I-RNA
146b I-RNA
as O
a O
metastasis O
- O
inhibiting O
miRNA O
in O
glioma B-Disease
. O

The O
results O
showed O
that O
the O
positive O
expressions O
of O
the O
mutated O
BCRA1 B-RNA
mRNA O
and O
p53 B-RNA
mRNA O
are O
involved O
in O
prostate B-Disease
cancer I-Disease
. O

MicroRNA B-RNA
- I-RNA
328 I-RNA
negatively O
regulates O
the O
expression O
of O
breast B-Disease
cancer I-Disease
resistance O
protein O
( O
BCRP O
/ O
ABCG2 O
) O
in O
human O
cancer O
cells O
. O

hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
205 I-RNA
as O
a O
highly O
specific O
marker O
for O
squamous B-Disease
cell I-Disease
lung I-Disease
carcinoma I-Disease
. O

Specific O
expression O
of O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
and O
miR B-RNA
- I-RNA
127 I-RNA
in O
testicular O
and O
central O
nervous O
system O
diffuse B-Disease
large I-Disease
B I-Disease
- I-Disease
cell I-Disease
lymphoma I-Disease
. O

Compared O
with O
normal O
breast O
samples O
, O
a O
panel O
of O
miRs O
was O
consistently O
dysregulated O
in O
breast B-Disease
cancer I-Disease
, O
including O
earlier O
- O
reported O
breast B-Disease
cancer I-Disease
- O
related O
miRs O
, O
such O
as O
upregulated O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
155 I-RNA
, O
miR B-RNA
- I-RNA
191 I-RNA
, O
and O
miR B-RNA
- I-RNA
196a I-RNA
, O
and O
downregulated O
miR O
- O
125b O
and O
miR O
- O
221 O
. O

Compared O
with O
normal O
breast O
samples O
, O
a O
panel O
of O
miRs O
was O
consistently O
dysregulated O
in O
breast B-Disease
cancer I-Disease
, O
including O
earlier O
- O
reported O
breast B-Disease
cancer I-Disease
- O
related O
miRs O
, O
such O
as O
upregulated O
miR O
- O
21 O
, O
miR O
- O
155 O
, O
miR O
- O
191 O
, O
and O
miR O
- O
196a O
, O
and O
downregulated O
miR B-RNA
- I-RNA
125b I-RNA
and O
miR B-RNA
- I-RNA
221 I-RNA
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
directly O
targets O
MARCKS O
and O
promotes O
apoptosis O
resistance O
and O
invasion O
in O
prostate B-Disease
cancer I-Disease
cells O
. O

BMP O
- O
6 O
inhibits O
microRNA B-RNA
- I-RNA
21 I-RNA
expression O
in O
breast B-Disease
cancer I-Disease
through O
repressing O
deltaEF1 O
and O
AP O
- O
1 O
. O

microRNA B-RNA
- I-RNA
451 I-RNA
Regulates O
Macrophage O
Migration O
Inhibitory O
Factor O
Proliferation O
of O
Gastrointestinal O
Cancer O
Cells O
Production O
. O

miR B-RNA
- I-RNA
146a I-RNA
: O
miR B-RNA
- I-RNA
146a I-RNA
contributes O
to O
abnormal O
activation O
of O
the O
type O
i O
interferon O
pathway O
in O
human O
lupus B-Disease
by O
targeting O
the O
key O
signaling O
proteins O
. O

miR O
- O
146a O
: O
miR B-RNA
- I-RNA
146 I-RNA
is O
intensely O
expressed O
in O
low O
- O
grade O
OA B-Disease
cartilage O
and O
that O
its O
expression O
is O
induced O
by O
stimulation O
of O
IL O
- O
1beta O

miR B-RNA
- I-RNA
532 I-RNA
- I-RNA
5p I-RNA
is O
a O
regulatory O
factor O
of O
RUNX3 O
, O
which O
is O
down O
- O
regulated O
during O
melanoma B-Disease
progression O

miR B-RNA
- I-RNA
17 I-RNA
: O
the O
most O
highly O
up O
- O
regulated O
miRNAs O
in O
medulloblastoma B-Disease

Change O
in O
expression O
of O
miR B-RNA
- I-RNA
let7c I-RNA
, O
miR B-RNA
- I-RNA
100 I-RNA
, O
and O
miR B-RNA
- I-RNA
218 I-RNA
from O
high O
grade O
localized O
prostate B-Disease
cancer I-Disease
to O
metastasis O
. O

We O
identified O
a O
subset O
of O
7 O
miRNAs O
( O
miR B-RNA
- I-RNA
145 I-RNA
, O
miR B-RNA
- I-RNA
30a I-RNA
- I-RNA
3p I-RNA
, O
miR B-RNA
- I-RNA
133a I-RNA
, O
miR B-RNA
- I-RNA
133b I-RNA
, O
miR B-RNA
- I-RNA
195 I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
and O
miR B-RNA
- I-RNA
199a I-RNA
* I-RNA
) O
that O
were O
significantly O
downregulated O
in O
BCs B-Disease
. O

Mir B-RNA
- I-RNA
24 I-RNA
emerged O
as O
a O
biomarker O
specific O
for O
KS B-Disease
. O

MicroRNAs B-RNA
15a I-RNA
and O
16 O
regulate O
tumor O
proliferation O
in O
multiple B-Disease
myeloma I-Disease
. O

The O
results O
of O
this O
study O
suggest O
that O
miR B-RNA
- I-RNA
124a I-RNA
is O
a O
key O
miRNA O
in O
the O
posttranscriptional O
regulatory O
mechanisms O
of O
RA B-Disease
synoviocytes O
. O

Epigenetic O
silencing O
of O
MicroRNA O
miR B-RNA
- I-RNA
107 I-RNA
regulates O
cyclin O
- O
dependent O
kinase O
6 O
expression O
in O
pancreatic B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
196a I-RNA
exerts O
a O
pro O
- O
oncogenic O
influence O
in O
colorectal B-Disease
cancer I-Disease
. O

These O
observations O
confirm O
that O
mir B-RNA
- I-RNA
34 I-RNA
is O
required O
for O
a O
normal O
cellular O
response O
to O
DNA O
damage O
in O
vivo O
resulting O
in O
altered O
cellular O
survival O
post O
- O
irradiation O
, O
and O
point O
to O
a O
potential O
therapeutic O
use O
for O
anti O
- O
miR O
- O
34 O
as O
a O
radiosensitizing O
agent O
in O
p53 O
- O
mutant O
breast B-Disease
cancer I-Disease
. O

Our O
results O
suggest O
that O
miR B-RNA
- I-RNA
221 I-RNA
/ O
222 O
is O
a O
regulator O
of O
the O
tumor O
suppressor O
gene O
p27Kip1 O
, O
and O
co O
- O
suppression O
of O
miR B-RNA
- I-RNA
221 I-RNA
/ O
222 O
expression O
in O
advanced O
gliomas O
may O
inhibit O
glioma B-Disease
cell O
proliferation O
by O
a O
mechanism O
involving O
the O
up O
- O
regulation O
of O
p27Kip1 O
in O
vitro O
and O
in O
vivo O
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
modulates O
biological O
functions O
of O
pancreatic B-Disease
cancer I-Disease
cells O
including O
their O
proliferation O
, O
invasion O
, O
and O
chemoresistance O
. O

Epigenetic O
silencing O
of O
the O
tumor O
suppressor O
microRNA O
Hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
124a I-RNA
regulates O
CDK6 O
expression O
and O
confers O
a O
poor O
prognosis O
in O
acute B-Disease
lymphoblastic I-Disease
leukemia I-Disease
. O

Decreased O
Expression O
of O
MicroRNA B-RNA
- I-RNA
143 I-RNA
and O
- O
145 O
in O
Human O
Gastric B-Disease
Cancers I-Disease
. O

Taken O
together O
, O
these O
findings O
suggest O
that O
miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
act O
as O
anti O
- O
oncomirs O
common O
to O
gastrointestinal O
tumors O
. O

The O
ratio O
of O
miR B-RNA
- I-RNA
92a I-RNA
/ O
miR B-RNA
- I-RNA
638 I-RNA
in O
plasma O
has O
strong O
potential O
for O
clinical O
application O
as O
a O
novel O
biomarker O
for O
detection O
of O
leukemia B-Disease
. O

Our O
data O
highlight O
an O
important O
role O
of O
miR B-RNA
- I-RNA
195 I-RNA
in O
cell O
cycle O
control O
and O
in O
the O
molecular O
etiology O
of O
HCC B-Disease
, O
and O
implicate O
the O
potential O
application O
of O
miR B-RNA
- I-RNA
195 I-RNA
in O
cancer O
therapy O
. O

MicroRNA B-RNA
- I-RNA
195 I-RNA
suppresses O
tumorigenicity O
and O
regulates O
G O
( O
1 O
) O
/ O
S O
transition O
of O
human O
hepatocellular B-Disease
carcinoma I-Disease
cells O
. O

These O
findings O
provide O
the O
first O
evidence O
that O
the O
up O
- O
regulated O
expressions O
of O
miR B-RNA
- I-RNA
335 I-RNA
in O
liver O
and O
WAT O
of O
obese O
mice O
might O
contribute O
to O
the O
pathophysiology O
of O
obesity B-Disease
. O

Thus O
, O
miR B-RNA
- I-RNA
92a I-RNA
may O
serve O
as O
a O
valuable O
therapeutic O
target O
in O
the O
setting O
of O
ischemic O
disease O
. O

On O
the O
contrary O
, O
an O
extracellular O
signal O
- O
regulated O
protein O
kinase O
5 O
( O
ERK5 O
) O
, O
which O
was O
determined O
to O
be O
a O
target O
of O
miR B-RNA
- I-RNA
143 I-RNA
in O
colon B-Disease
cancer I-Disease
DLD O
- O
1 O
cells O
, O
was O
time O
- O
dependently O
down O
- O
regulated O
at O
the O
translational O
level O
after O
the O
treatment O
. O

Role O
of O
microRNA B-RNA
- I-RNA
143 I-RNA
in O
Fas O
- O
mediated O
apoptosis O
in O
human O
T B-Disease
- I-Disease
cell I-Disease
leukemia I-Disease
Jurkat O
cells O
. O

miR B-RNA
- I-RNA
224 I-RNA
and O
miR O
- O
486 O
are O
associated O
with O
the O
progression O
of O
pancreatic B-Disease
ductal I-Disease
adenocarcinomas I-Disease

Genomic O
profiling O
of O
microRNAs O
in O
bladder B-Disease
cancer I-Disease
: O
miR B-RNA
- I-RNA
129 I-RNA
is O
associated O
with O
poor O
outcome O
and O
promotes O
cell O
death O
in O
vitro O
. O

MicroRNA B-RNA
- I-RNA
222 I-RNA
regulates O
cell O
invasion O
by O
targeting O
matrix O
metalloproteinase O
1 O
( O
MMP1 O
) O
and O
manganese O
superoxide O
dismutase O
2 O
( O
SOD2 O
) O
in O
tongue B-Disease
squamous I-Disease
cellcarcinoma I-Disease
cell O
lines O
. O

The O
PTEN O
- O
regulating O
microRNA O
miR B-RNA
- I-RNA
26a I-RNA
is O
amplified O
in O
high O
- O
grade O
glioma B-Disease
and O
facilitates O
gliomagenesis O
in O
vivo O
. O

Finally O
, O
we O
demonstrate O
that O
miR B-RNA
- I-RNA
26a I-RNA
- O
mediated O
PTEN B-RNA
repression O
in O
a O
murine O
glioma B-Disease
model O
both O
enhances O
de O
novo O
tumor O
formation O
and O
precludes O
loss O
of O
heterozygosity O
and O
the O
PTEN B-RNA
locus O
. O

The O
PTEN O
- O
regulating O
microRNA O
miR B-RNA
- I-RNA
26a I-RNA
is O
amplified O
in O
high O
- O
grade O
glioma B-Disease
and O
facilitates O
gliomagenesis O
in O
vivo O
. O

A O
miR B-RNA
- I-RNA
200 I-RNA
microRNA O
cluster O
as O
prognostic O
marker O
in O
advanced O
ovarian B-Disease
cancer I-Disease
. O

we O
demonstrated O
that O
the O
direct O
inhibition O
of O
LATS2 O
protein O
was O
mediated O
by O
miR B-RNA
- I-RNA
373 I-RNA
and O
manipulated O
the O
expression O
of O
miR B-RNA
- I-RNA
373 I-RNA
to O
affect O
esophageal B-Disease
cancer I-Disease
cells O
growth O
. O

MicroRNA O
- O
373 O
( O
miR B-RNA
- I-RNA
373 I-RNA
) O
post O
- O
transcriptionally O
regulates O
large O
tumor O
suppressor O
, O
homolog O
2 O
( O
LATS2 O
) O
and O
stimulates O
proliferation O
in O
human O
esophageal B-Disease
cancer I-Disease
. O

Locked O
nucleic O
acid O
in O
situ O
hybridization O
analysis O
of O
miR B-RNA
- I-RNA
21 I-RNA
expression O
during O
colorectal B-Disease
cancer I-Disease
development O
. O

Down O
- O
regulated O
miR B-RNA
- I-RNA
9 I-RNA
and O
miR B-RNA
- I-RNA
433 I-RNA
in O
human O
gastric B-Disease
carcinoma I-Disease
. O

We O
found O
that O
miR B-RNA
- I-RNA
10b I-RNA
expression O
was O
upregulated O
in O
all O
glioma B-Disease
samples O
compared O
to O
non O
- O
neoplastic O
brain O
tissues O
. O

The O
expression O
levels O
of O
miR O
- O
10b O
were O
associated O
with O
higher O
grade O
glioma B-Disease
. O

Our O
data O
indicated O
that O
miR B-RNA
- I-RNA
10b I-RNA
might O
play O
some O
role O
in O
the O
invasion O
of O
glioma B-Disease
cells O
. O

Regulation O
of O
the O
cell O
cycle O
gene O
, O
BTG2 O
, O
by O
miR B-RNA
- I-RNA
21 I-RNA
in O
human O
laryngeal B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
15a I-RNA
and I-RNA
miR I-RNA
- I-RNA
16 I-RNA
are O
implicated O
in O
cell O
cycle O
regulation O
in O
a O
Rb O
- O
dependent O
manner O
and O
are O
frequently O
deleted O
or O
down O
- O
regulated O
in O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
. O

Elevated O
expression O
of O
microRNAs B-RNA
155 I-RNA
, O
203 O
, O
210 O
and O
222 O
in O
pancreatic O
tumours O
associates O
with O
poorer O
survival O
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
targets O
LRRFIP1 O
and O
contributes O
to O
VM O
- O
26 O
resistance O
in O
glioblastoma B-Disease
multiforme I-Disease
. O

LOI O
of O
H19 B-RNA
can O
be O
identified O
in O
pre O
- O
eclamptic O
placentas O
and O
is O
associated O
with O
maternal O
blood O
pressures O
, O
which O
implies O
the O
involvement O
of O
H19 B-RNA
gene O
LOI O
in O
the O
pathogenesis O
of O
pre B-Disease
- I-Disease
eclampsia I-Disease
and O
its O
potential O
relationship O
with O
the O
severity O
of O
the O
disease O
. O

Numerous O
long O
ncRNAs O
are O
misregulated O
in O
various O
diseases O
, O
especially O
cancer O
, O
and O
some O
have O
been O
found O
to O
be O
very O
sensitive O
and O
specific O
markers O
of O
tumors O
, O
such O
as O
DD3 B-RNA
( O
also O
known O
as O
PCA3 O
) O
in O
prostate B-Disease
tumors I-Disease
. O

Coordinate O
Regulation O
of O
FOXO1 O
by O
miR B-RNA
- I-RNA
27a I-RNA
, O
miR B-RNA
- I-RNA
96 I-RNA
, O
and O
miR B-RNA
- I-RNA
182 I-RNA
in O
Breast B-Disease
Cancer I-Disease
Cells O
. O

miR B-RNA
- I-RNA
23a I-RNA
functions O
downstream O
of O
NFATc3 O
to O
regulate O
cardiac B-Disease
hypertrophy I-Disease
. O

Overexpressed O
; O
arrhythmogenic B-Disease
miR B-RNA
- I-RNA
1 I-RNA
, O
contributing O
to O
ischaemic O
arrhythmogenesis O
stimulated O
by O
beta O
- O
adrenergic O
pathway O
; O
downregulatied O
by O
propranolol O
together O
with O
SRF O
. O

CDODA O
- O
Me O
acts O
through O
down O
- O
regulated O
of O
miR B-RNA
- I-RNA
27a I-RNA
and O
this O
is O
accompanied O
by O
enhanced O
expression O
of O
ZBTB10 O
and O
Myt O
- O
1 O
which O
arrests O
colon B-Disease
cancer I-Disease
cells O
at O
G2 O
/ O
M O
phase O
. O

CDODA O
- O
Me O
acts O
through O
down O
- O
regulated O
of O
miR O
- O
27a O
and O
this O
is O
accompanied O
by O
enhanced O
expression O
of O
ZBTB10 B-RNA
and O
Myt B-RNA
- I-RNA
1 I-RNA
which O
arrests O
colon B-Disease
cancer I-Disease
cells O
at O
G2 O
/ O
M O
phase O
. O

miR B-RNA
- I-RNA
311 I-RNA
- I-RNA
3p I-RNA
regulate O
ERBB O
- O
2 O
expression O
and O
androgen O
receptor O
signaling O
in O
prostate B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
221 I-RNA
: O
Expression O
of O
microRNA O
- O
221 O
is O
progressively O
reduced O
in O
aggressive O
prostate B-Disease
cancer I-Disease
and O
metastasis O
. O

The O
microRNAs O
miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
are O
downregulated O
in O
multiple O
tumor O
types O
and O
are O
frequently O
deleted O
in O
chronic B-Disease
lymphocytic I-Disease
leukemia I-Disease
( I-Disease
CLL I-Disease
) I-Disease
, O
myeloma B-Disease
and O
mantle B-Disease
cell I-Disease
lymphoma I-Disease
. O

Knockdown O
of O
microRNA B-RNA
- I-RNA
181 I-RNA
by O
lentivirus O
decreases O
the O
arrhythmogenic B-Disease
effect O
of O
skeletal O
myoblast O
transplantation O
in O
rat O
with O
myocardial O
infarction O
. O

MicroRNA B-RNA
- I-RNA
330 I-RNA
acts O
as O
tumor O
suppressor O
and O
induces O
apoptosis O
of O
prostate B-Disease
cancer I-Disease
cells O
through O
E2F1 O
- O
mediated O
suppression O
of O
Akt O
phosphorylation O
. O

The O
down O
- O
regulation O
of O
miR B-RNA
- I-RNA
122a I-RNA
mediated O
by O
aberrant O
APC O
/ O
beta O
- O
catenin O
signaling O
is O
important O
to O
the O
pathogenesis O
of O
gastrointestinal B-Disease
cancers I-Disease
. O

Significant O
inverse O
correlation O
of O
microRNA B-RNA
- I-RNA
150 I-RNA
/ O
MYB B-RNA
and O
microRNA O
- O
222 O
/ O
p27 O
in O
myelodysplastic B-Disease
syndrome I-Disease
. O

Significant O
inverse O
correlation O
of O
microRNA O
- O
150 O
/ O
MYB O
and O
microRNA B-RNA
- I-RNA
222 I-RNA
/ O
p27 B-RNA
in O
myelodysplastic B-Disease
syndrome I-Disease
. O

miR B-RNA
- I-RNA
34c I-RNA
, O
miR B-RNA
- I-RNA
145 I-RNA
, O
or O
miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
5p I-RNA
expression O
markedly O
diminished O
proliferation O
of O
lung B-Disease
cancer I-Disease
cell O
lines O
, O
clinical O
implications O
discussed O
. O

Differential O
expression O
profiles O
of O
microRNAs O
between O
breast B-Disease
cancer I-Disease
cells O
and O
mammary O
epithelial O
cells O
: O
mir B-RNA
- I-RNA
18a I-RNA
and O
mir B-RNA
- I-RNA
195 I-RNA
were O
highly O
expressed O
in O
MCF O
- O
7 O
cells O
; O
target O
genes O
of O
mir O
- O
200b O
were O
predicted O
by O
informatics O
analysis O
. O

MicroRNA B-RNA
- I-RNA
143 I-RNA
targets O
DNA O
methyltransferases O
3A O
in O
colorectal B-Disease
cancer I-Disease
. O

expressed O
differently O
, O
miR B-RNA
- I-RNA
137 I-RNA
upregulated O
in O
non O
- O
cancerous O
colonic O
tissues O
from O
colon B-Disease
cancer I-Disease
patients O
with O
lymph O
node O
metastasis O
. O

Regulation O
of O
JAK2 O
by O
miR B-RNA
- I-RNA
135a I-RNA
: O
prognostic O
impact O
in O
classical O
Hodgkin B-Disease
lymphoma I-Disease
. O

MicroRNA B-RNA
- I-RNA
221 I-RNA
targets O
Bmf O
in O
hepatocellular B-Disease
carcinoma I-Disease
and O
correlates O
with O
tumor O
multifocality O
. O

Although O
miR B-RNA
- I-RNA
143 I-RNA
and I-RNA
miR I-RNA
- I-RNA
145 I-RNA
are O
highly O
expressed O
in O
normal O
tissues O
, O
they O
are O
significantly O
down O
- O
regulated O
in O
prostate B-Disease
cancer I-Disease
cells O
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
promotes O
cell O
proliferation O
and O
down O
- O
regulates O
the O
expression O
of O
programmed O
cell O
death O
4 O
( O
PDCD4 O
) O
in O
HeLa O
cervical B-Disease
carcinoma I-Disease
cells O
. O

These O
findings O
suggested O
that O
bcl2 O
is O
an O
important O
functional O
target O
for O
miR B-RNA
- I-RNA
34a I-RNA
, O
and O
the O
abnormal O
expression O
of O
miR B-RNA
- I-RNA
34a I-RNA
may O
contribute O
to O
the O
pathogenesis O
of O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
, O
at O
least O
in O
part O
by O
affecting O
the O
expression O
of O
bcl2 O
. O

MiR B-RNA
- I-RNA
107 I-RNA
and O
MiR B-RNA
- I-RNA
185 I-RNA
can O
induce O
cell O
cycle O
arrest O
in O
human O
non B-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
cell O
lines O
. O

Down O
- O
regulated O
microRNA B-RNA
- I-RNA
200a I-RNA
in O
Meningiomas B-Disease
Promotes O
Tumor O
Growth O
by O
Reducing O
E O
- O
cadherin O
and O
Activating O
the O
Wnt O
/ O
{ O
beta O
} O
catenin O
Signaling O
Pathway O
. O

Real O
- O
time O
reverse O
transcription O
polymerase O
chain O
reaction O
( O
RT O
- O
PCR O
) O
analysis O
demonstrated O
up O
- O
regulation O
of O
oncogenic O
miR B-RNA
- I-RNA
155 I-RNA
, O
miR B-RNA
- I-RNA
221 I-RNA
/ O
222 O
, O
and O
miR B-RNA
- I-RNA
21 I-RNA
and O
down O
- O
regulation O
of O
the O
most O
abundant O
liver O
- O
specific O
miR O
- O
122 O
at O
early O
stages O
of O
hepatocarcinogenesis B-Disease
. O

low O
expression O
of O
the O
miR B-RNA
- I-RNA
223 I-RNA
, O
miR B-RNA
- I-RNA
29c I-RNA
, O
miR B-RNA
- I-RNA
29b I-RNA
, O
and O
miR B-RNA
- I-RNA
181 I-RNA
family O
were O
strongly O
associated O
with O
disease O
progression O
in O
CLL B-Disease
cases O
harboring O
17p O
deletion O
. O

a O
role O
for O
the O
mir B-RNA
- I-RNA
15a I-RNA
/ O
16 O
- O
1 O
cluster O
in O
cell O
cycle O
regulation O
and O
suggest O
that O
these O
mature O
microRNAs O
in O
both O
the O
New O
Zealand O
Black O
model O
and O
human O
CLL B-Disease
may O
be O
targets O
for O
therapeutic O
efficacy O
in O
this O
disease O
. O

profiled O
four O
miRNAs O
, O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
210 I-RNA
, O
miR B-RNA
- I-RNA
155 I-RNA
, O
and O
miR B-RNA
- I-RNA
196a I-RNA
, O
all O
implicated O
in O
the O
development O
of O
pancreatic B-Disease
cancer I-Disease
with O
either O
proven O
or O
predicted O
target O
genes O
involved O
in O
critical O
cancer O
- O
associated O
cellular O
pathways O
. O

microRNA B-RNA
- I-RNA
21 I-RNA
or O
- O
221 O
arrests O
cell O
cycle O
, O
induces O
apoptosis O
, O
and O
sensitizes O
the O
effects O
of O
gemcitabine O
in O
pancreatic B-Disease
adenocarcinoma I-Disease
. O

miR B-RNA
- I-RNA
145 I-RNA
participates O
with O
TP53 O
in O
a O
death O
- O
promoting O
regulatory O
loop O
and O
targets O
estrogen O
receptor O
- O
alpha O
in O
human O
breast B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
34a I-RNA
as O
a O
prognostic O
marker O
of O
relapse O
in O
surgically O
resected O
non B-Disease
- I-Disease
small I-Disease
- I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
. O

hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
125b I-RNA
binding O
site O
in O
BMPR1B O
is O
Associated O
with O
Breast B-Disease
cancer I-Disease
pathogenesis O
. O

microRNA B-RNA
( I-RNA
miR I-RNA
) I-RNA
- I-RNA
16 I-RNA
, O
which O
is O
expressed O
at O
lower O
levels O
in O
prostate B-Disease
cancer I-Disease
cells O
, O
affects O
the O
proliferation O
of O
human O
prostate B-Disease
cancer I-Disease
cell O
lines O
both O
in O
vitro O
and O
in O
vivo O
. O

miR O
- O
16 O
: O
The O
miR B-RNA
- I-RNA
15a I-RNA
- O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
cluster O
controls O
prostate B-Disease
cancer I-Disease
by O
targeting O
multiple O
oncogenic O
activities O
. O

miR B-RNA
- I-RNA
21 I-RNA
, O
mir B-RNA
- I-RNA
31 I-RNA
, O
miR B-RNA
- I-RNA
130a I-RNA
, O
miR B-RNA
- I-RNA
146b I-RNA
and O
miR B-RNA
- I-RNA
377 I-RNA
were O
consistently O
upregulated O
, O
whereas O
miR O
- O
1 O
and O
miR O
- O
143 O
were O
downregulated O
in O
lung B-Disease
tumors I-Disease
relative O
to O
normal O
lungs O
. O

miR O
- O
21 O
, O
mir O
- O
31 O
, O
miR O
- O
130a O
, O
miR O
- O
146b O
and O
miR O
- O
377 O
were O
consistently O
upregulated O
, O
whereas O
miR B-RNA
- I-RNA
1 I-RNA
and I-RNA
miR I-RNA
- I-RNA
143 I-RNA
were O
downregulated O
in O
lung B-Disease
tumors I-Disease
relative O
to O
normal O
lungs O
. O

miR B-RNA
- I-RNA
128b I-RNA
is O
a O
potent O
glucocorticoid O
sensitizer O
in O
MLL O
- O
AF4 O
acute O
lymphocytic O
leukemia O
cells O
and O
exerts O
cooperative O
effects O
with O
miR B-RNA
- I-RNA
221 I-RNA
. O

MicroRNA B-RNA
- I-RNA
17 I-RNA
- I-RNA
3p I-RNA
is O
a O
prostate B-Disease
tumor I-Disease
suppressor O
in O
vitro O
and O
in O
vivo O
, O
and O
is O
decreased O
in O
high O
grade O
prostate O
tumors O
analyzed O
by O
laser O
capture O
microdissection O
. O

MicroRNA B-RNA
- I-RNA
34a I-RNA
inhibits O
glioblastoma B-Disease
growth O
by O
targeting O
multiple O
oncogenes O
. O

MicroRNA B-RNA
- I-RNA
34a I-RNA
inhibits O
uveal B-Disease
melanoma I-Disease
cell O
proliferation O
and O
migration O
through O
down O
- O
regulated O
of O
c O
- O
Met O
. O

Tanshinone O
IIA O
protects O
against O
sudden O
cardiac O
death O
induced O
by O
lethal B-Disease
arrhythmias I-Disease
via O
repression O
of O
microRNA B-RNA
- I-RNA
1 I-RNA
. O

When O
human O
head O
and O
neck O
or O
pancreatic B-Disease
tumor I-Disease
cells O
ectopically O
expressing O
mir B-RNA
- I-RNA
210 I-RNA
were O
implanted O
into O
immunodeficient O
mice O
, O
mir B-RNA
- I-RNA
210 I-RNA
repressed O
initiation O
of O
tumor O
growth O
. O

These O
data O
suggest O
a O
role O
for O
HSV O
- O
1 O
- O
induced O
miRNA B-RNA
- I-RNA
146a I-RNA
in O
the O
evasion O
of O
HSV O
- O
1 O
from O
the O
complement O
system O
, O
and O
the O
activation O
of O
key O
elements O
of O
the O
arachidonic O
acid O
cascade O
known O
to O
contribute O
to O
Alzheimer B-Disease
- O
type O
neuropathological O
change O
. O

miR B-RNA
- I-RNA
421 I-RNA
may O
involve O
in O
the O
early O
stage O
of O
stomach B-Disease
carcinogenesis I-Disease
and O
could O
be O
used O
as O
an O
efficient O
diagnostic O
biomarker O
. O

Gene O
silencing O
of O
MIR22 B-RNA
in O
acute B-Disease
lymphoblastic I-Disease
leukaemia I-Disease
involves O
histone O
modifications O
independent O
of O
promoter O
DNA O
methylation O
. O

Let B-RNA
- I-RNA
7a I-RNA
elevates O
p21 O
( O
WAF1 O
) O
levels O
by O
targeting O
of O
NIRF O
and O
suppresses O
the O
growth O
of O
A549 O
lung B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
221 I-RNA
: O
four O
microRNAs O
( O
miR B-RNA
- I-RNA
221 I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
, O
miR B-RNA
- I-RNA
106b I-RNA
and O
miR B-RNA
- I-RNA
410 I-RNA
) O
that O
could O
participate O
in O
pathogenesis O
of O
MPB B-Disease
. O

miR B-RNA
- I-RNA
150 I-RNA
as O
a O
plasma O
prognostich O
marker O
in O
patients O
with O
sepsis B-Disease
. O

microRNA B-RNA
- I-RNA
21 I-RNA
negatively O
regulates O
Cdc25A O
and O
cell O
cycle O
progression O
in O
colon B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
141 I-RNA
: O
miR B-RNA
- I-RNA
141 I-RNA
regulates O
SIP1 O
to O
inhibit O
migration O
and O
invasion O
of O
CRC B-Disease
cells O
. O

miR O
- O
34a O
: O
MiR B-RNA
- I-RNA
15b I-RNA
and O
miR B-RNA
- I-RNA
210 I-RNA
were O
significantly O
upregulated O
, O
miR O
- O
34a O
was O
significantly O
downregulated O
in O
melanomas O
. O

miR B-RNA
- I-RNA
34a I-RNA
: O
MiR O
- O
15b O
and O
miR O
- O
210 O
were O
significantly O
upregulated O
, O
miR B-RNA
- I-RNA
34a I-RNA
was O
significantly O
downregulated O
in O
melanomas O
. O

miR B-RNA
- I-RNA
196a I-RNA
- I-RNA
2 I-RNA
: O
Association O
of O
microRNA O
- O
196a O
- O
2 O
gene O
polymorphism O
with O
gastric B-Disease
cancer I-Disease
risk O
. O

miR B-RNA
- I-RNA
326 I-RNA
regulates O
TH O
- O
17 O
differentiation O
and O
is O
associated O
with O
the O
pathogenesis O
of O
multiple B-Disease
sclerosis I-Disease
. O

miR O
- O
200c O
: O
microRNA B-RNA
- I-RNA
200 I-RNA
family O
alterations O
is O
related O
to O
mesenchymal O
and O
drug O
- O
resistant O
phenotypes O
in O
human O
breast B-Disease
cancer I-Disease
cells O
. O

Collectively O
, O
the O
data O
obtained O
in O
the O
present O
study O
suggest O
anti O
- O
proliferative O
, O
chemosensitizer O
and O
putative O
pro O
- O
apoptotic O
roles O
for O
miR B-RNA
- I-RNA
143 I-RNA
in O
colon B-Disease
cancer I-Disease
. O

In O
vitro O
functional O
studies O
indicated O
that O
miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
appear O
to O
function O
in O
opposing O
manners O
to O
either O
inhibit O
or O
augment O
cell O
proliferation O
in O
a O
metastatic O
CRC B-Disease
model O
. O

Our O
results O
showed O
that O
HESRG B-RNA
was O
expressed O
strongly O
and O
diffusively O
in O
the O
nuclei O
of O
tumor O
cells O
in O
intracranial B-Disease
germinoma I-Disease
and O
embryonal B-Disease
carcinoma I-Disease
as O
well O
as O
in O
human O
embryonic O
stem O
cells O
. O

PCR O
analysis O
revealed O
primary O
cutaneous O
melanomas B-Disease
had O
an O
8 O
. O
6 O
- O
fold O
overexpression O
of O
miR B-RNA
- I-RNA
21 I-RNA
and O
a O
7 O
. O
5 O
- O
fold O
overexpression O
of O
miR B-RNA
- I-RNA
155 I-RNA
compared O
with O
benign O
naevi O
( O
P O
< O
0 O
. O
1 O
) O
. O

We O
thus O
identify O
let B-RNA
- I-RNA
7g I-RNA
as O
a O
unique O
member O
of O
the O
let O
- O
7 O
miRNA O
family O
which O
can O
serve O
as O
a O
prognostic O
biomarker O
in O
breast B-Disease
cancer I-Disease
and O
also O
propose O
a O
paradigm O
utilized O
by O
specific O
signaling O
molecules O
via O
let B-RNA
- I-RNA
7g I-RNA
to O
cooperatively O
promote O
breast B-Disease
cancer I-Disease
invasion O
and O
metastasis O
. O

Oncogenic O
KRAS O
Regulates O
miR B-RNA
- I-RNA
200c I-RNA
and O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
in O
a O
3D O
- O
Specific O
Manner O
in O
Colorectal B-Disease
Cancer I-Disease
Cells O
. O

miR B-RNA
- I-RNA
149 I-RNA
promotes O
epithelial O
- O
mesenchymal O
transition O
and O
invasion O
in O
nasopharyngeal B-Disease
carcinoma I-Disease
cells O
. O

miR B-RNA
- I-RNA
128 I-RNA
: O
Micro B-RNA
- I-RNA
RNA I-RNA
- I-RNA
128 I-RNA
( O
miRNA O
- O
128 O
) O
down O
- O
regulation O
in O
glioblastoma B-Disease
targets O
ARP5 O
( O
ANGPTL6 O
) O
, O
Bmi O
- O
1 O
and O
E2F O
- O
3a O
, O
key O
regulators O
of O
brain O
cell O
proliferation O
. O

Regional O
therapy O
with O
DTA B-RNA
- I-RNA
H19 I-RNA
vector O
suppresses O
growth O
of O
colon B-Disease
adenocarcinoma I-Disease
metastases O
in O
the O
rat O
liver O
. O

miR B-RNA
- I-RNA
32 I-RNA
, O
miR B-RNA
- I-RNA
182 I-RNA
and O
miR B-RNA
- I-RNA
143 I-RNA
dysregulated O
expression O
levels O
are O
related O
with O
different O
pathological O
stages O
of O
intestinal O
- O
type O
gastric B-Disease
cancers I-Disease
. O

MiR B-RNA
- I-RNA
138 I-RNA
Suppresses O
Expression O
of O
Hypoxia O
- O
inducible O
factor O
1a O
( O
HIF O
- O
1a O
) O
in O
Clear O
Cell O
Renal B-Disease
Cell I-Disease
Carcinoma I-Disease
786 O
- O
O O
Cells O
. O

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR B-RNA
- I-RNA
101 I-RNA
- I-RNA
1 I-RNA
is O
significantly O
associated O
with O
development O
of O
liver O
cirrhosis O
and O
hepatocellular B-Disease
carcinoma I-Disease
occurrence O
. O

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR O
- O
101 O
- O
1 O
is O
significantly O
associated O
with O
development O
of O
liver O
cirrhosis O
and O
hepatocellular B-Disease
carcinoma I-Disease
occurrence O
. O

The O
expression O
of O
miR B-RNA
- I-RNA
181b I-RNA
and O
miR B-RNA
- I-RNA
21 I-RNA
was O
significantly O
overexpressed O
in O
gastric B-Disease
tumors I-Disease
compared O
to O
normal O
gastric O
tissues O
. O

miR B-RNA
- I-RNA
216b I-RNA
suppresses O
tumor O
growth O
and O
invasion O
by O
targeting O
KRAS O
in O
nasopharyngeal B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
125b I-RNA
- I-RNA
2 I-RNA
overexpression O
might O
confer O
glioblastoma B-Disease
stem O
cells O
resistance O
to O
TMZ O
. O

Therefore O
, O
miR B-RNA
- I-RNA
637 I-RNA
could O
contributes O
to O
osteoporosis B-Disease
. O

A O
PCA3 B-RNA
score O
threshold O
of O
20 O
may O
have O
the O
highest O
utility O
for O
seletcing O
men O
with O
clinically O
insignificant O
prostate B-Disease
cancer I-Disease
in O
whom O
active O
surveillance O
may O
be O
appropriate O
, O
a O
PCA3 B-RNA
score O
threshold O
of O
50 O
may O
be O
used O
to O
identify O
men O
at O
high O
risk O
of O
harbouring O
significant O
prostate B-Disease
cancer I-Disease
who O
are O
candidates O
for O
RP O
. O

The O
authors O
identified O
a O
five O
- O
microRNA O
classifier O
( O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
210 I-RNA
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
182 I-RNA
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
486 I-RNA
- I-RNA
5p I-RNA
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
30a I-RNA
and O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
140 I-RNA
- I-RNA
3p I-RNA
) O
that O
could O
distinguish O
SCC O
( O
Squamous B-Disease
cell I-Disease
carcinoma I-Disease
) O
from O
normal O
lung O
tissues O
. O

The O
authors O
identified O
a O
five O
- O
microRNA O
classifier O
( O
hsa O
- O
miR O
- O
210 O
, O
hsa O
- O
miR O
- O
182 O
, O
hsa O
- O
miR O
- O
486 O
- O
5p O
, O
hsa O
- O
miR O
- O
30a O
and O
hsa O
- O
miR O
- O
140 O
- O
3p O
) O
that O
could O
distinguish O
SCC O
( O
Squamous B-Disease
cell I-Disease
carcinoma I-Disease
) O
from O
normal O
lung O
tissues O
. O

These O
findings O
indicated O
that O
the O
miR B-RNA
- I-RNA
483 I-RNA
- I-RNA
5p I-RNA
- I-RNA
SRF I-RNA
pathway O
may O
offer O
a O
novel O
strategy O
for O
treatment O
with O
angiogenesis O
in O
ischemic B-Disease
heart I-Disease
disease I-Disease
patients O
. O

The O
entire O
miR O
- O
200 O
family O
( O
miR B-RNA
- I-RNA
200a I-RNA
/ I-RNA
b I-RNA
/ I-RNA
c I-RNA
, O
miR B-RNA
- I-RNA
141 I-RNA
, O
and O
miR B-RNA
- I-RNA
429 I-RNA
) O
was O
up O
- O
regulated O
in O
cases O
of O
EEC O
( O
endometrioid B-Disease
endometrial I-Disease
adenocarcinoma I-Disease
) O
. O

MiR B-RNA
- I-RNA
17 I-RNA
Modulates O
Osteogenic O
Differentiation O
Through O
a O
Coherent O
Feed O
- O
Forward O
Loop O
in O
Mesenchymal O
Stem O
Cells O
Isolated O
from O
Periodontal O
Ligaments O
of O
Patients O
With O
Periodontitis B-Disease
. O

Expression O
of O
three O
neurosteroid O
synthesis O
enzyme O
- O
specific O
micro O
- O
RNAs O
( O
miR B-RNA
- I-RNA
338 I-RNA
, O
miR B-RNA
- I-RNA
155 I-RNA
and O
miR B-RNA
- I-RNA
491 I-RNA
) O
showed O
a O
bias O
towards O
induction O
in O
patients O
with O
multiple B-Disease
sclerosis I-Disease
( O
P O
< O
0 O
. O
5 O
) O
. O

Primer O
extension O
analysis O
confirmed O
enhanced O
expression O
of O
miR B-RNA
- I-RNA
21 I-RNA
and O
decreased O
expression O
of O
miR O
- O
128 O
, O
miR O
- O
124 O
, O
and O
miR O
- O
132 O
in O
glioblastomas O
compared O
to O
non O
- O
tumor O
brain O
tissue O
samples O
. O

Primer O
extension O
analysis O
confirmed O
enhanced O
expression O
of O
miR O
- O
21 O
and O
decreased O
expression O
of O
miR B-RNA
- I-RNA
128 I-RNA
, O
miR B-RNA
- I-RNA
124 I-RNA
, O
and O
miR B-RNA
- I-RNA
132 I-RNA
in O
glioblastomas O
compared O
to O
non O
- O
tumor O
brain O
tissue O
samples O
. O

Real O
- O
time O
PCR O
showed O
that O
miR B-RNA
- I-RNA
27b I-RNA
was O
up O
- O
regulated O
in O
glioma B-Disease
samples O
and O
glioma B-Disease
cells O
. O

miR B-RNA
- I-RNA
1 I-RNA
as O
a O
tumor O
suppressive O
microRNA O
targeting O
TAGLN2 O
in O
head B-Disease
and I-Disease
neck I-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

Elevated O
expression O
of O
HOTAIR B-RNA
is O
observed O
in O
primary O
and O
metastatic O
breast B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
200a I-RNA
regulates O
Nrf2 O
activation O
by O
targeting O
Keap1 B-RNA
mRNA O
in O
breast B-Disease
cancer I-Disease
cells O
. O

GWAS O
analysis O
revealed O
that O
rs1625579 O
within O
an O
intron O
of O
a O
putative O
primary O
transcript O
for O
MIR137 B-RNA
( I-RNA
microRNA I-RNA
137 I-RNA
) I-RNA
, O
a O
known O
regulator O
of O
neuronal O
development O
was O
associated O
with O
schizophrenia B-Disease
. O

MiR B-RNA
- I-RNA
34a I-RNA
Targeting O
of O
Notch O
Ligand O
Delta O
- O
Like O
1 O
Impairs O
CD15 O
/ O
CD133 O
Tumor O
- O
Propagating O
Cells O
and O
Supports O
Neural O
Differentiation O
in O
Medulloblastoma B-Disease
. O

The O
over O
- O
expression O
of O
a O
specific O
non O
- O
coding O
rna O
, O
ndm29 B-RNA
, O
reduces O
neuroblastoma B-Disease
development O
promoting O
cell O
differentiation O
. O

miR B-RNA
- I-RNA
122 I-RNA
was O
markedly O
decreased O
in O
azoospermia O
but O
increased O
in O
asthenozoospermia B-Disease
. O

microRNA B-RNA
- I-RNA
18a I-RNA
, O
a O
member O
of O
the O
oncogenic O
miR O
- O
17 O
- O
92 O
cluster O
, O
targets O
Dicer O
and O
suppresses O
cell O
proliferation O
in O
bladder B-Disease
cancer I-Disease
T24 O
cells O
. O

In O
conclusion O
, O
the O
results O
of O
this O
pilot O
study O
demonstrate O
that O
miR O
- O
15b O
and O
miR B-RNA
- I-RNA
21 I-RNA
are O
markers O
for O
gliomas B-Disease
, O
which O
can O
be O
assessed O
in O
the O
CSF O
by O
means O
of O
qRT O
- O
PCR O
. O

Four O
miRNAs O
( O
miR B-RNA
- I-RNA
326 I-RNA
, O
miR B-RNA
- I-RNA
155 I-RNA
, O
miR B-RNA
- I-RNA
146a I-RNA
, O
miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
3p I-RNA
) O
were O
aberrantly O
expressed O
in O
peripheral O
blood O
mononuclear O
cells O
from O
RRMS O
( O
relapsing O
remitting O
multiple B-Disease
sclerosis I-Disease
) O
patients O
compared O
to O
healthy O
controls O
. O

miR B-RNA
- I-RNA
146a I-RNA
has O
a O
role O
in O
the O
pathogenesis O
of O
systemic B-Disease
lupus I-Disease
erythematosus I-Disease
with O
atherosclerosis O
. O

Reduced O
miR B-RNA
- I-RNA
128 I-RNA
in O
breast B-Disease
tumor I-Disease
- O
initiating O
cells O
induces O
chemotherapeutic O
resistance O
via O
Bmi O
- O
1 O
and O
ABCC5 O
. O

MiR B-RNA
- I-RNA
17 I-RNA
/ I-RNA
106b I-RNA
seed O
family O
regulates O
p21 O
in O
Hodgkin B-Disease
' I-Disease
s I-Disease
lymphoma I-Disease
. O

The O
most O
pronounced O
differences O
of O
atherosclerotic O
plaques O
in O
DNA O
methylation O
levels O
were O
registered O
for O
a O
site O
which O
is O
located O
in O
CpG O
- O
island O
of O
imprinted O
gene O
H19 B-RNA
. O

miR B-RNA
- I-RNA
135a I-RNA
Regulates O
HOXA10 B-RNA
Expression O
in O
Endometriosis B-Disease
. O

MiR B-RNA
- I-RNA
185 I-RNA
Targets O
the O
DNA O
Methyltransferases O
1 O
and O
Regulates O
Global O
DNA O
Methylation O
in O
human O
glioma B-Disease
. O

Jumonji O
/ O
Arid1 O
B O
( O
JARID1B O
) O
promotes O
breast B-Disease
tumor I-Disease
cell O
cycle O
progression O
through O
epigenetic O
repression O
of O
micro O
RNA O
let B-RNA
- I-RNA
7e I-RNA
. O

MiR O
- O
125b O
promotes O
proliferation O
and O
migration O
of O
type O
II O
endometrial B-Disease
carcinoma I-Disease
cells O
through O
targeting O
TP53INP1 O
tumor O
suppressor O
in O
vitro O
and O
in O
vivo O
. O

NIRF O
is O
frequently O
upregulated O
in O
colorectal O
cancer O
and O
its O
oncogenicity O
can O
be O
suppressed O
by O
let B-RNA
- I-RNA
7a I-RNA
microRNA O
. O

Platelets O
in O
Patients O
with O
Premature O
Coronary B-Disease
Artery I-Disease
Disease I-Disease
Exhibit O
Upregulation O
of O
miRNA340 O
* O
and O
miRNA624 O
* O
. O

Silencing O
of O
miR B-RNA
- I-RNA
124 I-RNA
induces O
neuroblastoma B-Disease
SK O
- O
N O
- O
SH O
cell O
differentiation O
, O
cell O
cycle O
arrest O
and O
apoptosis O
through O
promoting O
AHR O
. O

miR B-RNA
- I-RNA
223 I-RNA
is O
overexpressed O
in O
T O
- O
lymphocytes O
of O
early O
rheumatoid B-Disease
arthritis I-Disease
patients O
. O

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR B-RNA
- I-RNA
101 I-RNA
- I-RNA
1 I-RNA
is O
significantly O
associated O
with O
development O
of O
liver B-Disease
cirrhosis I-Disease
and O
hepatocellular B-Disease
carcinoma I-Disease
occurrence O
. O

In O
addition O
, O
rs12375841 O
and O
its O
unique O
haplotype O
( O
ht2 O
) O
in O
miR O
- O
101 O
- O
2 O
show O
significant O
association O
with O
clearance O
of O
hepatitis O
B O
virus O
infection O
. O

RMRP B-RNA
mutations O
that O
lead O
to O
decreased O
RMRP B-RNA
levels O
are O
found O
in O
the O
pleiotropic O
syndrome O
Cartilage B-Disease
Hair I-Disease
Hypoplasia I-Disease
. O

miR B-RNA
- I-RNA
135b I-RNA
mediates O
NPM O
- O
ALK O
- O
driven O
oncogenicity O
and O
renders O
IL O
- O
17 O
- O
producing O
immunophenotype O
to O
anaplastic O
large O
cell O
lymphoma B-Disease
. O

Two O
microRNA O
species O
( O
miR B-RNA
- I-RNA
30e I-RNA
, O
miR B-RNA
- I-RNA
106b I-RNA
) O
were O
up O
- O
regulated O
in O
non O
- O
obese O
individuals O
with O
periodontal B-Disease
disease I-Disease
. O

Upregulation O
of O
micro B-RNA
RNA I-RNA
- I-RNA
146a I-RNA
( O
miRNA B-RNA
- I-RNA
146a I-RNA
) O
, O
a O
marker O
for O
inflammatory O
neurodegeneration O
, O
in O
sporadic O
Creutzfeldt B-Disease
- I-Disease
Jakob I-Disease
disease I-Disease
( O
sCJD O
) O
and O
Gerstmann B-Disease
- I-Disease
Straussler I-Disease
- I-Disease
Scheinker I-Disease
( O
GSS O
) O
syndrome O
. O

HOTAIR B-RNA
is O
causally O
involved O
in O
tumor O
progression O
. O

It O
is O
significantly O
overexpressed O
in O
metastatic O
breast B-Disease
cancer I-Disease
. O

The O
expression O
level O
of O
pir B-RNA
- I-RNA
823 I-RNA
in O
gastric B-Disease
cancer I-Disease
tissues O
was O
significant O
lower O
than O
that O
in O
non O
- O
cancerous O
tissues O
. O

After O
increase O
the O
level O
of O
pir B-RNA
- I-RNA
823 I-RNA
in O
gastric B-Disease
cancer I-Disease
cells O
, O
cell O
growth O
was O
inhibited O
. O

Inhibition O
of O
miR O
- O
15 O
Protects O
Against O
Cardiac O
Ischemic O
Injury O
. O

MiR B-RNA
- I-RNA
485 I-RNA
- I-RNA
5p I-RNA
was O
identified O
in O
these O
analyses O
as O
down O
- O
regulated O
in O
ependymomas O
when O
compared O
to O
normal O
controls O
. O

MiR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
and O
its O
paralogs O
were O
significantly O
overexpressed O
in O
colon B-Disease
tumor I-Disease
. O

Overexpression O
of O
miR B-RNA
- I-RNA
125b I-RNA
, O
a O
Novel O
Regulator O
of O
Innate O
Immunity O
, O
in O
Eosinophilic B-Disease
Chronic I-Disease
Rhinosinusitis I-Disease
with I-Disease
Nasal I-Disease
Polyps I-Disease
. O

Downregulation O
of O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
sensitizes O
glioma B-Disease
cells O
to O
temozolomide O
by O
regulating O
apoptosis O
independently O
of O
p53 O
status O
. O

miR B-RNA
- I-RNA
449a I-RNA
/ I-RNA
b I-RNA
was O
significantly O
down O
- O
regulated O
in O
lung B-Disease
cancer I-Disease
tissues O
compared O
with O
normal O
lung O
tissues O
, O
while O
HDAC1 O
was O
up O
- O
regulated O
in O
lung B-Disease
cancer I-Disease
tissues O
. O

let B-RNA
- I-RNA
7a I-RNA
- I-RNA
2 I-RNA
, O
7a O
- O
3 O
, O
7d O
, O
7f O
- O
2 O
downregulated O
in O
breast B-Disease
cancer I-Disease
. O

MiRNA B-RNA
- I-RNA
9 I-RNA
and O
MiRNA B-RNA
- I-RNA
200a I-RNA
distinguish O
hemangioblastomas O
from O
metastatic O
clear O
cell O
renal O
cell O
carcinomas O
in O
the O
CNS O
. O

Cardiac B-Disease
hypertrophy I-Disease
is O
positively O
regulated O
by O
miR B-RNA
- I-RNA
23a I-RNA
. O

miR B-RNA
- I-RNA
124 I-RNA
suppresses O
multiple O
steps O
of O
breast B-Disease
cancer I-Disease
metastasis O
by O
targeting O
a O
cohort O
of O
pro O
- O
metastatic O
genes O
in O
vitro O
. O

miR B-RNA
- I-RNA
128 I-RNA
and O
miR B-RNA
- I-RNA
27b I-RNA
were O
increased O
in O
naive O
and O
miR O
- O
340 O
in O
memory O
CD4 O
( O
+ O
) O
T O
cells O
from O
patients O
with O
multiple B-Disease
sclerosis I-Disease
, O
inhibiting O
Th2 O
cell O
development O
and O
favouring O
pro O
- O
inflammatory O
Th1 O
responses O
. O

Human O
miR B-RNA
- I-RNA
31 I-RNA
targets O
radixin O
and O
inhibits O
migration O
and O
invasion O
of O
glioma B-Disease
cells O
. O

miR B-RNA
- I-RNA
125b I-RNA
suppresses O
the O
proliferation O
and O
migration O
of O
osteosarcoma B-Disease
cells O
through O
down O
- O
regulation O
of O
STAT3 O
. O

High O
miR B-RNA
- I-RNA
26a I-RNA
and O
low O
CDC2 B-RNA
levels O
associate O
with O
decreased O
EZH2 O
expression O
and O
with O
favorable O
outcome O
on O
tamoxifen O
in O
metastatic O
breast B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
155 I-RNA
regulates O
HGAL O
expression O
and O
increases O
lymphoma B-Disease
cell O
motility O
. O

Histone O
deacetylases O
mediate O
the O
silencing O
of O
miR B-RNA
- I-RNA
15a I-RNA
, O
miR B-RNA
- I-RNA
16 I-RNA
and O
miR B-RNA
- I-RNA
29b I-RNA
in O
chronic B-Disease
lymphocytic I-Disease
leukemia I-Disease
. O

We O
found O
that O
miR B-RNA
- I-RNA
34a I-RNA
expression O
was O
down O
- O
regulated O
in O
5 O
breast B-Disease
cancer I-Disease
cell O
lines O
compared O
with O
the O
immortalized O
normal O
mammary O
epithelial O
cell O
line O
184A1 O
, O
and O
was O
also O
down O
- O
regulated O
by O
almost O
50 O
% O
in O
breast B-Disease
cancer I-Disease
samples O
compared O
with O
their O
corresponding O
adjacent O
non O
- O
malignant O
breast O
tissues O
. O

The O
miR B-RNA
- I-RNA
143 I-RNA
/ I-RNA
- I-RNA
145 I-RNA
cluster O
regulates O
plasminogen O
activator O
inhibitor O
- O
1 O
in O
bladder B-Disease
cancer I-Disease
. O

MiR B-RNA
- I-RNA
23b I-RNA
, O
which O
is O
downregulated O
in O
human O
colon B-Disease
cancer I-Disease
samples O
, O
potently O
mediates O
the O
multiple O
steps O
of O
metastasis O
, O
including O
tumour O
growth O
, O
invasion O
and O
angiogenesis O
in O
vivo O
. O

Establishment O
of O
a O
Novel O
Permissive O
Cell O
Line O
for O
the O
Propagation O
of O
Hepatitis B-Disease
C I-Disease
Virus O
by O
Expression O
of O
microRNA O
miR122 B-RNA
. O

The O
miRNA B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
mediates O
chemoresistance O
and O
enhances O
tumor O
growth O
in O
mantle B-Disease
cell I-Disease
lymphoma I-Disease
via O
PI3K O
/ O
AKT O
pathway O
activation O
. O

Increased O
expression O
of O
miR B-RNA
- I-RNA
21 I-RNA
, O
mir B-RNA
- I-RNA
135a I-RNA
and O
miR B-RNA
- I-RNA
335 I-RNA
was O
associated O
with O
clinical O
progression O
of O
CRC O
( O
colorectal B-Disease
cancer I-Disease
) O
, O
while O
miR O
- O
206 O
demonstrated O
an O
opposite O
trend O
. O

MiR B-RNA
- I-RNA
27b I-RNA
targets O
PPARgamma O
to O
inhibit O
growth O
, O
tumor O
progression O
and O
the O
inflammatory O
response O
in O
neuroblastoma B-Disease
cells O
. O

miR O
- O
1915 O
inhibits O
Bcl O
- O
2 O
to O
modulate O
multidrug O
resistance O
by O
increasing O
drug O
- O
sensitivity O
in O
human O
colorectal B-Disease
carcinoma I-Disease
cells O
. O

Silencing O
of O
miR B-RNA
- I-RNA
124 I-RNA
induces O
neuroblastoma B-Disease
SK O
- O
N O
- O
SH O
cell O
differentiation O
, O
cell O
cycle O
arrest O
and O
apoptosis O
through O
promoting O
AHR O
. O

The O
expression O
of O
miR B-RNA
- I-RNA
206 I-RNA
is O
increased O
in O
muscular B-Disease
dystrophy I-Disease
. O

Increased O
serum O
levels O
of O
miR B-RNA
- I-RNA
1266 I-RNA
in O
patients O
with O
psoriasis B-Disease
vulgaris O
. O

The O
opposite O
cellular O
effects O
of O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
on O
VSMCs O
and O
ECs O
may O
have O
important O
therapeutic O
applications O
in O
many O
vascular O
diseases O
such O
as O
atherosclerosis B-Disease
and O
restenosis O
after O
angioplasty O
. O

MiR B-RNA
- I-RNA
135a I-RNA
functions O
as O
a O
selective O
killer O
of O
malignant O
glioma B-Disease
. O

Increased O
miRNA B-RNA
- I-RNA
146a I-RNA
and O
miRNA B-RNA
- I-RNA
155 I-RNA
expressions O
in O
oral O
lichen B-Disease
planus I-Disease
. O

MiR23b B-RNA
Ameliorates O
Neuropathic B-Disease
Pain I-Disease
in O
Spinal O
Cord O
by O
Silencing O
NOX4 O
. O

These O
effects O
of O
miR B-RNA
- I-RNA
30e I-RNA
* I-RNA
were O
shown O
to O
be O
clinically O
relevant O
, O
as O
miR B-RNA
- I-RNA
30e I-RNA
* I-RNA
was O
found O
to O
be O
upregulated O
in O
primary O
human O
glioma B-Disease
cells O
and O
correlated O
with O
malignant O
progression O
and O
poor O
survival O
. O

MicroRNA O
Profiling O
Identifies O
miR O
- O
29 O
as O
a O
Regulator O
of O
Disease O
- O
Associated O
Pathways O
in O
Experimental O
Biliary B-Disease
Atresia I-Disease
. O

Interferon O
regulatory O
factor O
3 O
inhibits O
astrocyte O
inflammatory B-Disease
gene O
expression O
through O
suppression O
of O
the O
proinflammatory O
miR B-RNA
- I-RNA
155 I-RNA
and O
miR B-RNA
- I-RNA
155 I-RNA
* I-RNA
. O

MiR B-RNA
- I-RNA
335 I-RNA
is O
Required O
for O
Differentiation O
of O
Malignant O
Glioma B-Disease
Cells O
Induced O
by O
Activation O
of O
cAMP O
/ O
PKA O
Pathway O
. O

Novel O
oncogenic O
function O
of O
mesoderm O
development O
candidate O
1 O
and O
its O
regulation O
by O
MiR B-RNA
- I-RNA
574 I-RNA
- I-RNA
3p I-RNA
in O
bladder B-Disease
cancer I-Disease
cell O
lines O
. O

Schizophrenia B-Disease
- O
associated O
genes O
CSMD1 O
, O
C10orf26 O
, O
CACNA1C O
and O
TCF4 O
are O
miR B-RNA
- I-RNA
137 I-RNA
targets O
. O

a O
screening O
of O
micro O
- O
RNA O
( O
miRNA O
) O
from O
Down O
' O
s O
syndrome O
brain O
and O
peripheral O
tissues O
indicated O
an O
upregulation O
of O
a O
chromosome O
21 O
- O
encoded O
miRNA O
- O
155 O
and O
a O
decrease O
in O
the O
abundance O
of O
the O
miRNA O
- O
155 O
mRNA O
target O
complement O
factor O
H O
( O
CFH O
) O
, O
an O
important O
repressor O
of O
the O
innate O
immune O
response O
. O

miR B-RNA
- I-RNA
20a I-RNA
increases O
the O
metastatic O
potential O
of O
osteosarcoma B-Disease
cells O
by O
regulating O
Fas O
expression O
. O

Thus O
, O
the O
miR B-RNA
- I-RNA
200 I-RNA
family O
members O
participate O
importantly O
in O
fibrotic O
lung B-Disease
diseases I-Disease
and O
suggest O
that O
restoring O
miR B-RNA
- I-RNA
200 I-RNA
expression O
in O
the O
lungs O
may O
represent O
a O
novel O
therapeutic O
approach O
in O
treating O
pulmonary O
fibrotic O
diseases O
. O

Our O
preliminary O
study O
suggests O
that O
miR B-RNA
- I-RNA
34a I-RNA
, O
although O
having O
a O
role O
in O
late O
tumorigenesis O
, O
does O
not O
contribute O
to O
the O
inherited O
susceptibility O
to O
cutaneous O
melanoma B-Disease
. O

miR B-RNA
- I-RNA
20a I-RNA
, O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
106a I-RNA
, O
miR B-RNA
- I-RNA
181b I-RNA
, O
miR B-RNA
- I-RNA
203 I-RNA
, O
and O
miR B-RNA
- I-RNA
324 I-RNA
- I-RNA
5p I-RNA
were O
stable O
in O
colorectal B-Disease
cancer I-Disease
archival O
tissue O
blocks O
. O

miR B-RNA
- I-RNA
181a I-RNA
* I-RNA
: O
downregulated O
during O
human O
leukemic B-Disease
HL O
- O
60 O
cell O
differentiation O
induced O
by O
4 O
- O
hydroxynonenal O

Treatment O
with O
1 O
, O
25 O
( O
OH O
) O
( O
2 O
) O
D O
( O
3 O
) O
and O
/ O
or O
epigenetic O
drugs O
( O
5 O
- O
Aza O
, O
TSA O
) O
reduced O
the O
miR B-RNA
- I-RNA
27b I-RNA
expression O
in O
three O
out O
of O
four O
melanoma B-Disease
cell O
lines O
. O

GATA4 O
expression O
is O
primarily O
regulated O
via O
a O
miR B-RNA
- I-RNA
26b I-RNA
- O
dependent O
post O
- O
transcriptional O
mechanism O
during O
cardiac B-Disease
hypertrophy I-Disease
. O

Expression O
of O
NPAS3 O
in O
the O
Human O
Cortex O
is O
regulated O
by O
miR B-RNA
- I-RNA
17 I-RNA
During O
Development O
and O
has O
Implications O
for O
Schizophrenia B-Disease
. O

We O
first O
demonstrated O
that O
MEG3 B-RNA
expression O
was O
markedly O
decreased O
in O
glioma B-Disease
tissues O
compared O
with O
adjacent O
normal O
tissues O
. O

miR B-RNA
- I-RNA
122 I-RNA
regulates O
p53 O
/ O
Akt O
signalling O
and O
the O
chemotherapy O
- O
induced O
apoptosis O
in O
cutaneous O
T O
- O
cell O
lymphoma B-Disease
. O

A O
de O
novo O
balanced O
t O
( O
2 O
, O
6 O
) O
( O
p15 O
, O
p22 O
. O
3 O
) O
in O
a O
patient O
with O
West B-Disease
Syndrome I-Disease
disrupts O
a O
lnc O
- O
RNA O
, O
BX118339 B-RNA
. O

Loss O
of O
SHIP B-RNA
- I-RNA
1 I-RNA
protein O
expression O
in O
high O
- O
risk O
myelodysplastic O
syndromes O
is O
associated O
with O
miR B-RNA
- I-RNA
210 I-RNA
and O
miR B-RNA
- I-RNA
155 I-RNA
. O

MiR O
- O
663 O
, O
a O
microRNA O
targeting O
p21 O
( O
WAF1 O
/ O
CIP1 O
) O
, O
promotes O
the O
proliferation O
and O
tumorigenesis O
of O
nasopharyngeal B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
21 I-RNA
inhibitor O
sensitizes O
human O
OSCC O
( O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
) O
cells O
to O
cisplatin O
. O

let B-RNA
- I-RNA
7a I-RNA
- I-RNA
2 I-RNA
, O
7a O
- O
3 O
, O
7d O
, O
7f O
- O
2 O
downregulated O
in O
breast B-Disease
cancer I-Disease

Loss O
of O
brain O
- O
enriched O
miR B-RNA
- I-RNA
124 I-RNA
enhances O
the O
stem O
- O
like O
traits O
and O
invasiveness O
of O
glioma B-Disease
cells O
. O

In O
this O
study O
, O
we O
identified O
frequent O
upregulation O
of O
miR B-RNA
- I-RNA
196a I-RNA
and O
lincRNA O
HOTAIR B-RNA
in O
high O
- O
risk O
gastrointestinal B-Disease
stromal I-Disease
tumors I-Disease
( O
GIST O
) O
. O

Epstein O
- O
Barr O
virus O
latent O
membrane O
protein O
- O
1 O
protects O
B O
- O
cell O
lymphoma B-Disease
from O
rituximab O
- O
induced O
apoptosis O
through O
miR B-RNA
- I-RNA
155 I-RNA
- O
mediated O
Akt O
activation O
and O
up O
- O
regulation O
of O
Mcl O
- O
1 O
. O

Over O
- O
expression O
of O
miR B-RNA
- I-RNA
145 I-RNA
enhances O
the O
effectiveness O
of O
HSVtk O
gene O
therapy O
for O
malignant O
glioma B-Disease
. O

MiR B-RNA
- I-RNA
221 I-RNA
promotes O
cardiac O
hypertrophy B-Disease
in O
vitro O
through O
the O
modulation O
of O
p27 O
expression O
. O

miR B-RNA
- I-RNA
181a I-RNA
* I-RNA
: O
downregulated O
during O
human O
leukemic O
HL O
- O
60 O
cell O
differentiation O
induced O
by O
4 O
- O
hydroxynonenal O

Levels O
of O
miR B-RNA
- I-RNA
21 I-RNA
and O
let B-RNA
- I-RNA
7a I-RNA
microRNA O
were O
significantly O
higher O
in O
cholesteatoma B-Disease
tissue O
compared O
with O
normal O
skin O
, O
especially O
in O
paediatric O
patients O
. O

Loss O
of O
miR B-RNA
- I-RNA
133a I-RNA
expression O
associated O
with O
poor O
survival O
of O
breast B-Disease
cancer I-Disease
and O
restoration O
of O
miR B-RNA
- I-RNA
133a I-RNA
expression O
inhibited O
breast B-Disease
cancer I-Disease
cell O
growth O
and O
invasion O
. O

miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
is O
the O
regulator O
of O
Cx43 B-RNA
expression O
in O
human O
glioblastoma B-Disease
cells O
. O

miR B-RNA
- I-RNA
200b I-RNA
is O
involved O
in O
intestinal O
fibrosis O
of O
Crohn B-Disease
' I-Disease
s I-Disease
disease I-Disease
. O

Serum O
miR B-RNA
- I-RNA
16 I-RNA
, O
miR B-RNA
- I-RNA
25 I-RNA
, O
miR B-RNA
- I-RNA
222 I-RNA
and O
miR B-RNA
- I-RNA
324 I-RNA
- I-RNA
3p I-RNA
that O
were O
consistently O
differentially O
expressed O
between O
breast B-Disease
cancer I-Disease
cases O
and O
controls O
. O

miR B-RNA
- I-RNA
125b I-RNA
and I-RNA
miR I-RNA
- I-RNA
146a I-RNA
regulate O
Complement O
Factor O
H O
( O
CFH O
) O
in O
Alzheimer O
' O
s O
Disease O
( O
AD O
) O
Brain O
. O

The O
authors O
propose O
miR B-RNA
- I-RNA
31 I-RNA
and O
- O
375 O
as O
novel O
candidate O
microRNAs O
specifically O
associated O
with O
early O
- O
and O
late O
- O
stage O
malignant O
progression O
, O
respectively O
, O
in O
Barrett B-Disease
' I-Disease
s I-Disease
esophagus I-Disease
. O

The O
levels O
of O
miRNAs O
in O
normal O
lung O
tissue O
and O
lung O
tumors O
were O
compared O
; O
miR B-RNA
- I-RNA
27b I-RNA
and O
miR B-RNA
- I-RNA
134 I-RNA
levels O
were O
significantly O
lower O
in O
the O
tumors O
than O
normal O
tissue O
( O
3 O
. O
64 O
 O
4 O
. O
2 O
versus O
9 O
. O
75 O
 O
6 O
. O
58 O
and O
0 O
. O
64 O
 O
0 O
. O
75 O
versus O
1 O
. O
48 O
 O
1 O
. O
39 O
) O
. O

MiR B-RNA
- I-RNA
205 I-RNA
determines O
the O
radioresistance O
of O
human O
nasopharyngeal B-Disease
carcinoma I-Disease
by O
directly O
targeting O
PTEN O
. O

Histone O
deacetylase O
inhibition O
in O
colorectal B-Disease
cancer I-Disease
cells O
reveals O
competing O
roles O
for O
members O
of O
the O
oncogenic O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
. O

Downregulated O
expression O
of O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
181c I-RNA
in O
Fanconi B-Disease
anemia I-Disease
patients O
: O
implications O
in O
TNF O
- O
 O
regulation O
and O
proliferation O
of O
hematopoietic O
progenitor O
cells O
. O

MiR B-RNA
- I-RNA
135a I-RNA
targets O
JAK2 O
and O
inhibits O
gastric B-Disease
cancer I-Disease
cell O
proliferation O
. O

These O
findings O
demonstrate O
the O
importance O
of O
miR B-RNA
- I-RNA
1 I-RNA
in O
cardiac O
function O
and O
in O
the O
pathogenesis O
of O
heart B-Disease
failure I-Disease
via O
Sorcin O
- O
dependent O
calcium O
homeostasis O
. O

Progestin O
treatment O
decreases O
miR O
- O
29 O
, O
thereby O
relieving O
repression O
of O
one O
of O
its O
direct O
targets O
, O
the O
gene O
encoding O
ATPase O
, O
Na O
( O
+ O
) O
/ O
K O
( O
+ O
) O
transporting O
, O
beta O
1 O
polypeptide O
( O
ATP1B1 O
) O
. O

ATP1B1 O
serves O
to O
limit O
migration O
and O
invasion O
in O
breast B-Disease
cancer I-Disease
cells O
. O

Lastly O
, O
the O
authors O
demonstrate O
that O
PR O
itself O
is O
regulated O
by O
a O
progestin O
- O
upregulated O
miRNA O
, O
miR O
- O
513a O
- O
5p O
, O
providing O
a O
novel O
mechanism O
for O
tight O
control O
of O
PR O
protein O
expression O
. O

miR B-RNA
- I-RNA
124 I-RNA
, O
miR B-RNA
- I-RNA
147 I-RNA
and O
miR B-RNA
- I-RNA
193a I-RNA
- I-RNA
3p I-RNA
are O
three O
novel O
tumor O
suppressors O
that O
co O
- O
target O
EGFR O
- O
driven O
cell O
- O
cycle O
network O
proteins O
and O
inhibit O
cell O
- O
cycle O
progression O
and O
proliferation O
in O
breast O
cancer O
. O

Regulation O
of O
p14ARF B-RNA
expression O
by O
miR B-RNA
- I-RNA
24 I-RNA
: O
a O
potential O
mechanism O
compromising O
the O
p53 O
response O
during O
retinoblastoma B-Disease
development O
. O

miRNA B-RNA
- I-RNA
141 I-RNA
is O
a O
novel O
regulator O
of O
BMP O
- O
2 O
- O
mediated O
calcification O
in O
aortic B-Disease
stenosis I-Disease
. O

Insulin O
- O
like O
Growth O
Factor O
2 O
/ O
H19 B-RNA
Methylation O
at O
Birth O
and O
Risk O
of O
Overweight O
and O
Obesity B-Disease
in O
Children O
. O

MiR B-RNA
- I-RNA
196a I-RNA
Is O
Up O
- O
regulated O
in O
Gastric B-Disease
cancer I-Disease
and O
Promotes O
Cell O
proliferation O
by O
Down O
- O
regulating O
p27kip1 O
. O

Microarray O
analysis O
showed O
that O
serum O
miR B-RNA
- I-RNA
297 I-RNA
and O
miR O
- O
574 O
- O
5p O
were O
differentially O
expressed O
in O
sepsis B-Disease
survivors O
and O
nonsurvivors O
. O

Inhibition O
of O
mir B-RNA
- I-RNA
31 I-RNA
in O
aspc O
- O
1 O
and O
hpaf O
- O
ii O
pancreatic B-Disease
cancer I-Disease
cells O
with O
high O
endogenous O
expression O
and O
forced O
expression O
of O
miR B-RNA
- I-RNA
31 I-RNA
in O
MIA O
PaCa O
- O
2 O
with O
low O
endogenous O
levels O
led O
to O
reduced O
cell O
proliferation O
, O
migration O
, O
and O
invasion O
. O

Consistent O
with O
the O
RNA O
- O
seq O
results O
, O
PCA3 B-RNA
, O
FR0348383 B-RNA
and O
MALAT1 B-RNA
overexpression O
was O
found O
in O
80 O
% O
( O
32 O
/ O
40 O
) O
, O
72 O
. O
5 O
% O
( O
29 O
/ O
40 O
) O
, O
and O
82 O
. O
5 O
% O
( O
33 O
/ O
40 O
) O
of O
the O
prostate B-Disease
cancers I-Disease
respectively O
, O
whereas O
decreased O
FR0257520 O
expression O
was O
found O
in O
82 O
. O
5 O
% O
( O
33 O
/ O
40 O
) O
of O
the O
prostate B-Disease
cancers I-Disease
. O

MiR B-RNA
- I-RNA
155 I-RNA
is O
a O
liposarcoma B-Disease
oncogene O
that O
targets O
casein O
kinase O
- O
1 O
 O
and O
enhances O
 O
- O
catenin O
signaling O
. O

MicroRNA O
Let B-RNA
- I-RNA
7i I-RNA
is O
a O
Promising O
Serum O
Biomarker O
for O
Blast O
Induced O
Traumatic O
Brain O
Injury O
. O

Ursolic O
Acid O
Inhibits O
Proliferation O
and O
Induces O
Apoptosis O
in O
Human O
Glioblastoma B-Disease
Cell O
Lines O
U251 O
by O
Suppressing O
TGF O
- O
beta1 O
/ O
miR B-RNA
- I-RNA
21 I-RNA
/ O
PDCD4 O
Pathway O
. O

miR B-RNA
- I-RNA
196b I-RNA
directly O
targets O
both O
HOXA9 O
/ O
MEIS1 O
oncogenes O
and O
FAS O
tumour O
suppressor O
in O
MLL O
- O
rearranged O
leukaemia O
. O

miR B-RNA
- I-RNA
196a I-RNA
Downregulation O
Increases O
the O
Expression O
of O
Type O
I O
and O
III O
Collagens O
in O
Keloid B-Disease
Fibroblasts O
. O

MiR B-RNA
- I-RNA
138 I-RNA
induces O
cell O
cycle O
arrest O
by O
targeting O
cyclin O
D3 O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

Additionally O
, O
the O
relative O
ratio O
of O
SRA B-RNA
/ O
SRAP B-RNA
expression O
differs O
in O
breast B-Disease
cancer I-Disease
tumor O
cells O
, O
with O
higher O
recovery O
rates O
for O
patients O
for O
whom O
SRAP B-RNA
is O
overexpressed O
. O

MicroRNA B-RNA
146a I-RNA
( O
miR B-RNA
- I-RNA
146a I-RNA
) O
Is O
Over O
- O
Expressed O
during O
Prion O
Disease O
and O
Modulates O
the O
Innate O
Immune O
Response O
and O
the O
Microglial O
Activation O
State O
. O

Oncomir O
miR B-RNA
- I-RNA
125b I-RNA
regulates O
hematopoiesis B-Disease
by O
targeting O
the O
gene O
Lin28A O
. O

miR B-RNA
- I-RNA
206 I-RNA
was O
significantly O
up O
- O
regulated O
in O
prolactinomas O
following O
bromocriptine O
treatment O
. O

Repression O
of O
miR B-RNA
- I-RNA
142 I-RNA
by O
p300 O
and O
MAPK O
is O
required O
for O
survival O
signaling O
via O
gp130 O
during O
adaptive O
hypertrophy B-Disease
. O

Both O
miR B-RNA
- I-RNA
508 I-RNA
- I-RNA
3p I-RNA
and O
miR B-RNA
- I-RNA
509 I-RNA
- I-RNA
3p I-RNA
were O
down O
- O
regulated O
in O
renal B-Disease
cancer I-Disease
tissues O
. O

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR B-RNA
- I-RNA
101 I-RNA
- I-RNA
1 I-RNA
is O
significantly O
associated O
with O
development O
of O
liver O
cirrhosis O
and O
hepatocellular O
carcinoma O
occurrence O
. O

Real O
- O
time O
PCR O
approach O
confirmed O
that O
mir B-RNA
- I-RNA
155 I-RNA
, O
miR B-RNA
- I-RNA
181a I-RNA
and O
miR B-RNA
- I-RNA
222 I-RNA
were O
down O
- O
expressed O
in O
mesenchymal O
stromal O
cells O
from O
myelodysplastic B-Disease
syndrome I-Disease
patients O
. O

Secreted O
miRNAs O
( O
miR B-RNA
- I-RNA
143 I-RNA
/ O
145 O
) O
suppress O
atherogenesis O
. O

miR B-RNA
- I-RNA
15b I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
regulate O
TNF O
mediated O
hepatocyte O
apoptosis O
via O
BCL2 O
in O
acute O
liver B-Disease
failure I-Disease
. O

MiR B-RNA
- I-RNA
205 I-RNA
determines O
the O
radioresistance O
of O
human O
nasopharyngeal B-Disease
carcinoma I-Disease
by O
directly O
targeting O
PTEN O
. O

Real O
- O
time O
RT O
- O
PCR O
analysis O
demonstrated O
an O
increase O
in O
mir B-RNA
- I-RNA
21 I-RNA
and O
mir B-RNA
- I-RNA
302 I-RNA
expression O
level O
in O
CSCs B-Disease
( O
cancer O
stem O
cells O
) O
, O
relative O
to O
cancer O
cells O
, O
whereas O
let O
- O
7a O
expression O
level O
was O
decreased O
in O
CSC O
in O
comparison O
with O
cancer O
cells O
. O

Anril O
splicing O
variants O
play O
a O
role O
in O
coordinating O
tissue O
remodeling O
, O
by O
modulating O
the O
expression O
of O
genes O
involved O
in O
cell O
proliferation O
, O
apoptosis O
, O
extra O
- O
cellular O
matrix O
remodeling O
and O
inflammatory O
response O
to O
finally O
impact O
in O
the O
risk O
of O
cardiovascular O
disease O
and O
other O
pathologies O
. O

MiRNA B-RNA
- I-RNA
335 I-RNA
Suppresses O
Neuroblastoma B-Disease
Cell O
Invasiveness O
By O
Direct O
Targeting O
of O
Multiple O
Genes O
from O
the O
non O
- O
Canonical O
TGF O
- O
 O
Signalling O
Pathway O
. O

Upregulation O
of O
mir B-RNA
- I-RNA
506 I-RNA
leads O
to O
decreased O
AE2 O
expression O
in O
biliary O
epithelium O
of O
patients O
with O
primary B-Disease
biliary I-Disease
cirrhosis I-Disease

The O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
and O
its O
target O
THBS1 O
are O
differentially O
expressed O
in O
angiosarcomas O
dependent O
on O
MYC O
amplification O
. O

The O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
and O
its O
target O
THBS1 O
are O
differentially O
expressed O
in O
angiosarcomas B-Disease
dependent O
on O
MYC O
amplification O
. O

Overexpression O
of O
the O
lincRNA O
HOTAIR B-RNA
in O
breast O
and O
colorectal B-Disease
cancers I-Disease
is O
associated O
with O
increased O
PRC2 O
activity O
and O
an O
altered O
H3K27me3 O
distribution O
, O
and O
correlates O
with O
metastasis O
and O
a O
poor O
prognosis O
. O

The O
prostate B-Disease
cancer I-Disease
associated O
long O
ncRNA O
, O
PCAT B-RNA
- I-RNA
1 I-RNA
, O
is O
correlated O
with O
aggressive O
prostate B-Disease
cancer I-Disease
, O
and O
appears O
to O
have O
a O
prostate O
specific O
role O
in O
regulating O
cell O
proliferation O
. O

We O
thus O
identify O
let B-RNA
- I-RNA
7g I-RNA
as O
a O
unique O
member O
of O
the O
let O
- O
7 O
miRNA O
family O
which O
can O
serve O
as O
a O
prognostic O
biomarker O
in O
breast B-Disease
cancer I-Disease
and O
also O
propose O
a O
paradigm O
utilized O
by O
specific O
signaling O
molecules O
via O
let B-RNA
- I-RNA
7g I-RNA
to O
cooperatively O
promote O
breast B-Disease
cancer I-Disease
invasion O
and O
metastasis O
. O

Let B-RNA
- I-RNA
7b I-RNA
is O
a O
novel O
regulator O
of O
hepatitis B-Disease
C I-Disease
virus O
replication O
. O

Decrease O
of O
miR B-RNA
- I-RNA
146b I-RNA
- I-RNA
5p I-RNA
in O
Monocytes O
during O
Obesity B-Disease
Is O
Associated O
with O
Loss O
of O
the O
Anti O
- O
Inflammatory O
but O
Not O
Insulin O
Signaling O
Action O
of O
Adiponectin O
. O

We O
have O
presented O
expression O
microarray O
data O
showing O
that O
an O
increase O
in O
CRNDE B-RNA
expression O
is O
an O
early O
event O
in O
colorectal B-Disease
neoplasia I-Disease
, O
its O
transcription O
being O
elevated O
in O
> O
90 O
% O
of O
colorectal O
adenomas O
and O
adenocarcinomas O
. O

A O
distinct O
set O
of O
five O
microRNAs O
( O
miR B-RNA
- I-RNA
150 I-RNA
, O
miR B-RNA
- I-RNA
550 I-RNA
, O
miR B-RNA
- I-RNA
124a I-RNA
, O
miR B-RNA
- I-RNA
518b I-RNA
and O
miR B-RNA
- I-RNA
539 I-RNA
) O
was O
shown O
to O
be O
differentially O
expressed O
in O
gastritis O
as O
opposed O
to O
MALT O
lymphoma B-Disease
. O

The O
down O
- O
regulation O
of O
miR B-RNA
- I-RNA
25 I-RNA
and O
miR B-RNA
- I-RNA
30d I-RNA
could O
contribute O
to O
the O
process O
of O
thyroid O
cancer O
progression O
, O
leading O
to O
the O
development O
of O
anaplastic O
carcinomas O
targeting O
EZH2 B-RNA
mRNA O
. O

Based O
on O
the O
microarray O
data O
, O
the O
authors O
found O
frequent O
and O
marked O
overexpression O
of O
miR B-RNA
- I-RNA
10a I-RNA
, O
miR B-RNA
- I-RNA
92 I-RNA
, O
and O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
in O
pancreatic B-Disease
cancer I-Disease
cell O
lines O
. O

MiR B-RNA
- I-RNA
21 I-RNA
is O
up O
- O
regulated O
in O
psoriasis O
and O
suppresses O
T B-Disease
cell I-Disease
apoptosis I-Disease
. O

MiR B-RNA
- I-RNA
196a I-RNA
Is O
Up O
- O
regulated O
in O
Gastric B-Disease
cancer I-Disease
and O
Promotes O
Cell O
proliferation O
by O
Down O
- O
regulating O
p27kip1 O
. O

miR B-RNA
- I-RNA
143 I-RNA
, O
miR B-RNA
- I-RNA
222 I-RNA
, O
and O
miR B-RNA
- I-RNA
452 I-RNA
Are O
Useful O
as O
Tumor O
Stratification O
and O
Noninvasive O
Diagnostic O
Biomarkers O
for O
Bladder B-Disease
Cancer I-Disease
. O

miR B-RNA
- I-RNA
192 I-RNA
, O
miR B-RNA
- I-RNA
215 I-RNA
and O
miR B-RNA
- I-RNA
194 I-RNA
had O
a O
significantly O
lower O
expression O
in O
nephroblastomas B-Disease
regardless O
of O
the O
subtype O
compared O
with O
mature O
kidney O
measured O
by O
quantitative O
real O
- O
time O
- O
PCR O
. O

miR B-RNA
- I-RNA
192 I-RNA
, O
miR B-RNA
- I-RNA
194 I-RNA
, O
miR B-RNA
- I-RNA
215 I-RNA
, O
miR B-RNA
- I-RNA
200c I-RNA
and O
miR B-RNA
- I-RNA
141 I-RNA
are O
downregulated O
and O
their O
common O
target O
ACVR2B O
is O
strongly O
expressed O
in O
renal O
childhood O
neoplasms B-Disease
. O

miR B-RNA
- I-RNA
181b I-RNA
Promotes O
hepatic O
stellate O
cells O
proliferation O
by O
targeting O
p27 O
and O
is O
elevated O
in O
the O
serum O
of O
cirrhosis B-Disease
patients O
. O

Pure O
curcumin O
decreases O
the O
expression O
of O
WT1 O
by O
upregulation O
of O
miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
in O
leukemic O
cells O
. O

AntagomiR O
directed O
against O
miR B-RNA
- I-RNA
20a I-RNA
restores O
functional O
BMPR2 O
signalling O
and O
prevents O
vascular O
remodelling O
in O
hypoxia O
- O
induced O
pulmonary O
hypertension B-Disease
. O

In O
both O
murine O
and O
human O
leukemias O
, O
p53 O
inactivation O
contributed O
to O
the O
selective O
overexpression O
of O
oncogenic O
miR B-RNA
- I-RNA
92a I-RNA
and O
miR B-RNA
- I-RNA
19a I-RNA
, O
and O
down O
- O
regulation O
of O
tumor O
- O
suppressive O
miR O
- O
17 O
. O

In O
both O
murine O
and O
human O
leukemias O
, O
p53 O
inactivation O
contributed O
to O
the O
selective O
overexpression O
of O
oncogenic O
miR O
- O
92a O
and O
miR O
- O
19a O
, O
and O
down O
- O
regulation O
of O
tumor O
- O
suppressive O
miR B-RNA
- I-RNA
17 I-RNA
. O

Cellular O
MicroRNA O
let B-RNA
- I-RNA
7c I-RNA
Inhibits O
M1 O
Protein O
Expression O
of O
the O
H1N1 O
Influenza B-Disease
A O
Virus O
in O
Infected O
Human O
Lung O
Epithelial O
Cells O
. O

MiR B-RNA
- I-RNA
125b I-RNA
promotes O
proliferation O
and O
migration O
of O
type O
II O
endometrial B-Disease
carcinoma I-Disease
cells O
through O
targeting O
TP53INP1 O
tumor O
suppressor O
in O
vitro O
and O
in O
vivo O
. O

miR B-RNA
- I-RNA
15a I-RNA
and O
16 O
- O
1 O
are O
downregulated O
in O
CD4 O
( O
+ O
) O
T O
cells O
of O
multiple B-Disease
sclerosis I-Disease
relapsing O
patients O
. O

MiR B-RNA
- I-RNA
483 I-RNA
- I-RNA
5p I-RNA
suppresses O
the O
proliferation O
of O
glioma B-Disease
cells O
via O
directly O
targeting O
ERK1 O
. O

The O
expression O
of O
serum O
let B-RNA
- I-RNA
7e I-RNA
, O
miR B-RNA
- I-RNA
151 I-RNA
- I-RNA
5p I-RNA
, O
and O
miR B-RNA
- I-RNA
222 I-RNA
was O
significantly O
increased O
in O
PTC B-Disease
( O
papillary O
thyroid O
carcinomas O
) O
cases O
relative O
to O
benign O
cases O
and O
healthy O
controls O
. O

Stmn1 O
is O
a O
putative O
downstream O
target O
of O
mir B-RNA
- I-RNA
223 I-RNA
in O
gastric B-Disease
cancer I-Disease
. O

The O
driving O
miRNAs O
were O
miR B-RNA
- I-RNA
195 I-RNA
, O
miR B-RNA
- I-RNA
1280 I-RNA
, O
miR B-RNA
- I-RNA
140 I-RNA
- I-RNA
3p I-RNA
and O
miR B-RNA
- I-RNA
1246 I-RNA
in O
colorectal O
tumors O
. O

Serial O
selection O
for O
invasiveness O
increases O
expression O
of O
miR B-RNA
- I-RNA
143 I-RNA
/ O
miR B-RNA
- I-RNA
145 I-RNA
in O
glioblastoma B-Disease
cell O
lines O
. O

The O
lncRNA O
, O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
, O
which O
is O
up O
- O
regulated O
in O
human O
melanomas B-Disease
compared O
to O
melanocytes O
and O
keratinocytes O
, O
affects O
cell O
dynamics O
, O
including O
increased O
rate O
of O
wound O
closure O
upon O
ectopic O
expression O
. O

The O
levels O
of O
miR B-RNA
- I-RNA
10b I-RNA
and O
miR B-RNA
- I-RNA
21 I-RNA
are O
found O
significantly O
increased O
in O
the O
CSF O
( O
cerebrospinal O
fluid O
) O
of O
patients O
with O
glioblastoma B-Disease
and O
brain B-Disease
metastasis I-Disease
of I-Disease
breast I-Disease
and I-Disease
lung I-Disease
cancer I-Disease
, O
compared O
with O
tumors O
in O
remission O
and O
a O
variety O
of O
nonneoplastic O
conditions O
. O

The O
levels O
of O
miR B-RNA
- I-RNA
10b I-RNA
and O
miR B-RNA
- I-RNA
21 I-RNA
are O
found O
significantly O
increased O
in O
the O
CSF O
( O
cerebrospinal O
fluid O
) O
of O
patients O
with O
glioblastoma B-Disease
and O
brain O
metastasis O
of O
breast O
and O
lung O
cancer O
, O
compared O
with O
tumors O
in O
remission O
and O
a O
variety O
of O
nonneoplastic O
conditions O
. O

miR B-RNA
- I-RNA
133a I-RNA
in O
circulating O
monocytes O
is O
a O
potential O
biomarker O
for O
postmenopausal O
osteoporosis B-Disease
. O

miR B-RNA
- I-RNA
133a I-RNA
in O
circulating O
monocytes O
is O
a O
potential O
biomarker O
for O
postmenopausal B-Disease
osteoporosis I-Disease
. O

Decreased O
miR B-RNA
- I-RNA
181a I-RNA
Expression O
in O
Monocytes O
of O
Obese O
Patients O
Is O
Associated O
with O
the O
Occurrence O
of O
Metabolic O
Syndrome O
and O
Coronary B-Disease
Artery I-Disease
Disease I-Disease
. O

Genetic O
polymorphisms O
of O
IL17A B-RNA
( O
( O
rs2275913 O
( O
- O
197 O
G O
> O
A O
) O
, O
rs3748067 O
( O
* O
1249 O
C O
> O
T O
) O
) O
and O
pri B-RNA
- I-RNA
microRNA I-RNA
- I-RNA
938 I-RNA
( O
pri O
- O
miR O
- O
938 O
, O
rs2505901 O
( O
T O
> O
C O
) O
. O
) O
, O
targeting O
IL17A B-RNA
3 O
' O
- O
UTR O
, O
influence O
susceptibility O
to O
gastric O
cancer O
. O

Downregulated O
miR B-RNA
- I-RNA
214 I-RNA
contributes O
to O
intrahepatic O
cholangiocarcinoma B-Disease
metastasis O
by O
targeting O
Twist O
. O

The O
expressions O
of O
miR B-RNA
- I-RNA
21 I-RNA
and O
miR B-RNA
- I-RNA
210 I-RNA
in O
plasma O
of O
previously O
untreated O
lymphoma B-Disease
patient O
group O
were O
higher O
than O
those O
of O
the O
patients O
treated O
for O
6 O
or O
more O
courses O

miR B-RNA
- I-RNA
206 I-RNA
integrates O
multiple O
components O
of O
differentiation O
pathways O
to O
control O
the O
transition O
from O
growth O
to O
differentiation O
in O
rhabdomyosarcoma B-Disease
cells O
. O

Decreased O
miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
3p I-RNA
/ I-RNA
5p I-RNA
expression O
causes O
CD4 O
( O
+ O
) O
T O
cell O
activation O
and O
B O
cell O
hyperstimulation O
in O
systemic B-Disease
lupus I-Disease
erythematosus I-Disease
. O

MicroRNA O
let B-RNA
- I-RNA
7b I-RNA
targets O
important O
cell O
cycle O
molecules O
in O
malignant O
melanoma B-Disease
cells O
and O
interferes O
with O
anchorage O
- O
independent O
growth O
. O

The O
decreased O
expression O
level O
of O
miR B-RNA
- I-RNA
155 I-RNA
is O
correlated O
to O
asthma B-Disease
disease O
severity O
. O

These O
data O
indicate O
that O
miR B-RNA
- I-RNA
22 I-RNA
functions O
as O
an O
integrator O
of O
Ca O
( O
2 O
+ O
) O
homeostasis O
and O
myofibrillar O
protein O
content O
during O
stress O
in O
the O
heart O
and O
shed O
light O
on O
the O
mechanisms O
that O
enhance O
propensity O
toward O
heart B-Disease
failure I-Disease
. O

Inhibition O
of O
miRNA B-RNA
- I-RNA
221 I-RNA
Suppresses O
the O
Airway O
Inflammation O
in O
Asthma B-Disease
. O

BRAF O
- O
regulated O
lncRNA O
1 O
( O
BANCR B-RNA
) O
was O
identified O
as O
a O
recurrently O
overexpressed O
, O
previously O
unannotated O
693 O
- O
bp O
transcript O
on O
chromosome O
9 O
with O
a O
potential O
functional O
role O
in O
melanoma B-Disease
cell O
migration O
. O

Characterization O
of O
global O
microRNA O
expression O
reveals O
oncogenic O
potential O
of O
miR B-RNA
- I-RNA
145 I-RNA
in O
metastatic O
colorectal B-Disease
cancer I-Disease

High O
let B-RNA
- I-RNA
7a I-RNA
microRNA O
levels O
in O
KRAS O
- O
mutated O
colorectal O
carcinomas O
may O
rescue O
anti O
- O
EGFR O
therapy O
effects O
in O
patients O
with O
chemotherapy O
- O
refractory O
metastatic O
disease O
. O

Plasma O
levels O
of O
lipometabolism O
- O
related O
miR B-RNA
- I-RNA
122 I-RNA
and O
miR O
- O
370 O
are O
increased O
in O
patients O
with O
hyperlipidemia B-Disease
and O
associated O
with O
coronary O
artery O
disease O
. O

Plasma O
levels O
of O
lipometabolism O
- O
related O
miR B-RNA
- I-RNA
122 I-RNA
and O
miR B-RNA
- I-RNA
370 I-RNA
are O
increased O
in O
patients O
with O
hyperlipidemia O
and O
associated O
with O
coronary B-Disease
artery I-Disease
disease I-Disease
. O

miR O
- O
103 O
: O
In O
human O
breast B-Disease
cancer I-Disease
, O
high O
levels O
of O
miR B-RNA
- I-RNA
103 I-RNA
/ I-RNA
107 I-RNA
are O
associated O
with O
metastasis O
and O
poor O
outcome O

miR B-RNA
- I-RNA
103 I-RNA
/ I-RNA
107 I-RNA
Promote O
Metastasis O
of O
Colorectal O
Cancer O
by O
Targeting O
the O
Metastasis O
Suppressors O
DAPK O
and O
KLF4 O
. O

MiR B-RNA
- I-RNA
106b I-RNA
and O
MiR B-RNA
- I-RNA
15b I-RNA
modulate O
apoptosis O
and O
angiogenesis O
in O
myocardial B-Disease
infarction I-Disease
. O

Maternal O
obesity O
downregulates O
microRNA O
let B-RNA
- I-RNA
7g I-RNA
expression O
, O
a O
possible O
mechanism O
for O
enhanced O
adipogenesis O
during O
ovine O
fetal O
skeletal O
muscle O
development O
. O

Lentiviral O
expression O
of O
anti O
- O
microRNAs O
targeting O
miR B-RNA
- I-RNA
27a I-RNA
inhibits O
proliferation O
and O
invasiveness O
of O
U87 O
glioma B-Disease
cells O
. O

Increased O
circulating O
miR B-RNA
- I-RNA
625 I-RNA
- I-RNA
3p I-RNA
is O
a O
potential O
biomarker O
for O
patients O
with O
malignant O
pleural O
mesothelioma B-Disease
. O

MiR B-RNA
- I-RNA
34a I-RNA
Inhibits O
Proliferation O
and O
Migration O
of O
Breast B-Disease
Cancer I-Disease
Through O
Down O
- O
Regulation O
of O
Bcl O
- O
2 O
and O
SIRT1 O
. O

Re O
- O
expression O
of O
miR B-RNA
- I-RNA
200 I-RNA
by O
novel O
approaches O
regulates O
the O
expression O
of O
PTEN O
and O
MT1 O
- O
MMP O
in O
pancreatic B-Disease
cancer I-Disease
. O

Re O
- O
expression O
of O
miR B-RNA
- I-RNA
200 I-RNA
by O
novel O
approaches O
regulates O
the O
expression O
of O
PTEN O
and O
MT1 O
- O
MMP O
in O
pancreatic B-Disease
cancer I-Disease
. O

KRAS O
up O
- O
regulates O
the O
expression O
of O
miR B-RNA
- I-RNA
181a I-RNA
, O
miR B-RNA
- I-RNA
200c I-RNA
and O
miR B-RNA
- I-RNA
210 I-RNA
in O
a O
three O
- O
dimensional O
- O
specific O
manner O
in O
DLD O
- O
1 O
colorectal B-Disease
cancer I-Disease
cells O
. O

Upregulation O
of O
miRNA B-RNA
- I-RNA
146a I-RNA
and O
miRNA B-RNA
- I-RNA
155 I-RNA
in O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
ECF O
and O
CSFUpregulation O
of O
miRNA B-RNA
- I-RNA
146a I-RNA
and O
miRNA B-RNA
- I-RNA
155 I-RNA
in O
stressed O
human O
neuronal O
- O
glial O
primary O
coculturesThese O
included O
downregulation O
in O
the O
expression O
of O
an O
important O
repressor O
of O
the O
innate O
immune O
response O
, O
complement O
factor O
H O
( O
CFH O
) O
. O

The O
microRNA O
miR B-RNA
- I-RNA
23b I-RNA
suppresses O
IL O
- O
17 O
- O
associated O
autoimmune O
inflammation B-Disease
by O
targeting O
TAB2 O
, O
TAB3 O
and O
IKK O
- O
a O
. O

In O
several O
human O
cancers O
including O
lung B-Disease
cancer I-Disease
, O
uterine B-Disease
endometrial I-Disease
stromal I-Disease
sarcoma I-Disease
, O
cervical B-Disease
cancer I-Disease
and O
hepatocellular B-Disease
carcinoma I-Disease
( O
HCC O
) O
, O
MALAT1 B-RNA
is O
upregulated O
. O

PCAT B-RNA
- I-RNA
1 I-RNA
was O
highly O
upregulated O
in O
a O
subset O
of O
metastatic O
and O
high O
- O
grade O
localized O
prostate O
cancers O
. O

GAS5 B-RNA
expression O
is O
strongly O
reduced O
in O
actively O
growing O
leukemia B-Disease
cells O
or O
NIH3T3 O
cells O
. O

High O
expression O
was O
observed O
in O
cancer O
tissues O
, O
which O
was O
consistent O
with O
our O
previous O
study O
that O
NRG1 B-RNA
was O
highly O
expressed O
in O
lung B-Disease
cancer I-Disease
induced O
by O
nickel O
. O

miR B-RNA
- I-RNA
297 I-RNA
modulates O
multidrug O
resistance O
in O
human O
colorectal B-Disease
carcinoma I-Disease
by O
down O
- O
regulating O
MRP O
- O
2 O
. O

miR B-RNA
- I-RNA
297 I-RNA
modulates O
multidrug O
resistance O
in O
human O
colorectal B-Disease
carcinoma I-Disease
by O
down O
- O
regulating O
MRP O
- O
2 O
. O

MiR B-RNA
- I-RNA
222 I-RNA
modulates O
multidrug O
resistance O
in O
human O
colorectal B-Disease
carcinoma I-Disease
by O
down O
- O
regulating O
ADAM O
- O
17 O
. O

The O
overexpression O
of O
PRL O
- O
3 O
in O
colon B-Disease
cancer I-Disease
cells O
induced O
the O
expression O
of O
mir B-RNA
- I-RNA
21 I-RNA
, O
mir B-RNA
- I-RNA
17 I-RNA
and O
mir B-RNA
- I-RNA
19a I-RNA
by O
activating O
STAT3 O
. O

miR O
- O
15a O
/ O
16 O
- O
1 O
influences O
BCL2 O
expression O
in O
keratocystic O
odontogenic B-Disease
tumors I-Disease
. O

miR B-RNA
- I-RNA
200c I-RNA
is O
aberrantly O
expressed O
in O
leiomyomas O
in O
an O
ethnic O
- O
dependent O
manner O
and O
targets O
ZEBs O
, O
VEGFA O
, O
TIMP2 O
, O
and O
FBLN5 O
. O

miR B-RNA
- I-RNA
10b I-RNA
, O
19a O
, O
126 O
, O
145 O
, O
221 O
, O
296 O
- O
5p O
and O
378 O
were O
significantly O
down O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
compared O
to O
adjacent O
normal O
urothelium O
. O

MiR B-RNA
- I-RNA
21 I-RNA
Modulates O
hTERT O
Through O
a O
STAT3 O
- O
Dependent O
Manner O
on O
Glioblastoma B-Disease
Cell O
Growth O
. O

The O
activatory O
long O
non O
- O
coding O
RNA O
DBE B-RNA
- I-RNA
T I-RNA
reveals O
the O
epigenetic O
etiology O
of O
facioscapulohumeral B-Disease
muscular I-Disease
dystrophy I-Disease
. O

Upregulation O
of O
miR B-RNA
- I-RNA
31 I-RNA
* I-RNA
is O
negatively O
associated O
with O
recurrent O
/ O
newly O
formed O
oral B-Disease
leukoplakia I-Disease
. O

Upregulation O
of O
miR B-RNA
- I-RNA
196b I-RNA
confers O
a O
poor O
prognosis O
in O
glioblastoma B-Disease
patients O
via O
inducing O
a O
proliferative O
phenotype O
. O

Downregulated O
miR B-RNA
- I-RNA
195 I-RNA
detected O
in O
preeclamptic B-Disease
placenta I-Disease
affects O
trophoblast O
cell O
invasion O
via O
modulating O
ActRIIA O
expression O
. O

MiR B-RNA
- I-RNA
138 I-RNA
suppressed O
nasopharyngeal B-Disease
carcinoma I-Disease
growth O
and O
tumorigenesis O
by O
targeting O
the O
CCND1 O
oncogene O
. O

MiR B-RNA
- I-RNA
410 I-RNA
regulates O
MET O
to O
influence O
the O
proliferation O
and O
invasion O
of O
glioma B-Disease
. O

microRNA O
Regulatory O
Network O
Inference O
Identifies O
miR B-RNA
- I-RNA
34a I-RNA
as O
a O
Novel O
Regulator O
of O
TGF O
- O
beta O
Signaling O
in O
Glioblastoma B-Disease
. O

Multiple B-Disease
myeloma I-Disease
- O
associated O
chromosomal O
translocation O
activates O
orphan O
snoR O
ACA11 B-RNA
to O
suppress O
oxidative O
stress O

Progestin O
suppression O
of O
miR O
- O
29 O
potentiates O
dedifferentiation O
of O
breast B-Disease
cancer I-Disease
cells O
via O
KLF4 O
. O

Up O
- O
regulation O
of O
miR B-RNA
- I-RNA
182 I-RNA
expression O
after O
epigenetic O
modulation O
of O
human O
melanoma B-Disease
cells O
. O

miR B-RNA
- I-RNA
499 I-RNA
is O
increased O
in O
human O
and O
murine O
cardiac B-Disease
hypertrophy I-Disease
and O
cardiomyopathy B-Disease
, O
is O
sufficient O
to O
cause O
murine O
heart O
failure O
, O
and O
accelerates O
maladaptation O
to O
pressure O
overloading O
. O

Keratinization O
- O
associated O
miR B-RNA
- I-RNA
7 I-RNA
and O
miR B-RNA
- I-RNA
21 I-RNA
Regulate O
Tumor O
Suppressor O
Reversion O
- O
inducing O
Cysteine O
- O
rich O
Protein O
with O
Kazal O
Motifs O
( O
RECK O
) O
in O
Oral B-Disease
Cancer I-Disease
. O

MiR B-RNA
- I-RNA
138 I-RNA
Suppresses O
Expression O
of O
Hypoxia O
- O
inducible O
factor O
1a O
( O
HIF O
- O
1a O
) O
in O
Clear B-Disease
Cell I-Disease
Renal I-Disease
Cell I-Disease
Carcinoma I-Disease
786 O
- O
O O
Cells O
. O

MiR B-RNA
- I-RNA
218 I-RNA
reverses O
high O
invasiveness O
of O
glioblastoma B-Disease
cells O
by O
targeting O
the O
oncogenic O
transcription O
factor O
LEF1 O
. O

miR B-RNA
- I-RNA
29ab I-RNA
Deficiency O
Identifies O
a O
Negative O
Feedback O
Loop O
Controlling O
Th1 O
Bias O
That O
Is O
Dysregulated O
in O
Multiple B-Disease
Sclerosis I-Disease
. O

We O
demonstrated O
that O
H19 B-RNA
levels O
were O
markedly O
increased O
in O
gastric B-Disease
cancer I-Disease
cells O
and O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
normal O
controls O
. O

Thus O
, O
upregulation O
of O
miR B-RNA
- I-RNA
21 I-RNA
contributes O
to O
the O
protective O
effect O
of O
delayed O
ischemic O
preconditioning O
against O
subsequent O
renal O
ischemia B-Disease
- I-Disease
reperfusion I-Disease
injury I-Disease
. O

The O
concentration O
of O
miRNA B-RNA
- I-RNA
182 I-RNA
in O
glioma B-Disease
patients O
was O
found O
to O
be O
3 O
. O
1 O
times O
as O
high O
as O
that O
in O
healthy O
persons O
, O
a O
conclusion O
in O
excellent O
agreement O
with O
a O
separate O
qPCR O
measurement O
of O
the O
expression O
level O
. O

miR B-RNA
- I-RNA
340 I-RNA
is O
upregulated O
by O
demethylation O
of O
an O
upstream O
genomic O
region O
that O
occurs O
during O
the O
process O
of O
neuroblastoma B-Disease
cell O
differentiation O
induced O
by O
all O
- O
trans O
retinoic O
acid O
( O
ATRA O
) O
. O

Circulating O
miR O
- O
125b O
is O
a O
novel O
biomarker O
for O
screening O
non B-Disease
- I-Disease
small I-Disease
- I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
and O
predicts O
poor O
prognosis O
. O

let B-RNA
- I-RNA
7a I-RNA
- I-RNA
2 I-RNA
, O
7a O
- O
3 O
, O
7d O
, O
7f O
- O
2 O
downregulated O
in O
breast B-Disease
cancer I-Disease

Schizophrenia B-Disease
spectrum O
disorders O
and O
AD O
have O
also O
been O
linked O
with O
the O
rheelin O
( O
RELN O
) O
gene O
and O
its O
antisense O
transcript O
HAR1 B-RNA

The O
Gas5 B-RNA
transcript O
has O
been O
linked O
with O
increased O
susceptibility O
to O
systemic O
lupus O
erythaematosus O
in O
mouse O
models O
, O
presumably O
as O
a O
result O
of O
its O
effect O
on O
the O
immunosuppressant O
role O
of O
glucocorticoids O

Epigenetic O
regulation O
of O
miR B-RNA
- I-RNA
124 I-RNA
by O
Hepatitis O
C O
Virus O
core O
protein O
promotes O
migration O
and O
invasion O
of O
intrahepatic O
cholangiocarcinoma O
cells O
by O
targeting O
SMYD3 O
. O

We O
thus O
identify O
let B-RNA
- I-RNA
7g I-RNA
as O
a O
unique O
member O
of O
the O
let O
- O
7 O
miRNA O
family O
which O
can O
serve O
as O
a O
prognostic O
biomarker O
in O
breast B-Disease
cancer I-Disease
and O
also O
propose O
a O
paradigm O
utilized O
by O
specific O
signaling O
molecules O
via O
let B-RNA
- I-RNA
7g I-RNA
to O
cooperatively O
promote O
breast B-Disease
cancer I-Disease
invasion O
and O
metastasis O
. O

MiR B-RNA
- I-RNA
146a I-RNA
polymorphism O
is O
associated O
with O
asthma O
but O
not O
with O
systemic O
lupus O
erythematosus O
and O
juvenile O
rheumatoid O
arthritis O
in O
Mexican O
patients O
. O

A O
miR B-RNA
- I-RNA
1231 I-RNA
binding O
site O
polymorphism O
( O
rs17875871 O
) O
in O
the O
3 O
' O
UTR O
of O
IFNAR1 O
is O
associated O
with O
hepatocellular B-Disease
carcinoma I-Disease
susceptibility O
. O

Downregulated O
plasma O
miR O
- O
92a O
levels O
have O
clinical O
impact O
on O
multiple B-Disease
myeloma I-Disease
and O
related O
disorders O
. O

miR B-RNA
- I-RNA
210 I-RNA
activates O
notch O
signaling O
pathway O
in O
angiogenesis O
induced O
by O
cerebral O
ischemia B-Disease
. O

Expression O
of O
miRNA B-RNA
- I-RNA
146a I-RNA
in O
nasopharyngeal O
carcinoma O
is O
upregulated O
by O
Epstein O
- O
Barr O
virus O
latent O
membrane O
protein O
1 O
. O

Primary O
glioblastoma B-Disease
( O
GBM O
) O
was O
characterized O
exclusively O
by O
upregulation O
of O
mesenchymal O
markers O
, O
whereas O
secondary O
GBM O
was O
characterized O
by O
significant O
downregulation O
of O
mesenchymal O
markers O
, O
miR B-RNA
- I-RNA
21 I-RNA
, O
and O
- O
34a O
, O
and O
by O
upregulation O
of O
proneural O
markers O
and O
miR O
- O
504 O
. O

Primary O
glioblastoma B-Disease
( O
GBM O
) O
was O
characterized O
exclusively O
by O
upregulation O
of O
mesenchymal O
markers O
, O
whereas O
secondary O
GBM O
was O
characterized O
by O
significant O
downregulation O
of O
mesenchymal O
markers O
, O
miR O
- O
21 O
, O
and O
- O
34a O
, O
and O
by O
upregulation O
of O
proneural O
markers O
and O
miR B-RNA
- I-RNA
504 I-RNA
. O

Expression O
of O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
31 I-RNA
, O
miR B-RNA
- I-RNA
96 I-RNA
and O
miR B-RNA
- I-RNA
135b I-RNA
is O
correlated O
with O
the O
clinical O
parameters O
of O
colorectal B-Disease
cancer I-Disease
. O

Loss O
of O
miR B-RNA
- I-RNA
126 I-RNA
is O
crucial O
to O
pancreatic B-Disease
cancer I-Disease
progression O
. O

miR O
- O
146a O
rs2910164 O
C O
allele O
inhibited O
cell O
proliferation O
and O
significantly O
downregulates O
expression O
of O
IRAK1 B-RNA
and O
TRAF6 B-RNA
in O
bladder B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
182 I-RNA
, O
a O
p53 O
dependent O
miRNA O
, O
suppressed O
the O
expression O
of O
MITF O
, O
BCL2 O
, O
cyclin O
D2 O
and O
functioned O
as O
a O
potent O
tumor O
suppressor O
in O
uveal O
melanoma B-Disease
cells O
. O

MiR B-RNA
- I-RNA
218 I-RNA
inhibits O
invasion O
and O
metastasis O
of O
gastric B-Disease
cancer I-Disease
by O
targeting O
the O
Robo1 O
receptor O
. O

miR B-RNA
- I-RNA
433 I-RNA
is O
aberrantly O
expressed O
in O
myeloproliferative O
neoplasms O
and O
suppresses O
hematopoietic O
cell O
growth O
and O
differentiation O
. O

NEDD9 O
, O
a O
novel O
target O
of O
miR B-RNA
- I-RNA
145 I-RNA
, O
increases O
the O
invasiveness O
of O
glioblastoma B-Disease
. O

These O
findings O
suggest O
that O
PVT1 B-RNA
rearrangements O
may O
represent O
a O
novel O
molecular O
paradigm O
underlying O
the O
pathology O
of O
8q24 O
rearrangement O
- O
positive O
multiple B-Disease
myeloma I-Disease
. O

The O
results O
showed O
that O
the O
methylation O
of O
miR B-RNA
- I-RNA
124a I-RNA
and O
miR B-RNA
- I-RNA
34b I-RNA
/ I-RNA
c I-RNA
occured O
early O
in O
colorectal B-Disease
carcinogenesis I-Disease
and O
certain O
CRCs B-Disease
may O
arise O
from O
a O
field O
defect O
defined O
by O
the O
epigenetic O
inactivation O
of O
miRs O
. O

The O
Putative O
Tumor O
Suppressor O
miR O
- O
524 O
- O
5p O
Directly O
Targets O
Jagged O
- O
1 O
and O
Hes O
- O
1 O
in O
Glioma B-Disease
. O

Candidate O
schizophrenia B-Disease
gene O
ZNF804A O
is O
a O
target O
for O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
137 I-RNA
. O

miR B-RNA
- I-RNA
335 I-RNA
promotes O
cell O
proliferation O
by O
directly O
targeting O
Rb1 O
in O
meningiomas O
. O

miR B-RNA
- I-RNA
205 I-RNA
is O
a O
tumor O
suppressor O
microRNAin O
malignant O
melanoma B-Disease
. O

MiR B-RNA
- I-RNA
24 I-RNA
- O
mediated O
suppression O
of O
JP2 O
expression O
provides O
a O
novel O
molecular O
mechanism O
for O
E O
- O
C O
coupling O
regulation O
in O
heart O
cells O
and O
suggests O
a O
new O
target O
against O
heart B-Disease
failure I-Disease
. O

BCAR4 B-RNA
expression O
strongly O
sensitised O
ZR O
- O
75 O
- O
1 O
and O
MCF7 O
breast B-Disease
cancer I-Disease
cells O
to O
the O
combination O
of O
lapatinib O
and O
antioestrogens O
. O

miR B-RNA
- I-RNA
124 I-RNA
, O
miR B-RNA
- I-RNA
137 I-RNA
and O
miR B-RNA
- I-RNA
340 I-RNA
regulate O
colorectal B-Disease
cancer I-Disease
growth O
via O
inhibition O
of O
the O
Warburg O
effect O
. O

miR B-RNA
- I-RNA
92a I-RNA
is O
a O
critical O
regulator O
of O
the O
apoptosis O
pathway O
in O
glioblastoma B-Disease
with O
inverse O
expression O
of O
BCL2L11 O
. O

Upregulation O
of O
miRNA B-RNA
- I-RNA
221 I-RNA
and O
miRNA O
- O
485 O
- O
3p O
in O
pediatric O
asthma B-Disease
. O

CDA O
- O
2 O
induces O
cell O
differentiation O
through O
suppressing O
Twist O
/ O
SLUG O
signaling O
via O
miR B-RNA
- I-RNA
124 I-RNA
in O
glioma B-Disease
. O

MiR B-RNA
- I-RNA
138 I-RNA
Suppresses O
Expression O
of O
Hypoxia O
- O
inducible O
factor O
1a O
( O
HIF O
- O
1a O
) O
in O
Clear B-Disease
Cell I-Disease
Renal I-Disease
Cell I-Disease
Carcinoma O
786 O
- O
O O
Cells O
. O

Four O
miRNAs O
( O
miR B-RNA
- I-RNA
148b I-RNA
, O
miR B-RNA
- I-RNA
376c I-RNA
, O
miR B-RNA
- I-RNA
409 I-RNA
- I-RNA
3p I-RNA
and O
miR B-RNA
- I-RNA
801 I-RNA
) O
were O
shown O
to O
be O
significantly O
upregulated O
in O
the O
plasma O
of O
breast B-Disease
cancer I-Disease
patients O
. O

The O
strongest O
inhibitors O
of O
melanoma B-Disease
cell O
proliferation O
, O
including O
the O
miR B-RNA
- I-RNA
15 I-RNA
/ I-RNA
16 I-RNA
, O
miR B-RNA
- I-RNA
141 I-RNA
/ I-RNA
200a I-RNA
and O
miR B-RNA
- I-RNA
96 I-RNA
/ I-RNA
182 I-RNA
families O
of O
miRNAs O
and O
miR B-RNA
- I-RNA
203 I-RNA
. O

The O
expression O
of O
let B-RNA
- I-RNA
7c I-RNA
, O
let B-RNA
- I-RNA
7f I-RNA
, O
and O
miR B-RNA
- I-RNA
200c I-RNA
were O
significantly O
reduced O
in O
most O
patients O
whereas O
the O
expression O
of O
miR O
- O
486 O
- O
5p O
and O
miR O
- O
451 O
were O
significantly O
elevated O
in O
all O
pancreas B-Disease
cancer I-Disease
patients O
. O

Oncogenic O
miR B-RNA
- I-RNA
544 I-RNA
is O
an O
Important O
Molecular O
Target O
in O
Gastric O
Cancer O
. O

miR B-RNA
- I-RNA
16 I-RNA
upregulates O
ENaC O
, O
a O
major O
sodium O
channel O
involved O
in O
resolution O
of O
pulmonary O
edema O
in O
acute B-Disease
lung I-Disease
injury I-Disease
. O

Myelodysplastic B-Disease
syndrome I-Disease
with O
a O
t O
( O
2 O
; O
11 O
) O
( O
p21 O
; O
q23 O
- O
24 O
) O
and O
translocation O
breakpoint O
close O
to O
miR B-RNA
- I-RNA
125b I-RNA
- I-RNA
1 I-RNA
. O

miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
inhibit O
stem O
cell O
characteristics O
of O
PC O
- O
3 O
prostate B-Disease
cancer I-Disease
cells O
. O

we O
found O
a O
novel O
reciprocal O
loop O
between O
miR B-RNA
- I-RNA
21 I-RNA
and O
TGF O
 O
RIII O
in O
cardiac O
fibrosis O
caused O
by O
myocardial B-Disease
infarction I-Disease
in O
mice O
, O
and O
targeting O
this O
pathway O
could O
be O
a O
new O
strategy O
for O
the O
prevention O
and O
treatment O
of O
myocardial O
remodeling O
. O

TUG1 B-RNA
was O
up O
- O
regulated O
in O
bladder B-Disease
urothelial I-Disease
carcinoma I-Disease
compared O
to O
paired O
normal O
urothelium O
. O

we O
observed O
that O
miR B-RNA
- I-RNA
146a I-RNA
expression O
is O
also O
down O
- O
regulated O
in O
tuberculosis B-Disease
patients O
, O
both O
in O
PBMCs O
and O
PFMCs O
while O
miR O
- O
424 O
levels O
are O
elevated O
only O
in O
the O
peripheral O
compartments O
. O

Interestingly O
, O
we O
found O
that O
51A B-RNA
is O
expressed O
in O
human O
brains O
, O
being O
frequently O
upregulated O
in O
cerebral O
cortices O
from O
individuals O
with O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
. O

MiR B-RNA
- I-RNA
212 I-RNA
/ I-RNA
132 I-RNA
null O
mice O
are O
protected O
from O
pressure O
- O
overload O
- O
induced O
heart B-Disease
failure I-Disease
, O
whereas O
cardiomyocyte O
- O
specific O
overexpression O
of O
the O
miR B-RNA
- I-RNA
212 I-RNA
/ I-RNA
132 I-RNA
family O
leads O
to O
pathological O
cardiac O
hypertrophy O
, O
heart B-Disease
failure I-Disease
and O
death O
in O
mice O
. O

Inability O
of O
miR B-RNA
- I-RNA
146a I-RNA
inhibiting O
target O
gene O
IRAK1 O
may O
contribute O
to O
the O
persistent O
inflammation O
in O
lesions O
of O
psoriasis B-Disease
. O

only O
miR B-RNA
- I-RNA
223 I-RNA
( O
p O
= O
0 O
. O
35 O
) O
and O
miR O
- O
499 O
- O
5p O
( O
p O
< O
0 O
. O
1 O
) O
were O
significantly O
different O
between O
patients O
with O
mild O
sepsis B-Disease
and O
patients O
with O
severe O
sepsis B-Disease
and O
septic O
shock O
. O

MiR B-RNA
- I-RNA
145 I-RNA
may O
represent O
a O
potential O
therapeutic O
target O
for O
treatment O
of O
oxidative O
stress O
- O
associated O
cardiovascular O
diseases O
, O
such O
as O
myocardial O
ischemia O
/ O
reperfusion O
injury O
. O

Using O
quantitative O
RT O
- O
PCR O
analysis O
, O
we O
found O
that O
miR B-RNA
- I-RNA
34a I-RNA
was O
highly O
upregulated O
in O
the O
p53 O
wild O
- O
type O
A549 O
human O
lung B-Disease
cancer I-Disease
cell O
line O
when O
treated O
with O
the O
DNA O
damaging O
agent O
adriamycin O
( O
ADR O
) O
, O
but O
not O
in O
the O
SBC O
- O
5 O
cells O
harboring O
mutated O
p53 O
. O

We O
have O
provided O
the O
first O
evidence O
that O
expression O
of O
miR B-RNA
- I-RNA
196b I-RNA
was O
associated O
with O
the O
occurrence O
of O
pre O
- O
operative O
seizures O
in O
low O
- O
grade O
gliomas B-Disease
, O
and O
may O
predict O
seizure O
prognosis O
in O
patients O
without O
pre O
- O
operative O
seizures O

HIF O
- O
1a O
downregulates O
miR B-RNA
- I-RNA
17 I-RNA
/ I-RNA
20a I-RNA
directly O
targeting O
p21 O
and O
STAT3 O
: O
a O
role O
in O
myeloid B-Disease
leukemic I-Disease
cell O
differentiation O

up O
- O
regulated O
of O
miR B-RNA
- I-RNA
153 I-RNA
promotes O
cell O
proliferation O
via O
downregulation O
of O
the O
PTEN O
tumor O
suppressor O
gene O
in O
human O
prostate B-Disease
cancer I-Disease

miR B-RNA
- I-RNA
511 I-RNA
and O
miR B-RNA
- I-RNA
1297 I-RNA
inhibit O
human O
lung B-Disease
adenocarcinoma I-Disease
cell O
proliferation O
by O
targeting O
oncogene O
TRIB2 O

MiR B-RNA
- I-RNA
101 I-RNA
is O
involved O
in O
human O
breast B-Disease
carcinogenesis I-Disease
by O
targeting O
Stathmin1 O

our O
data O
indicates O
that O
miRNA B-RNA
- I-RNA
146b I-RNA
and O
PPAR O
 O
activation O
may O
be O
implicated O
in O
the O
regulation O
of O
Th17 O
responses O
and O
colitis B-Disease
in O
C O
. O
difficile O
- O
infected O
mice O
. O

MiR B-RNA
- I-RNA
328 I-RNA
expression O
is O
decreased O
in O
high O
- O
grade O
gliomas O
and O
is O
associated O
with O
worse O
survival O
in O
primary O
glioblastoma B-Disease

Blockade O
of O
miR B-RNA
- I-RNA
150 I-RNA
maturation O
by O
MLL O
- O
fusion O
/ O
MYC O
/ O
LIN O
- O
28 O
is O
required O
for O
MLL O
- O
associated O
leukemia B-Disease

Together O
, O
these O
data O
suggest O
that O
the O
alteration O
of O
miR B-RNA
- I-RNA
16 I-RNA
expression O
in O
decidua O
- O
derived O
mesenchymal O
stem O
cells O
may O
be O
involved O
in O
the O
development O
of O
pre B-Disease
- I-Disease
eclampsia I-Disease
. O

miR B-RNA
- I-RNA
18a I-RNA
promotes O
malignant O
progression O
by O
impairing O
microRNA O
biogenesis O
in O
nasopharyngeal B-Disease
carcinoma I-Disease

DNA O
- O
demethylating O
and O
anti O
- O
tumor O
activity O
of O
synthetic O
miR B-RNA
- I-RNA
29b I-RNA
mimics O
in O
multiple B-Disease
myeloma I-Disease

miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
affect O
the O
angiogenesis O
of O
multiple B-Disease
myeloma I-Disease
by O
targeting O
VEGF O

MiR B-RNA
- I-RNA
21 I-RNA
expression O
in O
the O
tumor O
cell O
compartment O
holds O
unfavorable O
prognostic O
value O
in O
gliomas B-Disease

MiR B-RNA
- I-RNA
26a I-RNA
regulates O
cell O
cycle O
and O
anoikis O
of O
human O
esophageal B-Disease
adenocarcinoma I-Disease
cells O
through O
Rb1 O
- O
E2F1 O
signaling O
pathway O

Silencing O
of O
miR B-RNA
- I-RNA
370 I-RNA
in O
human O
cholangiocarcinoma B-Disease
by O
allelic O
loss O
and O
interleukin O
- O
6 O
induced O
maternal O
to O
paternal O
epigenotype O
switch O

MiR B-RNA
- I-RNA
429 I-RNA
is O
an O
independent O
prognostic O
factor O
in O
colorectal O
cancer O
and O
exerts O
its O
anti O
- O
apoptotic O
function O
by O
targeting O
SOX2 O

the O
expression O
and O
methylation O
status O
of O
miR B-RNA
- I-RNA
200f I-RNA
could O
be O
used O
as O
hypothetical O
biomarkers O
to O
assess O
the O
occurrence O
of O
EMT O
in O
breast B-Disease
cancer I-Disease

MEX O
suppressed O
the O
hypoxic O
activation O
of O
signal O
transducer O
and O
activator O
of O
transcription O
3 O
( O
STAT3 O
) O
and O
the O
upregulation O
of O
the O
miR O
- O
17 O
superfamily O
of O
microRNA O
clusters O
, O
whereas O
it O
increased O
lung O
levels O
of O
miR B-RNA
- I-RNA
204 I-RNA
, O
a O
key O
microRNA O
, O
the O
expression O
of O
which O
is O
decreased O
in O
human O
pulmonary B-Disease
hypertension I-Disease
. O

Regulation O
of O
epidermal O
growth O
factor O
receptor O
signaling O
and O
erlotinib O
sensitivity O
in O
head B-Disease
and I-Disease
neck I-Disease
cancer I-Disease
cells O
by O
miR B-RNA
- I-RNA
7 I-RNA

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR B-RNA
- I-RNA
101 I-RNA
- I-RNA
1 I-RNA
is O
significantly O
associated O
with O
development O
of O
liver B-Disease
cirrhosis I-Disease
and O
hepatocellular B-Disease
carcinoma I-Disease
occurrence O
. O

PCA3 B-RNA
is O
a O
non O
- O
coding O
RNA O
( O
ncRNA O
) O
that O
is O
highly O
expressed O
in O
prostate B-Disease
cancer I-Disease
( O
PCa O
) O
cells O
, O
LNCaP O
siPCA3 O
- O
transfected O
cells O
significantly O
inhibited O
cell O
growth O
and O
viability O
, O
and O
increased O
the O
proportion O
of O
cells O
in O
the O
sub O
G0 O
/ O
G1 O
phase O
of O
the O
cell O
cycle O
and O
the O
percentage O
of O
pyknotic O
nuclei O
, O
compared O
to O
those O
transfected O
with O
scramble O
siRNA O
( O
siSCr O
) O
- O
transfected O
cells O
. O

miR B-RNA
- I-RNA
186 I-RNA
, O
miR B-RNA
- I-RNA
216b I-RNA
, O
miR B-RNA
- I-RNA
337 I-RNA
- I-RNA
3p I-RNA
, O
and O
miR B-RNA
- I-RNA
760 I-RNA
cooperatively O
induce O
cellular O
senescence O
by O
targeting O
alpha O
subunit O
of O
protein O
kinase O
CKII O
in O
human O
colorectal B-Disease
cancer I-Disease
cells O

The O
good O
, O
the O
bad O
and O
the O
ugly O
: O
a O
tale O
of O
miR B-RNA
- I-RNA
101 I-RNA
, O
miR B-RNA
- I-RNA
21 I-RNA
and O
miR B-RNA
- I-RNA
155 I-RNA
in O
pancreatic B-Disease
intraductal I-Disease
papillary I-Disease
mucinous I-Disease
neoplasms I-Disease

MiR B-RNA
- I-RNA
24 I-RNA
regulates O
the O
proliferation O
and O
invasion O
of O
glioma B-Disease
by O
ST7L O
via O
beta O
- O
catenin O
/ O
Tcf O
- O
4 O
signaling O

Hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
196a2 I-RNA
functional O
SNP O
is O
associated O
with O
severe O
toxicity O
after O
platinum O
- O
based O
chemotherapy O
of O
advanced O
nonsmall B-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
patients O
in O
a O
Chinese O
population O

The O
expression O
of O
CCAT1 B-RNA
and O
c O
- O
Myc O
shows O
strong O
association O
in O
gastric O
carcinomas O
. O

Moreover O
, O
abnormally O
expressed O
CCAT1 B-RNA
promotes O
cell O
proliferation O
and O
migration O
. O
. O

miR B-RNA
- I-RNA
137 I-RNA
Inhibits O
the O
Invasion O
of O
Melanoma B-Disease
Cells O
through O
Downregulation O
of O
Multiple O
Oncogenic O
Target O
Genes O

miR B-RNA
- I-RNA
137 I-RNA
Inhibits O
the O
Invasion O
of O
Melanoma B-Disease
Cells O
through O
Downregulation O
of O
Multiple O
Oncogenic O
Target O
Genes O

MALAT1 B-RNA
was O
upregulated O
in O
bladder B-Disease
urothelial I-Disease
carcinoma I-Disease
compared O
with O
matched O
normal O
urothelium O
( O
P O
= O
. O
8 O
) O
. O

MALAT1 B-RNA
was O
upregulated O
in O
bladder B-Disease
urothelial I-Disease
carcinoma I-Disease
compared O
with O
matched O
normal O
urothelium O
. O

The O
MALAT1 B-RNA
expression O
levels O
were O
greater O
in O
high O
- O
grade O
carcinomas O
than O
in O
low O
- O
grade O
carcinoma O
. O

The O
MALAT1 B-RNA
expression O
levels O
were O
greater O
in O
invasive O
carcinoma O
than O
in O
noninvasive O
carcinoma O
. O

MALAT1 B-RNA
plays O
an O
oncogenic O
role O
in O
urothelial O
carcinoma O
of O
the O
bladder O
. O

MicroRNA O
miR B-RNA
- I-RNA
34b I-RNA
/ I-RNA
c I-RNA
enhances O
cellular O
radiosensitivity O
of O
malignant O
pleural O
mesothelioma B-Disease
cells O

Compared O
with O
normal O
brain O
tissue O
, O
decreased O
expression O
of O
miR B-RNA
- I-RNA
383 I-RNA
but O
elevated O
expression O
of O
PRDX3 O
are O
medulloblastoma O
tumour O
and O
Daoy O
cell O
lines O

Epithelial O
- O
mesenchymal O
transition O
, O
a O
novel O
target O
of O
sulforaphane O
via O
COX O
- O
2 O
/ O
MMP2 O
, O
9 O
/ O
Snail O
, O
ZEB1 O
and O
miR B-RNA
- I-RNA
200c I-RNA
/ O
ZEB1 O
pathways O
in O
human O
bladder B-Disease
cancer I-Disease
cells O

mir B-RNA
- I-RNA
30 I-RNA
, O
mir B-RNA
- I-RNA
34 I-RNA
mir B-RNA
- I-RNA
30a I-RNA
- I-RNA
5p I-RNA
downregulated O
in O
lung B-Disease
cancer I-Disease
( O
Yanaihara O
et O
al O
. O
, O
2006 O
) O

In O
medulloblastoma B-Disease
cell O
lines O
, O
miR B-RNA
- I-RNA
124 I-RNA
was O
expressed O
at O
least O
6 O
. O
5 O
- O
fold O
lower O
compared O
with O
normal O
cerebellum O
, O
whereas O
CDK6 O
protein O
expression O
was O
detected O
in O
1 O
/ O
3 O
lines O
( O
D425 O
) O
. O

MiR B-RNA
- I-RNA
21 I-RNA
regulates O
biological O
behavior O
through O
the O
PTEN O
/ O
PI O
- O
3 O
K O
/ O
Akt O
signaling O
pathway O
in O
human O
colorectal B-Disease
cancer I-Disease
cells O

Anticancer O
role O
of O
MUC1 O
aptamer O
- O
miR B-RNA
- I-RNA
29b I-RNA
chimera O
in O
epithelial B-Disease
ovarian I-Disease
carcinoma I-Disease
cells O
through O
regulation O
of O
PTEN O
methylation O

miR B-RNA
- I-RNA
133a I-RNA
mediates O
TGF O
- O
beta O
- O
dependent O
de O
- O
repression O
of O
collagen O
- O
synthesis O
in O
hepatic O
stellate O
cells O
during O
liver B-Disease
fibrosis I-Disease

The O
CREB O
- O
miR B-RNA
- I-RNA
9 I-RNA
negative O
feedback O
minicircuitry O
coordinates O
the O
migration O
and O
proliferation O
of O
glioma B-Disease
cells O

DNA O
- O
demethylating O
and O
anti O
- O
tumor O
activity O
of O
synthetic O
miR B-RNA
- I-RNA
29b I-RNA
mimics O
in O
multiple B-Disease
myeloma I-Disease

Overexpression O
of O
miR B-RNA
- I-RNA
7 I-RNA
- I-RNA
1 I-RNA
Increases O
Efficacy O
of O
Green O
Tea O
Polyphenols O
for O
Induction O
of O
Apoptosis O
in O
Human O
Malignant O
Neuroblastoma B-Disease
SH O
- O
SY5Y O
and O
SK O
- O
N O
- O
DZ O
Cells O

MiR B-RNA
- I-RNA
320a I-RNA
is O
Downregulated O
in O
Patients O
with O
Myasthenia B-Disease
Gravis I-Disease
and O
Modulates O
Inflammatory O
Cytokines O
Production O
by O
Targeting O
Mitogen O
- O
activated O
Protein O
Kinase O
1 O

Decreased O
microRNA B-RNA
( I-RNA
miR I-RNA
) I-RNA
- I-RNA
145 I-RNA
and O
increased O
miR O
- O
224 O
expression O
in O
T O
cells O
from O
patients O
with O
systemic B-Disease
lupus I-Disease
erythematosus I-Disease
involved O
in O
lupus O
immunopathogenesis O

Plasma O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
, O
miR B-RNA
- I-RNA
20a I-RNA
and O
miR B-RNA
- I-RNA
22 I-RNA
are O
down O
- O
regulated O
in O
women O
with O
endometriosis B-Disease

miR B-RNA
- I-RNA
7 I-RNA
- I-RNA
5p I-RNA
may O
represent O
a O
novel O
tumor O
suppressor O
miRNA O
in O
melanoma B-Disease
, O
acting O
at O
least O
in O
part O
via O
its O
inhibition O
of O
IRS B-RNA
- O
2 O
expression O
and O
oncogenic O
Akt O
signaling O

Targeting O
of O
syndecan O
- O
1 O
by O
micro O
- O
ribonucleic O
acid O
miR B-RNA
- I-RNA
10b I-RNA
modulates O
invasiveness O
of O
endometriotic B-Disease
cells O
via O
dysregulation O
of O
the O
proteolytic O
milieu O
and O
interleukin O
- O
6 O
secretion O

BCR O
- O
ABL O
/ O
GATA1 O
/ O
miR O
- O
138 O
mini O
circuitry O
contributes O
to O
the O
leukemogenesis O
of O
chronic O
myeloid O
leukemia O

miR B-RNA
- I-RNA
200c I-RNA
Sensitizes O
Breast B-Disease
Cancer I-Disease
Cells O
to O
Doxorubicin O
Treatment O
by O
Decreasing O
TrkB O
and O
Bmi1 O
Expression O

miR B-RNA
- I-RNA
150 I-RNA
regulates O
high O
glucose O
- O
induced O
cardiomyocyte B-Disease
hypertrophy I-Disease
by O
targeting O
the O
transcriptional O
co O
- O
activator O
p300 O

miR B-RNA
- I-RNA
181a I-RNA
and O
inflammation O
: O
miRNA O
homeostasis O
response O
to O
inflammatory B-Disease
stimuli I-Disease
in O
vivo O

Reduced O
miR B-RNA
- I-RNA
150 I-RNA
is O
Associated O
with O
Poor O
Survival O
in O
Pulmonary O
Arterial O
Hypertension B-Disease

The O
upregulation O
of O
the O
lncRNA O
H19 B-RNA
contributes O
to O
tumorigenesis O
through O
p53 O
activity O
regulation O
, O
at O
least O
in O
gastric O
cancers O
. O

Epigenetic O
activation O
of O
the O
MiR O
- O
200 O
family O
contributes O
to O
H19 B-RNA
- O
mediated O
metastasis O
suppression O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

PDCD4 O
/ O
miR B-RNA
- I-RNA
21 I-RNA
dysregulation O
in O
inflammatory B-Disease
bowel I-Disease
disease I-Disease
- O
associated O
carcinogenesis O

Evaluation O
of O
single O
nucleotide O
polymorphisms O
in O
microRNAs O
( O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
196a2 I-RNA
rs11614913 O
C O
/ O
T O
) O
from O
Brazilian O
women O
with O
breast B-Disease
cancer I-Disease

Human O
hepatocellular B-Disease
carcinoma I-Disease
cell O
- O
specific O
miRNAs O
reveal O
the O
differential O
expression O
of O
miR B-RNA
- I-RNA
24 I-RNA
and O
miR B-RNA
- I-RNA
27a I-RNA
in O
cirrhotic O
/ O
non O
- O
cirrhotic O
HCC O

As O
a O
result O
, O
expression O
levels O
of O
miR B-RNA
- I-RNA
133b I-RNA
and O
miR O
- O
206 O
were O
both O
significantly O
decreased O
in O
osteosarcoma B-Disease
tissues O
and O
patients O
' O
sera O
( O
both O
P O
< O
0 O
. O
1 O
) O
. O

Subsite O
- O
based O
alterations O
in O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
, O
and O
miR B-RNA
- I-RNA
203 I-RNA
in O
squamous B-Disease
cell I-Disease
carcinoma I-Disease
of O
the O
oral O
cavity O
and O
correlation O
to O
important O
target O
proteins O

miR B-RNA
- I-RNA
370 I-RNA
modulates O
insulin O
receptor O
substrate O
- O
1 O
expression O
and O
inhibits O
the O
tumor O
phenotypes O
of O
oral B-Disease
carcinoma I-Disease

Subsite O
- O
based O
alterations O
in O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
, O
and O
miR B-RNA
- I-RNA
203 I-RNA
in O
squamous B-Disease
cell I-Disease
carcinoma I-Disease
of O
the O
oral O
cavity O
and O
correlation O
to O
important O
target O
proteins O

MiR B-RNA
- I-RNA
218 I-RNA
sensitizes O
glioma B-Disease
cells O
to O
apoptosis O
and O
inhibits O
tumorigenicity O
by O
regulating O
ECOP O
- O
mediated O
suppression O
of O
NF O
- O
kB O
activity O

The O
expression O
level O
of O
miR B-RNA
- I-RNA
218 I-RNA
is O
an O
important O
reference O
indicator O
for O
the O
assessment O
of O
the O
grade O
of O
gliomas B-Disease
. O

MiR B-RNA
- I-RNA
190 I-RNA
leads O
to O
aggressive O
phenotype O
of O
neuroblastoma B-Disease
through O
indirect O
activation O
of O
TrkB O
pathway O

Expression O
analysis O
of O
mir B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
, O
mir B-RNA
- I-RNA
20a I-RNA
and O
let B-RNA
- I-RNA
7a I-RNA
microRNAs O
and O
their O
target O
proteins O
in O
CD34 O
+ O
bone O
marrow O
cells O
of O
patients O
with O
myelodysplastic B-Disease
syndromes I-Disease

Targeting O
of O
TGFbeta O
signature O
and O
its O
essential O
component O
CTGF O
by O
miR B-RNA
- I-RNA
18 I-RNA
correlates O
with O
improved O
survival O
in O
glioblastoma B-Disease

Evaluation O
of O
single O
nucleotide O
polymorphisms O
in O
microRNAs O
( O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
196a2 I-RNA
rs11614913 O
C O
/ O
T O
) O
from O
Brazilian O
women O
with O
breast B-Disease
cancer I-Disease

MiR B-RNA
- I-RNA
124 I-RNA
targets O
Slug O
to O
regulate O
epithelial O
- O
mesenchymal O
transition O
and O
metastasis O
of O
breast B-Disease
cancer I-Disease

MIR O
- O
137 O
Suppresses O
Growth O
and O
Invasion O
, O
is O
Downregulated O
in O
Oligodendroglial B-Disease
Tumors I-Disease
and O
Targets O
CSE1L O

DNA O
- O
demethylating O
and O
anti O
- O
tumor O
activity O
of O
synthetic O
miR B-RNA
- I-RNA
29b I-RNA
mimics O
in O
multiple B-Disease
myeloma I-Disease

miR B-RNA
- I-RNA
24 I-RNA
- I-RNA
3p I-RNA
and O
miR B-RNA
- I-RNA
27a I-RNA
- I-RNA
3p I-RNA
promote O
cell O
proliferation O
in O
glioma B-Disease
cells O
via O
cooperative O
regulation O
of O
MXI1 O

A O
functional O
polymorphism O
at O
miR B-RNA
- I-RNA
491 I-RNA
- I-RNA
5p I-RNA
binding O
site O
in O
the O
3 O
' O
- O
UTR O
of O
MMP O
- O
9 O
gene O
confers O
increased O
risk O
for O
atherosclerotic B-Disease
cerebral I-Disease
infarction I-Disease
in O
a O
Chinese O
population O

An O
endothelial O
apelin O
- O
FGF O
link O
mediated O
by O
miR B-RNA
- I-RNA
424 I-RNA
and O
miR B-RNA
- I-RNA
503 I-RNA
is O
disrupted O
in O
pulmonary O
arterial O
hypertension B-Disease

The O
TNFa O
- O
induced O
miR B-RNA
- I-RNA
18a I-RNA
activates O
rheumatoid B-Disease
arthritis I-Disease
synovial O
fibroblasts O
through O
a O
feedback O
loop O
in O
NF O
- O
 O
B O
signaling O

Detection O
of O
the O
expression O
level O
of O
miR B-RNA
- I-RNA
140 I-RNA
using O
realtime O
fluorescent O
quantitative O
PCR O
in O
knee O
synovial O
fluid O
of O
osteoarthritis B-Disease
patients O

Synthetic O
miRNA O
- O
Mowers O
Targeting O
miR B-RNA
- I-RNA
183 I-RNA
- I-RNA
96 I-RNA
- I-RNA
182 I-RNA
Cluster O
or O
miR B-RNA
- I-RNA
210 I-RNA
Inhibit O
Growth O
and O
Migration O
and O
Induce O
Apoptosis O
in O
Bladder B-Disease
Cancer I-Disease
Cells O

Upregulation O
of O
miR B-RNA
- I-RNA
15b I-RNA
in O
NAFLD O
models O
and O
in O
the O
serum O
of O
patients O
with O
fatty B-Disease
liver I-Disease
disease O

Interestingly O
, O
down O
- O
regulation O
of O
micro B-RNA
- I-RNA
RNAs I-RNA
mmu I-RNA
- I-RNA
miR I-RNA
- I-RNA
30a I-RNA
and O
mmu B-RNA
- I-RNA
miR I-RNA
- I-RNA
141 I-RNA
as O
well O
as O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
193b I-RNA
clearly O
contributes O
to O
enhance O
the O
expression O
of O
this O
gene O
in O
mouse O
and O
human O
lymphomas O

miR B-RNA
- I-RNA
9 I-RNA
modulates O
the O
expression O
of O
interferon O
- O
regulated O
genes O
and O
MHC O
class O
I O
molecules O
in O
human O
nasopharyngeal B-Disease
carcinoma I-Disease
cells O

Clinical O
significance O
of O
the O
expression O
of O
long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
in O
primary O
hepatocellular B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
196b I-RNA
targets O
c O
- O
myc O
and O
Bcl O
- O
2 O
expression O
, O
inhibits O
proliferation O
and O
induces O
apoptosis O
in O
endometriotic O
stromal O
cells O

Tamoxifen O
Represses O
miR B-RNA
- I-RNA
200 I-RNA
MicroRNAs O
and O
Promotes O
Epithelial O
- O
to O
- O
Mesenchymal O
Transition O
by O
Up O
- O
Regulating O
c O
- O
Myc O
in O
Endometrial B-Disease
Carcinoma I-Disease
Cell O
Lines O

We O
further O
demonstrated O
that O
MEG3 B-RNA
markedly O
suppressed O
autophagy O
activation O
, O
whereas O
MEG3 B-RNA
knockdown O
activated O
autophagy O
in O
human O
bladder B-Disease
cancer I-Disease
cell O
lines O
. O

Downregulated O
MEG3 B-RNA
activates O
autophagy O
and O
increases O
cell O
proliferation O
in O
bladder B-Disease
cancer I-Disease
. O

The O
tumorigenic O
FGFR3 O
- O
TACC3 O
gene O
fusion O
escapes O
miR B-RNA
- I-RNA
99a I-RNA
regulation O
in O
glioblastoma B-Disease

Interactions O
of O
miR B-RNA
- I-RNA
323 I-RNA
/ O
miR B-RNA
- I-RNA
326 I-RNA
/ O
miR B-RNA
- I-RNA
329 I-RNA
and O
miR B-RNA
- I-RNA
130a I-RNA
/ O
miR B-RNA
- I-RNA
155 I-RNA
/ O
miR B-RNA
- I-RNA
210 I-RNA
as O
prognostic O
indicators O
for O
clinical O
outcome O
of O
glioblastoma B-Disease
patients O

Our O
study O
implies O
that O
the O
combination O
of O
Bcl B-RNA
- I-RNA
2 I-RNA
siRNA I-RNA
and O
miR B-RNA
- I-RNA
15a I-RNA
may O
be O
a O
useful O
approach O
in O
treatment O
for O
lymphoma B-Disease
. O

MEG3 B-RNA
: O
a O
novel O
long O
noncoding O
potentially O
tumour O
- O
suppressing O
RNA O
in O
meningiomas B-Disease
. O

Inhibition O
of O
miR B-RNA
- I-RNA
10b I-RNA
strongly O
reduced O
cell O
invasion O
and O
migration O
in O
glioblastoma B-Disease
cell O
and O
stem O
cell O
lines O
while O
overexpression O
of O
miR B-RNA
- I-RNA
10b I-RNA
induced O
cell O
migration O
and O
invasion O

MicroRNA O
miR O
- O
145 O
inhibits O
proliferation O
, O
invasiveness O
, O
and O
stem O
cell O
phenotype O
of O
an O
in O
vitro O
endometriosis B-Disease
model O
by O
targeting O
multiple O
cytoskeletal O
elements O
and O
pluripotency O
factors O

miR B-RNA
- I-RNA
34a I-RNA
inhibits O
the O
metastasis O
of O
osteosarcoma B-Disease
cells O
by O
repressing O
the O
expression O
of O
CD44 O
. O

Expression O
patterns O
of O
miR B-RNA
- I-RNA
124 I-RNA
, O
miR B-RNA
- I-RNA
134 I-RNA
, O
miR B-RNA
- I-RNA
132 I-RNA
, O
and O
miR B-RNA
- I-RNA
21 I-RNA
in O
an O
immature O
rat O
model O
and O
children O
with O
mesial B-Disease
temporal I-Disease
lobe I-Disease
epilepsy I-Disease
. O

qRT O
- O
PCR O
showed O
that O
miR B-RNA
- I-RNA
200c I-RNA
expression O
was O
upregulated O
in O
rat O
prolactinoma B-Disease
cell O
line O
compared O
with O
rat O
normal O
pituitary O
cells O

WASF3 O
regulates O
miR B-RNA
- I-RNA
200 I-RNA
inactivation O
by O
ZEB1 O
through O
suppression O
of O
KISS1 O
leading O
to O
increased O
invasiveness O
in O
breast B-Disease
cancer I-Disease
cells O

Hsa O
- O
mir O
- O
124 O
- O
3 O
CpG O
island O
methylation O
is O
associated O
with O
advanced O
tumours O
and O
disease O
recurrence O
of O
patients O
with O
clear O
cell O
renal O
cell O
carcinoma O

miR B-RNA
- I-RNA
125a I-RNA
/ I-RNA
b I-RNA
Regulates O
the O
Activation O
of O
Cancer O
Stem O
Cells O
in O
Paclitaxel O
- O
resistant O
Colon B-Disease
Cancer I-Disease

MiR B-RNA
- I-RNA
34a I-RNA
was O
either O
inhibited O
or O
ectopically O
expressed O
transiently O
in O
two O
choriocarcinoma B-Disease
cell O
lines O
( O
BeWo O
and O
JEG O
- O
3 O
) O
respectively O
. O

Clinical O
Impact O
of O
Circulating O
miR O
- O
221 O
in O
Plasma O
of O
Patients O
With O
Pancreatic B-Disease
Cancer I-Disease

Methylation O
- O
mediated O
silencing O
of O
the O
miR B-RNA
- I-RNA
124 I-RNA
genes O
facilitates O
pancreatic B-Disease
cancer I-Disease
progression O
and O
metastasis O
by O
targeting O
Rac1 O

Luciferase O
reporter O
assay O
confirmed O
that O
miR B-RNA
- I-RNA
124 I-RNA
, O
miR B-RNA
- I-RNA
128 I-RNA
, O
miR B-RNA
- I-RNA
146b I-RNA
and O
miR B-RNA
- I-RNA
218 I-RNA
conferred O
exogenous O
gene O
expression O
with O
glioma B-Disease
- O
specificity O
. O

Our O
investigation O
of O
the O
mechanisms O
underlying O
the O
decrease O
in O
miR B-RNA
- I-RNA
26a I-RNA
in O
this O
lymphoma B-Disease
revealed O
novel O
evidence O
that O
STAT3 O
, O
a O
major O
downstream O
substrate O
of O
NPM O
- O
ALK O
tyrosine O
kinase O
activity O
, O
suppresses O
MIR26A1 O
gene O
expression O
. O

Host O
microRNA O
molecular O
signatures O
associated O
with O
human O
H1N1 O
and O
H3N2 O
influenza B-Disease
A O
viruses O
reveal O
an O
unanticipated O
antiviral O
activity O
for O
miR B-RNA
- I-RNA
146a I-RNA

PRDM1 O
is O
directly O
targeted O
by O
miR B-RNA
- I-RNA
30a I-RNA
- I-RNA
5p I-RNA
and O
modulates O
the O
Wnt O
/ O
beta O
- O
catenin O
pathway O
in O
a O
Dkk1 O
- O
dependent O
manner O
during O
glioma B-Disease
growth O

miR B-RNA
- I-RNA
22 I-RNA
is O
an O
miRNA O
that O
has O
previously O
been O
shown O
to O
be O
downregulated O
in O
both O
HD O
and O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
brain O
. O

Bvht B-RNA
is O
necessary O
for O
activation O
of O
a O
core O
cardiovascular O
gene O
network O
and O
functions O
upstream O
of O
mesoderm O
posterior O
1 O

miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
221 I-RNA
and O
miR B-RNA
- I-RNA
222 I-RNA
expression O
and O
prostate B-Disease
cancer I-Disease
recurrence O
among O
obese O
and O
non O
- O
obese O
cases O

Characterization O
of O
global O
microRNA O
expression O
reveals O
oncogenic O
potential O
of O
miR B-RNA
- I-RNA
145 I-RNA
in O
metastatic O
colorectal B-Disease
cancer I-Disease

Here O
we O
found O
that O
H19 B-RNA
levels O
are O
remarkably O
increased O
in O
bladder B-Disease
cancer I-Disease
tissues O
, O
and O
upregulated O
H19 B-RNA
promotes O
bladder B-Disease
cancer I-Disease
cell O
migration O
in O
vitro O
and O
in O
vivo O
. O

TWIST1 O
regulates O
the O
activity O
of O
ubiquitin O
proteasome O
system O
via O
the O
miR B-RNA
- I-RNA
199 I-RNA
/ I-RNA
214 I-RNA
cluster O
in O
human O
end O
- O
stage O
dilated O
cardiomyopathy B-Disease

The O
Role O
of O
miR B-RNA
- I-RNA
18b I-RNA
in O
MDM2 O
- O
p53 O
Pathway O
Signaling O
and O
Melanoma B-Disease
Progression O

expression O
of O
Fendrr B-RNA
in O
plasma O
during O
heart B-Disease
failure I-Disease
is O
upregulated O

miR B-RNA
- I-RNA
106b I-RNA
facilitates O
glioma B-Disease
cell O
growth O
by O
promoting O
cell O
cycle O
progression O
through O
the O
negative O
regulation O
of O
RBL2 O

Quantitative O
real O
- O
time O
polymerase O
chain O
reaction O
( O
PCR O
) O
analysis O
for O
a O
selected O
panel O
of O
miRNAs O
indicated O
that O
circulating O
levels O
of O
miR B-RNA
- I-RNA
16 I-RNA
, O
miR B-RNA
- I-RNA
20b I-RNA
, O
miR B-RNA
- I-RNA
93 I-RNA
, O
miR B-RNA
- I-RNA
106b I-RNA
, O
miR B-RNA
- I-RNA
223 I-RNA
, O
and O
miR B-RNA
- I-RNA
423 I-RNA
- I-RNA
5p I-RNA
were O
significantly O
increased O
in O
response O
to O
hypertension O
- O
induced O
heart B-Disease
failure I-Disease

Stress O
Response O
of O
Glioblastoma B-Disease
Cells O
Mediated O
by O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
Targeting O
PTEN O
and O
the O
Passenger O
Strand O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
3p I-RNA
Targeting O
MDM2 O

miR B-RNA
- I-RNA
181a I-RNA
* I-RNA
: O
downregulated O
during O
human O
leukemic O
HL O
- O
60 O
cell O
differentiation O
induced O
by O
4 O
- O
hydroxynonenal O

a O
model O
for O
the O
combined O
regulatory O
activity O
of O
miR B-RNA
- I-RNA
200c I-RNA
and O
HuR B-RNA
on O
TUBB3 B-RNA
expression O
in O
ovarian B-Disease
cancer I-Disease

We O
found O
that O
H19 B-RNA
expression O
levels O
were O
remarkably O
increased O
in O
bladder B-Disease
cancer I-Disease
tissues O
as O
compared O
with O
adjacent O
normal O
control O
tissue O
, O
and O
forced O
expression O
of O
H19 B-RNA
promoted O
bladder B-Disease
cancer I-Disease
cell O
proliferation O
in O
vitro O
. O

miR B-RNA
- I-RNA
137 I-RNA
directly O
targets O
KDM1A B-RNA
mRNA O
in O
neuroblastoma B-Disease
cells O
, O
and O
activates O
cell O
properties O
consistent O
with O
tumor O
suppression O

miR B-RNA
- I-RNA
124a I-RNA
could O
function O
as O
a O
potent O
tumor O
suppressor O
in O
the O
development O
of O
uveal O
melanoma B-Disease

miR B-RNA
- I-RNA
145 I-RNA
is O
an O
invasion O
suppressor O
in O
metastatic O
melanoma B-Disease
cells O
. O

Poly O
( O
amido O
amine O
) O
is O
an O
ideal O
carrier O
of O
miR B-RNA
- I-RNA
7 I-RNA
for O
enhancing O
gene O
silencing O
effects O
on O
the O
EGFR O
pathway O
in O
U251 O
glioma B-Disease
cells O

miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
5p I-RNA
: O
were O
repressed O
, O
overexpression O
can O
inhibitu O
lung B-Disease
cancer I-Disease
growth O

A O
miR B-RNA
- I-RNA
151 I-RNA
binding O
site O
polymorphism O
in O
the O
3 O
' O
- O
untranslated O
region O
of O
the O
cyclin O
E1 O
gene O
associated O
with O
nasopharyngeal B-Disease
carcinoma I-Disease

MiR B-RNA
- I-RNA
106a I-RNA
is O
an O
independent O
prognostic O
marker O
in O
patients O
with O
glioblastoma B-Disease

miR B-RNA
- I-RNA
92b I-RNA
controls O
glioma B-Disease
proliferation O
and O
invasion O
through O
regulating O
Wnt O
/ O
beta O
- O
catenin O
signaling O
via O
Nemo O
- O
like O
kinase O

Intra O
- O
tumor O
injection O
of O
exosomes O
derived O
from O
miR O
- O
146 O
- O
expressing O
MSCs O
significantly O
reduced O
glioma B-Disease
xenograft O
growth O
in O
a O
rat O
model O
of O
primary O
brain O
tumor O
. O

these O
results O
identify O
age O
- O
induced O
expression O
of O
miR B-RNA
- I-RNA
34a I-RNA
and O
inhibition O
of O
its O
target O
PNUTS O
as O
a O
key O
mechanism O
that O
regulates O
cardiac O
contractile O
function O
during O
ageing O
and O
after O
acute B-Disease
myocardial I-Disease
infarction I-Disease
, O
by O
inducing O
DNA O
damage O
responses O
and O
telomere O
attrition O
. O

These O
effects O
were O
associated O
with O
decreased O
expression O
of O
Notch O
- O
1 O
and O
its O
downstream O
genes O
, O
such O
as O
vascular O
endothelial O
growth O
factor O
and O
matrix O
metalloproteinases O
, O
as O
well O
as O
increased O
expression O
of O
a O
panel O
of O
tumor O
- O
suppressive O
microRNAs O
( O
miRNAs O
) O
, O
including O
miR O
- O
34a O
, O
miR B-RNA
- I-RNA
143 I-RNA
, O
miR B-RNA
- I-RNA
145 I-RNA
and O
miR B-RNA
- I-RNA
200b I-RNA
/ I-RNA
c I-RNA
that O
are O
typically O
lost O
in O
osteosarcoma B-Disease
. O

The O
decrease O
of O
miR B-RNA
- I-RNA
1 I-RNA
and O
increase O
of O
AnxA5 O
appear O
as O
important O
modulators O
of O
NCX1 B-RNA
expression O
and O
activity O
during O
heart B-Disease
failure I-Disease
. O

miR B-RNA
- I-RNA
126 I-RNA
& I-RNA
126 I-RNA
* I-RNA
Restored O
Expressions O
Play O
a O
Tumor O
Suppressor O
Role O
by O
Directly O
Regulating O
ADAM9 O
and O
MMP7 O
in O
Melanoma B-Disease

Circulating O
levels O
of O
miR B-RNA
- I-RNA
423 I-RNA
- I-RNA
5p I-RNA
could O
be O
served O
as O
a O
diagnostic O
biomarker O
for O
heart B-Disease
failure I-Disease
caused O
by O
DCM O
. O

Targeting O
miR B-RNA
- I-RNA
21 I-RNA
inhibits O
in O
vitro O
and O
in O
vivo O
multiple B-Disease
myeloma I-Disease
cell O
growth O

Concomitant O
dysregulation O
of O
microRNAs O
miR B-RNA
- I-RNA
151 I-RNA
- I-RNA
3p I-RNA
and O
miR B-RNA
- I-RNA
126 I-RNA
correlates O
with O
improved O
survival O
in O
resected O
cholangiocarcinoma B-Disease

In O
our O
study O
, O
the O
expression O
of O
a O
subset O
of O
microRNAs O
was O
altered O
in O
distal O
gastric B-Disease
adenocarcinoma I-Disease
compared O
to O
normal O
tissue O
, O
miR B-RNA
- I-RNA
375 I-RNA
was O
significantly O
downregulated O
in O
distal O
gastric B-Disease
adenocarcinoma I-Disease
tissues O
, O
to O
a O
level O
that O
was O
significantly O
lower O
than O
cardia O
adenocarcinoma O
( O
p O
< O
0 O
. O
5 O
) O
. O

Expression O
of O
miR B-RNA
- I-RNA
126 I-RNA
and O
miR O
- O
508 O
- O
5p O
in O
endothelial O
progenitor O
cells O
is O
associated O
with O
the O
prognosis O
of O
chronic O
heart B-Disease
failure I-Disease
patients O

miR B-RNA
- I-RNA
206 I-RNA
is O
down O
- O
regulated O
in O
breast B-Disease
cancer I-Disease
and O
inhibits O
cell O
proliferation O
through O
the O
up O
- O
regulation O
of O
cyclinD2 O

MiR B-RNA
- I-RNA
134 I-RNA
regulates O
the O
proliferation O
and O
invasion O
of O
glioblastoma B-Disease
cells O
by O
reducing O
Nanog O
expression O

expression O
and O
function O
of O
miR B-RNA
- I-RNA
134 I-RNA
, O
which O
we O
found O
to O
be O
downregulated O
in O
glioma B-Disease
samples O
and O
the O
glioblastoma B-Disease
cell O
line O
U87 O
by O
SYBR O
green O
real O
- O
time O
quantitative O
reverse O
transcription O
- O
PCR O
( O
real O
- O
time O
PCR O
) O
. O

Primary O
Microcephaly O
Gene O
MCPH1 O
Shows O
Signatures O
of O
Tumor O
Suppressors O
and O
Is O
Regulated O
by O
miR B-RNA
- I-RNA
27a I-RNA
in O
Oral B-Disease
Squamous I-Disease
Cell I-Disease
Carcinoma I-Disease

Up O
- O
regulation O
of O
miR B-RNA
- I-RNA
182 I-RNA
expression O
in O
colorectal B-Disease
cancer I-Disease
tissues O
and O
its O
prognostic O
value O

miR B-RNA
- I-RNA
214 I-RNA
promotes O
tumorigenesis O
by O
targeting O
lactotransferrin O
in O
nasopharyngeal B-Disease
carcinoma I-Disease

In O
Vitro O
and O
in O
Vivo O
Anti O
- O
tumor O
Activity O
of O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
Inhibitors O
in O
Multiple B-Disease
Myeloma I-Disease

NPV O
- O
LDE O
- O
225 O
( O
Erismodegib O
) O
inhibits O
epithelial O
mesenchymal O
transition O
and O
self O
- O
renewal O
of O
glioblastoma B-Disease
initiating O
cells O
by O
regulating O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
128 I-RNA
, O
and O
miR B-RNA
- I-RNA
200 I-RNA

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR O
- O
101 O
- O
1 O
is O
significantly O
associated O
with O
development O
of O
liver B-Disease
cirrhosis I-Disease
and O
hepatocellular B-Disease
carcinoma I-Disease
occurrence O
. O

In O
addition O
, O
rs12375841 O
and O
its O
unique O
haplotype O
( O
ht2 O
) O
in O
miR O
- O
101 O
- O
2 O
show O
significant O
association O
with O
clearance O
of O
hepatitis O
B O
virus O
infection O
. O

Over O
- O
Expression O
of O
miR B-RNA
- I-RNA
106b I-RNA
Promotes O
Cell O
Migration O
and O
Metastasis O
in O
Hepatocellular B-Disease
Carcinoma I-Disease
by O
Activating O
Epithelial O
- O
Mesenchymal O
Transition O
Process O

miRNA B-RNA
- I-RNA
93 I-RNA
inhibits O
GLUT4 O
and O
is O
overexpressed O
in O
adipose O
tissue O
of O
Polycystic O
Ovary B-Disease
Syndrome I-Disease
patients O
and O
women O
with O
insulin O
resistance O

De O
novo O
13q31 O
. O
1 O
- O
q32 O
. O
1 O
interstitial O
deletion O
encompassing O
the O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
in O
a O
patient O
with O
Feingold B-Disease
syndrome I-Disease
- O
2 O
. O

In O
glioblastoma B-Disease
a O
high O
ratio O
of O
miR B-RNA
- I-RNA
17 I-RNA
to O
miR O
- O
221 O
/ O
222 O
was O
predictive O
of O
better O
overall O
survival O
suggesting O
that O
high O
miR O
- O
221 O
/ O
222 O
expression O
is O
more O
adverse O
for O
patients O
than O
high O
miR B-RNA
- I-RNA
17 I-RNA
expression O
. O

Interactions O
of O
miR B-RNA
- I-RNA
34b I-RNA
/ I-RNA
c I-RNA
and O
TP O
- O
53 O
polymorphisms O
on O
the O
risk O
of O
nasopharyngeal B-Disease
carcinoma I-Disease

miR B-RNA
- I-RNA
16 I-RNA
inhibits O
cell O
proliferation O
by O
targeting O
IGF1R O
and O
the O
Raf1 O
- O
MEK1 O
/ O
2 O
- O
ERK1 O
/ O
2 O
pathway O
in O
osteosarcoma B-Disease

Associations O
of O
pri B-RNA
- I-RNA
miR I-RNA
- I-RNA
34b I-RNA
/ I-RNA
c I-RNA
and O
pre B-RNA
- I-RNA
miR I-RNA
- I-RNA
196a2 I-RNA
Polymorphisms O
and O
Their O
Multiplicative O
Interactions O
with O
Hepatitis O
B O
Virus O
Mutations O
with O
Hepatocellular B-Disease
Carcinoma I-Disease
Risk O

Re O
- O
expression O
of O
miR B-RNA
- I-RNA
150 I-RNA
induces O
EBV O
- O
positive O
Burkitt B-Disease
lymphoma I-Disease
differentiation O
by O
modulating O
c O
- O
Myb O
in O
vitro O

Functional O
cooperation O
of O
miR B-RNA
- I-RNA
125a I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
, O
and O
miR B-RNA
- I-RNA
205 I-RNA
in O
entinostat O
- O
induced O
downregulation O
of O
erbB2 O
/ O
erbB3 O
and O
apoptosis O
in O
breast B-Disease
cancer I-Disease
cells O

miR B-RNA
- I-RNA
26a I-RNA
Plays O
an O
Important O
Role O
in O
Cell O
Cycle O
Regulation O
in O
ACTH O
- O
Secreting O
Pituitary O
Adenomas O
by O
Modulating O
Protein O
Kinase O
C O

We O
found O
that O
LINC00312 B-RNA
was O
significantly O
down O
- O
regulated O
in O
NPC B-Disease
tissues O
compared O
with O
non O
- O
cancerous O
nasopharyngeal O
epithelium O
tissues O
. O

Expression O
of O
LINC00312 B-RNA
, O
a O
long O
intergenic O
non O
- O
coding O
RNA O
, O
is O
negatively O
correlated O
with O
tumor O
size O
but O
positively O
correlated O
with O
lymph O
node O
metastasis O
in O
nasopharyngeal B-Disease
carcinoma I-Disease
. O

Tumorigenic O
Potential O
of O
miR B-RNA
- I-RNA
18A I-RNA
* I-RNA
in O
Glioma B-Disease
Initiating O
Cells O
Requires O
NOTCH O
- O
1 O
Signaling O

These O
results O
indicate O
that O
miR B-RNA
- I-RNA
200b I-RNA
targets O
the O
CREB1 O
gene O
and O
suppresses O
glioma B-Disease
cell O
growth O
, O
suggesting O
that O
miR B-RNA
- I-RNA
200b I-RNA
shows O
tumor O
- O
suppressive O
activity O
in O
human O
malignant O
glioma B-Disease
. O

Restoration O
of O
miR O
- O
1228 O
* O
Expression O
Suppresses O
Epithelial O
- O
Mesenchymal O
Transition O
in O
Gastric B-Disease
Cancer I-Disease

Genome O
- O
wide O
microRNA O
expression O
profiling O
in O
idiopathic O
non O
- O
obstructive O
azoospermia B-Disease
: O
significant O
up O
- O
regulation O
of O
miR B-RNA
- I-RNA
141 I-RNA
, O
miR B-RNA
- I-RNA
429 I-RNA
and O
miR B-RNA
- I-RNA
7 I-RNA
- I-RNA
1 I-RNA
- I-RNA
3p I-RNA

The O
lncRNA O
BDNF B-RNA
- I-RNA
AS I-RNA
is O
related O
to O
many O
neurological O
disorders O
, O
including O
Huntington B-Disease
' I-Disease
s I-Disease
disease I-Disease
( O
HD O
) O
, O
schizophrenia B-Disease
, O
and O
depression O
. O

miR B-RNA
- I-RNA
138 I-RNA
Overexpression O
is O
more O
powerful O
than O
hTERT O
knockdown O
to O
potentiate O
apigenin O
for O
apoptosis O
in O
neuroblastoma B-Disease
in O
vitro O
and O
in O
vivo O

The O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
cluster O
, O
miR B-RNA
- I-RNA
10b I-RNA
and O
miR B-RNA
- I-RNA
92a I-RNA
are O
highly O
upregulated O
in O
metastatic O
minimally O
invasive O
follicular O
thyroid B-Disease
carcinoma I-Disease

CCAT1 B-RNA
is O
up O
- O
regulated O
across O
the O
colon B-Disease
adenoma I-Disease
- I-Disease
carcinoma I-Disease
sequence O
. O

We O
observed O
a O
significant O
increase O
in O
miR B-RNA
- I-RNA
146a I-RNA
expression O
in O
the O
initial O
cohort O
of O
6 O
non O
- O
sepsis B-Disease
- O
SIRS O
patients O
compared O
to O
the O
4 O
sepsis B-Disease
patients O
( O
P O
= O
0 O
. O
1 O
) O

Following O
transfection O
with O
PTCSC3 B-RNA
, O
all O
three O
thyroid B-Disease
cancer I-Disease
cells O
originating O
from O
various O
pathological O
types O
of O
thyroid O
cancers O
demonstrated O
significant O
growth O
inhibition O
, O
cell O
cycle O
arrest O
and O
increased O
apoptosis O
. O

The O
expression O
of O
HOTAIR B-RNA
in O
ovarian B-Disease
cancer I-Disease
tissue O
was O
higher O
than O
that O
in O
normal O
ovarian O
tissue O
. O

The O
expression O
was O
statistically O
higher O
in O
poorly O
differentiated O
ovarian B-Disease
cancer I-Disease
than O
poorly O
- O
moderately O
, O
moderately O
- O
well O
, O
and O
well O
- O
differentiated O
ones O
( O
1 O
. O
65 O
+ O
/ O
- O
0 O
. O
41 O
vs O
. O
0 O
. O
39 O
+ O
/ O
- O
0 O
. O
14 O
, O
P O
< O
0 O
. O
5 O
) O
. O

we O
found O
that O
miRNA B-RNA
- I-RNA
223 I-RNA
was O
downregulated O
in O
both O
osteosarcoma B-Disease
patients O
' O
tumor O
tissues O
and O
osteosarcoma B-Disease
cell O
lines O
. O

In O
conclusion O
, O
we O
demonstrate O
that O
miR B-RNA
- I-RNA
150 I-RNA
is O
a O
potent O
leukemic O
tumor O
suppressor O
that O
regulates O
multiple O
oncogenes O
. O

miRNA O
expression O
profiling O
of O
human O
PDACs B-Disease
and O
adjacent O
normal O
pancreatic O
tissues O
identified O
16 O
upregulated O
miRNAs O
including O
miR B-RNA
- I-RNA
192 I-RNA
and O
8 O
downregulated O
miRNAs O
. O

These O
results O
may O
indicate O
that O
Llme23 B-RNA
can O
function O
as O
an O
oncogenic O
RNA O
and O
directly O
associate O
the O
PSF O
- O
binding O
lncRNA O
with O
human O
melanoma B-Disease
. O

qRT O
- O
PCR O
results O
showed O
that O
miR B-RNA
- I-RNA
27a I-RNA
significantly O
increased O
in O
specimens O
from O
glioblastoma B-Disease
comparing O
with O
normal O
human O
brain O
tissues O
. O

MYCN O
and O
HDAC2 O
cooperate O
to O
repress O
miR B-RNA
- I-RNA
183 I-RNA
signaling O
in O
neuroblastoma B-Disease
. O

Overexpression O
of O
miR B-RNA
- I-RNA
146a I-RNA
induces O
a O
state O
analogous O
to O
tolerance O
in O
BLP O
- O
stimulated O
cells O
and O
therefore O
may O
represent O
a O
future O
target O
for O
exogenous O
modulation O
of O
tolerance O
during O
microbial O
infection O
and O
sepsis B-Disease
. O

Our O
data O
suggest O
that O
miR B-RNA
- I-RNA
203 I-RNA
is O
a O
new O
prognostic O
factor O
in O
canine O
oral O
MMs O
and O
that O
miR B-RNA
- I-RNA
205 I-RNA
functions O
as O
a O
tumour O
suppressor O
by O
targeting O
erbb3 O
in O
both O
canine O
and O
human O
MM B-Disease
cells O
. O

Our O
results O
showed O
that O
PCAT B-RNA
- I-RNA
1 I-RNA
expression O
in O
CRC B-Disease
tissues O
was O
significantly O
upregulated O
compared O
with O
the O
matched O
normal O
tissues O
and O
the O
overexpression O
of O
PCAT B-RNA
- I-RNA
1 I-RNA
was O
found O
in O
64 O
% O
( O
62 O
/ O
81 O
) O
of O
CRC B-Disease
. O

CTBP1 B-RNA
- I-RNA
AS I-RNA
is O
predominantly O
localized O
in O
the O
nucleus O
and O
its O
expression O
is O
generally O
upregulated O
in O
prostate B-Disease
cancer I-Disease
. O

The O
results O
showed O
that O
AC096655 B-RNA
. I-RNA
1 I-RNA
- I-RNA
2 I-RNA
was O
significantly O
downregulated O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
paired O
adjacent O
non O
- O
tumorous O
tissues O
( O
P O
< O
0 O
. O
1 O
) O
. O

miR B-RNA
- I-RNA
181b I-RNA
independently O
predicted O
chemoresponse O
to O
temozolomide O
and O
enhanced O
temozolomide O
sensitivity O
via O
MEK1 O
downregulation O
. O

A O
combination O
of O
miR B-RNA
- I-RNA
181b I-RNA
and O
temozolomide O
may O
be O
an O
effective O
therapeutic O
strategy O
for O
gliomas O
. O

using O
the O
TANA O
modified O
antisense O
oligonucleotide O
against O
miR O
- O
34a O
, O
intracellular O
levels O
of O
miR O
- O
34 O
can O
be O
reduced O
, O
and O
consequently O
, O
the O
expression O
of O
its O
target O
oncogene O
V O
- O
myc O
myelocytomatosis O
viral O
related O
oncogene O
, O
neuroblastoma O
derived O
( O
MYCN O
) O
is O
enhanced O
. O

HOX O
antisense O
lincRNA O
HOXA B-RNA
- I-RNA
AS2 I-RNA
is O
an O
apoptosis O
repressor O
in O
all O
trans O
retinoic O
acid O
treated O
NB4 O
promyelocytic O
leukemia O
cells O
; O
The O
increase O
in O
death O
of O
HOXA B-RNA
- I-RNA
AS2 I-RNA
knockdown O
cells O
was O
accompanied O
by O
an O
elevated O
TNF O
- O
related O
apoptosis O
- O
inducing O
ligand O
( O
TRAIL O
) O
levels O
, O
but O
ATRA O
- O
induced O
NB4 O
cells O
treated O
with O
TRAIL O
did O
show O
an O
increase O
in O
HOXA B-RNA
- I-RNA
AS2 I-RNA
expression O
; O
These O
results O
demonstrate O
that O
all O
trans O
retinoic O
acid O
( O
ATRA O
) O
induction O
of O
HOXA B-RNA
- I-RNA
AS2 I-RNA
suppresses O
ATRA O
- O
induced O
apoptosis O
, O
possibly O
through O
a O
TRAIL O
- O
mediated O
pathway O

MALAT1 O
is O
upregulated O
in O
several O
cancer O
types O
and O
its O
overexpression O
has O
been O
linked O
to O
an O
increase O
in O
cell O
proliferation O
and O
migration O
in O
lung O
and O
colorectal O
cancer O
cells O
. O

miR O
- O
214 O
coordinates O
melanoma O
progression O
by O
upregulating O
ALCAM O
through O
TFAP2 O
and O
miR O
- O
148b O
downmodulation O
. O

In O
the O
current O
study O
, O
we O
demonstrate O
that O
the O
tumor O
- O
promoting O
lincRNA O
HOTAIR B-RNA
is O
induced O
by O
Col O
- O
1 O
and O
its O
expression O
inversely O
correlates O
with O
acinar O
morphogenesis O
, O
a O
differentiation O
feature O
of O
lung O
epithelial O
cells O
in O
rBM O
3 O
- O
D O
culture O
. O

These O
in O
vitro O
findings O
suggest O
that O
the O
elevated O
HOTAIR B-RNA
expression O
in O
tumor O
tissues O
results O
from O
cancer O
cells O
' O
response O
to O
Col O
- O
1 O
that O
is O
aberrantly O
enriched O
in O
the O
tumor O
microenvironment O
. O

Our O
findings O
indicate O
that O
tumor O
- O
promoting O
Col O
- O
1 O
up O
- O
regulates O
the O
expression O
of O
HOTAIR B-RNA
in O
NSCLC O
cells O
. O

These O
initial O
results O
warrant O
further O
investigation O
of O
HOTAIR B-RNA
and O
other O
lincRNA O
genes O
in O
lung O
tumorigenesis O
. O

Induction O
of O
long O
intergenic O
non O
- O
coding O
RNA O
HOTAIR O
in O
lung O
cancer O
cells O
by O
type O
I O
collagen O
. O

Our O
findings O
indicate O
that O
tumor O
- O
promoting O
Col O
- O
1 O
up O
- O
regulates O
the O
expression O
of O
HOTAIR O
in O
NSCLC O
cells O
. O

These O
initial O
results O
warrant O
further O
investigation O
of O
HOTAIR O
and O
other O
lincRNA O
genes O
in O
lung O
tumorigenesis O
. O

Moreover O
the O
expression O
of O
HOTAIR O
and O
Col O
- O
1 O
was O
concurrently O
up O
- O
regulated O
in O
human O
non O
- O
small O
cell O
lung O
cancer O
. O

qPCR O
confirmed O
that O
linc B-RNA
- I-RNA
UBC1 I-RNA
expression O
is O
up O
- O
regulated O
in O
60 O
cases O
( O
58 O
. O
8 O
% O
) O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
with O
normal O
adjacent O
tissues O
, O
and O
its O
overexpression O
correlates O
with O
lymph O
node O
metastasis O
and O
poor O
survival O
. O

In O
the O
validation O
set O
, O
miR B-RNA
- I-RNA
219 I-RNA
- I-RNA
5p I-RNA
expression O
was O
significantly O
downregulated O
( O
p O
= O
0 O
. O
98 O
) O
in O
glioblastoma B-Disease
patient O
samples O
( O
n O
= O
24 O
) O
by O
12 O
- O
fold O
( O
median O
log O
2 O
ratio O
of O
23 O
. O
6 O
) O
when O
compared O
to O
the O
control O
normal O
brain O
tissue O
( O
n O
= O
3 O
) O
. O
miR B-RNA
- I-RNA
219 I-RNA
- I-RNA
5p I-RNA
, O
repressed O
EGFR O
by O
directly O
binding O
to O
its O
3 O
' O
- O
UTR O
. O

The O
meta O
- O
analysis O
demonstrated O
that O
the O
miR B-RNA
- I-RNA
196a I-RNA
- I-RNA
2 I-RNA
polymorphism O
is O
associated O
with O
cancer O
susceptibility O
, O
especially O
lung B-Disease
cancer I-Disease
, O
colorectal B-Disease
cancer I-Disease
, O
and O
breast B-Disease
cancer I-Disease
among O
Asian O
populations O
. O

Subjects O
with O
current O
allergic B-Disease
rhinitis I-Disease
symptoms O
had O
increased O
levels O
of O
miR B-RNA
- I-RNA
155 I-RNA
, O
miR B-RNA
- I-RNA
205 I-RNA
, O
and O
miR B-RNA
- I-RNA
498 I-RNA
, O
but O
reduced O
levels O
of O
let B-RNA
- I-RNA
7e I-RNA
. O

miR B-RNA
- I-RNA
197 I-RNA
Expression O
in O
Peripheral O
Blood O
Mononuclear O
Cells O
from O
Hepatitis O
B O
Virus O
- O
Infected O
Patients O
. O

In O
surgical O
CAD O
patients O
, O
a O
decreased O
miR B-RNA
- I-RNA
133 I-RNA
expression O
is O
associated O
with O
variables O
characteristic O
of O
heart B-Disease
failure I-Disease
. O

The O
miR B-RNA
- I-RNA
132 I-RNA
and O
miR B-RNA
- I-RNA
212 I-RNA
are O
highly O
increased O
in O
the O
heart O
, O
aortic O
wall O
and O
kidney O
of O
rats O
with O
hypertension B-Disease
( O
159 O
 O
12 O
mm O
Hg O
) O
and O
cardiac O
hypertrophy O
following O
chronic O
AngII O
infusion O
. O

PAICS O
, O
an O
enzyme O
required O
for O
de O
novo O
purine O
biosynthesis O
, O
the O
long O
non O
- O
coding O
RNA O
MALAT1 B-RNA
and O
the O
MAST2 B-RNA
kinase O
are O
overexpressed O
in O
certain O
tumor O
entities O
and O
capable O
of O
suppressing O
apoptosis O
in O
human O
cells O
. O

Using O
a O
subcutaneous O
xenograft O
mouse O
model O
, O
we O
also O
demonstrated O
that O
glioblastoma B-Disease
tumor O
growth O
requires O
MAST2 B-RNA
expression O
. O

We O
found O
significantly O
higher O
TUG1 B-RNA
and O
n377360 O
expression O
levels O
in O
osteosarcoma B-Disease
tissues O
compared O
with O
matched O
non O
- O
tumorous O
tissues O
. O

QRT O
- O
PCR O
assay O
and O
ROC O
curve O
analyses O
revealed O
that O
miR B-RNA
- I-RNA
31 I-RNA
, O
miR B-RNA
- I-RNA
29a I-RNA
and O
miR B-RNA
- I-RNA
148a I-RNA
all O
had O
significant O
potential O
diagnostic O
value O
for O
critically O
ill O
patients O
infected O
with O
H1N1 O
influenza B-Disease
virus O

Silencing O
of O
miR B-RNA
- I-RNA
21 I-RNA
by O
locked O
nucleic O
acid O
- O
lipid O
nanocapsule O
complexes O
sensitize O
human O
glioblastoma B-Disease
cells O
to O
radiation O
- O
induced O
cell O
death O
. O

miR B-RNA
- I-RNA
96 I-RNA
regulates O
FOXO1 O
- O
mediated O
cell O
apoptosis O
in O
bladder B-Disease
cancer I-Disease
. O

The O
noncoding O
RNA O
expression O
profile O
and O
the O
effect O
of O
lncRNA O
AK126698 B-RNA
on O
cisplatin O
resistance O
in O
non B-Disease
- I-Disease
small I-Disease
- I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
cell O
. O

Tumor O
- O
suppressive O
effects O
of O
miR B-RNA
- I-RNA
29c I-RNA
on O
gliomas B-Disease
. O

Therefore O
, O
miR B-RNA
- I-RNA
29c I-RNA
can O
be O
used O
as O
a O
tumor O
suppressor O
in O
the O
gene O
therapy O
of O
malignant B-Disease
gliomas I-Disease
. O

miR B-RNA
- I-RNA
129 I-RNA
promotes O
apoptosis O
and O
enhances O
chemosensitivity O
to O
5 O
- O
fluorouracil O
in O
colorectal O
cancer O
. O

miR B-RNA
- I-RNA
129 I-RNA
promotes O
apoptosis O
and O
enhances O
chemosensitivity O
to O
5 O
- O
fluorouracil O
in O
colorectal B-Disease
cancer I-Disease
. O

Deregulated O
Serum O
Concentrations O
of O
Circulating O
Cell O
- O
Free O
MicroRNAs O
miR B-RNA
- I-RNA
17 I-RNA
, O
miR B-RNA
- I-RNA
34a I-RNA
, O
miR B-RNA
- I-RNA
155 I-RNA
, O
and O
miR B-RNA
- I-RNA
373 I-RNA
in O
Human O
Breast B-Disease
Cancer I-Disease
Development O
and O
Progression O
. O

High O
miR B-RNA
- I-RNA
26a I-RNA
and O
low O
CDC2 B-RNA
levels O
associate O
with O
decreased O
EZH2 O
expression O
and O
with O
favorable O
outcome O
on O
tamoxifen O
in O
metastatic O
breast B-Disease
cancer I-Disease
. O

MiR O
- O
26a O
Inhibits O
Proliferation O
and O
Migration O
of O
Breast O
Cancer O
through O
Repression O
of O
MCL O
- O
1 O
. O

Morphine O
induced O
exacerbation O
of O
sepsis B-Disease
is O
mediated O
by O
tempering O
endotoxin O
tolerance O
through O
modulation O
of O
miR O
- O
146a O
. O

Attenuation O
of O
dexamethasone O
- O
induced O
cell O
death O
in O
multiple B-Disease
myeloma I-Disease
is O
mediated O
by O
miR B-RNA
- I-RNA
125b I-RNA
expression O
. O

miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
miRNA O
cluster O
promotes O
kidney O
cyst O
growth O
in O
polycystic O
kidney O
disease O
. O

miR O
- O
124 O
radiosensitizes O
human O
glioma B-Disease
cells O
by O
targeting O
CDK4 O
. O

Loss O
of O
connective O
tissue O
growth O
factor O
as O
an O
unfavorable O
prognosis O
factor O
activates O
miR B-RNA
- I-RNA
18b I-RNA
by O
PI3K O
/ O
AKT O
/ O
C O
- O
Jun O
and O
C O
- O
Myc O
and O
promotes O
cell O
growth O
in O
nasopharyngeal B-Disease
carcinoma I-Disease
. O

CPEB1 O
, O
a O
histone O
- O
modified O
hypomethylated O
gene O
, O
is O
regulated O
by O
miR B-RNA
- I-RNA
101 I-RNA
and O
involved O
in O
cell O
senescence O
in O
glioma B-Disease
. O

Hydroquinone O
- O
induced O
miR B-RNA
- I-RNA
122 I-RNA
down O
- O
regulation O
elicits O
ADAM17 O
up O
regulation O
, O
leading O
to O
increased O
soluble O
TNF O
- O
 O
production O
in O
human O
leukemia B-Disease
cells O
with O
expressed O
Bcr O
/ O
Abl O
. O

Circadian O
gene O
Clock O
contributes O
to O
cell O
proliferation O
and O
migration O
of O
glioma B-Disease
and O
is O
directly O
regulated O
by O
tumor O
- O
suppressive O
miR O
- O
124 O
. O

miR B-RNA
- I-RNA
146a I-RNA
polymorphism O
influences O
levels O
of O
miR B-RNA
- I-RNA
146a I-RNA
, O
IRAK O
- O
1 O
, O
and O
TRAF O
- O
6 O
in O
young O
patients O
with O
coronary B-Disease
artery I-Disease
disease I-Disease
. O

Our O
results O
indicated O
that O
ectopic O
expression O
of O
miR B-RNA
- I-RNA
146a I-RNA
could O
not O
independently O
induce O
differentiation O
in O
lymphoblastic B-Disease
cells O
. O

miR B-RNA
- I-RNA
146b I-RNA
- I-RNA
5p I-RNA
inhibits O
glioma O
migration O
and O
invasion O
by O
targeting O
MMP16 O
. O

Here O
, O
we O
report O
that O
CCAT2 B-RNA
, O
a O
novel O
long O
noncoding O
RNA O
transcript O
( O
lncRNA O
) O
encompassing O
the O
rs6983267 O
SNP O
, O
is O
highly O
overexpressed O
in O
microsatellite O
- O
stable O
colorectal B-Disease
cancer I-Disease
and O
promotes O
tumor O
growth O
, O
metastasis O
, O
and O
chromosomal O
instability O
. O

CCAT2 B-RNA
, O
a O
novel O
noncoding O
RNA O
mapping O
to O
8q24 O
, O
underlies O
metastatic O
progression O
and O
chromosomal O
instability O
in O
colon B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
9 I-RNA
is O
an O
essential O
oncogenic O
microRNA O
specifically O
overexpressed O
in O
mixed O
lineage O
leukemia B-Disease
- O
rearranged O
leukemia B-Disease
. O

MiR B-RNA
- I-RNA
205 I-RNA
is O
downregulated O
in O
hereditary O
hemorrhagic O
telangiectasia O
and O
impairs O
TGF O
- O
beta O
signaling O
pathways O
in O
endothelial O
cells O
. O

MiR B-RNA
- I-RNA
424 I-RNA
regulates O
monocytic O
differentiation O
of O
human O
leukemia B-Disease
U937 O
cells O
by O
directly O
targeting O
CDX2 O
. O

We O
report O
, O
for O
the O
first O
time O
, O
that O
GRP O
- O
R O
- O
mediated O
tumorigenicity O
and O
increased O
metastatic O
potential O
in O
neuroblastoma B-Disease
are O
regulated O
, O
in O
part O
, O
by O
miR B-RNA
- I-RNA
335 I-RNA
and O
miR B-RNA
- I-RNA
363 I-RNA
. O

Involvement O
of O
FOS O
- O
mediated O
miR B-RNA
- I-RNA
181b I-RNA
/ O
miR B-RNA
- I-RNA
21 I-RNA
signalling O
in O
the O
progression O
of O
malignant O
gliomas B-Disease
. O

Our O
data O
validate O
an O
important O
clinical O
significance O
of O
miR B-RNA
- I-RNA
203 I-RNA
in O
gliomas B-Disease
, O
and O
reveal O
that O
it O
might O
be O
an O
intrinsic O
regulator O
of O
tumor O
progression O
and O
a O
potential O
prognostic O
factor O
for O
this O
dismal O
disease O
. O

Our O
study O
demonstrates O
that O
miR B-RNA
- I-RNA
145 I-RNA
has O
a O
tumor O
- O
suppressive O
function O
in O
glioblastoma B-Disease
in O
that O
it O
reduces O
proliferation O
, O
adhesion O
, O
and O
invasion O
of O
glioblastoma B-Disease
cells O
, O
apparently O
by O
suppressing O
the O
activity O
of O
oncogenic O
proteins O
Sox9 O
and O
ADD3 O
. O

MiR B-RNA
- I-RNA
124 I-RNA
inhibits O
the O
growth O
of O
glioblastoma B-Disease
through O
the O
downregulation O
of O
SOS1 O
. O

miR O
- O
19a O
and O
miR O
- O
19b O
overexpression O
in O
gliomas O
. O

miR B-RNA
- I-RNA
182 I-RNA
and O
miR O
- O
10a O
are O
key O
regulators O
of O
Treg O
specialisation O
and O
stability O
during O
Schistosome O
and O
Leishmania O
- O
associated O
inflammation O
. O

MiR B-RNA
- I-RNA
25 I-RNA
- I-RNA
3p I-RNA
attenuates O
the O
proliferation O
of O
tongue B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
cell O
line O
Tca8113 O
. O

miR B-RNA
- I-RNA
1 I-RNA
induces O
growth O
arrest O
and O
apoptosis O
in O
malignant O
mesothelioma B-Disease
. O

the O
expression O
level O
of O
miR B-RNA
- I-RNA
21 I-RNA
in O
serum O
was O
increased O
for O
patients O
in O
the O
glioblastomas B-Disease
compared O
with O
that O
in O
healthy O
controls O
. O

Tumor O
- O
suppressive O
function O
of O
protein O
- O
tyrosine O
phosphatase O
non O
- O
receptor O
type O
23 O
in O
testicular B-Disease
germ I-Disease
cell I-Disease
tumors I-Disease
is O
lost O
upon O
overexpression O
of O
miR142 B-RNA
- I-RNA
3p I-RNA
microRNA O
. O

MALAT B-RNA
- I-RNA
1 I-RNA
was O
up O
- O
regulated O
in O
human O
prostate B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
. O

Epirubicin O
- O
mediated O
expression O
of O
miR B-RNA
- I-RNA
302b I-RNA
is O
involved O
in O
osteosarcoma B-Disease
apoptosis O
and O
cell O
cycle O
regulation O
. O

Knockdown O
of O
long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
suppresses O
tumor O
invasion O
and O
reverses O
epithelial O
- O
mesenchymal O
transition O
in O
gastric B-Disease
cancer I-Disease
. O

Chr9p21 O
encodes O
the O
long O
non O
- O
coding O
RNA O
( O
ncRNA O
) O
antisense O
non O
- O
coding O
RNA O
in O
the O
INK4 O
locus O
( O
ANRIL B-RNA
) O
. O

ANRIL B-RNA
expression O
is O
associated O
with O
the O
Chr9p21 O
genotype O
and O
correlated O
with O
atherosclerosis B-Disease
severity O

Together O
, O
our O
study O
shows O
thatHOTAIR O
is O
overexpressed O
in O
metastatic O
tissue O
, O
which O
is O
associated O
with O
the O
ability O
of O
HOTAIR B-RNA
to O
promote O
melanoma B-Disease
cell O
motility O
and O
invasion O
. O

MiR B-RNA
- I-RNA
329 I-RNA
may O
inhibit O
cell O
proliferation O
in O
human O
glioma B-Disease
cells O
through O
regulating O
E2F1 O
- O
mediated O
suppression O
of O
Akt O
pathway O
. O

Our O
results O
support O
the O
link O
between O
miR B-RNA
- I-RNA
221 I-RNA
and O
obesity B-Disease
development O
as O
well O
as O
obesity B-Disease
related O
inflammatory O
status O
. O

Circulating O
miR B-RNA
- I-RNA
130b I-RNA
reflects O
the O
degree O
of O
obesity O
and O
could O
serve O
as O
a O
potential O
biomarker O
for O
hypertriacylglycerolae O
and O
metabolic B-Disease
syndrome I-Disease
. O

Circulating O
miR B-RNA
- I-RNA
130b I-RNA
could O
function O
as O
a O
metabolic O
mediator O
for O
adipose O
muscle O
crosstalk O
and O
might O
be O
involved O
in O
the O
pathogenesis O
of O
obesity O
associated O
metabolic O
diseases O
. O

The O
expression O
ratio O
of O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
and O
miR O
- O
155 O
correlates O
with O
grading O
in O
canine O
splenic O
lymphoma B-Disease
. O

We O
report O
that O
GNG12 B-RNA
- I-RNA
AS1 I-RNA
is O
coexpressed O
with O
DIRAS3 B-RNA
in O
several O
tissues O
and O
coordinately O
downregulated O
with O
DIRAS3 B-RNA
in O
breast O
cancers O
. O

miR B-RNA
- I-RNA
122 I-RNA
targets O
NOD2 O
to O
decrease O
intestinal O
epithelial O
cell O
injury O
in O
Crohn B-Disease
' I-Disease
s I-Disease
disease I-Disease
. O

We O
recently O
reported O
that O
miR B-RNA
- I-RNA
126 I-RNA
, O
miR B-RNA
- I-RNA
130a I-RNA
, O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
27a I-RNA
, O
and O
miR B-RNA
- I-RNA
27b I-RNA
were O
downregulated O
in O
EPCs O
from O
type O
II O
diabetes O
mellitus O
( O
DM O
) O
patients O
, O
and O
downregulation O
of O
miR B-RNA
- I-RNA
126 I-RNA
impairs O
EPC O
function O
. O

Comprehensive O
microRNA O
analysis O
identifies O
miR B-RNA
- I-RNA
24 I-RNA
and O
miR B-RNA
- I-RNA
125a I-RNA
- I-RNA
5p I-RNA
as O
plasma O
biomarkers O
for O
rheumatoid B-Disease
arthritis I-Disease
. O

miRNA B-RNA
- I-RNA
218 I-RNA
inhibits O
osteosarcoma B-Disease
cell O
migration O
and O
invasion O
by O
down O
- O
regulating O
of O
TIAM1 O
, O
MMP2 O
and O
MMP9 O
. O

These O
findings O
indicate O
that O
miR O
- O
206 O
may O
have O
a O
key O
role O
in O
osteosarcoma O
pathogenesis O
and O
development O
. O

It O
could O
serve O
as O
a O
useful O
biomarker O
for O
prediction O
of O
osteosarcoma O
progression O
, O
and O
provide O
a O
potential O
target O
for O
gene O
therapy O
. O

miR B-RNA
- I-RNA
485 I-RNA
acts O
as O
a O
tumor O
suppressor O
by O
inhibiting O
cell O
growth O
and O
migration O
in O
breast B-Disease
carcinoma I-Disease
T47D O
cells O
. O

Here O
, O
we O
found O
aberrant O
up O
- O
regulation O
of O
HOTAIR B-RNA
in O
gastric B-Disease
adenocarcinoma I-Disease
samples O
compared O
with O
normal O
adjacent O
gastric O
epithelium O
tissues O
. O

The O
miR B-RNA
- I-RNA
92b I-RNA
functions O
as O
a O
potential O
oncogene O
by O
targeting O
on O
Smad3 O
in O
glioblastomas B-Disease
. O

MiR B-RNA
- I-RNA
21 I-RNA
mediates O
the O
radiation O
resistance O
of O
glioblastoma B-Disease
cells O
by O
regulating O
PDCD4 O
and O
hMSH2 O
. O

MiR B-RNA
- I-RNA
376c I-RNA
down O
- O
regulation O
accelerates O
EGF O
- O
dependent O
migration O
by O
targeting O
GRB2 O
in O
the O
HuCCT1 O
human O
intrahepatic B-Disease
cholangiocarcinoma I-Disease
cell O
line O
. O

The O
physiopathological O
significance O
of O
miR B-RNA
- I-RNA
210 I-RNA
is O
context O
dependent O
. O

In O
the O
ischemic O
skeletal O
muscle O
it O
seems O
to O
be O
cytoprotective O
, O
regulating O
oxidative O
metabolism O
and O
oxidative O
stress O
. O

This O
negative O
correlation O
between O
miR B-RNA
- I-RNA
21 I-RNA
and O
GAS5 B-RNA
is O
also O
seen O
in O
breast O
tumor O
specimens O
. O

miR B-RNA
- I-RNA
137 I-RNA
regulates O
the O
constitutive O
androstane O
receptor O
and O
modulates O
doxorubicin O
sensitivity O
in O
parental O
and O
doxorubicin O
- O
resistant O
neuroblastoma B-Disease
cells O
. O

PRNCR1 B-RNA
may O
play O
an O
important O
role O
in O
the O
progression O
of O
castration O
resistant O
prostate B-Disease
cancer I-Disease
through O
mediating O
the O
expression O
of O
AR O

Fecal O
miR B-RNA
- I-RNA
106a I-RNA
is O
a O
good O
molecular O
marker O
to O
identify O
colorectal B-Disease
cancer I-Disease
patients O
from O
among O
those O
with O
negative O
iFOBT O
results O
. O

FmiRT O
combined O
with O
iFOBT O
may O
improve O
the O
sensitivity O
to O
detect O
colorectal B-Disease
cancer I-Disease
. O

Lower O
levels O
of O
hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
15a I-RNA
, O
which O
decreases O
VEGFA O
, O
in O
the O
CD4 O
+ O
T O
cells O
of O
pediatric O
patients O
with O
asthma B-Disease
. O

MiR B-RNA
- I-RNA
101 I-RNA
inhibits O
melanoma B-Disease
cell O
invasion O
and O
proliferation O
by O
targeting O
MITF O
and O
EZH2 O
. O

Mechanical O
stretch O
modulates O
the O
homeostasis O
of O
the O
hBEC O
secretome O
involving O
miR B-RNA
- I-RNA
155 I-RNA
and O
that O
hMSCs O
can O
be O
used O
as O
a O
potential O
therapeutic O
approach O
to O
reverse O
bronchial O
epithelial O
inflammation O
in O
asthma B-Disease
. O

MiR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
and O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
cluster O
members O
target O
KIT O
and O
ETV1 O
in O
human O
gastrointestinal O
stromal O
tumours O
. O

miR B-RNA
- I-RNA
335 I-RNA
suppresses O
migration O
and O
invasion O
by O
targeting O
ROCK1 O
in O
osteosarcoma B-Disease
cells O

Microvesicle O
- O
mediated O
delivery O
of O
miR B-RNA
- I-RNA
21 I-RNA
among O
tubular O
epithelial O
cells O
might O
shed O
new O
light O
on O
the O
mechanism O
of O
progressive O
renal B-Disease
fibrosis I-Disease
. O

The O
EnSCs O
can O
differentiate O
to O
oligodendrocyte O
cells O
by O
the O
overexpression O
of O
miR B-RNA
- I-RNA
338 I-RNA
, O
and O
these O
cells O
can O
be O
used O
as O
a O
unique O
source O
for O
cell O
therapy O
of O
neurodegenerative O
disease O
. O

A O
novel O
tetranucleotide O
repeat O
polymorphism O
within O
KCNQ1OT1 B-RNA
confers O
risk O
for O
hepatocellular B-Disease
carcinoma I-Disease
. O

Kaposi B-Disease
' I-Disease
s I-Disease
sarcoma I-Disease
- O
associated O
herpesvirus O
encodes O
a O
mimic O
of O
cellular O
miR B-RNA
- I-RNA
23 I-RNA
. O

PIWIL2 B-RNA
and O
piR B-RNA
- I-RNA
932 I-RNA
expressed O
significantly O
higher O
in O
the O
breast B-Disease
cancer I-Disease
cells O
that O
were O
induced O
by O
EMT O
, O
and O
they O
could O
form O
immune O
complexes O
through O
immunoprecipitation O
, O
whereas O
in O
PIWIL2 B-RNA
expressed O
breast B-Disease
cancer I-Disease
stem O
cells O
, O
the O
level O
of O
Latexin O
expression O
significantly O
reduced O
because O
of O
its O
promoter O
region O
CpG O
island O
was O
methylated O

The O
results O
showed O
that O
SUMO1P3 B-RNA
was O
significantly O
up O
- O
regulated O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
paired O
- O
adjacent O
nontumorous O
tissues O
( O
p O
< O
0 O
. O
1 O
) O
. O

Up O
- O
regulation O
of O
SUMO1 O
pseudogene O
3 O
( O
SUMO1P3 B-RNA
) O
in O
gastric B-Disease
cancer I-Disease
and O
its O
clinical O
association O
. O

Long O
non O
- O
coding O
RNA O
HNF1A B-RNA
- I-RNA
AS1 I-RNA
regulates O
proliferation O
and O
migration O
in O
oesophageal B-Disease
adenocarcinoma I-Disease
cells O
. O

miR B-RNA
- I-RNA
34a I-RNA
, O
miR B-RNA
- I-RNA
137 I-RNA
and O
miR B-RNA
- I-RNA
182 I-RNA
all O
had O
lower O
expression O
levels O
in O
uveal B-Disease
melanoma I-Disease
cell O
lines O
, O
compared O
with O
normal O
cells O

TFAM O
is O
directly O
regulated O
by O
miR B-RNA
- I-RNA
23b I-RNA
in O
glioma B-Disease
. O

Comprehensive O
analysis O
of O
the O
transcriptional O
landscape O
of O
the O
human O
FMR1 B-RNA
gene O
reveals O
two O
new O
long O
noncoding O
RNAs O
differentially O
expressed O
in O
Fragile B-Disease
X I-Disease
syndrome I-Disease
and O
Fragile O
X O
- O
associated O
tremor O
/ O
ataxia O
syndrome O
. O

We O
found O
that O
MEG3 B-RNA
levels O
were O
markedly O
decreased O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
adjacent O
normal O
tissues O
. O

Downregulated O
long O
noncoding O
RNA O
MEG3 B-RNA
is O
associated O
with O
poor O
prognosis O
and O
promotes O
cell O
proliferation O
in O
gastric B-Disease
cancer I-Disease
. O

Blockage O
of O
a O
miR B-RNA
- I-RNA
21 I-RNA
/ O
EGFR O
regulatory O
feedback O
loop O
augments O
anti O
- O
EGFR O
therapy O
in O
glioblastomas B-Disease
. O

we O
found O
that O
the O
downregulation O
of O
miR B-RNA
- I-RNA
106a I-RNA
- I-RNA
5p I-RNA
in O
astrocytomas O
is O
associated O
with O
poor O
prognosis O
. O
We O
then O
performed O
bioinformatics O
analysis O
based O
on O
multiple O
target O
prediction O
algorithms O
to O
obtain O
candidate O
target O
genes O
that O
were O
further O
validated O
by O
computational O
predictions O
, O
western O
blot O
analysis O
, O
quantitative O
real O
- O
time O
PCR O
, O
and O
the O
luciferase O
reporter O
assay O
. O

Fas O
- O
activated O
serine O
/ O
threonine O
kinase O
( O
FASTK O
) O
was O
identified O
as O
a O
direct O
target O
of O
miR B-RNA
- I-RNA
106a I-RNA
- I-RNA
5p I-RNA
. O

Our O
data O
unravel O
the O
crucial O
immunomodulatory O
role O
of O
miR B-RNA
- I-RNA
146a I-RNA
in O
pDCs O
and O
may O
add O
to O
our O
understanding O
of O
aberrant O
responses O
in O
autoimmune B-Disease
diseases I-Disease
. O

targeting O
miR B-RNA
- I-RNA
663 I-RNA
or O
its O
specific O
downstream O
targets O
in O
human O
VSMCs O
may O
represent O
an O
attractive O
approach O
for O
the O
treatment O
of O
proliferative O
vascular B-Disease
diseases I-Disease
. O

antagonizing O
miR B-RNA
- I-RNA
130b I-RNA
may O
be O
a O
new O
therapeutic O
entry O
point O
for O
treating O
Fragile B-Disease
X I-Disease
syndrome I-Disease
. O

Long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
, O
a O
driver O
of O
malignancy O
, O
predicts O
negative O
prognosis O
and O
exhibits O
oncogenic O
activity O
in O
oesophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
145 I-RNA
may O
have O
a O
cell O
type O
- O
specific O
function O
and O
play O
important O
roles O
in O
the O
process O
of O
BM O
from O
lung B-Disease
adenocarcinoma I-Disease
. O

We O
verify O
that O
the O
expression O
level O
of O
gas5 B-RNA
is O
significantly O
decreased O
in O
pancreatic B-Disease
cancer I-Disease
tissues O
compared O
with O
normal O
control O
. O

Hence O
, O
we O
conclude O
that O
aberrant O
expression O
of O
miR B-RNA
- I-RNA
210 I-RNA
may O
contribute O
to O
trophoblast O
function O
and O
that O
miR B-RNA
- I-RNA
210 I-RNA
is O
a O
novel O
predictive O
serum O
biomarker O
for O
preeclampsia B-Disease
that O
can O
help O
in O
identifying O
at O
- O
risk O
women O
for O
monitoring O
and O
treatment O
. O

Our O
data O
offer O
evidence O
that O
upregulated O
expression O
of O
miR B-RNA
- I-RNA
214 I-RNA
may O
be O
linked O
to O
tumor O
progression O
and O
adverse O
prognosis O
in O
pediatric B-Disease
osteosarcoma I-Disease
. O
Further O
investigation O
in O
prospective O
studies O
would O
appear O
warranted O
. O

Downregulation O
of O
miR B-RNA
- I-RNA
151 I-RNA
- I-RNA
5p I-RNA
contributes O
to O
increased O
susceptibility O
to O
arrhythmogenesis O
during O
myocardial B-Disease
infarction I-Disease
with O
estrogen O
deprivation O
. O

Identification O
of O
novel O
MicroRNA O
signatures O
linked O
to O
experimental O
autoimmune O
myasthenia B-Disease
gravis I-Disease
pathogenesis O
: O
down O
- O
regulated O
miR B-RNA
- I-RNA
145 I-RNA
promotes O
pathogenetic O
Th17 O
cell O
response O
. O

These O
experiments O
define O
a O
novel O
VEGF O
- O
miR B-RNA
- I-RNA
1 I-RNA
- O
Mpl O
- O
P O
- O
selectin O
effector O
pathway O
in O
lung O
Th2 O
inflammation O
and O
herald O
the O
utility O
of O
miR B-RNA
- I-RNA
1 I-RNA
and O
Mpl O
as O
potential O
therapeutic O
targets O
for O
asthma B-Disease
. O

These O
findings O
establish O
miR B-RNA
- I-RNA
26a I-RNA
as O
a O
regulator O
of O
bone O
morphogenic O
protein O
/ O
SMAD1 O
- O
mediated O
EC O
angiogenic O
responses O
, O
and O
that O
manipulating O
miR B-RNA
- I-RNA
26a I-RNA
expression O
could O
provide O
a O
new O
target O
for O
rapid O
angiogenic O
therapy O
in O
ischemic O
disease O
states O
. O

In O
summary O
, O
we O
demonstrate O
that O
miR O
- O
31 O
, O
miR B-RNA
- I-RNA
206 I-RNA
, O
miR B-RNA
- I-RNA
424 I-RNA
, O
and O
miR B-RNA
- I-RNA
146a I-RNA
are O
novel O
specific O
biomarkers O
of O
inflammatory B-Disease
bowel I-Disease
disease I-Disease
. O

Our O
results O
indicate O
that O
miR O
- O
29a O
decreases O
cholestatic O
liver B-Disease
injury I-Disease
and O
fibrosis O
after O
BDL O
, O
at O
least O
partially O
, O
by O
modulating O
the O
extrinsic O
rather O
than O
intrinsic O
pathway O
of O
apoptosis O
. O

H19 B-RNA
promotes O
pancreatic O
cancer O
metastasis O
by O
derepressing O
let B-RNA
- I-RNA
7 I-RNA
' O
s O
suppression O
on O
its O
target O
HMGA2 O
- O
mediated O
EMT O
; O
We O
further O
demonstrated O
that O
H19 B-RNA
promoted O
PDAC O
cell O
invasion O
and O
migration O
at O
least O
partially O
by O
increasing O
HMGA2 O
- O
mediated O
epithelial O
- O
mesenchymal O
transition O
( O
EMT O
) O
through O
antagonizing O
let B-RNA
- I-RNA
7 I-RNA
. O

Comparing O
with O
respective O
normal O
cell O
line O
, O
H19 B-RNA
was O
found O
highly O
expressed O
in O
stomach B-Disease
cancer I-Disease
cell O
lines O
( O
AGS O
, O
MGC O
- O
803 O
and O
SGC O
- O
7901 O
) O
and O
hepatocellular B-Disease
carcinoma I-Disease
cell O
lines O
( O
SMMC O
- O
7721 O
and O
HepG2 O
) O
, O
while B-Disease
lowly I-Disease
expressed I-Disease
in I-Disease
lung I-Disease
cancer I-Disease
cell I-Disease
line I-Disease
( I-Disease
A549 I-Disease
) I-Disease
and I-Disease
prostate I-Disease
cancer I-Disease
cell O
lines O
( O
Du O
- O
145 O
and O
PC O
- O
3 O
) O
. O

Comparing O
with O
respective O
normal O
cell O
line O
, O
H19 B-RNA
was O
found O
highly O
expressed O
in O
stomach O
cancer O
cell O
lines O
( O
AGS O
, O
MGC O
- O
803 O
and O
SGC O
- O
7901 O
) O
and O
hepatocellular O
carcinoma O
cell O
lines O
( O
SMMC O
- O
7721 O
and O
HepG2 O
) O
, O
while O
lowly O
expressed O
in O
lung B-Disease
cancer I-Disease
cell O
line O
( O
A549 O
) O
and O
prostate B-Disease
cancer I-Disease
cell O
lines O
( O
Du O
- O
145 O
and O
PC O
- O
3 O
) O
. O

We O
found O
that O
comparing O
with O
respective O
normal O
cell O
line O
, O
uc001lsz B-RNA
was O
lowly O
expressed O
in O
gastric B-Disease
cancer I-Disease
( O
AGS O
, O
MGC O
- O
803 O
and O
SGC O
- O
7901 O
) O
, O
lung B-Disease
cancer I-Disease
( O
A549 O
) O
and O
liver B-Disease
cancer I-Disease
( O
SMMC O
- O
7721 O
and O
HepG2 O
) O
cell O
lines O
, O
while O
only O
highly O
expressed O
in O
prostate B-Disease
cancer I-Disease
( O
Du O
- O
145 O
and O
PC O
- O
3 O
) O
cell O
line O
( O
Figure O
3C O
) O
. O

Ets O
- O
2 O
regulates O
apoptosis O
process O
by O
regulating O
the O
expression O
of O
UCA1 B-RNA
, O
moreover O
UCA1 B-RNA
may O
be O
involved O
in O
the O
activation O
of O
Akt O
signaling O
pathway O
by O
Ets O
- O
2 O
in O
bladder B-Disease
cancer I-Disease
cells O

In O
the O
present O
study O
, O
we O
found O
that O
the O
GAS5 B-RNA
expression O
is O
commonly O
downregulated O
in O
bladder B-Disease
cancer I-Disease
cell O
lines O
and O
human O
specimens O
. O

The O
results O
support O
a O
role O
for O
miR B-RNA
- I-RNA
34a I-RNA
in O
the O
pathophysiology O
of O
preeclampsia B-Disease
, O
through O
deregulation O
of O
the O
pri O
- O
miRNA O
expression O
and O
its O
altered O
maturation O
. O

Expression O
of O
lncRNA B-RNA
- I-RNA
DQ786227 I-RNA
in O
both O
lung B-Disease
cancer I-Disease
cells O
differed O
from O
that O
in O
BEAS O
- O
2B O
cells O
. O

Collectively O
, O
the O
present O
study O
established O
a O
new O
system O
approach O
for O
the O
investigation O
of O
microRNAs O
, O
and O
the O
microRNA O
- O
target O
pairs O
, O
particular O
has B-RNA
- I-RNA
miR I-RNA
- I-RNA
320a I-RNA
and O
Arf1 O
, O
may O
have O
important O
roles O
in O
osteopetrosis O
. O

serum O
miR B-RNA
- I-RNA
122 I-RNA
has O
strong O
potential O
as O
a O
novel O
, O
specific O
and O
noninvasive O
biomarker O
for O
diagnosis O
of O
cholestasis O
- O
induced O
liver B-Disease
injury I-Disease
. O

miR B-RNA
- I-RNA
150 I-RNA
promotes O
myeloid O
differentiation O
, O
a O
previously O
uncharacterized O
role O
for O
this O
miRNA O
, O
and O
that O
absent O
or O
low O
miR B-RNA
- I-RNA
150 I-RNA
expression O
contributes O
to O
blocked O
myeloid O
differentiation O
in O
acute O
leukemia O
cells O
. O

These O
findings O
demonstrate O
miRNA O
induction O
by O
influenza B-Disease
A O
virus O
infection O
and O
elucidate O
an O
example O
of O
miRNA O
control O
of O
antiviral O
gene O
expression O
in O
human O
cells O
, O
defining O
a O
role O
for O
miR B-RNA
- I-RNA
449b I-RNA
in O
regulation O
of O
HDAC1 O
and O
antiviral O
cytokine O
signaling O
. O

Markedly O
higher O
levels O
of O
lncRNA O
- O
JADE O
were O
observed O
in O
human O
breast B-Disease
tumours I-Disease
in O
comparison O
with O
normal O
breast O
tissues O
. O

the O
expression O
of O
miR B-RNA
- I-RNA
33a I-RNA
increased O
with O
the O
progression O
of O
liver B-Disease
fibrosis I-Disease
. O

These O
results O
suggested O
that O
anti O
- O
miR B-RNA
- I-RNA
33a I-RNA
inhibit O
activation O
and O
extracellular O
matrix O
production O
, O
at O
least O
in O
part O
, O
via O
the O
activation O
of O
PI3K O
/ O
Akt O
pathway O
and O
PPAR O
- O
 O
and O
anti O
sense O
of O
miR B-RNA
- I-RNA
33a I-RNA
may O
be O
a O
novel O
potential O
therapeutic O
approach O
for O
treating O
hepatic O
fibrosis O
in O
the O
future O
. O

The O
toll O
- O
like O
receptor O
3 O
ligand O
, O
poly O
( O
I O
: O
C O
) O
, O
improves O
immunosuppressive O
function O
and O
therapeutic O
effect O
of O
mesenchymal O
stem O
cells O
on O
sepsis B-Disease
via O
inhibiting O
MiR B-RNA
- I-RNA
143 I-RNA
. O

apolipoprotein O
- O
mediated O
lipid O
transport O
emerged O
as O
an O
infection O
- O
inducible O
pathway O
under O
miR B-RNA
- I-RNA
146 I-RNA
knockdown O
conditions O
, O
suggesting O
a O
possible O
function O
of O
miR B-RNA
- I-RNA
146 I-RNA
in O
regulating O
lipid O
metabolism O
during O
inflammation B-Disease
. O

HOTAIR B-RNA
, O
a O
prognostic O
factor O
in O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
, O
inhibits O
WIF B-RNA
- I-RNA
1 I-RNA
expression O
and O
activates O
Wnt O
pathway O
; O
inverse O
correlation O
between O
HOTAIR B-RNA
and O
WIF B-RNA
- I-RNA
1 I-RNA
expression O
was O
demonstrated O
both O
in O
ESCC O
cells O
and O
tissues O
; O
HOTAIR B-RNA
directly O
decreased O
WIF B-RNA
- I-RNA
1 I-RNA
expression O
by O
promoting O
its O
histone O
H3K27 O
methylation O
in O
the O
promoter O
region O
and O
then O
activated O
the O
Wnt O
/ O
beta O
- O
catenin O
signaling O
pathway O
; O
This O
newly O
identified O
HOTAIR B-RNA
/ O
WIF B-RNA
- I-RNA
1 I-RNA
axis O
clarified O
the O
molecular O
mechanism O
of O
ESCC O
cell O
metastasis O

Elevated O
expression O
of O
specific O
microRNAs O
( O
miRNA O
) O
in O
peripheral O
blood O
- O
derived O
mononuclear O
cells O
( O
PBMC O
) O
, O
particularly O
miR B-RNA
- I-RNA
146a I-RNA
and O
miR B-RNA
- I-RNA
155 I-RNA
, O
is O
associated O
with O
rheumatoid B-Disease
arthritis I-Disease
( O
RA O
) O
. O

miR B-RNA
- I-RNA
122 I-RNA
is O
a O
liver O
- O
specific O
microRNA O
associated O
with O
many O
liver O
diseases O

miRNA27a O
is O
a O
biomarker O
for O
predicting O
chemosensitivity O
and O
prognosis O
in O
metastatic O
or O
recurrent O
gastric B-Disease
cancer I-Disease
. O

Decreased O
miR B-RNA
- I-RNA
106a I-RNA
inhibits O
glioma B-Disease
cell O
glucose O
uptake O
and O
proliferation O
by O
targeting O
SLC2A3 O
in O
GBM O
. O

The O
expression O
of O
HOTAIR B-RNA
was O
significantly O
higher O
in O
cancer O
lesions O
than O
in O
adjacent O
non O
- O
cancerous O
tissues O
in O
human O
gastric O
cancers O
. O

Impact O
of O
the O
genome O
- O
wide O
schizophrenia B-Disease
risk O
single O
nucleotide O
polymorphism O
( O
rs1625579 O
) O
in O
miR B-RNA
- I-RNA
137 I-RNA
on O
brain O
structures O
in O
healthy O
individuals O
. O

The O
expression O
of O
miR B-RNA
- I-RNA
369 I-RNA
- I-RNA
3p I-RNA
is O
increased O
in O
both O
serum O
samples O
and O
skin O
tissues O
from O
psoriasis B-Disease
patients O
, O
and O
its O
level O
in O
the O
skin O
positively O
correlates O
with O
disease O
severity O
. O

C O
. O
57 O
C O
> O
T O
Mutation O
in O
MIR B-RNA
184 I-RNA
is O
Responsible O
for O
Congenital O
Cataracts O
and O
Corneal O
Abnormalities O
in O
a O
Five O
- O
generation O
Family O
from O
Galicia O
, O
Spain O
. O

C O
- O
Myc O
negatively O
controls O
the O
tumor O
suppressor O
PTEN O
by O
upregulating O
miR B-RNA
- I-RNA
26a I-RNA
in O
glioblastoma B-Disease
multiforme O
cells O
. O

miR B-RNA
- I-RNA
338 I-RNA
- I-RNA
3p I-RNA
suppresses O
neuroblastoma B-Disease
proliferation O
, O
invasion O
and O
migration O
through O
targeting O
PREX2a O
. O

Both O
vascular O
smooth O
muscle O
- O
specific O
miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
expressions O
were O
decreased O
in O
states O
of O
atherosclerosis B-Disease
and O
/ O
or O
CKD O
or O
both O
, O
and O
the O
expression O
level O
of O
protein O
target O
Myocardin O
was O
increased O
. O

Aberrant O
Hh O
signaling O
in O
mature O
osteoblasts O
is O
responsible O
for O
the O
pathogenesis O
of O
osteoblastic O
osteosarcoma B-Disease
through O
Yap1 B-RNA
and O
H19 B-RNA
overexpression O

microRNA O
miR B-RNA
- I-RNA
150 I-RNA
and O
miR B-RNA
- I-RNA
4772 I-RNA
- I-RNA
5p I-RNA
- I-RNA
iso I-RNA
were O
able O
to O
discriminate O
between O
patients O
who O
have O
systemic O
inflammatory O
response O
syndrome O
and O
patients O
with O
sepsis B-Disease
. O

FGF10 B-RNA
- I-RNA
AS1 I-RNA
is O
upregulated O
in O
heart O
tissue O
of O
ventricular B-Disease
septal I-Disease
defects I-Disease

MiR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
target O
the O
DNA O
methyltransferase O
MGMT O
in O
glioma B-Disease
cells O
. O

Altered O
expression O
of O
miR B-RNA
- I-RNA
24 I-RNA
, O
miR B-RNA
- I-RNA
126 I-RNA
and O
miR B-RNA
- I-RNA
365 I-RNA
does O
not O
affect O
viability O
of O
childhood O
TCF3 O
- O
rearranged O
leukemia B-Disease
cells O
. O

miRNA B-RNA
- I-RNA
199a I-RNA
- O
5p O
regulates O
VEGFA O
in O
endometrial O
mesenchymal O
stem O
cells O
and O
contributes O
to O
the O
pathogenesis O
of O
endometriosis B-Disease
. O

Nfat O
and O
miR B-RNA
- I-RNA
25 I-RNA
cooperate O
to O
reactivate O
the O
transcription O
factor O
Hand2 O
in O
heart B-Disease
failure I-Disease
. O

The O
flank O
sequences O
of O
miR B-RNA
- I-RNA
145 I-RNA
and O
miR B-RNA
- I-RNA
143 I-RNA
play O
a O
critical O
role O
in O
their O
aberrant O
expression O
in O
VSMCs O
and O
vascular O
walls O
. O

The O
genetically O
engineered O
smart O
miRNAs O
based O
on O
their O
flank O
sequences O
may O
have O
broadly O
therapeutic O
applications O
for O
many O
vascular B-Disease
diseases I-Disease
. O

Collectively O
, O
our O
findings O
show O
the O
critical O
roles O
of O
miR B-RNA
- I-RNA
106b I-RNA
- I-RNA
5p I-RNA
and O
its O
targets O
, O
RBL1 O
, O
RBL2 O
and O
CASP8 O
, O
in O
glioma O
tumorigenesis O
and O
provide O
potential O
candidates O
for O
malignant B-Disease
glioma I-Disease
therapy O
. O

Our O
study O
shows O
that O
miR B-RNA
- I-RNA
200b I-RNA
/ I-RNA
c I-RNA
has O
a O
critical O
role O
in O
the O
regulation O
of O
the O
tumorigenic O
and O
metastatic O
capacity O
of O
cholangiocarcinoma B-Disease
and O
reveals O
the O
probable O
underlying O
mechanisms O
. O

Gallic O
acid O
induces O
apoptosis O
and O
inhibits O
cell O
migration O
by O
upregulating O
miR B-RNA
- I-RNA
518b I-RNA
in O
SW1353 O
human O
chondrosarcoma B-Disease
cells O
. O

Downregulation O
of O
miR B-RNA
- I-RNA
183 I-RNA
inhibits O
apoptosis O
and O
enhances O
the O
invasive O
potential O
of O
endometrial O
stromal O
cells O
in O
endometriosis B-Disease
. O

mTORC O
1 O
inhibitor O
PRP O
- O
1 O
caused O
significant O
upregulation O
of O
tumor O
suppressors O
, O
such O
as O
miR20a B-RNA
, O
miR125b B-RNA
, O
and O
miR192 B-RNA
; O
and O
downregulation O
of O
onco O
miRNAs O
, O
miR509 O
- O
3p O
, O
miR589 O
, O
miR490 O
- O
3p O
, O
miR O
550 O
in O
human O
chondrosarcoma B-Disease
JJ012 O
cell O
line O

mTORC O
1 O
inhibitor O
PRP O
- O
1 O
caused O
significant O
upregulation O
of O
tumor O
suppressors O
, O
such O
as O
miR20a O
, O
miR125b O
, O
and O
miR192 O
; O
and O
downregulation O
of O
onco O
miRNAs O
, O
miR509 B-RNA
- I-RNA
3p I-RNA
, O
miR589 B-RNA
, O
miR490 B-RNA
- I-RNA
3p I-RNA
, O
miR B-RNA
550 I-RNA
in O
human O
chondrosarcoma B-Disease
JJ012 O
cell O
line O

In O
addition O
, O
univariate O
and O
multivariate O
analysis O
revealed O
that O
PVT O
- O
1 O
expression O
level O
was O
an O
independent O
risk O
factor O
for O
overall O
survival O
of O
colorectal B-Disease
cancer I-Disease
patients O
. O

overexpression O
of O
miR B-RNA
- I-RNA
193a I-RNA
- I-RNA
3p I-RNA
, O
miR B-RNA
- I-RNA
224 I-RNA
, O
miR B-RNA
- I-RNA
148a I-RNA
, O
miR B-RNA
- I-RNA
23b I-RNA
, O
miR B-RNA
- I-RNA
365 I-RNA
, O
and O
miR B-RNA
- I-RNA
10b I-RNA
compared O
with O
other O
subgroup O
medulloblastomas O
. O

HOTAIR B-RNA
expression O
was O
significantly O
higher O
in O
HGG O
than O
in O
low O
- O
grade O
glioma B-Disease
. O

Moreover O
, O
as O
shown O
in O
Fig O
. O
1A O
, O
GBM O
demonstrated O
a O
significant O
increase O
in O
HOTAIR B-RNA
transcript O
levels O
, O
compared O
with O
that O
observed O
in O
normal O
tissues O
, O
LGGs O
, O
or O
AGs O
. O

expression O
of O
0610012D04Rik B-RNA
in O
plasma O
during O
heart B-Disease
failure I-Disease
is O
upregulated O

MiR B-RNA
- I-RNA
21 I-RNA
in O
the O
extracellular O
vesicles O
( O
EVs O
) O
of O
cerebrospinal O
fluid O
( O
CSF O
) O
: O
a O
platform O
for O
glioblastoma B-Disease
biomarker O
development O
. O

miR B-RNA
- I-RNA
582 I-RNA
- I-RNA
5p I-RNA
is O
upregulated O
in O
patients O
with O
active O
tuberculosis B-Disease
and O
inhibits O
apoptosis O
of O
monocytes O
by O
targeting O
FOXO1 O
. O

MiR B-RNA
- I-RNA
26a I-RNA
enhances O
the O
radiosensitivity O
of O
glioblastoma B-Disease
multiforme O
cells O
through O
targeting O
of O
ataxia O
- O
telangiectasia O
mutated O
. O

MiR B-RNA
- I-RNA
320a I-RNA
downregulation O
is O
associated O
with O
imatinib O
resistance O
in O
gastrointestinal B-Disease
stromal I-Disease
tumors I-Disease
. O

miR B-RNA
- I-RNA
451 I-RNA
played O
a O
tumor O
- O
suppressing O
role O
through O
modulating O
the O
expression O
of O
PGE2 O
and O
CCND1 O
, O
suggesting O
a O
novel O
target O
for O
the O
diagnosis O
and O
treatment O
of O
osteosarcoma B-Disease
. O

Upregulation O
of O
miR B-RNA
- I-RNA
135b I-RNA
is O
involved O
in O
the O
impaired O
osteogenic O
differentiation O
of O
mesenchymal O
stem O
cells O
derived O
from O
multiple B-Disease
myeloma I-Disease
patients O
. O

The O
methylation O
status O
of O
miR B-RNA
- I-RNA
124a I-RNA
seen O
in O
this O
study O
concurs O
with O
that O
reported O
in O
tumor O
cells O
, O
indicating O
epigenetic O
dysregulation O
constituents O
, O
a O
mechanism O
in O
the O
development O
of O
rheumatoid B-Disease
arthritis I-Disease
. O

MiR B-RNA
- I-RNA
192 I-RNA
directly O
binds O
and O
regulates O
Dicer1 O
expression O
in O
neuroblastoma B-Disease
. O

Two O
specific O
miRNAs O
transferred O
efficiently O
between O
these O
cells O
- O
- O
miR O
- O
142 O
and O
miR B-RNA
- I-RNA
223 I-RNA
 O
and O
both O
were O
endogenously O
expressed O
in O
macrophages O
and O
not O
in O
HCCs B-Disease
. O

Protumorigenic O
effects O
of O
mir B-RNA
- I-RNA
145 I-RNA
loss O
in O
malignant O
pleural B-Disease
mesothelioma I-Disease
. O

miR B-RNA
- I-RNA
203 I-RNA
, O
a O
tumor O
suppressor O
frequently O
down O
- O
regulated O
by O
promoter O
hypermethylation O
in O
rhabdomyosarcoma B-Disease
. O

MiR B-RNA
- I-RNA
134 I-RNA
/ I-RNA
487b I-RNA
/ I-RNA
655 I-RNA
cluster O
regulates O
TGF O
- O
 O
- O
induced O
epithelial O
- O
mesenchymal O
transition O
and O
drug O
resistance O
to O
gefitinib O
by O
targeting O
MAGI2 O
in O
lung B-Disease
adenocarcinoma I-Disease
cells O
. O

Reply O
to O
miR B-RNA
- I-RNA
122 I-RNA
, O
IL28B O
genotype O
and O
the O
response O
to O
interferon O
in O
chronic B-Disease
hepatitis I-Disease
C I-Disease
virus I-Disease
infection O
. O

the O
present O
study O
demonstrated O
the O
clinical O
significance O
of O
miR B-RNA
- I-RNA
203 I-RNA
in O
gliomas B-Disease
and O
suggested O
that O
miR B-RNA
- I-RNA
203 I-RNA
was O
able O
to O
inhibit O
the O
proliferation O
and O
invasion O
of O
glioma O
cells O
, O
partially O
at O
least O
via O
suppressing O
the O
protein O
expression O
of O
PLD2 O
. O

MIR137 O
gene O
and O
target O
gene O
CACNA1C O
of O
miR B-RNA
- I-RNA
137 I-RNA
contribute O
to O
schizophrenia B-Disease
susceptibility O
in O
Han O
Chinese O
. O

Differential O
microRNA O
expression O
profiles O
between O
malignant O
rhabdoid O
tumor O
and O
epithelioid O
sarcoma O
: O
miR193a B-RNA
- I-RNA
5p I-RNA
is O
suggested O
to O
downregulate O
SMARCB1 B-RNA
mRNA O
expression O
. O

Plasma O
miR B-RNA
- I-RNA
122 I-RNA
expression O
is O
correlated O
with O
hepatectomy O
- O
induced O
liver O
injury O
in O
patients O
with O
HCC B-Disease
. O

The O
expression O
of O
miR B-RNA
- I-RNA
25 I-RNA
is O
increased O
in O
colorectal B-Disease
cancer I-Disease
and O
is O
associated O
with O
patient O
prognosis O
. O

Regulation O
of O
neurotropic O
signaling O
by O
the O
inducible O
, O
NF O
- O
kB O
- O
sensitive O
miRNA B-RNA
- I-RNA
125b I-RNA
in O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
( O
AD O
) O
and O
in O
primary O
human O
neuronal O
- O
glial O
( O
HNG O
) O
cells O
. O

miR B-RNA
- I-RNA
199a I-RNA
- I-RNA
5p I-RNA
is O
a O
key O
regulator O
of O
the O
unfolded O
protein O
response O
in O
AAT O
- O
deficient O
monocytes O
, O
and O
epigenetic O
silencing O
of O
its O
expression O
regulates O
this O
process O
in O
chronic B-Disease
obstructive I-Disease
pulmonary I-Disease
disease I-Disease
. O

miR B-RNA
- I-RNA
146a I-RNA
enhances O
the O
oncogenicity O
of O
oral B-Disease
carcinoma I-Disease
by O
concomitant O
targeting O
of O
the O
IRAK1 O
, O
TRAF6 O
and O
NUMB O
genes O
. O

Tumor O
- O
suppressing O
effects O
of O
miR B-RNA
- I-RNA
141 I-RNA
in O
human O
osteosarcoma B-Disease
. O

This O
confirmed O
that O
there O
was O
significant O
downregulation O
of O
miR B-RNA
- I-RNA
1 I-RNA
in O
glioblastoma B-Disease
multiforme O
compared O
with O
surrounding O
brain O
. O

In O
non O
- O
functioning O
pituitary O
adenomas O
, O
25 O
miRNA O
genes O
were O
up O
- O
regulated O
( O
six O
by O
over O
5 O
- O
fold O
) O
and O
15 O
were O
down O
- O
regulated O
( O
six O
by O
more O
than O
10 O
- O
fold O
) O
. O
miR B-RNA
- I-RNA
124a I-RNA
was O
the O
most O
up O
- O
regulated O
gene O
( O
38 O
. O
58 O
- O
fold O
) O
, O
and O
miR B-RNA
- I-RNA
31 I-RNA
the O
most O
down O
- O
regulated O
gene O
( O
21 O
. O
5 O
- O
fold O
) O

Our O
case O
adds O
further O
information O
about O
genotype O
 O
phenotype O
correlation O
and O
supports O
the O
hypothesis O
that O
SNORD116 B-RNA
plays O
a O
major O
role O
in O
the O
pathogenesis O
of O
Prader B-Disease
- I-Disease
Willi I-Disease
syndrome I-Disease
. O

microRNA O
expression O
in O
hepatitis O
B O
virus O
infected O
primary O
treeshrew O
hepatocytes O
and O
the O
independence O
of O
intracellular O
miR B-RNA
- I-RNA
122 I-RNA
level O
for O
de O
novo O
HBV O
infection O
in O
culture O
. O

Ionizing O
radiation O
- O
inducible O
miR B-RNA
- I-RNA
494 I-RNA
promotes O
glioma B-Disease
cell O
invasion O
through O
EGFR O
stabilization O
by O
targeting O
p190B O
rhoGAP O
. O

miR B-RNA
- I-RNA
329 I-RNA
suppresses O
the O
growth O
and O
motility O
of O
neuroblastoma B-Disease
by O
targeting O
KDM1A O
. O

Our O
data O
show O
that O
miR B-RNA
- I-RNA
21 I-RNA
may O
be O
a O
candidate O
independent O
marker O
for O
gliomas B-Disease
, O
especially O
those O
with O
high O
pathological O
grades O
, O
and O
this O
could O
also O
be O
a O
potential O
therapeutic O
target O
for O
molecular O
glioma O
therapy O
. O

SMARCB1 B-RNA
expression O
in O
epithelioid B-Disease
sarcoma I-Disease
is O
regulated O
by O
miR B-RNA
- I-RNA
206 I-RNA
, O
miR B-RNA
- I-RNA
381 I-RNA
, O
and O
miR B-RNA
- I-RNA
671 I-RNA
- I-RNA
5p I-RNA
on O
Both O
mRNA O
and O
protein O
levels O
. O

The O
present O
study O
demonstrates O
for O
the O
first O
time O
the O
role O
of O
miR B-RNA
- I-RNA
141 I-RNA
and O
its O
target O
genes O
in O
the O
occurrence O
of O
HSCR O
, O
and O
provides O
us O
a O
new O
direction O
for O
the O
study O
of O
the O
pathogenesis O
of O
Hirschsprung B-Disease
' I-Disease
s I-Disease
disease I-Disease
. O

miRNA B-RNA
- I-RNA
491 I-RNA
- I-RNA
5p I-RNA
and O
GIT1 B-RNA
serve O
as O
modulators O
and O
biomarkers O
for O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
invasion O
and O
metastasis O
. O

Genetic O
variation O
at O
the O
miR B-RNA
- I-RNA
125b I-RNA
binding O
site O
may O
play O
functional O
roles O
to O
protect O
against O
endometriosis B-Disease
progression O
. O

Bcl O
- O
xL O
silencing O
induces O
alterations O
in O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
608 I-RNA
expression O
and O
subsequent O
cell O
death O
in O
A549 O
and O
SK O
- O
LU1 O
human O
lung B-Disease
adenocarcinoma I-Disease
cells O
. O

Mir B-RNA
- I-RNA
29 I-RNA
repression O
in O
bladder B-Disease
outlet I-Disease
obstruction I-Disease
contributes O
to O
matrix O
remodeling O
and O
altered O
stiffness O
. O

MiR B-RNA
- I-RNA
181c I-RNA
modulates O
the O
proliferation O
, O
migration O
, O
and O
invasion O
of O
neuroblastoma B-Disease
cells O
by O
targeting O
Smad7 O
. O

miR B-RNA
- I-RNA
125b I-RNA
promotes O
cell O
proliferation O
by O
directly O
targeting O
Lin28 O
in O
glioblastoma B-Disease
stem O
cells O
with O
low O
expression O
levels O
of O
miR B-RNA
- I-RNA
125b I-RNA
. O

We O
found O
that O
miR B-RNA
- I-RNA
23a I-RNA
& O
miR B-RNA
- I-RNA
23b I-RNA
were O
up O
- O
regulated O
in O
radiation O
induced O
thymic O
lymphoma B-Disease
tissue O
samples O
. O

Finally O
, O
THRIL B-RNA
expression O
was O
correlated O
with O
the O
severity O
of O
symptoms O
in O
patients O
with O
Kawasaki B-Disease
disease I-Disease
, O
an O
acute O
inflammatory O
disease O
of O
childhood O
. O

MicroRNA O
expression O
profiles O
distinguish O
liposarcoma B-Disease
subtypes O
and O
implicate O
miR B-RNA
- I-RNA
145 I-RNA
and O
miR B-RNA
- I-RNA
451 I-RNA
as O
tumor O
suppressors O
. O

MiR B-RNA
- I-RNA
92a I-RNA
mediates O
AZD6244 O
induced O
apoptosis O
and O
G1 O
- O
phase O
arrest O
of O
lymphoma B-Disease
cells O
by O
targeting O
Bim O
. O

The O
expression O
levels O
of O
H19 B-RNA
and O
miR B-RNA
- I-RNA
675 I-RNA
in O
five O
gastric B-Disease
cancer I-Disease
cell O
lines O
were O
correlated O
with O
each O
other O
. O

A O
Primary O
Study O
on O
Down O
- O
Regulated O
miR B-RNA
- I-RNA
9 I-RNA
- I-RNA
1 I-RNA
and O
Its O
Biological O
Significances O
in O
Methylmalonic B-Disease
Acidemia I-Disease
. O

MiR B-RNA
- I-RNA
133b I-RNA
is O
down O
- O
regulated O
in O
human O
osteosarcoma B-Disease
and O
inhibits O
osteosarcoma B-Disease
cells O
proliferation O
, O
migration O
and O
invasion O
, O
and O
promotes O
apoptosis O
. O

ZNF300P1 B-RNA
lincRNA O
expression O
is O
regulating O
cell O
polarity O
, O
motility O
, O
and O
adhesion O
and O
loss O
of O
expression O
may O
contribute O
to O
the O
metastatic O
potential O
of O
ovarian B-Disease
cancer I-Disease
cells O

These O
findings O
link O
the O
alteration O
of O
leptin O
and O
insulin O
signaling O
to O
the O
up O
- O
regulation O
of O
hypothalamic O
miR B-RNA
- I-RNA
200a I-RNA
which O
could O
be O
a O
new O
target O
for O
treatment O
of O
obesity B-Disease
. O

Long O
non O
- O
coding O
RNA O
GHET1 B-RNA
promotes O
gastric B-Disease
carcinoma I-Disease
cell O
proliferation O
by O
increasing O
c O
- O
Myc O
mRNA O
stability O
. O

Effects O
of O
common O
polymorphisms O
rs2910164 O
in O
miR B-RNA
- I-RNA
146a I-RNA
and O
rs11614913 O
in O
miR O
- O
196a2 O
on O
susceptibility O
to O
colorectal B-Disease
cancer I-Disease
: O
a O
systematic O
review O
meta O
- O
analysis O
. O

miR B-RNA
- I-RNA
155 I-RNA
suppresses O
bacterial O
clearance O
in O
Pseudomonas O
aeruginosa O
- O
induced O
keratitis B-Disease
by O
targeting O
Rheb O
. O

miR B-RNA
- I-RNA
20b I-RNA
regulates O
expression O
of O
proteinase O
- O
activated O
receptor O
- O
1 O
( O
PAR O
- O
1 O
) O
thrombin O
receptor O
in O
melanoma B-Disease
cells O
. O

gradual O
increase O
in O
miR B-RNA
- I-RNA
21 I-RNA
and O
miR B-RNA
- I-RNA
23a I-RNA
levels O
in O
all O
tumor O
grades O
whereas O
miR O
- O
7 O
and O
miR O
- O
137 O
were O
significantly O
down O
- O
regulated O
depending O
on O
the O
glioma O
grade O
. O

gradual O
increase O
in O
miR O
- O
21 O
and O
miR O
- O
23a O
levels O
in O
all O
tumor O
grades O
whereas O
miR B-RNA
- I-RNA
7 I-RNA
and O
miR B-RNA
- I-RNA
137 I-RNA
were O
significantly O
down O
- O
regulated O
depending O
on O
the O
glioma O
grade O
. O

Up O
- O
regulation O
of O
miR B-RNA
- I-RNA
200b I-RNA
in O
biliary B-Disease
atresia I-Disease
patients O
accelerates O
proliferation O
and O
migration O
of O
hepatic O
stallate O
cells O
by O
activating O
PI3K O
/ O
Akt O
signaling O
. O

Levels O
of O
circulating O
miR B-RNA
- I-RNA
133a I-RNA
are O
elevated O
in O
sepsis B-Disease
and O
predict O
mortality O
in O
critically O
ill O
patients O
. O

Salmonella B-Disease
can O
upregulate O
intestinal O
epithelial O
miR O
- O
128 O
expression O
, O
which O
, O
in O
turn O
, O
decreases O
levels O
of O
epithelial O
cell O
- O
secreted O
M O
- O
CSF O
and O
M O
- O
CSF O
- O
induced O
macrophage O
recruitment O
. O
mir O
- O
9 O
- O
5p O

Serum O
miR B-RNA
- I-RNA
122 I-RNA
levels O
are O
related O
to O
coagulation O
disorders O
in O
sepsis B-Disease
patients O
. O

Down O
- O
regulation O
of O
miR B-RNA
- I-RNA
29b I-RNA
is O
essential O
for O
pathogenesis O
of O
uterine O
leiomyoma B-Disease
. O

IL O
- O
6 O
and O
TNF O
- O
 O
induced O
obesity B-Disease
- O
related O
inflammatory O
response O
through O
transcriptional O
regulation O
of O
miR B-RNA
- I-RNA
146b I-RNA
. O

A O
predicted O
miR B-RNA
- I-RNA
330 I-RNA
- I-RNA
3p I-RNA
target O
site O
SNP O
( O
rs41305272 O
) O
in O
mitogen O
- O
activated O
protein O
kinase O
kinase O
5 O
( O
MAP2K5 O
) O
mRNA O
was O
in O
LD O
with O
a O
reported O
GWAS O
- O
identified O
variant O
for O
restless B-Disease
legs I-Disease
syndrome I-Disease
( O
RLS O
) O
. O

miR B-RNA
- I-RNA
342 I-RNA
- I-RNA
5p I-RNA
decreases O
ankyrin O
G O
levels O
in O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
transgenic O
mouse O
models O
. O

A O
common O
variant O
in O
pre B-RNA
- I-RNA
miR I-RNA
- I-RNA
146 I-RNA
is O
associated O
with O
coronary B-Disease
artery I-Disease
disease I-Disease
risk O
and O
its O
mature O
miRNA O
expression O
. O

miR B-RNA
- I-RNA
132 I-RNA
targeting O
cyclin O
E1 O
suppresses O
cell O
proliferation O
in O
osteosarcoma B-Disease
cells O
. O

miR B-RNA
- I-RNA
222 I-RNA
regulates O
the O
cell O
biological O
behavior O
of O
oral O
squamous O
cell O
carcinoma O
by O
targeting O
PUMA O
. O

Plasma O
miR B-RNA
- I-RNA
126 I-RNA
is O
a O
potential O
biomarker O
for O
early O
prediction O
of O
type B-Disease
2 I-Disease
diabetes I-Disease
mellitus I-Disease
in O
susceptible O
individuals O
. O

We O
found O
that O
UCA1 B-RNA
was O
upregulated O
in O
breast B-Disease
tumors I-Disease
compared O
with O
the O
normal O
breast O
tissue O
. O

Long O
non O
- O
coding O
RNA O
UCA1 B-RNA
promotes O
breast B-Disease
tumor I-Disease
growth O
by O
suppression O
of O
p27 O
( O
Kip1 O
) O
. O

Serum O
miR B-RNA
- I-RNA
19a I-RNA
predicts O
resistance O
to O
FOLFOX O
chemotherapy O
in O
advanced O
colorectal O
cancer O
cases O
. O

Relation O
of O
reduced O
expression O
of O
MiR B-RNA
- I-RNA
150 I-RNA
in O
platelets O
to O
atrial B-Disease
fibrillation I-Disease
in O
patients O
with O
chronic O
systolic O
heart B-Disease
failure I-Disease
. O

miR B-RNA
- I-RNA
17 I-RNA
inhibitor O
suppressed O
osteosarcoma B-Disease
tumor O
growth O
and O
metastasis O
via O
increasing O
PTEN O
expression O
. O

DSS O
- O
induced O
chronic O
inflammation O
downregulates O
miR B-RNA
- I-RNA
133a I-RNA
and O
miR B-RNA
- I-RNA
143 I-RNA
/ I-RNA
145 I-RNA
, O
which O
is O
reportedly O
associated O
with O
human O
colorectal O
cancer O
and O
PI3K O
/ O
Akt O
activation O
. O

mir B-RNA
- I-RNA
300 I-RNA
promotes O
self O
- O
renewal O
and O
inhibits O
the O
differentiation O
of O
glioma B-Disease
stem O
- O
like O
cells O
. O

Genomic O
analyses O
reveal O
broad O
impact O
of O
miR B-RNA
- I-RNA
137 I-RNA
on O
genes O
associated O
with O
malignant O
transformation O
and O
neuronal O
differentiation O
in O
glioblastoma B-Disease
cells O
. O

By O
analyzing O
glioma O
gene O
expression O
data O
sets O
, O
we O
found O
increased O
H19 B-RNA
in O
high O
grade O
gliomas B-Disease
. O

miR B-RNA
- I-RNA
33a I-RNA
is O
up O
- O
regulated O
in O
chemoresistant O
osteosarcoma B-Disease
and O
promotes O
osteosarcoma B-Disease
cell O
resistance O
to O
cisplatin O
by O
down O
- O
regulating O
TWIST O
. O

Inhibition O
of O
miRNA B-RNA
- I-RNA
21 I-RNA
prevents O
fibrogenic O
activation O
in O
podocytes O
and O
tubular O
cells O
in O
IgA B-Disease
nephropathy I-Disease
. O

Expression O
of O
the O
long O
non O
- O
coding O
RNAs O
MEG3 B-RNA
, O
HOTAIR O
, O
and O
MALAT O
- O
1 O
in O
non O
- O
functioning O
pituitary O
adenomas O
and O
their O
relationship O
to O
tumor O
behavior O
. O

PCAT B-RNA
- I-RNA
1 I-RNA
overexpression O
in O
Du145 O
prostate B-Disease
cancer I-Disease
cells O
( O
which O
lack O
endogenous O
expression O
of O
this O
lncRNA O
) O
, O
PCAT B-RNA
- I-RNA
1 I-RNA
overexpression O
in O
RWPE O
benign O
prostate O
cells O
( O
which O
lack O
endogenous O
expression O
of O
this O
lncRNA O
) O
, O
and O
stable O
knockdown O
of O
PCAT B-RNA
- I-RNA
1 I-RNA
in O
LNCaP O
prostate B-Disease
cancer I-Disease
cells O
( O
which O
harbor O
high O
endogenous O
levels O
of O
PCAT B-RNA
- I-RNA
1 I-RNA
expression O
) O
( O
Fig O
. O
1A O
, O
left O
) O
. O

In O
conclusion O
, O
mir B-RNA
- I-RNA
216a I-RNA
controls O
ox O
- O
LDL O
induced O
autophagy O
in O
HUVECs O
by O
regulating O
intracellular O
levels O
of O
BECN1 O
and O
may O
have O
a O
relevant O
role O
in O
the O
pathogenesis O
of O
cardiovascular O
disorders O
and O
atherosclerosis B-Disease
. O

Expressions O
of O
miR B-RNA
- I-RNA
15a I-RNA
and O
its O
target O
gene O
HSPA1B O
in O
the O
spermatozoa O
of O
patients O
with O
varicocele B-Disease
. O

Taken O
together O
, O
these O
data O
indicate O
that O
loss O
of O
miR B-RNA
- I-RNA
223 I-RNA
/ I-RNA
- I-RNA
223 I-RNA
* I-RNA
causes O
an O
aggravation O
of O
sepsis B-Disease
- O
induced O
inflammation O
, O
myocardial O
dysfunction O
and O
mortality O
. O

We O
showed O
that O
cisplatin O
- O
based O
chemotherapy O
results O
in O
up O
- O
regulation O
of O
UCA1 B-RNA
expression O
in O
patients O
with O
bladder B-Disease
cancer I-Disease
. O

The O
findings O
indicate O
that O
miR B-RNA
- I-RNA
124 I-RNA
- I-RNA
5p I-RNA
functions O
as O
a O
tumor O
suppressor O
and O
could O
serve O
as O
a O
molecular O
marker O
for O
glioma B-Disease
diagnosis O
and O
as O
a O
potential O
therapeutic O
target O
in O
GBM O
treatment O
. O

These O
results O
indicate O
that O
suppressed O
miR B-RNA
- I-RNA
1 I-RNA
expression O
in O
chordoma B-Disease
may O
in O
part O
be O
a O
driver O
for O
tumor O
growth O
, O
and O
that O
miR B-RNA
- I-RNA
1 I-RNA
has O
potential O
to O
serve O
as O
prognostic O
biomarker O
and O
therapeutic O
target O
for O
chordoma B-Disease
patients O
. O

A O
lentivirus O
- O
mediated O
miR B-RNA
- I-RNA
23b I-RNA
sponge O
diminishes O
the O
malignant O
phenotype O
of O
glioma B-Disease
cells O
in O
vitro O
and O
in O
vivo O
. O

Hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
125b I-RNA
was O
down O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
compared O
with O
matched O
normal O
urothelium O
. O

We O
examined O
the O
expression O
of O
MEG3 B-RNA
in O
52 O
gastric B-Disease
cancer I-Disease
samples O
using O
quantitative O
qPCR O
and O
found O
the O
down O
- O
regulation O
of O
MEG3 B-RNA
in O
both O
gastric B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
. O

PCAT18 B-RNA
is O
specifically O
expressed O
in O
the O
prostate O
compared O
to O
11 O
other O
normal O
tissues O
( O
p O
< O
0 O
. O
5 O
) O
and O
up O
- O
regulated O
in O
PCa B-Disease
compared O
to O
15 O
other O
neoplasms O
( O
p O
< O
0 O
. O
1 O
) O
. O

Down O
- O
regulation O
of O
ncRAN B-RNA
, O
a O
long O
non O
- O
coding O
RNA O
, O
contributes O
to O
colorectal B-Disease
cancer I-Disease
cell O
migration O
and O
invasion O
and O
predicts O
poor O
overall O
survival O
for O
colorectal B-Disease
cancer I-Disease
patients O
. O

The O
results O
showed O
that O
the O
expression O
level O
of O
LINC00152 B-RNA
in O
gastric B-Disease
carcinoma I-Disease
was O
significantly O
increased O
, O
compared O
with O
matched O
normal O
tissue O
( O
P O
= O
0 O
. O
45 O
) O
and O
normal O
mucosa O
from O
health O
control O
( O
P O
= O
0 O
. O
4 O
) O
, O
respectively O
. O

miR B-RNA
- I-RNA
663 I-RNA
is O
a O
novel O
prognostic O
biomarker O
and O
a O
potential O
therapeutic O
candidate O
for O
glioblastoma B-Disease
. O

Specifically O
, O
we O
looked O
for O
the O
changes O
of O
long O
non O
- O
coding O
RNA O
metastasis O
associated O
lung O
adenocarcinoma O
transcript O
1 O
( O
MALAT B-RNA
- I-RNA
1 I-RNA
) O
, O
which O
is O
found O
extensively O
and O
highly O
expressed O
in O
several O
kinds O
of O
tumor O
cells O
, O
including O
breast O
carcinoma O
. O

Our O
present O
study O
reveals O
a O
novel O
autophagic O
regulating O
model O
that O
is O
composed O
of O
E2F1 O
, O
miR B-RNA
- I-RNA
325 I-RNA
and O
ARC O
. O

Modulation O
of O
their O
levels O
may O
provide O
a O
new O
approach O
for O
tackling O
cardiac B-Disease
failure I-Disease
. O

Dendrosomal O
curcumin O
nanoformulation O
downregulates O
pluripotency O
genes O
via O
miR B-RNA
- I-RNA
145 I-RNA
activation O
in O
U87MG O
glioblastoma B-Disease
cells O
. O

The O
highly O
upregulated O
lncRNA O
HULC B-RNA
in O
liver B-Disease
cancer I-Disease
was O
found O
in O
the O
blood O
of O
HCC O
patients O
, O
promising O
a O
potential O
biomarker O
. O

MiRNAs O
, O
especially O
miR B-RNA
- I-RNA
499 I-RNA
and O
miR B-RNA
- I-RNA
133a I-RNA
, O
may O
be O
suitable O
for O
use O
as O
diagnostic O
biomarkers O
of O
myocardial B-Disease
infarction I-Disease
. O

miR B-RNA
- I-RNA
146a I-RNA
promotes O
the O
initiation O
and O
progression O
of O
melanoma B-Disease
by O
activating O
Notch O
signaling O
. O

However O
, O
miR B-RNA
- I-RNA
10a I-RNA
, O
miR B-RNA
- I-RNA
192 I-RNA
, O
and O
miR B-RNA
- I-RNA
194 I-RNA
were O
significantly O
increased O
in O
plasma O
of O
rats O
with O
renal O
ischemia B-Disease
- I-Disease
reperfusion I-Disease
injury I-Disease
, O
among O
which O
miR B-RNA
- I-RNA
10a I-RNA
was O
elevated O
within O
1 O
h O
after O
reperfusion O
, O
whereas O
miR B-RNA
- I-RNA
192 I-RNA
and O
miR B-RNA
- I-RNA
194 I-RNA
were O
elevated O
at O
6 O
h O
after O
injury O
. O

Transcriptional O
consequences O
of O
schizophrenia B-Disease
candidate O
miR B-RNA
- I-RNA
137 I-RNA
manipulation O
in O
human O
neural O
progenitor O
cells O
. O

This O
is O
the O
first O
study O
showing O
that O
miR B-RNA
- I-RNA
27a I-RNA
can O
function O
as O
an O
oncogene O
by O
targeting O
MAP2K4 O
in O
the O
osteosarcoma B-Disease
MG63 O
cell O
line O
. O

An O
increased O
ratio O
of O
serum O
miR B-RNA
- I-RNA
21 I-RNA
to O
miR B-RNA
- I-RNA
181a I-RNA
levels O
is O
associated O
with O
the O
early O
pathogenic O
process O
of O
chronic B-Disease
obstructive I-Disease
pulmonary I-Disease
disease I-Disease
in O
asymptomatic O
heavy O
smokers O
. O

CHRF B-RNA
is O
able O
to O
directly O
bind O
to O
miR O
- O
489 O
and O
regulate O
Myd88 O
expression O
and O
hypertrophy B-Disease

miR B-RNA
- I-RNA
126 I-RNA
contributes O
to O
Parkinson B-Disease
' I-Disease
s I-Disease
disease I-Disease
by O
dysregulating O
the O
insulin O
- O
like O
growth O
factor O
/ O
phosphoinositide O
3 O
- O
kinase O
signaling O
. O

In O
conclusion O
, O
the O
present O
study O
is O
the O
first O
to O
demonstrate O
that O
ACE2 B-RNA
may O
be O
subject O
to O
post O
- O
transcriptional O
regulation O
and O
reveals O
a O
novel O
potential O
therapeutic O
target O
, O
miR B-RNA
- I-RNA
421 I-RNA
, O
which O
could O
be O
exploited O
to O
modulate O
ACE2 B-RNA
expression O
in O
disease O
. O

These O
studies O
identified O
a O
novel O
mechanism O
whereby O
miR B-RNA
- I-RNA
195 I-RNA
regulates O
SIRT1 O
- O
mediated O
tissue O
damage O
in O
diabetic B-Disease
retinopathy I-Disease
. O

Mir B-RNA
- I-RNA
592 I-RNA
regulates O
the O
induction O
and O
cell O
death O
- O
promoting O
activity O
of O
p75NTR O
in O
neuronal O
ischemic O
injury O
. O

LincRNA O
- O
p21 O
enhances O
the O
sensitivity O
of O
radiotherapy O
for O
human O
colorectal B-Disease
cancer I-Disease
by O
targeting O
the O
Wnt O
/ O
 O
- O
catenin O
signaling O
pathway O
. O

lower O
expression O
of O
miR B-RNA
- I-RNA
181a I-RNA
/ I-RNA
b I-RNA
/ I-RNA
c I-RNA
/ I-RNA
d I-RNA
subunits O
contributes O
to O
astrocytoma O
tumorigenesis O
, O
and O
their O
overexpression O
could O
inhibit O
the O
invasive O
proliferation O
of O
glioblastoma B-Disease
cells O
by O
targeting O
Rap1B O
mediated O
cytoskeleton O
remodeling O
and O
related O
molecular O
( O
Cdc42 O
, O
RhoA O
and O
N O
- O
cadherin O
) O
changes O
, O
suggesting O
that O
miR O
- O
181 O
was O
a O
critical O
regulator O
and O
might O
be O
an O
important O
target O
for O
glioblastoma B-Disease
treatment O
. O

Targeting O
miR B-RNA
- I-RNA
21 I-RNA
may O
represent O
a O
potential O
therapeutic O
option O
for O
the O
treatment O
of O
psoriasis B-Disease
. O

HOTAIR B-RNA
long O
non O
- O
coding O
RNA O
is O
a O
negative O
prognostic O
factor O
not O
only O
in O
primary O
tumors O
, O
but O
also O
in O
the O
blood O
of O
colorectal B-Disease
cancer I-Disease
patients O
. O

CRC B-Disease
patients O
had O
higher O
HOTAIR B-RNA
expression O
in O
blood O
than O
healthy O
controls O
, O
whereas O
there O
was O
no O
difference O
in O
HOTAIR B-RNA
levels O
between O
tumor O
and O
adjacent O
mucosa O
of O
CRC B-Disease
patients O
. O

We O
report O
for O
the O
first O
time O
elevated O
miR B-RNA
- I-RNA
29a I-RNA
expression O
in O
PBMCs O
of O
patients O
with O
ankylosing B-Disease
spondylitis I-Disease
, O
and O
miR B-RNA
- I-RNA
29a I-RNA
might O
be O
used O
as O
a O
useful O
diagnostic O
marker O
in O
new O
bone O
formation O
but O
cannot O
reflect O
disease O
activity O
. O

These O
results O
suggest O
that O
miR B-RNA
- I-RNA
499 I-RNA
delivered O
by O
the O
present O
system O
has O
excellent O
potency O
to O
treat O
cancer O
via O
integrative O
anticancer O
actions O
. O

Heat O
shock O
protein O
47 O
regulated O
by O
miR B-RNA
- I-RNA
29a I-RNA
to O
enhance O
glioma B-Disease
tumor O
growth O
and O
invasion O
. O

The O
result O
of O
this O
study O
suggest O
that O
miR B-RNA
- I-RNA
155 I-RNA
is O
involved O
in O
the O
cell O
proliferation O
regulation O
of O
CD4 O
( O
+ O
) O
CD25 O
( O
+ O
) O
Treg O
cells O
, O
and O
play O
some O
role O
in O
the O
immunological O
dissonance O
in O
sepsis B-Disease
. O

We O
provide O
first O
time O
evidence O
through O
tissue O
microarray O
and O
quantitative O
PCR O
validation O
of O
mir B-RNA
- I-RNA
182 I-RNA
in O
the O
expression O
of O
lung B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

Seed O
- O
targeting O
anti O
- O
miR B-RNA
- I-RNA
21 I-RNA
inhibiting O
malignant O
progression O
of O
retinoblastoma B-Disease
and O
analysis O
of O
their O
phosphorylation O
signaling O
pathways O
. O

miR B-RNA
- I-RNA
22 I-RNA
targets O
the O
3 O
' O
UTR O
of O
HMGB1 B-RNA
and O
inhibits O
the O
HMGB1 B-RNA
- O
associated O
autophagy O
in O
osteosarcoma B-Disease
cells O
during O
chemotherapy O
. O

MiR B-RNA
- I-RNA
21 I-RNA
modulates O
chemosensitivity O
of O
tongue B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
cells O
to O
cisplatin O
by O
targeting O
PDCD4 O
. O

The O
increased O
levels O
of O
the O
oncogene O
- O
like O
miR B-RNA
- I-RNA
182 I-RNA
increase O
the O
risk O
for O
disease O
progression O
and O
predict O
poor O
overall O
survival O
for O
colorectal B-Disease
adenocarcinoma I-Disease
patients O
. O

We O
found O
that O
HOTAIR B-RNA
expression O
is O
inversely O
correlated O
to O
miR B-RNA
- I-RNA
141 I-RNA
expression O
in O
renal B-Disease
carcinoma I-Disease
cells O
. O

Overexpression O
of O
miR B-RNA
- I-RNA
210 I-RNA
is O
associated O
with O
SDH B-Disease
- I-Disease
related I-Disease
pheochromocytomas I-Disease
, O
paragangliomas B-Disease
, O
and O
gastrointestinal B-Disease
stromal I-Disease
tumours I-Disease
. O

Long O
non O
- O
coding O
RNA O
Loc554202 B-RNA
regulates O
proliferation O
and O
migration O
in O
breast B-Disease
cancer I-Disease
cells O
. O

In O
conclusion O
, O
miR B-RNA
- I-RNA
429 I-RNA
serves O
as O
a O
tumor O
suppressor O
via O
interaction O
with O
ZEB1 O
. O

Our O
finding O
may O
provide O
a O
new O
target O
for O
osteosarcoma B-Disease
therapy O
. O

Blunted O
expression O
of O
miR B-RNA
- I-RNA
199a I-RNA
- I-RNA
5p I-RNA
in O
regulatory O
T O
cells O
of O
patients O
with O
chronic B-Disease
obstructive I-Disease
pulmonary I-Disease
disease I-Disease
compared O
to O
unaffected O
smokers O
. O

MLK3 B-RNA
is O
upregulated O
in O
metastatic O
melanoma B-Disease
, O
and O
regulates O
cell O
proliferation O
and O
invasion O
in O
melanoma B-Disease
cells O
. O

In O
Crohn B-Disease
' I-Disease
s I-Disease
disease I-Disease
fibrosis O
- O
reduced O
expression O
of O
the O
miR B-RNA
- I-RNA
29 I-RNA
family O
enhances O
collagen O
expression O
in O
intestinal O
fibroblasts O
. O

miR B-RNA
- I-RNA
125b I-RNA
inhibitor O
enhance O
the O
chemosensitivity O
of O
glioblastoma B-Disease
stem O
cells O
to O
temozolomide O
by O
targeting O
Bak1 O
. O

In O
the O
present O
study O
, O
we O
showed O
that O
lncRNA O
- O
UCA1 B-RNA
expression O
in O
bladder B-Disease
cancer I-Disease
cells O
was O
upregulated O
by O
transcription O
factor O
CCAAT O
/ O
enhancer O
binding O
protein O
a O
( O
C O
/ O
EBPa O
) O
, O
The O
transcriptional O
activation O
of O
lncRNA O
- O
UCA1 B-RNA
by O
C O
/ O
EBPa O
also O
contributes O
to O
the O
increased O
viability O
and O
decreased O
apoptosis O
of O
bladder B-Disease
cancer I-Disease
cells O
. O

MiR B-RNA
- I-RNA
155 I-RNA
( O
- O
/ O
- O
) O
mice O
are O
highly O
resistant O
to O
experimental O
autoimmune O
encephalomyelitis B-Disease
( O
EAE O
) O

miR B-RNA
- I-RNA
566 I-RNA
activated O
EGFR O
signaling O
and O
its O
inhibition O
sensitized O
glioblastoma B-Disease
cells O
to O
anti O
- O
EGFR O
therapy O
. O

MiR B-RNA
- I-RNA
18a I-RNA
regulates O
the O
proliferation O
, O
migration O
and O
invasion O
of O
human O
glioblastoma B-Disease
cell O
by O
targeting O
neogenin O
. O

This O
study O
shows O
that O
miR B-RNA
- I-RNA
146a I-RNA
and O
Ets B-RNA
- I-RNA
1 I-RNA
are O
both O
associated O
with O
pediatric O
uveitis B-Disease
in O
Han O
Chinese O
. O

Human O
colorectal B-Disease
cancer I-Disease
- O
specific O
CCAT1 B-RNA
- I-RNA
L I-RNA
lncRNA O
regulates O
long O
- O
range O
chromatin O
interactions O
at O
the O
MYC O
locus O
. O

Overexpression O
of O
long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
predicts O
poor O
patient O
prognosis O
and O
promotes O
tumor O
metastasis O
in O
epithelial B-Disease
ovarian I-Disease
cancer I-Disease
. O

Long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
promotes O
cell O
migration O
and O
invasion O
via O
down O
- O
regulation O
of O
RNA O
binding O
motif O
protein O
38 O
in O
hepatocellular B-Disease
carcinoma I-Disease
cells O
. O

The O
mitochondrial O
long O
noncoding O
RNA O
uc022bqs O
. O
1 O
( O
LIPCAR B-RNA
) O
was O
downregulated O
early O
after O
myocardial B-Disease
infarction I-Disease
but O
upregulated O
during O
later O
stages O
. O

in O
mutant O
mice O
lacking O
miR B-RNA
- I-RNA
206 I-RNA
, O
reinnervation O
is O
impaired O
following O
nerve O
injury O
and O
loss O
of O
NMJs O
is O
accelerated O
in O
a O
mouse O
model O
of O
amyotrophic B-Disease
lateral I-Disease
sclerosis I-Disease
( O
ALS O
) O
. O

In O
this O
study O
, O
a O
total O
of O
9 O
downregulated O
miRNAs O
( O
miR B-RNA
- I-RNA
195 I-RNA
, O
miR B-RNA
- I-RNA
223 I-RNA
, O
miR B-RNA
- I-RNA
218 I-RNA
, O
miR B-RNA
- I-RNA
17 I-RNA
, O
miR B-RNA
- I-RNA
18a I-RNA
, O
miR B-RNA
- I-RNA
19b1 I-RNA
, O
miR B-RNA
- I-RNA
92a1 I-RNA
, O
miR B-RNA
- I-RNA
379 I-RNA
, O
and O
miR B-RNA
- I-RNA
411 I-RNA
) O
and O
7 O
upregulated O
miRNAs O
( O
miR O
- O
210 O
, O
miR O
- O
30a O
- O
3p O
, O
miR O
- O
518b O
, O
miR O
- O
524 O
, O
miR B-RNA
- I-RNA
17 I-RNA
- O
3p O
, O
miR O
- O
151 O
, O
and O
miR O
- O
193b O
) O
were O
identified O
in O
severe O
preeclampsia B-Disease
( O
sPE O
) O
placentas O
when O
compared O
with O
normal O
pregnant O
controls O
. O

In O
this O
study O
, O
a O
total O
of O
9 O
downregulated O
miRNAs O
( O
miR O
- O
195 O
, O
miR O
- O
223 O
, O
miR O
- O
218 O
, O
miR O
- O
17 O
, O
miR O
- O
18a O
, O
miR O
- O
19b1 O
, O
miR O
- O
92a1 O
, O
miR O
- O
379 O
, O
and O
miR O
- O
411 O
) O
and O
7 O
upregulated O
miRNAs O
( O
miR B-RNA
- I-RNA
210 I-RNA
, O
miR B-RNA
- I-RNA
30a I-RNA
- I-RNA
3p I-RNA
, O
miR B-RNA
- I-RNA
518b I-RNA
, O
miR B-RNA
- I-RNA
524 I-RNA
, O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
3p I-RNA
, O
miR B-RNA
- I-RNA
151 I-RNA
, O
and O
miR B-RNA
- I-RNA
193b I-RNA
) O
were O
identified O
in O
severe O
preeclampsia B-Disease
( O
sPE O
) O
placentas O
when O
compared O
with O
normal O
pregnant O
controls O
. O

PCGEM1 B-RNA
, O
PCA3 B-RNA
( O
prostate B-Disease
cancer I-Disease
antigen O
3 O
, O
known O
also O
as O
DD3 O
, O
differential O
display O
code O
3 O
) O
and O
PCNCR1 B-RNA
( O
prostate B-Disease
cancer I-Disease
ncRNA O
1 O
) O
are O
involved O
in O
prostate B-Disease
cancer I-Disease
, O
while O
HULC O
( O
highly O
up O
- O
regulated O
in O
liver O
cancer O
) O
is O
involved O
with O
liver O
cancer O
. O

PCGEM1 O
, O
PCA3 O
( O
prostate O
cancer O
antigen O
3 O
, O
known O
also O
as O
DD3 O
, O
differential O
display O
code O
3 O
) O
and O
PCNCR1 O
( O
prostate O
cancer O
ncRNA O
1 O
) O
are O
involved O
in O
prostate O
cancer O
, O
while O
HULC B-RNA
( O
highly O
up O
- O
regulated O
in O
liver B-Disease
cancer I-Disease
) O
is O
involved O
with O
liver B-Disease
cancer I-Disease
. O

MALAT1 B-RNA
, O
also O
known O
as O
NEAT2 O
( O
nuclear O
- O
enriched O
abundant O
transcript O
2 O
) O
, O
was O
initially O
discovered O
as O
a O
predictive O
biomarker O
for O
metastasis O
development O
in O
lung B-Disease
cancer I-Disease
. O

Differentially O
expressed O
miRNAs O
in O
Ewing B-Disease
sarcoma I-Disease
compared O
to O
mesenchymal O
stem O
cells O
: O
low O
miR B-RNA
- I-RNA
31 I-RNA
expression O
with O
effects O
on O
proliferation O
and O
invasion O
. O

c O
- O
Myc O
- O
induced O
, O
long O
, O
noncoding O
H19 B-RNA
affects O
cell O
proliferation O
and O
predicts O
a O
poor O
prognosis O
in O
patients O
with O
gastric B-Disease
cancer I-Disease
. O

Detection O
of O
an O
activated O
JAK3 O
variant O
and O
a O
Xq26 O
. O
3 O
microdeletion O
causing O
loss O
of O
PHF6 B-RNA
and O
miR B-RNA
- I-RNA
424 I-RNA
expression O
in O
myelodysplastic O
syndromes O
by O
combined O
targeted O
next O
generation O
sequencing O
and O
SNP O
array O
analysis O
. O

Our O
findings O
reveal O
a O
new O
regulatory O
pathway O
of O
YY1 O
/ O
HDACs O
/ O
miR B-RNA
- I-RNA
155 I-RNA
/ O
HBP1 O
in O
macrophage O
- O
derived O
foam O
cell O
formation O
during O
early O
atherogenesis O
and O
suggest O
that O
miR B-RNA
- I-RNA
155 I-RNA
is O
a O
potential O
therapeutic O
target O
for O
atherosclerosis B-Disease
. O

Linc00963 O
: O
a O
novel O
, O
long O
non O
- O
coding O
RNA O
involved O
in O
the O
transition O
of O
prostate B-Disease
cancer I-Disease
from O
androgen O
- O
dependence O
to O
androgen O
- O
independence O
. O

miR B-RNA
- I-RNA
21 I-RNA
targets O
15 O
- O
PGDH O
and O
promotes O
cholangiocarcinoma B-Disease
growth O
. O

Antisense O
long O
non O
- O
coding O
RNA O
PCNA B-RNA
- I-RNA
AS1 I-RNA
promotes O
tumor O
growth O
by O
regulating O
proliferating O
cell O
nuclear O
antigen O
in O
hepatocellular O
carcinoma O
. O

Long O
non O
- O
coding O
RNA O
91H B-RNA
contributes O
to O
the O
occurrence O
and O
progression O
of O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
by O
inhibiting O
IGF2 B-RNA
expression O
. O

Here O
we O
found O
that O
LncRNA O
ZXF1 B-RNA
levels O
were O
remarkably O
increased O
in O
lung B-Disease
adenocarcinoma I-Disease
tissues O
compared O
with O
adjacent O
non O
- O
cancerous O
lung O
tissues O
, O
and O
up O
- O
regulated O
LncRNA O
ZXF1 B-RNA
was O
correlated O
with O
lymph O
node O
metastasis O
, O
tumor O
pathological O
stage O
and O
the O
extent O
of O
lymph O
node O
metastasis O
. O

MALAT1 B-RNA
plays O
a O
role O
in O
cell O
migration O
and O
tumor O
metastasis O
, O
as O
demonstrated O
by O
knockout O
of O
MALAT1 B-RNA
in O
lung B-Disease
cancer I-Disease
cell O
line O
( O
Gutschner O
et O
al O
. O
, O
2013 O
) O
. O

PBMC O
and O
exosome O
- O
derived O
Hotair O
is O
a O
critical O
regulator O
and O
potent O
marker O
for O
rheumatoid B-Disease
arthritis I-Disease
. O

There O
was O
a O
significant O
increase O
in O
miR B-RNA
- I-RNA
210 I-RNA
expression O
in O
glioblastomas B-Disease
compared O
with O
anaplastic O
astrocytomas O
( O
p O
< O
0 O
. O
1 O
) O
, O
glioblastomas B-Disease
compared O
with O
diffuse O
astrocytomas O
( O
p O
< O
0 O
. O
1 O
) O
, O
and O
anaplastic O
astrocytomas O
compared O
with O
diffuse O
astrocytomas O
. O

The O
results O
demonstrated O
that O
the O
expression O
of O
miR B-RNA
- I-RNA
210 I-RNA
was O
significantly O
reduced O
in O
oligodendroglial O
tumours O
, O
compared O
with O
the O
mean O
expression O
levels O
observed O
in O
normal O
brain O
tissues O
. O

LncRNA O
- O
UCA1 B-RNA
was O
upregulated O
by O
hypoxia O
in O
bladder B-Disease
cancer I-Disease
cells O
. O

The O
long O
noncoding O
RNA O
MALAT1 B-RNA
induces O
lung B-Disease
cancer I-Disease
cell O
migration O
and O
plays O
a O
pivotal O
role O
in O
lung B-Disease
cancer I-Disease
metastasis O

The O
results O
showed O
that O
HOTAIR B-RNA
expression O
in O
cervical B-Disease
cancer I-Disease
tissues O
was O
significantly O
upregulated O
compared O
with O
the O
matched O
nontumorous O
tissues O
( O
P O
< O
0 O
. O
1 O
) O
. O

miR B-RNA
- I-RNA
22 I-RNA
inhibits O
osteosarcoma B-Disease
cell O
proliferation O
and O
migration O
by O
targeting O
HMGB1 O
and O
inhibiting O
HMGB1 O
- O
mediated O
autophagy O
. O

miR21 B-RNA
is O
upregulated O
in O
grade O
IV O
( O
glioblastoma B-Disease
multiforme I-Disease
( O
GBM O
) O
) O
vs O
. O

Overexpressed O
MALAT1 B-RNA
was O
found O
in O
many O
solid O
tumors O
such O
as O
lung B-Disease
cancer I-Disease
, O
cervical B-Disease
cancer I-Disease
, O
and O
HCC O
. O

Our O
data O
showed O
that O
HOTAIR B-RNA
expression O
was O
higher O
in O
endometrial B-Disease
cancer I-Disease
cells O
and O
tissues O
than O
in O
normal O
endometrial O
tissues O
. O

MicroRNA B-RNA
- I-RNA
1 I-RNA
( I-RNA
miR I-RNA
- I-RNA
1 I-RNA
) I-RNA
inhibits O
chordoma B-Disease
cell O
migration O
and O
invasion O
by O
targeting O
slug O
. O

We O
found O
that O
AFB1 B-RNA
could O
up O
- O
regulate O
the O
expression O
of O
H19 B-RNA
and O
promote O
cell O
growth O
and O
invasion O
by O
hepatocellular O
carcinoma O
HepG2 O
cells O
. O

In O
this O
study O
, O
we O
observed O
that O
the O
lncRNA O
- O
activated O
by O
TGF O
- O
 O
( O
lncRNA B-RNA
- I-RNA
ATB I-RNA
) O
was O
upregulated O
in O
hepatocellular B-Disease
carcinoma I-Disease
( O
HCC O
) O
metastases O
and O
associated O
with O
poor O
prognosis O
. O

Lnc O
RNA O
HOTAIR B-RNA
functions O
as O
a O
competing O
endogenous O
- O
RNA O
- O
to O
regulate O
HER2 B-RNA
expression O
by O
sponging O
miR B-RNA
- I-RNA
331 I-RNA
- I-RNA
3p I-RNA
in O
gastric B-Disease
cancer I-Disease
. O

In O
the O
43 O
breast B-Disease
cancer I-Disease
tissues O
, O
PVT1 B-RNA
expression O
was O
significantly O
higher O
in O
those O
with O
the O
GG O
genotype O
than O
that O
in O
the O
GA O
or O
AA O
genotype O
. O

HOTAIR B-RNA
is O
a O
long O
non O
- O
coding O
RNA O
( O
lncRNA O
) O
that O
has O
been O
implicated O
with O
cancer O
but O
has O
not O
been O
studied O
in O
cardiac B-Disease
disease I-Disease
. O

We O
have O
found O
that O
HOTAIR B-RNA
levels O
are O
decreased O
in O
BAVs O
and O
in O
human O
aortic O
interstitial O
cells O
( O
AVICs O
) O
exposed O
to O
cyclic O
stretch O
. O

In O
this O
preclinical O
study O
, O
the O
consequences O
of O
decreased O
GAS5 B-RNA
expression O
for O
breast B-Disease
cancer I-Disease
cell O
survival O
following O
treatment O
with O
chemotherapeutic O
agents O
are O
addressed O
. O

MiR B-RNA
- I-RNA
145 I-RNA
inhibits O
osteosarcoma B-Disease
cells O
proliferation O
and O
invasion O
by O
targeting O
ROCK1 O
. O

MiR B-RNA
- I-RNA
34c I-RNA
inhibits O
osteosarcoma B-Disease
metastasis O
and O
chemoresistance O
. O

MiR B-RNA
- I-RNA
101 I-RNA
, O
downregulated O
in O
retinoblastoma B-Disease
, O
functions O
as O
a O
tumor O
suppressor O
in O
human O
retinoblastoma B-Disease
cells O
by O
targeting O
EZH2 O
. O

Overexpression O
of O
lncRNA O
H19 B-RNA
enhances O
carcinogenesis O
and O
metastasis O
of O
gastric B-Disease
cancer I-Disease
; O
An O
H19 B-RNA
co O
- O
expression O
network O
identified O
ISM1 B-RNA
as O
a O
binding O
protein O
of O
H19 B-RNA
, O
and O
its O
expression O
was O
positively O
correlated O
with O
that O
of O
H19 B-RNA
; O
Our O
results O
suggest O
that O
the O
effect O
of O
H19 B-RNA
in O
GC O
is O
mediated O
by O
the O
direct O
upregulation O
of O
ISM1 B-RNA
and O
the O
indirect O
suppression O
of O
CALN1 B-RNA
expression O
via O
miR B-RNA
- I-RNA
675 I-RNA
. O

Overexpression O
of O
- O
lncRNA O
- O
H19 B-RNA
enhances O
carcinogenesis O
and O
metastasis O
of O
gastric B-Disease
cancer I-Disease
. O

Long O
- O
noncoding O
- O
RNA O
- O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
is O
upregulated O
in O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
and O
associated O
with O
poor O
prognosis O
. O

The O
level O
of O
ncRuPAR B-RNA
in O
gastric B-Disease
cancer I-Disease
was O
low O
, O
and O
its O
expression O
level O
was O
associated O
with O
invasion O
depth O
, O
lymph O
node O
metastasis O
, O
distant O
metastasis O
, O
tumor O
size O
, O
and O
TNM O
stage O
. O

These O
findings O
indicate O
that O
ncRuPAR B-RNA
might O
be O
a O
potential O
marker O
for O
gastric B-Disease
cancer I-Disease
diagnosis O
. O
ncRuPAR B-RNA
might O
also O
be O
a O
tumor O
suppressor O
because O
it O
regulates O
the O
expression O
of O
PAR O
- O
1 O
. O

we O
observed O
a O
differential O
expression O
of O
another O
three O
miRNAs O
( O
miR B-RNA
- I-RNA
320 I-RNA
, O
miR B-RNA
- I-RNA
320b I-RNA
and O
miR B-RNA
- I-RNA
629 I-RNA
) O
between O
the O
progressive B-Disease
multifocal I-Disease
leukoencephalopathy I-Disease
( O
PML O
) O
and O
non O
- O
PML O
groups O
after O
12 O
months O
of O
treatment O
( O
t12 O
) O
; O
and O
a O
positive O
correlation O
was O
found O
between O
therapy O
time O
and O
the O
expression O
of O
miR B-RNA
- I-RNA
320 I-RNA
. O

P53 O
- O
regulated O
long O
non O
- O
coding O
RNA O
TUG1 B-RNA
affects O
cell O
proliferation O
in O
human O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
, O
partly O
through O
epigenetically O
regulating O
HOXB7 O
expression O
. O

To O
identify O
how O
miR B-RNA
- I-RNA
200a I-RNA
contributes O
to O
meningioma B-Disease
pathogenesis O
at O
the O
molecular O
level O
, O
we O
used O
a O
comparative O
protein O
profiling O
approach O
using O
Gel O
- O
nanoLC O
- O
MS O
/ O
MS O
and O
identified O
approximately O
130 O
dysregulated O
proteins O
in O
miR B-RNA
- I-RNA
200a I-RNA
- O
overexpressing O
meningioma B-Disease
cells O
. O

Expression O
of O
miR B-RNA
- I-RNA
124 I-RNA
in O
a O
neuroblastoma B-Disease
cells O
line O
was O
sufficient O
to O
up O
- O
regulate O
a O
significant O
fraction O
of O
nervous O
system O
- O
specific O
Ezh2 O
target O
genes O
. O

Decreased O
expression O
of O
long O
noncoding O
RNA O
GAS5 B-RNA
indicates O
a O
poor O
prognosis O
and O
promotes O
cell O
proliferation O
in O
gastric B-Disease
cancer I-Disease
. O

In O
this O
study O
, O
we O
show O
that O
lncRNA O
UCA1 B-RNA
promotes O
glycolysis O
in O
bladder B-Disease
cancer I-Disease
cells O
, O
and O
that O
UCA1 B-RNA
- O
induced O
hexokinase O
2 O
( O
HK2 O
) O
functions O
as O
an O
important O
mediator O
in O
this O
process O
. O

We O
further O
show O
that O
UCA1 B-RNA
activates O
mTOR O
to O
regulate O
HK2 O
through O
both O
activation O
of O
STAT3 O
and O
repression O
of O
microRNA143 O
. O

highly O
expressed O
, O
can O
promote O
the O
metastasis O
of O
melanoma O
. O

The O
expression O
levels O
of O
UCA1 O
and O
Malat B-RNA
- I-RNA
1 I-RNA
lncRNAs O
had O
the O
potential O
to O
be O
prognostic O
indicators O
in O
metastasis O
of O
melanomas B-Disease
. O

Deep O
MicroRNA O
sequencing O
reveals O
downregulation O
of O
miR B-RNA
- I-RNA
29a I-RNA
in O
neuroblastoma B-Disease
central O
nervous O
system O
metastasis O
. O

The O
lncUSMycN B-RNA
gene O
was O
coamplified O
with O
MYCN O
in O
88 O
of O
341 O
human O
neuroblastoma B-Disease
tissues O
. O

H19 B-RNA
promotes O
pancreatic B-Disease
cancer I-Disease
metastasis O
by O
derepressing O
let O
- O
7 O
' O
s O
suppression O
on O
its O
target O
HMGA2 O
- O
mediated O
EMT O

linc O
- O
ROR O
was O
upregulated O
in O
breast B-Disease
tumor I-Disease
and O
ectopic O
overexpression O
of O
linc O
- O
ROR O
in O
immortalized O
human O
mammary O
epithelial O
cells O
induced O
an O
epithelial O
- O
to O
- O
mesenchymal O
transition O
( O
EMT O
) O
program O
. O

GAS5 B-RNA
- O
derived O
snoRNA O
expression O
was O
induced O
by O
DNA O
damage O
in O
a O
p53 O
- O
dependent O
manner O
in O
colorectal B-Disease
cancer I-Disease
cell O
lines O
and O
their O
levels O
were O
not O
affected O
by O
DICER O

In O
this O
study O
, O
we O
found O
that O
Sox2ot B-RNA
was O
up O
- O
regulated O
over O
two O
folds O
in O
53 O
. O
1 O
% O
of O
human O
primary O
lung B-Disease
cancers I-Disease
( O
44 O
/ O
83 O
) O
. O

TRPM2 B-RNA
- I-RNA
AS I-RNA
is O
overexpressed O
in O
prostate B-Disease
cancer I-Disease
( O
PCa O
) O
. O

In O
the O
present O
study O
, O
it O
was O
identified O
that O
MALAT1 B-RNA
expression O
was O
upregulated O
in O
cervical B-Disease
cancer I-Disease
cell O
linecompared O
with O
normal O
cervical O
squamous O
cell O
samples O
. O

The O
expression O
of O
HOTAIR B-RNA
was O
markedly O
increased O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
adjacent O
non O
- O
tumoral O
tissues O
. O

The O
HOTAIR B-RNA
transcripts O
were O
expressed O
at O
higher O
levels O
in O
the O
tumor O
tissues O
compared O
with O
adjacent O
normal O
tissues O
( O
p O
< O
0 O
. O
1 O
) O
, O
indicating O
that O
HOTAIR B-RNA
was O
frequently O
up O
- O
regulated O
in O
GBC O
. O
A O
positive O
correlation O
between O
c O
- O
Myc O
and O
HOTAIR B-RNA
mRNA O
levels O
was O
observed O
in O
gallbladder O
cancer O
tissues O
. O

miR B-RNA
- I-RNA
124 I-RNA
expression O
is O
negatively O
correlated O
with O
a O
hypoxic O
gene O
signature O
in O
glioblastoma B-Disease
patient O
samples O
, O
suggesting O
that O
low O
miR B-RNA
- I-RNA
124 I-RNA
levels O
contribute O
to O
pro O
- O
survival O
adaptive O
pathways O
in O
this O
disease O
. O

The O
expression O
levels O
of O
HMlincRNA717 B-RNA
in O
five O
gastric B-Disease
cancer I-Disease
cell O
lines O
, O
AGS O
, O
BGC O
- O
823 O
, O
HGC O
- O
27 O
, O
MGC O
- O
803 O
, O
and O
SGC O
- O
7901 O
, O
were O
significantly O
downregulated O
than O
those O
in O
normal O
gastric O
mucosal O
epithelial O
cell O
line O
GES O
- O
1 O
. O

Compared O
to O
matched O
adjacent O
non O
- O
tumorous O
tissues O
, O
FER1L4 B-RNA
expression O
levels O
in O
91 O
. O
80 O
% O
( O
56 O
/ O
61 O
) O
of O
gastric B-Disease
cancer I-Disease
tissues O
are O
significantly O
decreased O
. O

BANCR B-RNA
was O
abnormally O
overexpressed O
in O
human O
malignant B-Disease
melanoma I-Disease
cell O
lines O
and O
tissues O
, O
and O
increased O
with O
tumor O
stages O
. O

Our O
study O
revealed O
that O
miR B-RNA
- I-RNA
200a I-RNA
is O
a O
candidate O
tumor O
suppressor O
in O
neuroblastoma B-Disease
, O
through O
direct O
targeting O
of O
AP O
- O
2 O
 O
. O

Results O
show O
that O
compared O
with O
adjacent O
nontumor O
tissues O
the O
expression O
level O
of O
ABHD11 B-RNA
- I-RNA
AS1 I-RNA
in O
gastric B-Disease
cancer I-Disease
tissues O
was O
significantly O
increased O
. O

In O
this O
study O
, O
we O
found O
that O
long O
non O
- O
coding O
RNA O
H19 B-RNA
( O
H19 B-RNA
) O
and O
H19 B-RNA
- O
derived O
microRNA O
- O
675 O
( O
miR O
- O
675 O
) O
were O
significantly O
downregulated O
in O
the O
metastatic O
prostate B-Disease
cancer I-Disease
cell O
line O
M12 O
compared O
with O
the O
non O
- O
metastatic O
prostate O
epithelial O
cell O
line O
P69 O
. O

In O
the O
present O
study O
, O
we O
first O
examined O
the O
function O
of O
UCA1 B-RNA
in O
5637 O
bladder B-Disease
cancer I-Disease
cells O
, O
which O
express O
high O
levels O
of O
UCA1 B-RNA
. O

The O
expression O
of O
SOX2 B-RNA
and O
SOX2OT B-RNA
is O
concordant O
in O
breast B-Disease
cancer I-Disease
, O
differentially O
expressed O
in O
estrogen O
receptor O
positive O
and O
negative O
breast B-Disease
cancer I-Disease
samples O
and O
that O
both O
are O
up O
- O
regulated O
in O
suspension O
culture O
conditions O
that O
favor O
growth O
of O
stem O
cell O
phenotypes O
. O

Among O
the O
tested O
lncRNAs O
, O
HOTAIR B-RNA
and O
NEAT1 B-RNA
were O
most O
highly O
expressed O
in O
lymph O
node O
metastasis O
. O

However O
, O
only O
HOTAIR B-RNA
was O
subsequently O
found O
to O
be O
involved O
in O
lung B-Disease
cancer I-Disease
cell O
motility O
and O
invasion O
, O
as O
assessed O
by O
in O
vitro O
migration O
and O
invasion O
assay O
. O

miR B-RNA
- I-RNA
421 I-RNA
may O
promote O
neuroblastoma B-Disease
cell O
growth O
and O
motility O
partially O
by O
targeting O
menin O
. O

Here O
, O
we O
report O
that O
downregulated O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
1 I-RNA
and O
upregulated O
lncRNA O
urothelial O
cancer O
associated O
1 O
( O
UCA1 B-RNA
) O
were O
inversely O
expressed O
in O
bladder B-Disease
cancer I-Disease
. O

Thus O
, O
miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
3p I-RNA
directly O
targets O
CD133 O
to O
regulate O
its O
ability O
to O
confer O
cancer O
and O
stem O
cell O
- O
like O
features O
in O
HCC B-Disease
. O

In O
agreement O
, O
we O
found O
a O
strong O
correlation O
between O
high O
EFNA3 B-RNA
expression O
and O
shorter O
metastasis O
- O
free O
survival O
in O
breast B-Disease
cancer I-Disease
patients O
. O

LncRNAs O
MONC B-RNA
and O
MIR100HG B-RNA
are O
regulators O
of O
hematopoiesis O
and O
oncogenes O
in O
the O
development O
of O
myeloid B-Disease
leukemia I-Disease

A O
novel O
long O
non O
- O
coding O
RNA O
FOXCUT B-RNA
and O
mRNA O
FOXC1 B-RNA
pair O
promote O
progression O
and O
predict O
poor O
prognosis O
in O
esophageal O
squamous O
cell O
carcinoma O
. O

The O
long O
noncoding O
RNA O
SChLAP1 B-RNA
promotes O
aggressive O
prostate B-Disease
cancer I-Disease
and O
antagonizes O
the O
SWI O
/ O
SNF O
complex O

The O
data O
confirmed O
that O
ASO3690 B-RNA
, O
ENST00000491282 B-RNA
, O
and O
XLOC B-RNA
_ I-RNA
575 I-RNA
were O
overexpressed O
in O
pulmonary B-Disease
adenocarcinoma I-Disease
, O
whereas O
AK124939 O
expression O
was O
decreased O

The O
expression O
of O
HOTAIR B-RNA
was O
significantly O
elevated O
in O
various O
gastric B-Disease
cancer I-Disease
cell O
lines O
and O
tissues O
compared O
to O
normal O
control O
. O

Therefore O
, O
the O
data O
reported O
in O
the O
present O
study O
demonstrates O
that O
miR B-RNA
- I-RNA
181 I-RNA
is O
an O
important O
regulator O
in O
glioma B-Disease
. O

MiR B-RNA
- I-RNA
7 I-RNA
, O
inhibited O
indirectly O
by O
lincRNA O
HOTAIR B-RNA
, O
directly O
inhibits O
SETDB1 O
and O
reverses O
the O
EMT O
of O
breast O
cancer O
stem O
cells O
by O
downregulating O
the O
STAT3 O
pathway O
. O

RP11 B-RNA
- I-RNA
133F8 I-RNA
. I-RNA
2 I-RNA
expression O
of O
EGFR O
exon O
19 O
deletions O
in O
lung B-Disease
adenocarcinoma I-Disease
was O
significantly O
higher O
than O
wild O
- O
type O
EGFR O
tissues O
, O
while O
LOC440905 B-RNA
expression O
of O
EGFR O
exon O
19 O
deletions O
in O
lung B-Disease
adenocarcinoma I-Disease
was O
significantly O
lower O
than O
wild O
- O
type O
EGFR O
tissues O
. O

The O
expression O
of O
LOC100132354 B-RNA
was O
significantly O
higher O
in O
lung B-Disease
adenocarcinoma I-Disease
than O
in O
the O
adjacent O
tissues O
, O
while O
the O
expression O
of O
RPLP0P2 O
was O
significantly O
lower O
in O
lung B-Disease
adenocarcinoma I-Disease
than O
in O
the O
adjacent O
tissues O
. O

The O
expression O
of O
LOC100132354 O
was O
significantly O
higher O
in O
lung B-Disease
adenocarcinoma I-Disease
than O
in O
the O
adjacent O
tissues O
, O
while O
the O
expression O
of O
RPLP0P2 B-RNA
was O
significantly O
lower O
in O
lung B-Disease
adenocarcinoma I-Disease
than O
in O
the O
adjacent O
tissues O
. O

The O
expression O
of O
exosomal O
miR B-RNA
- I-RNA
21 I-RNA
and O
HOTAIR B-RNA
was O
significantly O
higher O
in O
patients O
with O
laryngeal O
squamous O
cell O
carcinomaLSCC O
than O
those O
with O
vocal O
cord O
polyps O
, O
The O
patients O
with O
lymph O
node O
metastasis O
had O
higher O
serum O
exosomal O
miR B-RNA
- I-RNA
21 I-RNA
and O
HOTAIR B-RNA
expressions O
than O
those O
without O
. O

Overexpression O
of O
LCAL1 B-RNA
in O
normal O
BEAS O
- O
2B O
cells O
is O
proof O
of O
principle O
that O
this O
lncRNA O
is O
sufficient O
to O
affetc O
cellular O
growth O
independently O
of O
other O
common O
cancer O
mutations O
, O
thus O
highlighting O
the O
importance O
of O
LCAL1 B-RNA
in O
lung B-Disease
cancer I-Disease
biology O
. O

miR B-RNA
- I-RNA
338 I-RNA
- I-RNA
3p I-RNA
is O
over O
- O
expressed O
in O
blood O
, O
CFS O
, O
serum O
and O
spinal O
cord O
from O
sporadic O
amyotrophic B-Disease
lateral I-Disease
sclerosis I-Disease
patients O
. O

The O
epigenetic O
regulation O
of O
SOX9 O
by O
miR B-RNA
- I-RNA
145 I-RNA
in O
human O
chondrosarcoma B-Disease
. O

lncRNA O
HOTAIR B-RNA
expression O
was O
found O
to O
be O
elevated O
in O
renal O
carcinoma O
cells O
. O

Suppressed O
expression O
of O
long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
inhibits O
proliferation O
and O
tumourigenicity O
of O
renal B-Disease
carcinoma I-Disease
cells O
. O

The O
rs10965235 O
SNP O
in O
the O
CDKN2B O
- O
AS O
gene O
was O
significantly O
associated O
with O
endometriosis B-Disease
in O
this O
Korean O
population O
. O

The O
expression O
of O
lincRNA B-RNA
- I-RNA
p21 I-RNA
was O
dramatically O
downregulated O
in O
atherosclerotic O
plaques O
of O
ApoE O
( O
- O
/ O
- O
) O
mice O
, O
an O
animal O
model O
for O
atherosclerosis B-Disease
. O

Decreased O
expression O
of O
the O
long O
non O
- O
coding O
RNA O
FENDRR B-RNA
is O
associated O
with O
poor O
prognosis O
in O
gastric B-Disease
cancer I-Disease
and O
FENDRR B-RNA
regulates O
gastric B-Disease
cancer I-Disease
cell O
metastasis O
by O
affecting O
fibronectin1 O
expression O
. O

Our O
results O
revealed O
that O
CCAT1 B-RNA
was O
significantly O
overexpressed O
in O
colon B-Disease
cancer I-Disease
tissues O
when O
compared O
with O
normal O
tissues O
, O
and O
its O
increased O
expression O
was O
correlated O
with O
patients O
' O
clinical O
stage O
, O
lymph O
nodes O
metastasis O
, O
and O
survival O
time O
after O
surgery O
. O

Together O
, O
these O
results O
show O
that O
GAS5 B-RNA
contributes O
to O
the O
pathogenesis O
of O
OA B-Disease
by O
acting O
as O
a O
negative O
regulator O
of O
miR B-RNA
- I-RNA
21 I-RNA
and O
thereby O
regulating O
cell O
survival O
. O

Reciprocal O
regulation O
of O
PCGEM1 B-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
promote O
proliferation O
of O
LNCaP O
prostate B-Disease
cancer I-Disease
cells O
. O
To O
test O
this O
hypothesis O
, O
the O
interaction O
between O
PCGEM1 B-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
was O
examined O
using O
a O
luciferase O
reporter O
assay O
. O

Increased O
level O
of O
long O
noncoding O
RNA O
MALAT1 B-RNA
promotes O
lung B-Disease
cancer I-Disease
brain O
metastasis O
by O
inducing O
EMT O
, O
which O
may O
be O
a O
promising O
prognosis O
factor O
and O
therapeutic O
target O
to O
treat O
lung B-Disease
cancer I-Disease
brain O
metastasis O
in O
future O

miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
promotes O
cholangiocarcinoma B-Disease
growth O
: O
evidence O
for O
PTEN O
as O
downstream O
target O
and O
IL O
- O
6 O
/ O
Stat3 O
as O
upstream O
activator O
. O

The O
expression O
of O
lncRNA O
AC006050 B-RNA
. I-RNA
3 I-RNA
- I-RNA
3 I-RNA
was O
significantly O
lower O
in O
PR O
samples O
compared O
to O
the O
PD O
samples O
in O
another O
60 O
lung O
squamous O
cell O
carcinoma O
patients O
. O

PVT1 B-RNA
showed O
higher O
expression O
in O
human O
gastric B-Disease
cancer I-Disease
tissues O
than O
in O
adjacent O
non O
- O
cancerous O
tissues O
and O
in O
SGC7901 O
paclitaxel O
- O
resistant O
cells O
compared O
with O
SGC7901 O
cells O
. O

PVT1 B-RNA
expression O
was O
correlated O
with O
lymph O
node O
invasion O
of O
gastric B-Disease
cancer I-Disease
. O

The O
results O
showed O
that O
the O
expression O
level O
of O
AC138128 B-RNA
. I-RNA
1 I-RNA
in O
GC O
was O
significantly O
decreased O
compared O
to O
that O
in O
NAT O
. O

Overexpression O
of O
MT1DP B-RNA
resulted O
in O
reduced O
cell O
proliferation O
and O
colony O
formation O
in O
soft O
agar O
, O
but O
increased O
apoptosis O
in O
liver B-Disease
cancer I-Disease
cells O
, O
whereas O
knockdown O
of O
this O
lncRNA O
had O
the O
opposite O
effetc O
, O
indicating O
that O
MT1DP B-RNA
acts O
as O
a O
tumor O
suppressor O
. O

Polymorphisms O
and O
haplotypes O
of O
the O
miR B-RNA
- I-RNA
148 I-RNA
/ I-RNA
152 I-RNA
family O
are O
associated O
with O
the O
risk O
and O
clinicopathological O
features O
of O
gastric B-Disease
cancer I-Disease
in O
a O
Northern O
Chinese O
population O
. O

In O
the O
present O
study O
, O
our O
results O
showed O
that O
MALAT B-RNA
- I-RNA
1 I-RNA
expression O
levels O
were O
upregulated O
in O
pancreatic B-Disease
cancer I-Disease
tissues O
compared O
with O
adjacent O
noncancerous O
controls O
. O

Our O
results O
support O
the O
potential O
of O
miR B-RNA
- I-RNA
215 I-RNA
as O
a O
prognostic O
predictor O
for O
breast B-Disease
cancer I-Disease
with O
its O
high O
expression O
in O
cancer O
tissues O
and O
its O
relationship O
with O
other O
clinicopathologic O
factors O
and O
survival O
. O

MiR B-RNA
- I-RNA
410 I-RNA
Is O
Overexpressed O
in O
Liver O
and O
Colorectal B-Disease
Tumors I-Disease
and O
Enhances O
Tumor O
Cell O
Growth O
by O
Silencing O
FHL1 O
via O
a O
Direct O
/ O
Indirect O
Mechanism O

Long O
noncoding O
RNA O
GAPLINC B-RNA
regulates O
CD44 O
- O
dependent O
cell O
invasiveness O
and O
associates O
with O
poor O
prognosis O
of O
gastric B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
382 I-RNA
inhibits O
osteosarcoma B-Disease
metastasis O
and O
relapse O
by O
targeting O
Y O
box O
- O
binding O
protein O
1 O
. O

The O
CACS8 B-RNA
SNP O
rs10505477 O
may O
contribute O
to O
the O
survival O
of O
gastric B-Disease
cancer I-Disease
and O
be O
a O
potential O
prognostic O
biomarker O
of O
gastric B-Disease
cancer I-Disease
. O

In O
conclusion O
, O
this O
study O
showed O
that O
miR B-RNA
- I-RNA
141 I-RNA
may O
contribute O
to O
the O
progression O
of O
bladder B-Disease
cancer I-Disease
and O
its O
upregulation O
may O
be O
independently O
associated O
with O
favorable O
prognosis O
of O
bladder B-Disease
cancer I-Disease
, O
suggesting O
that O
miR B-RNA
- I-RNA
141 I-RNA
might O
serve O
as O
a O
promising O
biological O
marker O
for O
further O
risk O
stratification O
in O
the O
management O
of O
bladder B-Disease
cancer I-Disease
. O

AK024556 O
( O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
) O
was O
highly O
up O
- O
regulated O
in O
human O
prostate B-Disease
cancer I-Disease
cell O
line O
PC3 O
but O
not O
in O
LNCaP O
, O
and O
siRNA O
knockdown O
of O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
in O
PC3 O
cells O
inhibited O
cell O
proliferation O
and O
invasion O
and O
increased O
cell O
apoptosis O
. O

The O
downregulation O
of O
miR B-RNA
- I-RNA
144 I-RNA
is O
associated O
with O
the O
growth O
and O
invasion O
of O
osteosarcoma B-Disease
cells O
through O
the O
regulation O
of O
TAGLN O
expression O
. O

We O
identified O
miR B-RNA
- I-RNA
23a I-RNA
as O
a O
tumor O
suppressor O
in O
osteosarcoma B-Disease
. O

Our O
data O
clarify O
the O
mechanism O
of O
osteosarcoma B-Disease
progression O
and O
demonstrated O
the O
potential O
for O
exploiting O
miR B-RNA
- I-RNA
23a I-RNA
as O
a O
diagnostic O
marker O
for O
osteosarcoma B-Disease
. O

HOTAIR B-RNA
was O
robustly O
expressed O
in O
the O
native O
basal O
- O
like O
breast B-Disease
cancer I-Disease
cells O
and O
inhibition O
of O
HOTAIR B-RNA
reduced O
the O
basal O
- O
like O
gene O
expression O
and O
growth O
. O

miR B-RNA
- I-RNA
382 I-RNA
inhibits O
tumor O
growth O
and O
enhance O
chemosensitivity O
in O
osteosarcoma B-Disease
. O

Analysis O
of O
miR B-RNA
- I-RNA
34a I-RNA
expression O
in O
human O
medulloblastomas B-Disease
and O
medulloblastoma O
cell O
lines O
revealed O
significantly O
lower O
levels O
than O
in O
normal O
human O
cerebellum O
. O

Re O
- O
expression O
of O
miR B-RNA
- I-RNA
34a I-RNA
in O
human O
medulloblastoma O
cells O
reduced O
cell O
viability O
and O
proliferation O
, O
induced O
apoptosis O
and O
downregulated O
the O
miR B-RNA
- I-RNA
34a I-RNA
target O
genes O
, O
MYCN O
and O
SIRT1 O
. O

We O
observed O
that O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
146a I-RNA
and O
miR B-RNA
- I-RNA
182 I-RNA
were O
significantly O
over O
expressed O
in O
triple B-Disease
negative I-Disease
breast I-Disease
cancer I-Disease
. O

The O
levels O
of O
plasma O
LINC00152 B-RNA
were O
significantly O
elevated O
in O
gastric B-Disease
cancer I-Disease
patients O
compared O
with O
healthy O
controls O
. O

miR B-RNA
- I-RNA
451 I-RNA
may O
play O
an O
important O
role O
in O
tumor O
growth O
and O
metastasis O
in O
osteosarcoma B-Disease
. O

When O
all O
groups O
were O
compared O
versus O
control O
, O
miR B-RNA
- I-RNA
30c I-RNA
- I-RNA
5p I-RNA
, O
miR B-RNA
- I-RNA
223 I-RNA
- I-RNA
3p I-RNA
, O
miR B-RNA
- I-RNA
302c I-RNA
- I-RNA
3p I-RNA
and I-RNA
miR I-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
were O
found O
significantly O
deregulated O
for O
cirrhosis O
and O
HCC B-Disease
. O

We O
found O
that O
GAS5 B-RNA
expression O
was O
markedly O
downregulated O
in O
cervical B-Disease
cancer I-Disease
tissues O
than O
in O
corresponding O
adjacent O
normal O
tissues O
. O

In O
this O
study O
, O
we O
demonstrated O
that O
GHET1 B-RNA
was O
upregulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
to O
adjacent O
normal O
tissues O
and O
its O
over O
- O
expression O
correlates O
with O
tumor O
size O
, O
advanced O
tumor O
and O
lymph O
node O
status O
, O
and O
poor O
survival O
. O

miR B-RNA
- I-RNA
646 I-RNA
might O
be O
a O
tumor O
suppressor O
in O
osteosarcoma B-Disease
via O
the O
regulation O
of O
FGF2 O
, O
which O
provided O
a O
potential O
prognostic O
biomarker O
and O
therapeutic O
target O
. O

The O
expression O
level O
of O
HOTAIR B-RNA
in O
cervical B-Disease
cancer I-Disease
tissues O
was O
higher O
than O
that O
in O
corresponding O
non O
- O
cancerous O
tissues O
. O

Association O
of O
the O
miR B-RNA
- I-RNA
149 I-RNA
Rs2292832 O
polymorphism O
with O
papillary B-Disease
thyroid I-Disease
cancer I-Disease
risk O
and O
clinicopathologic O
characteristics O
in O
a O
Chinese O
population O
. O

Furthermore O
, O
in O
patients O
with O
breast B-Disease
cancer I-Disease
, O
high O
tumor O
NEAT1 B-RNA
expression O
correlates O
with O
poor O
survival O
, O
all O
of O
which O
are O
hallmarks O
of O
increased O
tumorigenesis O
. O

LOC401317 B-RNA
, O
a O
p53 O
- O
regulated O
long O
non O
- O
coding O
RNA O
, O
inhibits O
cell O
proliferation O
and O
induces O
apoptosis O
in O
the O
nasopharyngeal B-Disease
carcinoma I-Disease
cell O
line O
HNE2 O
. O

In O
our O
research O
, O
the O
MALAT1 B-RNA
messenger O
RNA O
( O
mRNA O
) O
was O
highly O
expressed O
in O
human O
osteosarcoma B-Disease
tissues O
, O
and O
its O
expression O
level O
was O
closely O
correlated O
with O
pulmonary O
metastasis O
. O

Our O
study O
showed O
that O
genetic O
variants O
in O
HOTAIR B-RNA
were O
associated O
with O
risk O
of O
colorectal B-Disease
cancer I-Disease
and O
rs7958904 O
may O
act O
as O
a O
potential O
biomarker O
for O
predicting O
the O
risk O
of O
colorectal B-Disease
cancer I-Disease
. O

HIF2PUT B-RNA
expression O
levels O
were O
positively O
correlated O
with O
HIF O
- O
2a O
in O
osteosarcoma B-Disease
tissues O
. O

It O
showed O
that O
BC040587 B-RNA
expression O
was O
down O
regulated O
both O
in O
BC B-Disease
samples O
and O
in O
BC B-Disease
cell O
linecompared O
with O
corresponding O
normal O
control O
. O

MiR B-RNA
- I-RNA
199a I-RNA
- I-RNA
3p I-RNA
promotes O
gastric B-Disease
cancer I-Disease
progression O
by O
targeting O
ZHX1 O
. O

MiR B-RNA
- I-RNA
132 I-RNA
prohibits O
proliferation O
, O
invasion O
, O
migration O
, O
and O
metastasis O
in O
breast B-Disease
cancer I-Disease
by O
targeting O
HN1 O
. O

We O
identified O
and O
validated O
high O
SChLAP1 O
expression O
as O
significantly O
prognostic O
for O
metastatic O
disease O
progression O
of O
prostate B-Disease
cancer I-Disease
. O

In O
breast B-Disease
cancer I-Disease
tissues O
, O
we O
found O
that O
IRAIN B-RNA
lncRNA O
was O
transcribed O
from O
an O
intronic O
promoter O
in O
an O
antisense O
diretcion O
as O
compared O
to O
the O
IGF1R B-RNA
coding O
mRNA O
. O

We O
found O
that O
AATBC B-RNA
was O
overexpressed O
in O
bladder B-Disease
cancer I-Disease
patient O
tissues O
and O
positively O
correlated O
with O
tumor O
grade O
and O
pT O
stage O
. O

miR B-RNA
- I-RNA
101 I-RNA
may O
act O
as O
a O
tumor O
suppressor O
, O
which O
is O
commonly O
downregulated O
in O
both O
osteosarcoma B-Disease
tissues O
and O
cells O
. O

Our O
results O
indicated O
that O
lncRNA O
MALAT1 B-RNA
was O
highly O
expressed O
in O
pancreatic B-Disease
cancer I-Disease
compared O
with O
adjacent O
non O
- O
cancerous O
tissues O
, O
and O
positively O
correlated O
with O
clinical O
stage O
, O
tumor O
size O
, O
lymph O
node O
metastasis O
, O
and O
distant O
metastasis O
in O
pancreatic B-Disease
cancer I-Disease
patients O
. O

We O
found O
that O
there O
were O
significantly O
lower O
levels O
of O
LEIGC B-RNA
expression O
in O
gastric B-Disease
cancer I-Disease
tissue O
. O

SChLAP1 B-RNA
expression O
increases O
with O
prostate B-Disease
cancer I-Disease
progression O
, O
and O
high O
SChLAP1 B-RNA
expression O
by O
ISH O
is O
associated O
with O
poor O
outcome O
after O
radical O
prostatetcomy O
in O
patients O
. O

Our O
study O
revealed O
that O
miR B-RNA
- I-RNA
200c I-RNA
/ I-RNA
141 I-RNA
was O
downregulated O
by O
CpG O
island O
methylation O
and O
TGF O
- O
 O
signaling O
, O
which O
decreased O
ZEB1 O
/ O
2 O
expression O
and O
increased O
E O
- O
cadherin O
expression O
to O
inhibit O
migration O
and O
invasion O
of O
gastric B-Disease
cancer I-Disease
cells O
and O
provides O
powerful O
evidence O
for O
the O
application O
of O
decitabine O
in O
gastric B-Disease
cancer I-Disease
treatment O
. O

Here O
, O
we O
report O
a O
novel O
function O
of O
PCGEM1 B-RNA
that O
provides O
growth O
advantages O
for O
prostate B-Disease
cancer I-Disease
cells O
by O
regulating O
tumor O
metabolism O
via O
c O
- O
Myc O
activation O
. O

The O
expression O
levels O
of O
MDC1 B-RNA
- O
AS O
and O
MDC1 B-RNA
was O
down O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
. O

We O
identified O
a O
lncRNA O
neuroblastoma B-Disease
associated O
transcript O
- O
1 O
( O
NBAT B-RNA
- I-RNA
1 I-RNA
) O
as O
a O
biomarker O
significantly O
predicting O
clinical O
outcome O
of O
neuroblastoma B-Disease
. O

Urine O
MALAT B-RNA
- I-RNA
1 I-RNA
is O
a O
promising O
biomarker O
for O
predicting O
prostate B-Disease
cancer I-Disease
risk O
. O

We O
report O
that O
miR B-RNA
- I-RNA
1290 I-RNA
directly O
targets O
the O
NAT1 B-RNA
3 O
' O
- O
UTR O
and O
that O
NAT1 B-RNA
protein O
expression O
is O
correlated O
with O
improved O
OS O
of O
breast B-Disease
cancer I-Disease
patients O
. O

The O
stimulation O
of O
colon B-Disease
cancer I-Disease
progression O
by O
TADC O
- O
derived O
CCL5 O
was O
associated O
with O
the O
up O
- O
regulation O
of O
non O
- O
coding O
RNA O
metastasis O
- O
associated O
lung O
adenocarcinoma O
transcript O
1 O
( O
MALAT O
- O
1 O
) O
, O
which O
subsequently O
increased O
the O
expression O
of O
Snail O
. O

Stable O
knockdown O
of O
HOTAIR B-RNA
significantly O
suppressed O
tumor O
growth O
and O
sensitized O
cervical B-Disease
cancer I-Disease
to O
radiotherapy O
in O
vivo O
. O

kaplan O
- O
meier O
survival O
analysis O
showed O
that O
the O
lower O
expression O
of O
miR B-RNA
- I-RNA
125a I-RNA
- I-RNA
3p I-RNA
was O
associated O
with O
a O
poor O
prognosis O
of O
GBM B-Disease
patients O
. O

AGS O
human O
gastric B-Disease
carcinoma I-Disease
cell O
line O
showed O
an O
elevated O
level O
of O
CCAT1 B-RNA
expression O
. O

In O
glioblastoma B-Disease
we O
identified O
12 O
suitable O
lncRNAs O
, O
the O
top O
five O
are O
LUST B-RNA
( O
stability O
value O
0 O
. O
16 O
) O
, O
SNHG4 B-RNA
( O
stability O
value O
0 O
. O
19 O
) O
, O
EgoA B-RNA
( O
stability O
value O
0 O
. O
34 O
) O
, O
H19 B-RNA
upstream O
conserved O
1 O
and O
2 O
( O
stability O
value O
0 O
. O
35 O
) O
and O
EGO O
B O
( O
stability O
value O
0 O
. O
36 O
) O
. O

The O
miR B-RNA
- I-RNA
212 I-RNA
/ O
Sox4 O
interaction O
plays O
an O
important O
role O
of O
in O
the O
osteosarcoma B-Disease
progression O
. O

SOX4 O
was O
oncogenic O
in O
chondrosarcoma B-Disease
and O
negatively O
regulated O
by O
miR B-RNA
- I-RNA
30a I-RNA
in O
vitro O
. O

HOTAIR B-RNA
over O
- O
expression O
and O
PCBP1 O
down O
- O
regulation O
and O
the O
ensuing O
malignant O
phenotype O
in O
both O
cultured O
and O
xenografts O
gastric B-Disease
cancer I-Disease
cells O
. O

HOTAIR B-RNA
over O
- O
expression O
and O
PCBP1 O
down O
- O
regulation O
and O
the O
ensuing O
malignant O
phenotype O
in O
both O
cultured O
and O
xenografts O
gastric B-Disease
cancer I-Disease
cells O
. O

HOTAIR B-RNA
Long O
Noncoding O
RNA O
Promotes O
Gastric B-Disease
Cancer I-Disease
Metastasis O
through O
Suppression O
of O
Poly O
r O
( O
C O
) O
- O
Binding O
Protein O
( O
PCBP O
) O
1 O
. O

LncRNA O
MALAT1 B-RNA
expression O
was O
increased O
in O
glioma B-Disease
tissues O
compared O
with O
paired O
adjacent O
brain O
normal O
tissues O
. O

Suppression O
of O
hepatocellular B-Disease
carcinoma I-Disease
by O
baculovirus O
- O
mediated O
expression O
of O
long O
non O
- O
coding O
RNA O
PTENP1 B-RNA
and O
MicroRNA O
regulation O
. O

miR B-RNA
- I-RNA
23a I-RNA
functions O
as O
a O
tumor O
suppressor O
in O
osteosarcoma B-Disease
, O
and O
its O
inhibitory O
effect O
on O
tumor O
are O
mediated O
chiefly O
through O
downregulation O
of O
SATB1 O
. O

miR B-RNA
- I-RNA
29s I-RNA
effectively O
blocked O
DNMT3A O
and O
3B O
expression O
by O
degrading O
their O
mRNAs O
in O
U87MG O
glioblastoma O
cell O
line O
. O

Targeting O
of O
Runx2 O
by O
miR B-RNA
- I-RNA
135 I-RNA
and O
miR B-RNA
- I-RNA
203 I-RNA
Impairs O
Progression O
of O
Breast B-Disease
Cancer I-Disease
and O
Metastatic O
Bone O
Disease O
. O

expression O
of O
miR B-RNA
- I-RNA
3189 I-RNA
- I-RNA
3p I-RNA
was O
downregulated O
in O
astrocytoma B-Disease
and O
glioblastoma B-Disease
clinical O
samples O
compared O
to O
control O
brain O
tissue O
. O

beta O
- O
Elemene O
inhibits O
the O
proliferation O
of O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
by O
regulating O
long O
noncoding O
RNA O
- O
mediated O
inhibition O
of O
hTERT B-RNA
expression O
. O

MiR B-RNA
- I-RNA
204 I-RNA
, O
down O
- O
regulated O
in O
retinoblastoma B-Disease
, O
regulates O
proliferation O
and O
invasion O
of O
human O
retinoblastoma B-Disease
cells O
by O
targeting O
CyclinD2 O
and O
MMP O
- O
9 O
. O

RP4 B-RNA
- I-RNA
583P15 I-RNA
. I-RNA
10 I-RNA
, O
an O
up O
- O
regulated O
lncRNA O
, O
was O
found O
to O
be O
located O
downstream O
of O
the O
natural O
antisense O
of O
the O
ZBTB46 O
gene O
, O
which O
may O
regulated O
breast B-Disease
cancer I-Disease
through O
influence O
immune O
system O
. O

miR O
- O
26b O
inhibits O
proliferation O
, O
migration O
, O
invasion O
and O
apoptosis O
induction O
via O
the O
downregulation O
of O
6 O
- O
phosphofructo O
- O
2 O
- O
kinase O
/ O
fructose O
- O
2 O
, O
6 O
- O
bisphosphatase O
- O
3 O
driven O
glycolysis O
in O
osteosarcoma B-Disease
cells O
. O

ASLNC04080 B-RNA
was O
the O
most O
significantly O
upregulated O
lncRNA O
in O
microarray O
data O
, O
highly O
expressed O
in O
22 O
out O
of O
24 O
endometrial B-Disease
carcinoma I-Disease
tissues O
and O
HEC O
- O
1 O
- O
B O
cell O
line O
. O

DRAIC B-RNA
expression O
predicts O
good O
prognosis O
in O
a O
wide O
range O
of O
malignancies O
, O
including O
bladder B-Disease
cancer I-Disease
, O
low O
- O
grade O
gliomas B-Disease
, O
lung B-Disease
adenocarcinoma I-Disease
, O
stomach B-Disease
adenocarcinoma I-Disease
, O
renal B-Disease
clear I-Disease
cell I-Disease
carcinoma I-Disease
, O
hepatocellular B-Disease
carcinoma I-Disease
, O
skin B-Disease
melanoma I-Disease
, O
and O
stomach B-Disease
adenocarcinoma I-Disease
. O

Moreover O
, O
we O
demonstrate O
that O
loss O
of O
imprinting O
at O
the O
chromosome O
12qF1 O
region O
is O
associated O
with O
miRNA O
overexpression O
in O
human O
hepatocellular B-Disease
carcinoma I-Disease
and O
stem O
cells O
, O
suggesting O
initiation O
of O
precancerous O
changes O
in O
young O
mice O
deficient O
in O
miR B-RNA
- I-RNA
122 I-RNA
. O

miR B-RNA
- I-RNA
137 I-RNA
and O
miR B-RNA
- I-RNA
197 I-RNA
Induce O
Apoptosis O
and O
Suppress O
Tumorigenicity O
by O
Targeting O
MCL O
- O
1 O
in O
Multiple B-Disease
Myeloma I-Disease
. O

TINCR B-RNA
is O
strongly O
upregulated O
in O
human O
gastric B-Disease
carcinoma I-Disease
( O
GC O
) O
, O
where O
it O
was O
found O
to O
contribute O
to O
oncogenesis O
and O
cancer O
progression O
. O

HOTAIR B-RNA
was O
commonly O
overexpressed O
in O
osteosarcoma B-Disease
, O
which O
significantly O
correlated O
with O
advanced O
tumor O
stage O
, O
highly O
histological O
grade O
and O
poor O
prognosis O
. O

MicroRNA B-RNA
- I-RNA
10b I-RNA
inhibition O
reduces O
E2F1 O
- O
mediated O
transcription O
and O
miR O
- O
15 O
/ O
16 O
activity O
in O
glioblastoma B-Disease
. O

SPRY4 B-RNA
- I-RNA
IT1 I-RNA
expression O
was O
significantly O
upregulated O
in O
48 O
breast B-Disease
cancer I-Disease
tumor I-Disease
tissues O
comparedwith O
normal O
tissues O
. O

Inhibition O
of O
linc B-RNA
- I-RNA
UBC1 I-RNA
suppressed O
the O
proliferation O
, O
motility O
and O
invasion O
of O
gastric B-Disease
cancer I-Disease
cells O
. O

Our O
results O
suggest O
that O
miR B-RNA
- I-RNA
504 I-RNA
may O
be O
a O
prognostic O
predictor O
and O
be O
involved O
in O
tumorigencity O
as O
a O
tumor O
suppressor O
of O
malignant B-Disease
glioma I-Disease
. O

Expression O
levels O
of O
lncRNA O
CCAT2 B-RNA
in O
gastric B-Disease
cancer I-Disease
tissues O
were O
significantly O
higher O
than O
those O
in O
adjacent O
non O
- O
tumor O
tissues O
. O

The O
results O
showed O
that O
lncRNA O
LET B-RNA
expression O
in O
cervical B-Disease
cancer I-Disease
tissues O
was O
significantly O
down O
- O
regulated O
compared O
with O
the O
adjacent O
non O
- O
tumor O
tissues O
. O

LncRNAs O
H19 B-RNA
, O
LSINCT5 O
, O
and O
XIST B-RNA
have O
a O
close O
relationship O
to O
the O
development O
of O
ovarian B-Disease
cancer I-Disease
occurrence O
, O
growth O
, O
invasion O
, O
and O
metastasis O
, O
and O
they O
can O
promote O
ovarian B-Disease
cancer I-Disease
cell O
proliferation O
. O

Long O
non O
- O
coding O
RNA O
MALAT1 B-RNA
regulates O
hyperglycaemia O
induced O
inflammatory O
process O
in O
the O
endothelial O
cells O
. O

These O
findings O
revealed O
that O
a O
lower O
expression O
level O
of O
miR B-RNA
- I-RNA
15b I-RNA
was O
closely O
related O
to O
a O
shorter O
overall O
survival O
, O
suggesting O
that O
miR B-RNA
- I-RNA
15b I-RNA
could O
be O
an O
intrinsic O
factor O
that O
plays O
an O
important O
role O
in O
the O
malignant O
progression O
of O
gliomas B-Disease
. O

The O
level O
of O
HOTAIR B-RNA
expression O
in O
GBM B-Disease
was O
higher O
than O
in O
other O
low O
grade O
gliomas O
and O
normal O
brain O
tissues O
. O

The O
results O
indicated O
that O
the O
expression O
level O
of O
HOTAIR B-RNA
was O
higher O
in O
epithelial O
ovarian B-Disease
cancer I-Disease
tissues O
than O
the O
level O
in O
the O
benign O
ovarian O
tissues O
. O

miR B-RNA
- I-RNA
182 I-RNA
integrates O
apoptosis O
, O
growth O
, O
and O
differentiation O
programs O
in O
glioblastoma B-Disease
. O

H19 B-RNA
lncRNA O
mediates O
17beta O
- O
estradiol O
- O
induced O
cell O
proliferation O
in O
MCF O
- O
7 O
breast B-Disease
cancer I-Disease
cells O
, O
H19 B-RNA
lncRNA O
was O
much O
higher O
in O
estrogen O
receptor O
( O
ER O
) O
- O
positive O
MCF O
- O
7 O
breast B-Disease
cancer I-Disease
cells O
than O
in O
ER O
- O
negative O
MDA O
- O
MB O
- O
231 O
cells O

MiR B-RNA
- I-RNA
206 I-RNA
, O
a O
Cerebellum O
Enriched O
miRNA O
Is O
Downregulated O
in O
All O
Medulloblastoma B-Disease
Subgroups O
and O
Its O
Overexpression O
Is O
Necessary O
for O
Growth O
Inhibition O
of O
Medulloblastoma B-Disease
Cells O
. O

Finally O
, O
miR B-RNA
- I-RNA
34a I-RNA
is O
tightly O
associated O
with O
survival O
of O
patients O
with O
gastric B-Disease
cancer I-Disease
. O

HNF1A B-RNA
- I-RNA
AS1 I-RNA
was O
significantly O
up O
- O
regulated O
in O
lung B-Disease
adenocarcinoma I-Disease
tissues O
compared O
with O
corresponding O
non O
- O
tumor O
tissues O
, O
and O
its O
expression O
level O
was O
significantly O
correlated O
with O
TNM O
stage O
, O
tumor O
size O
, O
and O
lymph O
node O
metastasis O
. O

Our O
qPCR O
results O
showed O
that O
high O
LINC00472 B-RNA
expression O
was O
associated O
with O
less O
aggressive O
breast B-Disease
tumors I-Disease
and O
more O
favorable O
disease O
outcomes O
. O

Patients O
with O
high O
expression O
of O
LINC00472 B-RNA
had O
significantly O
reduced O
risk O
of O
relapse O
and O
death O
compared O
to O
those O
with O
low O
expression O
. O

Cell O
culture O
experiments O
showed O
that O
up O
- O
regulation O
of O
LINC00472 B-RNA
expression O
could O
suppress O
breast O
cancer O
cell O
proliferation O
and O
migration O
. O

Elevated O
expression O
of O
UCA1 B-RNA
RNA O
was O
identified O
in O
ovarian B-Disease
cancer I-Disease
tissues O
compared O
with O
normal O
tissues O
. O

Hypoxia O
- O
induced O
miR B-RNA
- I-RNA
181b I-RNA
enhances O
angiogenesis O
of O
retinoblastoma B-Disease
cells O
by O
targeting O
PDCD10 O
and O
GATA6 O
. O

Reduced O
- O
expression O
of O
miR B-RNA
- I-RNA
454 I-RNA
in O
osteosarcoma B-Disease
cells O
promoted O
tumour O
growth O
by O
targeting O
c O
- O
Met O
, O
thus O
miR B-RNA
- I-RNA
454 I-RNA
may O
be O
a O
potential O
therapy O
target O
for O
this O
tumour O
. O

MiR O
- O
221 O
/ O
222 O
overexpression O
significantly O
promoted O
pancreatic B-Disease
cancer I-Disease
cell O
proliferation O
and O
invasion O
while O
inhibiting O
apoptosis O
. O

Long O
noncoding O
RNA O
PVT1 B-RNA
indicates O
a O
poor O
prognosis O
of O
gastric B-Disease
cancer I-Disease
and O
promotes O
cell O
proliferation O
through O
epigenetically O
regulating O
p15 O
and O
p16 O
. O

a O
significant O
association O
between O
the O
rs57095329 O
SNP O
of O
the O
miR B-RNA
- I-RNA
146a I-RNA
gene O
and O
the O
risk O
of O
drug O
resistant O
epilepsy O
( O
DRE O
) O
( O
genotypes O
, O
p O
= O
0 O
. O
258 O
and O
alleles O
, O
p O
= O
0 O
. O
108 O
) O
. O
Moreover O
, O
the O
rs57095329 O
A O
allele O
was O
found O
to O
be O
associated O
with O
a O
reduced O
risk O
of O
seizures B-Disease
frequency O
in O
DRE O
patients O
( O
all O
p O
< O
0 O
. O
1 O
) O
. O

These O
results O
demonstrated O
that O
baicalein O
probably O
somehow O
promoted O
the O
BANCR B-RNA
expression O
which O
negatively O
regulated O
Wnt O
signaling O
transduction O
, O
thus O
suppressing O
the O
viability O
of O
osteosarcoma B-Disease
MG O
- O
63 O
cells O
. O

In O
our O
results O
, O
lncRNA O
BANCR B-RNA
is O
overexpressed O
in O
retinoblastoma B-Disease
tissues O
and O
cell O
lineand O
is O
associated O
with O
tumor O
size O
, O
choroidal O
invasion O
, O
and O
optic O
nerve O
invasion O
. O

Infiltrating O
mast O
cells O
enhance O
prostate B-Disease
cancer I-Disease
invasion O
via O
altering O
LncRNA O
- O
HOTAIR B-RNA
/ O
PRC2 O
- O
androgen O
receptor O
( O
AR O
) O
- O
MMP9 O
signals O
and O
increased O
stem O
/ O
progenitor O
cell O
population O
. O

ZXF2 B-RNA
was O
overexpressed O
in O
lung B-Disease
adenocarcinoma I-Disease
tissues O
and O
the O
high O
expression O
of O
ZXF B-RNA
was O
closely O
related O
to O
tumor O
progression O
through O
c O
- O
Myc O
related O
pathway O
. O

Long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
promotes O
tumor O
cell O
invasion O
and O
metastasis O
by O
recruiting O
EZH2 O
and O
repressing O
E O
- O
cadherin O
in O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

Results O
showed O
that O
UCA1 B-RNA
expression O
was O
remarkably O
increased O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
compared O
with O
that O
in O
the O
normal O
control O
. O

UCA1 B-RNA
expression O
was O
remarkably O
increased O
in O
gastric O
tissues O
and O
cell O
linecompared O
with O
that O
in O
the O
normal O
control O
, O
high O
UCA1 B-RNA
expression O
correlated O
with O
worse O
differentiation O
, O
tumor O
size O
, O
invasion O
depth O
and O
TNM O
stage O
in O
gastric B-Disease
cancer I-Disease
, O
increased O
UCA1 B-RNA
expression O
contributed O
to O
poor O
overall O
survival O
and O
disease O
- O
free O
survival O
of O
patients O
. O

LINC01133 B-RNA
is O
upregulated O
in O
lung O
squamous O
cell O
cancer O
and O
predicts O
survival O

HOTTIP O
is O
expressed O
in O
pancreatic B-Disease
cancer I-Disease
cell O
lineand O
knockdown O
of O
HOTTIP O
by O
RNA O
interference O
( O
siHOTTIP O
) O
in O
Panc1 O
pancreatic B-Disease
cancer I-Disease
cells O
decreased O
proliferation O
, O
induced O
apoptosis O
and O
decreased O
migration O
. O

In O
this O
study O
, O
we O
found O
that O
cervical O
carcinoma O
high O
- O
expressed O
lncRNA O
1 O
( O
lncRNA O
- O
CCHE1 B-RNA
) O
was O
significantly O
upregulated O
in O
cervical O
cancer O
tissues O
. O

Our O
results O
showed O
that O
GAS5 B-RNA
was O
significantly O
downregulated O
in O
lung B-Disease
adenocarcinoma I-Disease
tissues O
compared O
with O
the O
paired O
adjacent O
non O
- O
tumorous O
tissue O
samples O
. O

we O
found O
that O
HOTAIR B-RNA
was O
increased O
in O
the O
peripheral O
blood O
mononuclear O
cells O
and O
cancer O
tissues O
from O
breast B-Disease
cancer I-Disease
patients O
, O
and O
was O
especially O
higher O
in O
patients O
with O
metastatic O
breast B-Disease
cancer I-Disease
. O

In O
this O
study O
, O
we O
show O
that O
BANCR B-RNA
expression O
was O
significantly O
down O
- O
regulated O
in O
colorectal B-Disease
cancer I-Disease
tissues O
compared O
with O
normal O
tissues O
, O
and O
overexpression O
of O
BANCR B-RNA
suppressed O
colorectal B-Disease
cancer I-Disease
cell O
growth O
in O
vitro O
and O
in O
vivo O
. O

We O
found O
that O
CCDC26 B-RNA
transcripts O
were O
abundant O
in O
the O
nuclear O
fraction O
of O
K562 O
human O
myeloid B-Disease
leukemia I-Disease
cells O
. O

Long O
noncoding O
RNA O
, O
CCDC26 B-RNA
, O
controls O
myeloid B-Disease
leukemia I-Disease
cell O
growth O
through O
regulation O
of O
KIT O
expression O
. O

In O
this O
study O
, O
we O
found O
that O
PCAT B-RNA
- I-RNA
1 I-RNA
was O
up O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
compared O
to O
paired O
normal O
urothelium O
. O
PCAT B-RNA
- I-RNA
1 I-RNA
plays O
oncogenic O
roles O
. O

Downregulation O
of O
miR B-RNA
- I-RNA
22 I-RNA
acts O
as O
an O
unfavorable O
prognostic O
biomarker O
in O
osteosarcoma B-Disease
. O

Overexpression O
of O
long O
non O
- O
coding O
RNA O
PVT1 B-RNA
in O
gastric B-Disease
cancer I-Disease
cells O
promotes O
the O
development O
of O
multidrug O
resistance O
. O

LncRNA O
GAS5 B-RNA
down O
- O
regulation O
reduced O
the O
YBX1 O
protein O
level O
, O
which O
decreased O
YBX1 O
- O
transactivated O
p21 O
expression O
and O
abolished O
G1 O
phase O
cell O
cycle O
arrest O
in O
stomach B-Disease
cancer I-Disease
. O

These O
findings O
indicate O
that O
miR B-RNA
- I-RNA
217 I-RNA
may O
act O
as O
a O
tumor O
suppressor O
in O
osteosarcoma B-Disease
and O
would O
serve O
as O
a O
novel O
therapeutic O
agent O
for O
miRNA O
- O
based O
therapy O
. O

miR B-RNA
- I-RNA
20a I-RNA
mediates O
temozolomide O
- O
resistance O
in O
glioblastoma B-Disease
cells O
via O
negatively O
regulating O
LRIG1 B-RNA
expression O
. O

miR B-RNA
- I-RNA
27a I-RNA
expression O
may O
be O
elevated O
in O
sera O
of O
osteosarcoma B-Disease
patients O
and O
in O
turn O
contributes O
to O
aggressive O
progression O
of O
this O
malignancy O
. O

MiR B-RNA
- I-RNA
144 I-RNA
Inhibits O
Uveal B-Disease
Melanoma I-Disease
Cell O
Proliferation O
and O
Invasion O
by O
Regulating O
c O
- O
Met O
Expression O
. O

The O
expression O
level O
of O
ANRIL B-RNA
was O
increased O
up O
to O
13 O
. O
6 O
- O
fold O
by O
PLD O
inhibition O
in O
H460 O
human O
lung B-Disease
cancer I-Disease
cells O
. O

To O
further O
validate O
whether O
the O
reported O
HOTAIR B-RNA
has O
potential O
role O
in O
predict O
the O
prognosis O
in O
patients O
with O
digestive O
system O
cancer O
, O
we O
conducted O
an O
independent O
validation O
set O
including O
71 O
gastric B-Disease
cancer I-Disease
cases O
by O
the O
method O
of O
qRT O
- O
PCR O
. O

The O
expression O
level O
of O
AI364715 B-RNA
in O
gastric B-Disease
cancer I-Disease
tissues O
was O
downregulated O
. O

These O
findings O
uncover O
a O
plausible O
mechanism O
for O
NF O
- O
 O
B O
- O
sustained O
TGF O
- O
 O
/ O
Smad O
activation O
via O
miR B-RNA
- I-RNA
148a I-RNA
in O
glioblastoma B-Disease
, O
and O
may O
suggest O
a O
new O
target O
for O
clinical O
intervention O
in O
human O
cancer O
. O

Down O
- O
expression O
of O
miR B-RNA
- I-RNA
182 I-RNA
in O
osteosarcoma B-Disease
promoted O
tumor O
growth O
, O
migration O
and O
invasion O
by O
targeting O
TIAM1 O
. O

Sulforaphane O
enhances O
temozolomide O
- O
induced O
apoptosis O
because O
of O
down O
- O
regulation O
of O
miR B-RNA
- I-RNA
21 I-RNA
via O
Wnt O
/ O
 O
- O
catenin O
signaling O
in O
glioblastoma B-Disease
. O

We O
identified O
colorectal B-Disease
cancer I-Disease
- O
associated O
lncRNA O
( O
CCAL B-RNA
) O
as O
a O
key O
regulator O
of O
CRC O
progression O
. O

Expression O
profiles O
of O
five O
lnc O
- O
RNAs O
( O
MEG3 O
, O
HULC O
, O
HOTAIR O
, O
NEAT1 B-RNA
, O
and O
MALAT O
- O
1 O
) O
previously O
shown O
to O
be O
involved O
in O
cancer O
metastasis O
were O
detected O
by O
qPCR O
in O
5 O
pairs O
of O
papillary B-Disease
thyroid I-Disease
cancer I-Disease
and O
11 O
matched O
lymph O
node O
metastatic O
tissues O
. O

miRNA B-RNA
- I-RNA
449a I-RNA
is O
downregulated O
in O
osteosarcoma B-Disease
and O
promotes O
cell O
apoptosis O
by O
targeting O
BCL2 O
. O

Up O
- O
Regulation O
of O
MiR B-RNA
- I-RNA
300 I-RNA
Promotes O
Proliferation O
and O
Invasion O
of O
Osteosarcoma B-Disease
by O
Targeting O
BRD7 O
. O

LncRNA O
BCAR4 B-RNA
wires O
up O
signaling O
transduction O
in O
breast B-Disease
cancer I-Disease

In O
clinical O
specimens O
, O
CASC15 B-RNA
levels O
increased O
during O
melanoma B-Disease
progression O
and O
were O
independent O
predictors O
of O
disease O
recurrence O
in O
a O
cohort O
of O
141 O
patients O
with O
AJCC O
( O
American O
Joint O
Committee O
on O
Cancer O
) O
stage O
III O
lymph O
node O
metastasis O
. O

In O
the O
present O
study O
, O
we O
demonstrated O
that O
HULC B-RNA
was O
significantly O
up O
- O
regulated O
in O
osteosarcoma B-Disease
tissues O
and O
cell O
linecompared O
with O
normal O
controls O
, O
and O
over O
- O
expression O
of O
HULC B-RNA
was O
correlated O
with O
clinical O
stage O
and O
distant O
metastasis O
. O

Expression O
of O
long O
non O
- O
coding O
RNA O
DLX6 B-RNA
- I-RNA
AS1 I-RNA
in O
lung B-Disease
adenocarcinoma I-Disease
. O

In O
our O
results O
, O
the O
expression O
of O
BANCR B-RNA
was O
increased O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
paired O
adjacent O
normal O
tissues O
. O

Amplification O
of O
Long O
Noncoding O
RNA O
ZFAS1 B-RNA
Promotes O
Metastasis O
in O
Hepatocellular B-Disease
Carcinoma I-Disease
. O

LncRNA O
TUG1 B-RNA
( O
taurine O
upregulated O
gene O
1 O
) O
was O
highly O
expressed O
in O
glioma B-Disease
vascular O
endothelial O
cells O
from O
glioma B-Disease
tissues O
. O

H19 B-RNA
lncRNA O
alters O
stromal O
cell O
growth O
via O
IGF O
signaling O
in O
the O
endometrium O
of O
women O
with O
endometriosis B-Disease
. O

The O
Long O
Noncoding O
RNA O
MEG3 B-RNA
Is O
Downregulated O
and O
Inversely O
Associated O
with O
VEGF B-RNA
Levels O
in O
Osteoarthritis O
. O
The O
results O
show O
that O
human O
MEG3 B-RNA
is O
significantly O
downregulated O
in O
OA B-Disease
patients O
compared O
to O
normal O
cartilage O
samples O
. O

Conclusively O
, O
our O
preliminary O
findings O
indicate O
that O
serum O
miR B-RNA
- I-RNA
145 I-RNA
upregulated O
in O
acute O
ischemic O
stroke O
might O
be O
a O
new O
biomarker O
for O
acute B-Disease
ischemia I-Disease
stroke O
evaluation O
. O

In O
this O
study O
, O
we O
report O
that O
HOTAIR B-RNA
may O
function O
as O
a O
ceRNA O
to O
regulate O
the O
expression O
of O
MAPK1 O
through O
competition O
for O
miR B-RNA
- I-RNA
1 I-RNA
, O
miR B-RNA
- I-RNA
214 I-RNA
- I-RNA
3p I-RNA
, O
or O
miR B-RNA
- I-RNA
330 I-RNA
- I-RNA
5p I-RNA
in O
ovarian O
SKOV3 O
cells O
, O
providing O
a O
new O
insight O
in O
the O
treatment O
of O
ovarian B-Disease
cancer I-Disease
. O

Knockdown O
of O
long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
inhibits O
cisplatin O
resistance O
of O
gastric B-Disease
cancer I-Disease
cells O
through O
inhibiting O
the O
PI3K O
/ O
Akt O
and O
Wnt O
/ O
beta O
- O
catenin O
signaling O
pathways O
by O
up O
- O
regulating O
miR O
- O
34a O
; O
HOTAIR B-RNA
directly O
bound O
to O
miR O
- O
34a O
. O

The O
expression O
levels O
of O
lncRNA O
- O
AK058003 O
were O
increased O
significantly O
in O
the O
breast B-Disease
cancer I-Disease
tissues O
and O
were O
found O
to O
strongly O
correlate O
with O
the O
severity O
of O
the O
breast B-Disease
cancer I-Disease
clinical O
stage O
. O

The O
expression O
of O
MALAT1 B-RNA
in O
the O
whole O
blood O
of O
lung B-Disease
cancer I-Disease
patients O
with O
metastasis O
was O
stronger O
compared O
to O
non O
- O
metastasis O
, O
which O
showed O
that O
MALAT1 B-RNA
promotes O
the O
tumor O
metastasis O
and O
additionally O
, O
the O
whole O
blood O
with O
lymph O
node O
metastasis O
represented O
a O
lower O
expression O
of O
MALAT1 B-RNA
compared O
to O
bone O
or O
brain O
metastasis O
. O

The O
variant O
genotype O
of O
AC008392 B-RNA
. I-RNA
1 I-RNA
SNP O
rs7248320 O
was O
significantly O
associated O
with O
increased O
risk O
of O
HCC B-Disease
and O
cervical B-Disease
cancer I-Disease
. O

Long O
noncoding O
RNA O
derived O
from O
CD244 B-RNA
signaling O
epigenetically O
controls O
CD8 O
+ O
T O
- O
cell O
immune O
responses O
in O
tuberculosis O
infection O
. O

Consistently O
, O
TGF B-RNA
 I-RNA
1 I-RNA
mRNA O
expression O
is O
positively O
correlated O
with O
ZEB2NAT B-RNA
transcript O
and O
ZEB2 O
protein O
levels O
in O
human O
bladder B-Disease
cancer I-Disease
specimens O
. O

The O
Interaction O
Between O
MiR B-RNA
- I-RNA
141 I-RNA
and O
lncRNA O
- O
H19 B-RNA
in O
Regulating O
Cell O
Proliferation O
and O
Migration O
in O
Gastric B-Disease
Cancer I-Disease
. O

miR B-RNA
- I-RNA
21 I-RNA
is O
an O
oncogenic O
microRNA O
( O
miRNA O
) O
with O
an O
emerging O
role O
as O
therapeutic O
target O
in O
human O
malignancies O
, O
including O
multiple B-Disease
myeloma I-Disease
( O
MM O
) O

The O
detected O
lncRNA O
- O
UCA1 B-RNA
level O
was O
significantly O
lower O
in O
healthy O
donors O
and O
benign O
groups O
compared O
to O
bladder B-Disease
cancer I-Disease
samples O
. O

YAP1 B-RNA
and O
H19 B-RNA
expression O
levels O
were O
markedly O
elevated O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cells O
, O
and O
H19 B-RNA
expression O
was O
found O
to O
be O
significantly O
associated O
with O
YAP1 B-RNA
expression O
. O

The O
YAP1 B-RNA
oncogene O
contributes O
to O
bladder B-Disease
cancer I-Disease
cell O
proliferation O
and O
migration O
by O
regulating O
the O
H19 B-RNA
long O
noncoding O
RNA O
. O

The O
results O
demonstrated O
that O
RP11 B-RNA
- I-RNA
119F7 I-RNA
. I-RNA
4 I-RNA
expression O
was O
significantly O
downregulated O
in O
the O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
the O
matched O
NATs O
( O
P O
< O
0 O
. O
1 O
) O
and O
was O
significantly O
associated O
with O
the O
macroscopic O
type O
( O
P O
= O
0 O
. O
41 O
) O
and O
Lauren O
grade O
( O
P O
= O
0 O
. O
20 O
) O
. O

HOTAIR B-RNA
level O
was O
significantly O
higher O
in O
human O
hepatocarocinoma B-Disease
tissues O
and O
play O
tumorigenesis O
roles O
by O
downregulating O
SETD2 B-RNA
in O
liver O
cancer O
stem O
cells O
. O

HOTAIR B-RNA
may O
also O
mediate O
changes O
at O
an O
epigenetic O
level O
to O
affect O
gene O
expression O
and O
contribute O
to O
tumor O
aetiology O
. O

In O
summary O
, O
the O
results O
showed O
that O
COL O
and O
ITG O
genes O
, O
PIK3CG O
, O
PIK3R5 O
, O
IL7 O
and O
lncRNA O
TCONS O
- O
68220 O
may O
play O
a O
role O
in O
gastric B-Disease
cancer I-Disease
. O

LINC00313 B-RNA
could O
be O
a O
biomarker O
for O
lung B-Disease
cancer I-Disease

We O
also O
confirmed O
that O
miR B-RNA
- I-RNA
203 I-RNA
and O
oncogene O
ADAM9 O
( O
a O
disintegrin O
and O
metalloproteinase O
9 O
) O
/ O
oncogenic O
long O
non O
- O
coding O
RNA O
HULC B-RNA
( O
highly O
up O
- O
regulated O
in O
liver O
cancer O
) O
were O
inversely O
expressed O
in O
hepatocellular B-Disease
carcinoma I-Disease
( O
HCC O
) O
tissues O
or O
cell O
lines O
. O

Quantitative O
RT O
- O
PCR O
demonstrated O
that O
HOTAIR B-RNA
expression O
was O
up O
- O
regulated O
in O
glioma B-Disease
tissues O
and O
cell O
lines O
. O

Direct O
transfection O
of O
miR B-RNA
- I-RNA
137 I-RNA
mimics O
is O
more O
effective O
than O
DNA O
demethylation O
of O
miR B-RNA
- I-RNA
137 I-RNA
promoter O
to O
augment O
anti O
- O
tumor O
mechanisms O
of O
delphinidin O
in O
human O
glioblastoma B-Disease
U87MG O
and O
LN18 O
cells O
. O

Long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
promotes O
HLA O
- O
G O
expression O
via O
inhibiting O
miR B-RNA
- I-RNA
152 I-RNA
in O
gastric B-Disease
cancer I-Disease
cells O
. O

We O
found O
that O
MALAT1 B-RNA
was O
downregulated O
in O
breast B-Disease
tumor I-Disease
cell O
lineand O
cancer O
tissue O
, O
and O
showed O
that O
knockdown O
of O
MALAT1 B-RNA
in O
breast O
cancer O
cell O
lineinduced O
an O
epithelial O
- O
to O
- O
mesenchymal O
transition O
( O
EMT O
) O
program O
via O
phosphatidylinositide O
- O
3 O
kinase O
- O
AKT O
pathways O
. O

The O
results O
indicated O
that O
the O
expression O
of O
CCAT1 B-RNA
was O
significantly O
increased O
in O
HCC B-Disease
tissues O
and O
cells O
compared O
with O
controls O
. O

We O
found O
for O
the O
first O
time O
that O
the O
lncRNA O
ZMAT1 B-RNA
transcript I-RNA
variant I-RNA
2 I-RNA
is O
downregulated O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
adjacent O
normal O
tissues O
. O

We O
found O
that O
miR B-RNA
- I-RNA
675 I-RNA
expression O
levels O
were O
remarkably O
increased O
in O
bladder O
cancer O
tissues O
as O
compared O
with O
adjacent O
noncancerous O
tissues O
or O
normal O
bladder O
tissue O
from O
health O
donors O
; O
moreover O
, O
enhanced O
miR B-RNA
- I-RNA
675 I-RNA
expression O
was O
also O
observed O
in O
bladder O
cancer O
cell O
lines O
. O

Taken O
together O
, O
our O
results O
suggest O
that O
miR B-RNA
- I-RNA
497 I-RNA
modulates O
the O
sensitivity O
to O
cisplatin O
at O
least O
in O
part O
through O
PI3K O
/ O
Akt O
pathway O
in O
osteosarcoma B-Disease
cells O
. O

We O
found O
the O
human O
ortholog O
of O
TUNA O
, O
linc00617 O
, O
was O
upregulated O
in O
breast B-Disease
cancer I-Disease
samples O
. O

Serum O
miR B-RNA
- I-RNA
126 I-RNA
, O
but O
not O
miR O
- O
146a O
, O
miR O
- O
let O
- O
7a O
or O
miR O
- O
26a O
, O
levels O
were O
significantly O
correlated O
with O
relative O
perihematomal B-Disease
edema I-Disease
( O
PHE O
) O
volume O
on O
days O
3 O
- O
4 O
( O
r O
= O
- O
0 O
. O
714 O
P O
< O
0 O
. O
1 O
) O
in O
patients O
with O
ICH O
. O

miR B-RNA
- I-RNA
25 I-RNA
promotes O
glioblastoma B-Disease
cell O
proliferation O
and O
invasion O
by O
directly O
targeting O
NEFL O
. O

In O
summary O
, O
we O
show O
that O
the O
10q O
- O
located O
miRNAs O
miR B-RNA
- I-RNA
107 I-RNA
, O
miR B-RNA
- I-RNA
146b I-RNA
- I-RNA
5p I-RNA
, O
miR B-RNA
- I-RNA
346 I-RNA
and O
miR B-RNA
- I-RNA
1287 I-RNA
- I-RNA
5p I-RNA
are O
frequently O
down O
- O
regulated O
in O
malignant B-Disease
gliomas I-Disease
and O
thereby O
may O
support O
overexpression O
of O
important O
glioma O
growth O
- O
promoting O
genes O
. O

we O
identified O
four O
miRNAs O
( O
miR B-RNA
- I-RNA
107 I-RNA
, O
miR B-RNA
- I-RNA
146b I-RNA
- I-RNA
5p I-RNA
, O
miR B-RNA
- I-RNA
346 I-RNA
, O
miR B-RNA
- I-RNA
1287 I-RNA
- I-RNA
5p I-RNA
) O
whose O
expression O
was O
frequently O
down O
- O
regulated O
in O
anaplastic O
astrocytomas O
and O
/ O
or O
glioblastomas B-Disease
. O

Long O
non O
- O
coding O
RNA O
MEG3 B-RNA
induces O
renal B-Disease
cell I-Disease
carcinoma I-Disease
cells O
apoptosis O
by O
activating O
the O
mitochondrial O
pathway O
. O

We O
found O
that O
CRNDE B-RNA
expression O
was O
up O
- O
regulated O
while O
miR B-RNA
- I-RNA
186 I-RNA
expression O
was O
down O
- O
regulated O
in O
GSCs B-Disease
. O

MiR B-RNA
- I-RNA
141 I-RNA
Inhibits O
Gastric B-Disease
Cancer I-Disease
Proliferation O
by O
Interacting O
with O
Long O
Noncoding O
RNA O
MEG3 B-RNA
and O
Down O
- O
Regulating O
E2F3 B-RNA
Expression O
. O

SPRY4 B-RNA
- I-RNA
IT1 I-RNA
expression O
is O
decreased O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
associated O
with O
larger O
tumor O
size O
, O
advanced O
pathological O
stage O
, O
deeper O
depth O
of O
invasion O
and O
lymphatic O
metastasis O
. O

Upregulation O
of O
miR B-RNA
- I-RNA
130b I-RNA
enhances O
stem O
cell O
- O
like O
phenotype O
in O
glioblastoma B-Disease
by O
inactivating O
the O
Hippo O
signaling O
pathway O
. O

Findings O
of O
this O
study O
confirmed O
higher O
MALAT1 B-RNA
expression O
in O
HR O
- O
HPV O
( O
+ O
) O
cervical B-Disease
cancer I-Disease
. O

We O
suggested O
that O
NEAT1 B-RNA
was O
upregulated O
in O
glioma B-Disease
tissues O
than O
noncancerous O
brain O
tissues O
. O

In O
this O
study O
, O
we O
found O
that O
lncRNA O
- O
LET B-RNA
was O
significantly O
downregulated O
in O
nasopharyngeal B-Disease
carcinoma I-Disease
( O
NPC O
) O
tissues O
compared O
with O
corresponding O
normal O
tissues O
. O

AFAP1 B-RNA
- I-RNA
AS1 I-RNA
was O
the O
most O
significantly O
upregulated O
in O
lung B-Disease
cancer I-Disease
and O
associated O
with O
poor O
prognosis O
. O

Basal B-RNA
expression O
of O
primary O
and O
mature O
forms O
of O
miR B-RNA
- I-RNA
367 I-RNA
were O
detected O
in O
four O
human O
medulloblastoma B-Disease
cell O
lines O
and O
expression O
of O
the O
latter O
was O
found O
to O
be O
upregulated O
upon O
enforced O
expression O
of O
OCT4A O
. O

miR B-RNA
- I-RNA
144 I-RNA
- I-RNA
3p I-RNA
level O
was O
significantly O
down O
- O
regulated O
in O
glioma B-Disease
compared O
with O
the O
non O
- O
neoplastic O
brain O
tissues O
, O
and O
decreased O
with O
ascending O
grades O
. O

Long O
non O
- O
coding O
RNA O
MEG3 B-RNA
functions O
as O
a O
competing O
endogenous O
RNA O
to O
regulate O
gastric B-Disease
cancer I-Disease
progression O
. O

MiR B-RNA
- I-RNA
145 I-RNA
functions O
as O
a O
tumor O
suppressor O
targeting O
NUAK1 O
in O
human O
intrahepatic B-Disease
cholangiocarcinoma I-Disease
. O

LncRNA O
- O
AP001631 B-RNA
. I-RNA
9 I-RNA
promotes O
cell O
migration O
in O
gastric B-Disease
cancer I-Disease
. O

MiRNA B-RNA
- I-RNA
15a I-RNA
inhibits O
proliferation O
, O
migration O
and O
invasion O
by O
targeting O
TNFAIP1 O
in O
human O
osteosarcoma B-Disease
cells O
. O

These O
findings O
suggest O
that O
miR O
- O
218 O
inhibits O
MDR O
of O
gastric B-Disease
cancer I-Disease
cells O
by O
down O
- O
regulating O
SMO B-RNA
expression O
. O

Increased O
Expression O
of O
miR B-RNA
- I-RNA
21 I-RNA
Predicts O
Poor O
Prognosis O
in O
Patients O
With O
Hepatocellular B-Disease
Carcinoma I-Disease

The O
effects O
of O
H19 B-RNA
overexpression O
on O
glioblastoma B-Disease
cell O
invasion O
and O
angiogenesis O
were O
detected O
by O
in O
vitro O
Matrigel O
invasion O
and O
endothelial O
tube O
formation O
assay O
. O

The O
effects O
of O
up O
- O
regulation O
of O
miR O
- O
1 O
were O
similar O
to O
that O
of O
silencing O
K O
- O
RAS O
and O
MALAT1 B-RNA
in O
breast B-Disease
cancer I-Disease
cells O

This O
study O
provides O
new O
insights O
into O
miRNA B-RNA
- I-RNA
202 I-RNA
in O
osteosarcoma B-Disease
as O
a O
potential O
molecular O
target O
for O
chemotherapy O
. O

GAS5 B-RNA
Inhibits O
Gastric B-Disease
Cancer I-Disease
Cell O
Proliferation O
Partly O
by O
Modulating O
CDK6 O
. O

The O
results O
showed O
that O
ABHD11 B-RNA
- I-RNA
AS1 I-RNA
levels O
in O
gastric B-Disease
cancer I-Disease
tissues O
were O
significantly O
higher O
than O
those O
in O
other O
tissues O
. O

Our O
data O
revealed O
that O
ectopic O
expression O
of O
PTEN O
restored O
the O
effects O
of O
miR B-RNA
- I-RNA
454 I-RNA
on O
cell O
proliferation O
and O
invasion O
in O
uveal B-Disease
melanoma I-Disease
cells O
. O

Analyses O
of O
online O
microRNA O
data O
base O
revealed O
that O
expression O
level O
of O
three O
microRNAs O
, O
microRNA O
- O
24 O
( O
miR B-RNA
- I-RNA
24 I-RNA
) O
, O
microRNA O
- O
320a O
( O
miR B-RNA
- I-RNA
320a I-RNA
) O
, O
and O
microRNA O
- O
423 O
- O
5p O
( O
miR B-RNA
- I-RNA
423 I-RNA
- I-RNA
5p I-RNA
) O
were O
down O
- O
regulated O
in O
colorectal B-Disease
cancer I-Disease
( O
CRC O
) O
. O

We O
demonstrated O
that O
lincRNA B-RNA
- I-RNA
p21 I-RNA
acted O
as O
a O
tumor O
suppressive O
lncRNA O
in O
human O
hepatocellular B-Disease
carcinoma I-Disease
. O

DACOR1 B-RNA
shows O
high O
, O
tissue O
- O
specific O
expression O
in O
the O
normal O
colon O
but O
was O
repressed O
in O
a O
panel O
of O
colon B-Disease
tumors I-Disease
and O
patient O
- O
derived O
colon O
cancer O
cell O
lines O
. O

Results O
showed O
that O
NEAT1 B-RNA
expression O
in O
colorectal B-Disease
cancer I-Disease
was O
up O
- O
regulated O
in O
72 O
. O
0 O
% O
( O
172 O
/ O
239 O
) O
cases O
compared O
with O
corresponding O
normal O
counterparts O
, O
and O
related O
to O
tumor O
differentiation O
, O
invasion O
, O
metastasis O
and O
TNM O
stage O
. O

Relative O
high O
BCAR4 B-RNA
mRNA O
expression O
was O
identified O
in O
IPH O
- O
926 O
, O
a O
cell O
line O
derived O
from O
an O
endocrine O
- O
resistant O
lobular O
breast B-Disease
cancer I-Disease
. O

In O
the O
present O
study O
, O
we O
confirmed O
that O
TUG1 B-RNA
was O
overexpressed O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
established O
cell O
lines O
. O

The O
expression O
of O
BANCR B-RNA
was O
significantly O
up O
- O
regulated O
while O
PTCSC3 B-RNA
and O
NAMA B-RNA
were O
significantly O
down O
- O
regulated O
in O
papillary O
thyroid O
carcinoma O
( O
PTC O
) O
compared O
to O
that O
in O
normal O
tissue O
. O

Expression O
quantitative O
trait O
loci O
in O
long O
non O
- O
coding O
RNA O
ZNRD1 O
- O
AS1 O
influence O
cervical B-Disease
cancer I-Disease
development O
. O

LncRNA O
NALT O
interaction O
with O
NOTCH1 O
promoted O
cell O
proliferation O
in O
pediatric O
T O
cell O
acute O
lymphoblastic O
leukemia O
. O

LncRNA O
NALT B-RNA
interaction O
with O
NOTCH1 O
promoted O
cell O
proliferation O
in O
pediatric O
T O
cell O
acute O
lymphoblastic O
leukemia O
. O

Therefore O
, O
we O
assessed O
the O
functional O
consequences O
of O
GAS5 B-RNA
by O
designing O
short O
interfering O
RNAs O
( O
siRNAs O
) O
in O
lung B-Disease
adenocarcinoma I-Disease
. O

Long O
non O
- O
coding O
RNA O
TUG1 B-RNA
is O
up O
- O
regulated O
in O
hepatocellular B-Disease
carcinoma I-Disease
and O
promotes O
cell O
growth O
and O
apoptosis O
by O
epigenetically O
silencing O
of O
KLF2 O
. O

These O
findings O
provide O
evidence O
that O
miR B-RNA
- I-RNA
539 I-RNA
plays O
a O
key O
role O
in O
inhibiting O
osteosarcoma B-Disease
cell O
invasion O
and O
migration O
and O
can O
regulating O
MMP8 O
expression O
in O
osteosarcoma B-Disease
cells O
. O

In O
conclusion O
, O
miR B-RNA
- I-RNA
132 I-RNA
inhibited O
cell O
growth O
and O
metastasis O
in O
osteosarcoma B-Disease
cells O
by O
downregulation O
of O
Sox4 O
, O
and O
knockdown O
of O
Sox4 O
was O
essential O
for O
the O
miR B-RNA
- I-RNA
132 I-RNA
- O
inhibited O
cell O
growth O
and O
metastasis O
in O
osteosarcoma B-Disease
cells O
. O

We O
showed O
that O
overexpression O
of O
H19 B-RNA
/ I-RNA
miR I-RNA
- I-RNA
675 I-RNA
enhanced O
the O
aggressive O
phenotype O
of O
breast B-Disease
cancer I-Disease
cells O
including O
increased O
cell O
proliferation O
and O
migration O
in O
vitro O
, O
and O
increased O
tumor O
growth O
and O
metastasis O
in O
vivo O
. O

In O
this O
study O
, O
we O
report O
that O
HOTAIR B-RNA
( O
HOX O
antisense O
intergenic O
RNA O
) O
is O
upregulated O
in O
tamoxifen O
- O
resistant O
breast B-Disease
cancer I-Disease
tissues O
compared O
to O
their O
primary O
counterparts O
. O

Here O
, O
Gas5 O
is O
found O
to O
be O
downregulated O
in O
glioma B-Disease
specimens O
and O
U87 O
and O
U251 O
glioma B-Disease
cell O
lines O
. O

Using O
patient O
- O
derived O
glioblastoma B-Disease
CSCs O
, O
we O
confirmed O
that O
JAM O
- O
A O
is O
suppressed O
by O
miR B-RNA
- I-RNA
145 I-RNA
. O

miR675 B-RNA
upregulates O
long O
noncoding O
RNA O
H19 B-RNA
through O
activating O
EGR1 O
in O
human O
liver B-Disease
cancer I-Disease
. O

Take O
together O
, O
our O
results O
demonstrated O
that O
miR B-RNA
- I-RNA
203 I-RNA
act O
as O
a O
tumor O
suppressor O
miRNA O
through O
regulating O
RAB22A B-RNA
expression O
and O
suggested O
its O
involvement O
in O
osteosarcoma B-Disease
progression O
and O
carcinogenesis O
. O

Long O
noncoding O
RNA O
HOXA B-RNA
- I-RNA
AS2 I-RNA
promotes O
gastric B-Disease
cancer I-Disease
proliferation O
by O
epigenetically O
silencing O
P21 O
/ O
PLK3 O
/ O
DDIT3 O
expression O
. O

HBx O
- O
related O
long O
non O
- O
coding O
RNA O
DBH B-RNA
- I-RNA
AS1 I-RNA
promotes O
cell O
proliferation O
and O
survival O
by O
activating O
MAPK O
signaling O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

Taken O
together O
, O
our O
results O
suggest O
that O
miR B-RNA
- I-RNA
221 I-RNA
enhances O
the O
proliferation O
, O
invasion O
and O
migration O
ability O
of O
osteosarcoma B-Disease
cells O
partly O
by O
suppressing O
PTEN O
. O

MALAT1 B-RNA
expression O
is O
significantly O
increased O
in O
cervical B-Disease
cancer I-Disease
than O
in O
normal O
tissues O
. O

Our O
studies O
suggested O
that O
the O
miR O
- O
146a O
rs2910164 O
polymorphism O
might O
marginally O
contribute O
to O
a O
decreased O
risk O
of O
gastric B-Disease
cancer I-Disease
, O
especially O
in O
Caucasians O
, O
whereas O
the O
miR B-RNA
- I-RNA
196a2 I-RNA
rs11614913 O
polymorphism O
might O
not O
be O
associated O
with O
susceptibility O
to O
GC O
. O

Our O
data O
provide O
new O
insights O
for O
the O
involvement O
of O
miR B-RNA
- I-RNA
191 I-RNA
in O
osteosarcoma B-Disease
and O
suggest O
that O
the O
increased O
expression O
of O
miR B-RNA
- I-RNA
191 I-RNA
may O
be O
associated O
with O
aggressive O
tumor O
progression O
and O
adverse O
outcome O
. O

In O
this O
study O
, O
we O
analyzed O
expression O
of O
four O
long O
noncoding O
RNAs O
( O
lncRNAs O
) O
namely O
SOX2OT B-RNA
, O
PTPRG B-RNA
- I-RNA
AS1 I-RNA
, O
ANRASSF1 B-RNA
, O
and O
ANRIL B-RNA
in O
38 O
breast O
cancer O
tissues O
and O
their O
adjacent O
noncancerous O
tissues O
( O
ANCTs O
) O
. O

ANRASSF1 B-RNA
expression O
was O
not O
detected O
in O
any O
noncancerous O
tissue O
. O

All O
lncRNAs O
showed O
significant O
overexpression O
in O
tumor O
tissues O
compared O
with O
ANCTs O
. O

The O
knockdown O
of O
H19lncRNA O
reveals O
its O
regulatory O
role O
in O
pluripotency O
and O
tumorigenesis O
of O
human O
embryonic B-Disease
carcinoma I-Disease
cells O
. O

LncRNA O
- O
DLEU1 B-RNA
was O
highly O
expressed O
in O
the O
MCF O
- O
7 O
cells O
in O
breast B-Disease
cancer I-Disease

LINC01016 B-RNA
and O
LINC00160 B-RNA
are O
direct O
transcriptional O
targets O
of O
ERalpha O
, O
correlate O
with O
Eralpha O
expression O
in O
clinical O
samples O
, O
and O
show O
prognostic O
significance O
in O
relation O
to O
breast B-Disease
cancer I-Disease
survival O
. O

Long O
noncoding O
RNA O
PVT1 B-RNA
modulates O
thyroid B-Disease
cancer I-Disease
cell O
proliferation O
by O
recruiting O
EZH2 O
and O
regulating O
thyroid O
- O
stimulating O
hormone O
receptor O
( O
TSHR O
) O
. O

We O
first O
confirmed O
the O
high O
expression O
level O
of O
CCAT2 B-RNA
in O
breast B-Disease
cancer I-Disease
tissues O
and O
breast B-Disease
cancer I-Disease
cell O
lineby O
reverse O
transcription O
quantitative O
polymerase O
chain O
reaction O
( O
RT O
- O
qPCR O
) O
assay O
, O
and O
we O
further O
analyzed O
the O
relationship O
between O
CCAT2 B-RNA
expression O
and O
clinical O
prognostic O
factors O
. O

Decreased O
expression O
of O
long O
non O
- O
coding O
RNA O
WT1 B-RNA
- I-RNA
AS I-RNA
promotes O
cell O
proliferation O
and O
invasion O
in O
gastric B-Disease
cancer I-Disease
. O
Finally O
, O
we O
found O
that O
WT1 B-RNA
- I-RNA
AS I-RNA
overexpression O
could O
decrease O
ERK O
protein O
phosphorylation O
. O

Our O
study O
indicates O
that O
WT1 B-RNA
- I-RNA
AS I-RNA
is O
significantly O
down O
- O
regulated O
in O
gastric O
cancers O
and O
may O
be O
correlated O
with O
tumor O
progression O
. O

Our O
findings O
indicate O
that O
HOTAIR B-RNA
expression O
has O
prognostic O
value O
for O
bladder B-Disease
cancer I-Disease
progression O
, O
recurrence O
, O
and O
survival O
and O
suggest O
that O
HOTAIR B-RNA
plays O
active O
roles O
in O
modulating O
the O
cancer O
epigenome O
, O
becoming O
an O
interesting O
candidate O
as O
a O
target O
for O
cancer O
diagnosis O
and O
therapy O
. O

Analysis O
of O
the O
Polycomb O
- O
related O
lncRNAs O
HOTAIR B-RNA
and O
ANRIL B-RNA
in O
bladder B-Disease
cancer I-Disease
. O

We O
found O
that O
MALAT1 B-RNA
exist O
a O
higher O
fold O
change O
( O
Tumor O
/ O
Normal O
) O
in O
clear O
cell O
kidney B-Disease
carcinoma I-Disease
( O
KIRC O
) O
from O
The O
Cancer O
Genome O
Atlas O
( O
TCGA O
) O
Data O
Portal O
and O
a O
negative O
correlation O
with O
miR O
- O
200s O
family O
. O

The O
results O
of O
our O
study O
showed O
that O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
was O
up O
- O
regulated O
in O
human O
glioma B-Disease
tissues O
and O
cell O
lines O
. O

Expression O
and O
clinical O
significance O
of O
long O
non O
- O
coding O
RNA O
HNF1A B-RNA
- I-RNA
AS1 I-RNA
in O
human O
gastric B-Disease
cancer I-Disease
. O

Involvement O
of O
long O
noncoding O
RNA O
MALAT1 B-RNA
in O
the O
pathogenesis O
of O
diabetic O
cardiomyopathy O
. O

The O
results O
showed O
that O
PACER B-RNA
was O
overexpressed O
in O
osteosarcoma B-Disease
tissues O
and O
cell O
lines O
compared O
with O
normal O
tissues O
and O
osteoblasts O
, O
respectively O
. O

Linc B-RNA
- I-RNA
NeD125 I-RNA
represents O
the O
host O
gene O
for O
miR B-RNA
- I-RNA
125b I-RNA
- I-RNA
1 I-RNA
, O
a O
microRNA O
with O
an O
established O
role O
as O
negative O
regulator O
of O
human O
neuroblastoma B-Disease
cell O
proliferation O
. O

Skp2 O
regulates O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
cell O
growth O
by O
Meg3 O
and O
miR B-RNA
- I-RNA
3163 I-RNA
. O

We O
found O
that O
lncRNA B-RNA
- I-RNA
ATB I-RNA
expression O
was O
decreased O
in O
pancreatic B-Disease
cancer I-Disease
tissues O
and O
pancreatic B-Disease
cancer I-Disease
cell O
lines O
. O

c O
- O
Myc O
- O
regulated O
long O
non O
- O
coding O
RNA O
H19 B-RNA
indicates O
a O
poor O
prognosis O
and O
affects O
cell O
proliferation O
in O
non O
- O
small O
- O
cell O
lung O
cancer O
. O

Long O
non O
- O
coding O
RNA O
small O
nucleolar O
RNA O
host O
gene O
12 O
( O
SNHG12 B-RNA
) O
promotes O
cell O
proliferation O
and O
migration O
by O
upregulating O
angiomotin O
gene O
expression O
in O
human O
osteosarcoma B-Disease
cells O
. O

Tumor O
- O
suppressive O
microRNAs O
( O
miR B-RNA
- I-RNA
26a I-RNA
/ I-RNA
b I-RNA
, O
miR B-RNA
- I-RNA
29a I-RNA
/ I-RNA
b I-RNA
/ I-RNA
c I-RNA
and O
miR B-RNA
- I-RNA
218 I-RNA
) O
concertedly O
suppressed O
metastasis O
- O
promoting O
LOXL4 O
in O
head B-Disease
and I-Disease
neck I-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

The O
expression O
of O
miR B-RNA
- I-RNA
200c I-RNA
may O
be O
an O
important O
prognosis O
factor O
in O
pancreatic B-Disease
cancer I-Disease
, O
and O
it O
could O
be O
a O
novel O
therapeutic O
target O
of O
pancreatic B-Disease
cancer I-Disease
. O

We O
measured O
the O
expression O
level O
of O
lincRNA B-RNA
- I-RNA
p21 I-RNA
and O
found O
that O
it O
was O
significantly O
downregulated O
in O
CRC B-Disease
specimens O
, O
as O
compared O
to O
the O
paired O
non O
- O
cancerous O
colorectal O
epithelia O
from O
24 O
patients O
. O

The O
levels O
of O
miR B-RNA
- I-RNA
214 I-RNA
in O
hair O
shafts O
of O
patients O
with O
dermatomyositis B-Disease
were O
significantly O
higher O
than O
those O
of O
normal O
subjects O
and O
patients O
with O
scleroderma O
. O

TUG1 B-RNA
was O
significantly O
overexpressed O
in O
the O
osteosarcoma B-Disease
tissues O
compared O
with O
matched O
adjacent O
normal O
tissues O
and O
was O
closely O
correlated O
with O
tumor O
size O
, O
post O
- O
operative O
chemotherapy O
, O
and O
Enneking O
surgical O
stage O
. O

We O
determined O
expression O
of O
83 O
long O
non O
- O
coding O
RNAs O
( O
lncRNAs O
) O
and O
identified O
ZFAS1 B-RNA
to O
be O
significantly O
up O
- O
regulated O
in O
colorectal B-Disease
cancer I-Disease
( O
CRC O
) O
tissue O
. O

LncRNA O
- O
GAS5 B-RNA
induces O
PTEN B-RNA
expression O
through O
inhibiting O
miR B-RNA
- I-RNA
103 I-RNA
in O
endometrial B-Disease
cancer I-Disease
cells O
. O

Here O
, O
we O
found O
that O
PVT1 B-RNA
was O
upregulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cells O
. O

Further O
experiments O
revealed O
that O
PVT1 B-RNA
promoted O
cell O
proliferation O
and O
suppressed O
cell O
apoptosis O
. O

Overexpression O
of O
long O
non O
- O
coding O
RNA O
HOTAIR B-RNA
leads O
to O
chemoresistance O
by O
activating O
the O
Wnt O
/ O
 O
- O
catenin O
pathway O
in O
human O
ovarian B-Disease
cancer I-Disease
. O

PRNCR1 B-RNA
was O
significantly O
overexpressed O
in O
CRC B-Disease
tissues O
compared O
with O
the O
expression O
in O
adjacent O
tissues O
, O
with O
an O
average O
fold O
increase O
of O
10 O
. O
55 O
. O

A O
functional O
variant O
in O
miR B-RNA
- I-RNA
155 I-RNA
regulation O
region O
contributes O
to O
lung B-Disease
cancer I-Disease
risk O
and O
survival O
. O

Here O
, O
we O
demonstrated O
that O
overexpression O
of O
lncRNA O
- O
UCA1 B-RNA
could O
induce O
epithelial O
to O
mesenchymal O
transition O
( O
EMT O
) O
and O
increase O
the O
migratory O
and O
invasive O
abilities O
of O
bladder B-Disease
cancer I-Disease
cells O
. O

Overexpression O
of O
the O
long O
non O
- O
coding O
RNA O
PVT1 B-RNA
is O
correlated O
with O
leukemic O
cell O
proliferation O
in O
acute B-Disease
promyelocytic I-Disease
leukemia I-Disease
. O

The O
results O
of O
the O
present O
study O
demonstrated O
that O
knockdown O
of O
GAS5 B-RNA
expression O
promoted O
bladder B-Disease
cancer I-Disease
cell O
proliferation O
, O
whereas O
overexpression O
of O
GAS5 B-RNA
suppressed O
cell O
proliferation O
. O

Long O
noncoding O
RNA O
BC032469 B-RNA
, O
a O
novel O
competing O
endogenous O
RNA O
, O
upregulates O
hTERT O
expression O
by O
sponging O
miR B-RNA
- I-RNA
1207 I-RNA
- I-RNA
5p I-RNA
and O
promotes O
proliferation O
in O
gastric B-Disease
cancer I-Disease
. O

The O
expression O
of O
HEIH O
and O
HULC B-RNA
in O
hepatocellular B-Disease
carcinoma I-Disease
cell O
line O
was O
significantly O
increased O
compared O
with O
human O
normal O
hepatocyte O
line O
( O
P O
< O
0 O
. O
5 O
) O
. O

The O
level O
of O
these O
ten O
lncRNAs O
in O
breast B-Disease
tumors I-Disease
and O
adjacent O
normal O
tissues O
were O
evaluated O
, O
which O
suggested O
that O
HOTAIR B-RNA
and O
MALAT1 O
increased O
most O
significantly O
, O
and O
LUNAR1 O
and O
GAS5 O
decreased O
most O
significantly O
. O

Results O
showed O
that O
the O
expression O
level O
of O
lncRNA B-RNA
- I-RNA
n336928 I-RNA
( O
noncode O
database O
ID O
: O
n336928 O
) O
was O
significantly O
higher O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
to O
that O
in O
adjacent O
noncancerous O
tissues O
. O

LncRNA O
HOTAIR B-RNA
is O
highly O
expressed O
in O
prostate B-Disease
cancer I-Disease
, O
which O
is O
associated O
with O
the O
growth O
and O
invasiveness O
of O
prostate B-Disease
cancer I-Disease
cells O
. O

Whole O
blood O
NEAT1 B-RNA
expression O
was O
significantly O
higher O
in O
colorectal B-Disease
cancer I-Disease
patients O
than O
in O
NCs O
. O

Our O
research O
revealed O
that O
the O
expression O
levels O
of O
MVIH B-RNA
in O
breast B-Disease
cancer I-Disease
tissues O
were O
higher O
than O
in O
adjacent O
noncancerous O
tissues O
, O
and O
high O
MVIH B-RNA
expression O
was O
correlated O
with O
Ki67 O
expression O
. O

We O
have O
shown O
that O
the O
elevated O
level O
of O
CRNDE B-RNA
transcripts O
significantly O
increases O
the O
risk O
of O
death O
and O
recurrence O
in O
ovarian B-Disease
cancer I-Disease
patients O
. O

LINC00472 B-RNA
is O
functionally O
a O
tumor O
suppressor O
, O
and O
that O
assessing O
its O
expression O
in O
breast B-Disease
tumors I-Disease
may O
have O
clinical O
implications O
in O
breast O
cancer O
management O
. O

Our O
results O
found O
that O
the O
expression O
level O
of O
C21orF96 B-RNA
was O
over O
- O
expressed O
in O
positive O
lymph O
node O
tissues O
and O
gastric B-Disease
cancer I-Disease
tissues O
. O

We O
observed O
that O
MEG3 B-RNA
was O
downregulated O
in O
cervical B-Disease
cancer I-Disease
tissues O
, O
compared O
to O
the O
adjacent O
normal O
tissues O
, O
and O
was O
negatively O
related O
with O
FIGO O
stages O
, O
tumor O
size O
, O
lymphatic O
metastasis O
, O
HR O
- O
HPV O
infection O
and O
the O
expression O
of O
homo O
sapiens O
microRNA B-RNA
- I-RNA
21 I-RNA
( O
miR O
- O
21 O
) O
. O

We O
observed O
that O
MALAT1 B-RNA
expression O
was O
up O
- O
regulated O
in O
human O
osteosarcoma B-Disease
cell O
lineand O
tissues O
. O

MEG3 B-RNA
decreased O
significantly O
in O
prostate B-Disease
cancer I-Disease
tissues O
relative O
to O
adjacent O
normal O
tissues O
. O

JMJD1A O
- O
MALAT1 B-RNA
- O
MAPK O
signaling O
might O
participate O
in O
the O
JMJD1A O
- O
induced O
cell O
proliferation O
of O
gastric B-Disease
cancer I-Disease
. O

Our O
results O
proved O
that O
MALAT1 B-RNA
expression O
was O
up O
- O
regulated O
in O
brain O
microvessels O
of O
human O
glioma B-Disease
and O
glioma B-Disease
endothelial O
cells O
( O
GECs O
) O
which O
were O
obtained O
by O
co O
- O
culturing O
endothelial O
cells O
with O
glioma B-Disease
cells O
. O

The O
most O
abundant O
AER O
- O
lncRNA O
, O
DSCAM B-RNA
- I-RNA
AS1 I-RNA
, O
is O
expressed O
in O
ERa O
+ O
breast B-Disease
carcinoma I-Disease
, O
but O
not O
in O
pre O
- O
neoplastic O
lesions O
, O
and O
correlates O
inversely O
with O
EMT O
markers O
. O

The O
expression O
levels O
of O
miR B-RNA
- I-RNA
18a I-RNA
in O
the O
invasive O
meningioma B-Disease
group O
were O
significantly O
reduced O
compared O
with O
those O
in O
the O
control O
and O
non O
- O
invasive O
meningioma B-Disease
groups O
( O
P O
< O
0 O
. O
5 O
) O
, O
whereas O
the O
levels O
of O
miR B-RNA
- I-RNA
18a I-RNA
in O
the O
non O
- O
invasive O
meningioma B-Disease
group O
were O
significantly O
lower O
compared O
with O
those O
in O
the O
control O
group O
( O
P O
< O
0 O
. O
5 O
) O
. O

Long O
non O
- O
coding O
RNA O
FTX B-RNA
was O
significantly O
upregulated O
in O
colorectal B-Disease
cancer I-Disease
tissues O
, O
and O
low O
long O
non O
- O
coding O
RNA O
FTX B-RNA
expression O
was O
significantly O
correlated O
with O
differentiation O
grade O
, O
lymph O
vascular O
invasion O
, O
and O
clinical O
stage O
. O

Herein O
, O
we O
showed O
that O
expression O
of O
both O
lncRNA O
- O
HIF2PUT B-RNA
and O
HIF B-RNA
- I-RNA
2a I-RNA
were O
significantly O
higher O
in O
CRC B-Disease
cell O
lines O
than O
in O
a O
normal O
colon O
epithelial O
cell O
line O
FHC O
. O

Serum O
miRNAs O
panel O
( O
miR B-RNA
- I-RNA
16 I-RNA
- I-RNA
2 I-RNA
* I-RNA
, O
miR B-RNA
- I-RNA
195 I-RNA
, O
miR B-RNA
- I-RNA
2861 I-RNA
, O
miR B-RNA
- I-RNA
497 I-RNA
) O
as O
novel O
non O
- O
invasive O
biomarkers O
for O
detection O
of O
cervical O
cancer O
. O

The O
breast B-Disease
tumor I-Disease
tissues O
expressed O
low O
levels O
of O
circ O
- O
Foxo3 B-RNA
, O
Foxo3P B-RNA
and O
Foxo3 B-RNA
compared O
with O
normal O
tissues O
. O

Upregulated O
expression O
of O
long O
noncoding O
RNA O
SNHG15 B-RNA
promotes O
cell O
proliferation O
and O
invasion O
through O
regulates O
MMP2 O
/ O
MMP9 O
in O
patients O
with O
GC B-Disease
. O

The O
levels O
of O
MEG3 B-RNA
expression O
were O
significantly O
decreased O
in O
glioma B-Disease
tissues O
compared O
with O
normal O
brain O
tissues O
. O

We O
reported O
that O
MALAT1 B-RNA
was O
upregulated O
in O
triple O
- O
negative O
breast B-Disease
cancer I-Disease
( O
TNBC O
) O
tissues O
. O

Decreased O
long O
noncoding O
RNA O
MIR31HG B-RNA
is O
correlated O
with O
poor O
prognosis O
and O
contributes O
to O
cell O
proliferation O
in O
gastric B-Disease
cancer I-Disease
. O

MALAT1 B-RNA
functions O
as O
a O
competing O
endogenous O
RNA O
to O
mediate O
Rac1 B-RNA
expression O
by O
sequestering O
miR B-RNA
- I-RNA
101b I-RNA
in O
liver O
fibrosis O
. O

Malat1 B-RNA
represents O
an O
exciting O
therapeutic O
target O
, O
and O
Malat1 B-RNA
ASOs O
represent O
a O
potential O
therapy O
for O
inhibiting O
breast B-Disease
cancer I-Disease
progression O
. O

We O
screened O
the O
expression O
level O
of O
two O
novel O
transcripts O
, O
SOX2OT B-RNA
- I-RNA
7 I-RNA
and O
SOX2OT B-RNA
- I-RNA
8 I-RNA
in O
five O
selected O
human O
cancer O
cell O
lines O
( O
HeLa O
, O
MCF7 O
, O
HepG2 O
, O
U O
- O
87 O
MG O
and O
NT2 O
) O
by O
Real O
time O
RT O
- O
PCR O
. O

To O
facilitate O
the O
comparison O
of O
cell O
lines O
, O
HeLa O
cell O
line O
( O
which O
showed O
the O
least O
expression O
values O
) O
was O
considered O
as O
calibrator O
. O

Here O
we O
report O
that O
ANRIL B-RNA
is O
involved O
in O
the O
proliferation O
of O
colorectal B-Disease
cancer I-Disease
HCT116 O
cells O
in O
two O
- O
and O
three O
- O
dimensional O
culture O
. O

Under O
- O
expression O
of O
MALAT B-RNA
- I-RNA
1 I-RNA
during O
early O
placentation O
may O
be O
involved O
in O
the O
pathogenesis O
of O
preeclampsia B-Disease
. O

This O
study O
for O
the O
first O
time O
provided O
evidence O
that O
miR B-RNA
- I-RNA
203 I-RNA
could O
be O
an O
independent O
potential O
prognostic O
marker O
for O
patients O
with O
melanoma B-Disease
, O
and O
might O
even O
become O
a O
new O
therapeutic O
target O
for O
the O
treatment O
of O
melanoma B-Disease
. O

In O
the O
present O
study O
, O
we O
found O
that O
lncRNA O
CCAT2 B-RNA
was O
up O
- O
regulated O
in O
cervical B-Disease
squamous I-Disease
cell I-Disease
cancer I-Disease
tissues O
compared O
to O
the O
adjacent O
non O
- O
tumor O
tissues O
. O

PCNA B-RNA
- I-RNA
AS1 I-RNA
expression O
levels O
were O
increased O
in O
68 O
of O
90 O
gastric B-Disease
cancer I-Disease
tissues O
( O
75 O
. O
56 O
% O
) O
and O
were O
associated O
with O
invasion O
, O
but O
not O
associated O
with O
other O
clinicopathological O
characteristics O
. O

LINC00663 B-RNA
expression O
was O
most O
prominent O
in O
A172 O
glioblastoma B-Disease
cells O
. O

Additionally O
, O
LINC00663 B-RNA
was O
shown O
to O
be O
expressed O
at O
low O
levels O
in O
DU O
- O
145 O
and O
PC3 O
prostate B-Disease
cancer I-Disease
, O
HGC O
- O
27 O
stomach B-Disease
carcinoma I-Disease
, O
CRL O
- O
1469 O
pancreatic B-Disease
carcinoma I-Disease
, O
A549 O
lung B-Disease
cancer I-Disease
, O
MCF7 O
breast B-Disease
cancer I-Disease
, O
and O
BCPAP O
thyroid B-Disease
cancer I-Disease
cell O
lines O

stable O
overexpression O
of O
miR B-RNA
- I-RNA
125b I-RNA
in O
osteosarcoma B-Disease
cell O
lines O
U2OS O
and O
MG O
- O
63 O
inhibited O
cell O
proliferation O
, O
migration O
, O
and O
invasion O
. O

High O
expression O
of O
long O
non O
- O
coding O
RNA O
AFAP1 B-RNA
- I-RNA
AS1 I-RNA
predicts O
chemoradioresistance O
and O
poor O
prognosis O
in O
patients O
with O
esophageal O
squamous O
cell O
carcinoma O
treated O
with O
definitive O
chemoradiotherapy O
. O

Long O
non O
- O
coding O
RNA O
HNF1A O
- O
AS O
is O
upregulated O
and O
promotes O
cell O
proliferation O
and O
metastasis O
in O
nasopharyngeal O
carcinoma O
. O

overexpression O
of O
miR B-RNA
- I-RNA
421 I-RNA
promoted O
osteosarcoma B-Disease
cell O
line O
MG O
- O
63 O
proliferation O
, O
migration O
, O
and O
invasion O
. O

H19 B-RNA
serves O
as O
a O
diagnostic O
biomarker O
and O
up O
- O
regulation O
of O
H19 B-RNA
expression O
contributes O
to O
poor O
prognosis O
in O
patients O
with O
gastric B-Disease
cancer I-Disease
. O

HOTAIR B-RNA
was O
up O
- O
regulated O
in O
bladder B-Disease
transitional I-Disease
cell I-Disease
carcinoma I-Disease
( O
TCC O
) O
tissues O
and O
cell O
lines O
compared O
with O
normal O
bladder O
transitional O
cell O
( O
NBTC O
) O
tissues O
and O
bladder O
epithelial O
immortalized O
SV O
- O
HUC O
- O
1 O
cells O
, O
and O
its O
expression O
level O
had O
positive O
correlation O
with O
histological O
grades O
of O
TCC O
. O

Here O
, O
we O
reported O
a O
novel O
lncRNA O
, O
tumor O
suppressor O
candidate O
7 O
( O
TUSC7 B-RNA
) O
, O
was O
significantly O
downregulated O
in O
osteosarcoma B-Disease
tissues O
compared O
with O
paired O
non O
- O
tumor O
tissues O
and O
low O
expression O
of O
TUSC7 B-RNA
indicated O
poor O
survival O
. O

Long O
non O
- O
coding O
RNA O
BACE1 B-RNA
- I-RNA
AS I-RNA
is O
a O
novel O
target O
for O
anisomycin O
- O
mediated O
suppression O
of O
ovarian B-Disease
cancer I-Disease
stem O
cell O
proliferation O
and O
invasion O
. O

In O
the O
present O
study O
, O
we O
identified O
that O
lncRNA O
lnc B-RNA
- I-RNA
MX1 I-RNA
- I-RNA
1 I-RNA
is O
over O
- O
expressed O
in O
prostate B-Disease
cancer I-Disease
tissues O
compared O
with O
their O
adjacent O
normal O
prostate O
tissues O
by O
gene O
expression O
array O
profiling O
. O

We O
found O
that O
the O
expression O
level O
of O
LOC400891 B-RNA
was O
higher O
in O
PCa B-Disease
tissues O
and O
cells O
compared O
to O
adjacent O
non O
- O
tumor O
tissues O
and O
normal O
prostate O
stromal O
immortalized O
cells O
WPMY O
- O
1 O
. O

Down O
- O
regulation O
of O
MALAT1 B-RNA
inhibits O
cervical B-Disease
cancer I-Disease
cell O
invasion O
and O
metastasis O
by O
inhibition O
of O
epithelial O
- O
mesenchymal O
transition O
. O

In O
this O
study O
, O
we O
found O
that O
SUMO1P3 B-RNA
was O
significantly O
up O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
with O
paired O
- O
adjacent O
nontumorous O
tissues O
in O
a O
cohort O
of O
55 O
bladder B-Disease
cancer I-Disease
patients O
. O

we O
found O
that O
linc B-RNA
- I-RNA
POU3F3 I-RNA
could O
promote O
the O
distribution O
of O
Tregs O
in O
peripheral O
blood O
T O
cell O
which O
caused O
an O
enhanced O
cell O
proliferation O
of O
gastric B-Disease
cancer I-Disease
cells O
by O
recruiting O
TGF O
- O
beta O
as O
well O
as O
activating O
TGF O
- O
beta O
signal O
pathway O
. O

Low O
- O
expression O
of O
PIWIL1 B-RNA
/ I-RNA
2 I-RNA
/ I-RNA
4 I-RNA
and O
piR B-RNA
- I-RNA
823 I-RNA
was O
significantly O
associated O
with O
worse O
overall O
survival O
rate O
in O
renal B-Disease
cell I-Disease
carcinoma I-Disease
( O
RCC O
) O
patients O

Compared O
with O
normal O
tissues O
, O
the O
expression O
of O
MEG3 B-RNA
was O
significantly O
lower O
in O
GBC B-Disease
tissues O
, O
whereas O
the O
expression O
of O
ANRIL B-RNA
was O
significantly O
higher O
( O
both O
P O
< O
0 O
. O
5 O
) O
. O

Taken O
together O
, O
following O
several O
distinct O
associations O
between O
miRNA O
expression O
and O
diverse O
clinical O
parameters O
, O
the O
current O
study O
repeatedly O
highlighted O
miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
24 I-RNA
- I-RNA
1 I-RNA
as O
candidate O
oncogenic O
molecules O
associated O
with O
inferior O
prognosis O
in O
children O
diagnosed O
with O
ependymoma B-Disease
. O

our O
results O
indicated O
that O
AK027294 B-RNA
down O
- O
regulation O
significantly O
inhibited O
colorectal B-Disease
cancer I-Disease
cells O
proliferation O
and O
migration O
, O
but O
promoted O
cell O
apoptosis O
( O
P O
< O
0 O
. O
5 O
) O
. O

UCA1 B-RNA
was O
upregulated O
by O
miR B-RNA
- I-RNA
196a I-RNA
and O
positively O
correlated O
with O
miR B-RNA
- I-RNA
196a I-RNA
, O
whereas O
UCA1 B-RNA
and O
miR B-RNA
- I-RNA
196a I-RNA
were O
negatively O
correlated O
with O
p27kip1 O
, O
which O
was O
downregulated O
in O
bladder B-Disease
cancer I-Disease
patients O
. O

In O
this O
study O
, O
we O
demonstrated O
that O
FGF14 O
antisense O
RNA O
2 O
( O
FGF14 B-RNA
- I-RNA
AS2 I-RNA
) O
, O
a O
novel O
long O
non O
- O
coding O
RNA O
, O
was O
significantly O
down O
- O
regulated O
in O
breast B-Disease
cancer I-Disease
tissue O
compared O
with O
adjacent O
normal O
tissue O
both O
in O
validated O
cohort O
and O
TCGA O
cohort O
. O

Our O
findings O
showed O
that O
expression O
of O
lncRNA O
MEG3 B-RNA
was O
clearly O
lower O
in O
osteosarcoma B-Disease
tissues O
compared O
with O
adjacent O
non O
- O
tumor O
tissues O
. O

we O
provide O
the O
first O
evidence O
that O
CCAT1 B-RNA
regulates O
miR O
- O
490 O
in O
gastric B-Disease
cancer I-Disease
( O
GC O
) O
cells O
. O

In O
breast B-Disease
cancer I-Disease
, O
the O
rs11515 O
CG O
genotype O
is O
more O
frequent O
and O
associated O
with O
a O
more O
aggressive O
tumor O
that O
could O
be O
due O
to O
increased O
ANRIL B-RNA
and O
reduced O
p16 O
( O
INK4a O
) O
expression O
. O

Compared O
to O
the O
CC O
genotype O
, O
the O
CG O
genotype O
was O
associated O
with O
lower O
expression O
of O
CDKN2A O
/ O
p16INK4a O
, O
and O
higher O
expression O
of O
ANRIL B-RNA
. O

Our O
findings O
support O
a O
potential O
oncogenic O
role O
for O
SOX2OT O
in O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
tumor O
genesis O
and O
SOX2OT O
seems O
a O
promising O
therapeutic O
candidate O
for O
NSCLC O
. O

Lentiviral O
- O
mediated O
overexpression O
of O
long O
non O
- O
coding O
RNA O
GAS5 B-RNA
reduces O
invasion O
by O
mediating O
MMP2 O
expression O
and O
activity O
in O
human O
melanoma B-Disease
cells O
. O
Overexpressing O
lncRNA O
GAS5 B-RNA
inhibited O
the O
migration O
and O
invasion O
ability O
of O
melanoma B-Disease
SK O
- O
Mel O
- O
110 O
cells O
, O
partially O
by O
decreasing O
the O
MMP2 O
expression O
and O
its O
activity O
. O

The O
expression O
of O
lncRNA O
- O
ATB O
was O
higher O
in O
the O
renal B-Disease
cell I-Disease
carcinoma I-Disease
tissues O
and O
renal O
cancer O
cells O
than O
in O
the O
adjacent O
non O
- O
tumor O
tissues O
and O
normal O
human O
proximal O
tubule O
epithelial O
cells O
HK O
- O
2 O
. O

Fenofibrate O
significantly O
inhibited O
proliferation O
of O
pancreatic B-Disease
cancer I-Disease
cells O
, O
increased O
MEG3 B-RNA
expression O
and O
p53 O
levels O
. O

UCA1 B-RNA
expression O
in O
ovarian B-Disease
cancer I-Disease
tissues O
was O
significantly O
upregulated O
compared O
with O
normal O
ovarian O
tissues O
. O

SChLAP1 B-RNA
was O
overexpressed O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
to O
paired O
normal O
bladder O
tissues O
. O

UCA1 B-RNA
functions O
as O
a O
competing O
endogenous O
RNA O
to O
suppress O
epithelial B-Disease
ovarian I-Disease
cancer I-Disease
metastasis O
. O

Here O
, O
we O
show O
that O
the O
KCNQ1OT1 B-RNA
transcriptional O
level O
was O
significantly O
increased O
in O
human O
colorectal B-Disease
cancer I-Disease
cells O
in O
which O
B O
- O
catenin O
was O
excessively O
accumulated O
in O
the O
nucleus O
. O

MALAT1 B-RNA
long O
ncRNA O
promotes O
gastric B-Disease
cancer I-Disease
metastasis O
by O
suppressing O
PCDH10 O
. O
In O
particular O
, O
we O
found O
that O
long O
noncoding O
RNA O
( O
lncRNA O
) O
MALAT1 B-RNA
binds O
EZH2 O
, O
suppresses O
the O
tumor O
suppressor O
PCDH10 O
, O
and O
promotes O
gastric O
cellular O
migration O
and O
invasion O
. O

MiR B-RNA
- I-RNA
26b I-RNA
inhibits O
melanoma B-Disease
cell O
proliferation O
and O
enhances O
apoptosis O
by O
suppressing O
TRAF5 O
- O
mediated O
MAPK O
activation O
. O

These O
results O
indicate O
that O
H19 B-RNA
interacts O
with O
HuR O
and O
regulates O
the O
intestinal B-Disease
epithelial I-Disease
barrier I-Disease
function I-Disease
via O
the O
H19 B-RNA
- O
encoded O
miR O
- O
675 O
by O
altering O
ZO O
- O
1 O
and O
E O
- O
cadherin O
expression O
posttranscriptionally O
. O

Decreased O
expression O
of O
hsa B-RNA
_ I-RNA
circ I-RNA
_ I-RNA
1988 I-RNA
in O
colorectal B-Disease
cancer I-Disease
and O
its O
clinical O
significances O
. O

Compared O
with O
adjacent O
normal O
tissues O
, O
UCA1 B-RNA
was O
significantly O
upregulated O
in O
colon B-Disease
cancer I-Disease
tissues O
, O
especially O
in O
cases O
with O
LNM O
and O
advanced O
TNM O
stages O
. O

Our O
data O
thus O
define O
miR B-RNA
- I-RNA
138 I-RNA
as O
a O
glioblastoma B-Disease
cell O
survival O
- O
promoting O
miRNA O
associated O
with O
resistance O
to O
TMZ O
therapy O
in O
vitro O
and O
with O
tumor O
progression O
in O
vivo O
. O

Highly O
upregulated O
in O
liver O
cancer O
( O
HULC B-RNA
) O
is O
a O
long O
noncoding O
RNA O
( O
lncRNA O
) O
that O
acts O
as O
an O
oncogene O
in O
gliomas B-Disease
. O

Pioglitazone O
up O
- O
regulates O
long O
non O
- O
coding O
RNA O
MEG3 B-RNA
to O
protect O
endothelial O
progenitor O
cells O
via O
increasing O
HDAC7 O
expression O
in O
metabolic B-Disease
syndrome I-Disease
. O

Our O
results O
showed O
that O
the O
expression O
of O
PANDAR B-RNA
was O
significantly O
increased O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
paired O
adjacent O
normal O
tissues O
. O

LincRNA B-RNA
- I-RNA
ROR I-RNA
promotes O
invasion O
, O
metastasis O
and O
tumor O
growth O
in O
pancreatic B-Disease
cancer I-Disease
through O
activating O
ZEB1 O
pathway O
. O

In O
this O
study O
, O
we O
found O
that O
TUG1 B-RNA
is O
significantly O
increased O
and O
is O
correlated O
with O
outcomes O
in O
gastric B-Disease
cancer I-Disease
( O
GC O
) O
. O

High O
expression O
of O
miR B-RNA
- I-RNA
200c I-RNA
may O
predict O
improved O
survival O
in O
women O
with O
ovarian B-Disease
cancer I-Disease
and O
high O
expression O
of O
the O
miR B-RNA
- I-RNA
200 I-RNA
family O
significantly O
improves O
overall O
survival O
for O
Asian O
women O
. O

Aberrant O
KDM5B O
expression O
promotes O
aggressive O
breast B-Disease
cancer I-Disease
through O
MALAT1 B-RNA
overexpression O
and O
downregulation O
of O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
448 I-RNA
. O

miR O
- O
124 O
downregulation O
leads O
to O
breast B-Disease
cancer I-Disease
progression O
via O
LncRNA O
- O
MALAT1 B-RNA
regulation O
and O
CDK4 O
/ O
E2F1 O
signal O
activation O
. O

lncRNA O
BC088254 B-RNA
may O
have O
a O
certain O
role O
in O
myocardial O
hypertrophy B-Disease
induced O
by O
TAC O

The O
inhibition O
of O
miR B-RNA
- I-RNA
34a I-RNA
decreased O
proliferation O
, O
migration O
and O
invasion O
in O
cholangiocarcinoma B-Disease
cells O
. O

In O
this O
study O
we O
identified O
long O
non O
- O
coding O
RNA O
( O
lncRNA O
) O
MALAT1 B-RNA
can O
function O
as O
a O
ceRNA O
of O
cell O
division O
cycle O
42 O
( O
cdc42 O
) O
3 O
' O
UTR O
in O
inducing O
migration O
and O
invasion O
of O
breast B-Disease
cancer I-Disease
cells O
via O
miR O
- O
1 O
. O

we O
found O
that O
H19 B-RNA
depended O
on O
miR B-RNA
- I-RNA
675 I-RNA
to O
enhance O
the O
proliferation O
and O
invasion O
of O
gastric B-Disease
cancer I-Disease
AGS O
cells O
, O
and O
the O
expression O
of O
miR B-RNA
- I-RNA
675 I-RNA
was O
positively O
correlated O
with O
H19 B-RNA
in O
patients O
with O
gastric B-Disease
cancer I-Disease
. O

We O
found O
that O
MEG3 B-RNA
rs7158663 O
AA O
genotype O
, O
but O
not O
GA O
genotype O
, O
had O
significant O
increased O
colorectal B-Disease
cancer I-Disease
risk O
, O
compared O
with O
GG O
genotype O
( O
OR O
= O
1 O
. O
96 O
and O
P O
= O
0 O
. O
6 O
for O
AA O
versus O
GG O
, O
and O
OR O
= O
1 O
. O
20 O
and O
P O
= O
0 O
. O
171 O
for O
GA O
versus O
GG O
) O
. O

The O
role O
and O
potential O
mechanisms O
of O
LncRNA O
- O
TATDN1 B-RNA
on O
metastasis O
and O
invasion O
of O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
. O

The O
Meta O
- O
analysis O
results O
showed O
that O
high O
- O
expression O
of O
HOTAIR B-RNA
is O
significantly O
associated O
with O
clinicopathological O
features O
in O
gastric O
cancer O
patients O
, O
especially O
in O
the O
depth O
of O
tumor O
invasion O
, O
lymph O
node O
metastasis O
, O
vessel O
invasion O
, O
lymphatic O
vessel O
involvement O
and O
TNM O
stage O
, O
but O
there O
is O
no O
association O
between O
HOTAIR B-RNA
overexpression O
and O
other O
clinicopathological O
features O
. O

MALAT1 B-RNA
might O
regulate O
the O
development O
of O
retinal B-Disease
neurodegeneration I-Disease
through O
CREB O
signaling O
. O

Our O
findings O
suggest O
that O
EVI1 B-RNA
is O
frequently O
up O
- O
regulated O
and O
regulates O
a O
cluster O
of O
lncRNAs O
in O
HBV O
- O
related O
hepatocellular B-Disease
carcinoma I-Disease
( O
HCC O
) O
. O

We O
confirm O
the O
tumour O
- O
suppressive O
function O
of O
two O
lncRNAs O
( O
TUG1 B-RNA
and O
CTB O
- O
89H12 O
. O
4 O
) O
and O
their O
regulation O
of O
PTEN O
expression O
in O
prostate B-Disease
cancer I-Disease
. O

we O
investigated O
the O
expression O
of O
EPB41L4A B-RNA
- I-RNA
AS2 I-RNA
in O
breast B-Disease
cancer I-Disease
tissues O
and O
evaluated O
its O
relationship O
with O
the O
clinicopathological O
features O
and O
prognosis O
of O
patients O
with O
breast B-Disease
cancer I-Disease
. O

Epigenetic O
silencing O
of O
miR B-RNA
- I-RNA
181c I-RNA
by O
DNA O
methylation O
in O
glioblastoma B-Disease
cell O
lines O
. O

In O
this O
study O
, O
we O
discovered O
that O
the O
expression O
of O
H19 B-RNA
increased O
in O
GBM B-Disease
cell O
lines O
. O

ANCR B-RNA
might O
be O
an O
oncogenic O
lncRNA O
that O
promoted O
proliferation O
of O
osteosarcoma B-Disease
. O

Long O
non O
- O
coding O
RNA O
TUSC7 B-RNA
acts O
a O
molecular O
sponge O
for O
miR O
- O
10a O
and O
suppresses O
EMT O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

Melanoma B-Disease
addiction O
to O
the O
long O
non O
- O
coding O
RNA O
SAMMSON B-RNA
. O

Loss O
of O
TINCR B-RNA
expression O
promotes O
proliferation O
, O
metastasis O
through O
activating O
EpCAM O
cleavage O
in O
colorectal B-Disease
cancer I-Disease
. O

Long O
non O
- O
coding O
RNA O
CASC11 B-RNA
interacts O
with O
hnRNP O
- O
K O
and O
activates O
the O
WNT O
/ O
beta O
- O
catenin O
pathway O
to O
promote O
growth O
and O
metastasis O
in O
colorectal B-Disease
cancer I-Disease

Long O
noncoding O
RNA O
MALAT1 B-RNA
promotes O
malignant O
development O
of O
esophageal O
squamous O
cell O
carcinoma O
by O
targeting O
beta O
- O
catenin O
via O
Ezh2 O
. O

Here O
, O
we O
found O
that O
CCAT2 B-RNA
was O
upregulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
. O

In O
our O
study O
, O
we O
first O
reported O
that O
HIF1AAS2 O
was O
up O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cells O
, O
and O
HIF1A B-RNA
- I-RNA
AS2 I-RNA
expression O
level O
in O
bladder B-Disease
cancer I-Disease
tissues O
is O
positively O
associated O
with O
advanced O
clinical O
pathologic O
grade O
and O
TNM O
phase O
. O

MiR B-RNA
- I-RNA
138 I-RNA
Acts O
as O
a O
Tumor O
Suppressor O
by O
Targeting O
EZH2 O
and O
Enhances O
Cisplatin O
- O
Induced O
Apoptosis O
in O
Osteosarcoma B-Disease
Cells O
. O

The O
OTUB1 O
- O
isoform O
2 O
expression O
levels O
were O
higher O
in O
the O
gastric B-Disease
cancer I-Disease
samples O
than O
in O
the O
paratumorous O
gland O
samples O
. O

The O
effects O
of O
FGFR3 B-RNA
- I-RNA
AS1 I-RNA
on O
osteosarcoma B-Disease
cell O
proliferation O
and O
cell O
cycle O
were O
determined O
by O
Cell O
Counting O
Kit O
- O
8 O
, O
Ethynyl O
deoxyuridine O
incorporation O
assay O
and O
flow O
cytometry O
. O

Here O
, O
we O
found O
that O
lncRNA O
- O
ANRIL B-RNA
was O
upregulated O
in O
human O
gastric B-Disease
cancer I-Disease
tissues O
. O

Compared O
with O
benign O
pancreatic O
tumour O
( O
BPT O
) O
and O
normal O
pancreatic O
tissues O
( O
NPT O
) O
, O
HOTAIR B-RNA
, O
HOTTIP O
and O
PVT1 O
were O
significantly O
up O
- O
regulated O
in O
pancreatic B-Disease
cancer I-Disease
tissues O
( O
PCT O
) O
. O

Expression O
of O
the O
lncRNA O
GAS5 B-RNA
was O
decreased O
in O
SKBR O
- O
3 O
/ O
Tr O
cells O
and O
in O
breast B-Disease
cancer I-Disease
tissue O
from O
trastuzumab O
- O
treated O
patients O
. O

E2F1 B-RNA
- O
induced O
upregulation O
of O
long O
noncoding O
RNA O
LINC00668 O
predicts O
a O
poor O
prognosis O
of O
gastric B-Disease
cancer I-Disease
and O
promotes O
cell O
proliferation O
through O
epigenetically O
silencing O
of O
CKIs O
. O

Long O
Noncoding O
RNA O
PICSAR B-RNA
Promotes O
Growth O
of O
Cutaneous B-Disease
Squamous I-Disease
Cell I-Disease
Carcinoma I-Disease
by O
Regulating O
ERK1 O
/ O
2 O
Activity O
. O

BANCR B-RNA
overexpression O
was O
observed O
in O
osteosarcoma B-Disease
cell O
lineand O
clinical O
specimens O
. O

In O
the O
current O
study O
, O
a O
newly O
found O
lncRNA O
Z38 B-RNA
, O
which O
was O
identified O
through O
combining O
experiments O
of O
suppression O
subtractive O
hybridization O
( O
SSH O
) O
and O
reverse O
dot O
- O
blotting O
, O
was O
found O
to O
have O
high O
expression O
in O
breast B-Disease
cancer I-Disease
. O

Silence O
of O
long O
noncoding O
RNA O
UCA1 B-RNA
inhibits O
malignant O
proliferation O
and O
chemotherapy O
resistance O
to O
adriamycin O
in O
gastric B-Disease
cancer I-Disease
. O

CRNDE B-RNA
overexpression O
facilitated O
cell O
proliferation O
, O
migration O
, O
and O
invasion O
, O
while O
inhibited O
glioma B-Disease
cells O
apoptosis O
. O

In O
conclusion O
, O
our O
study O
demonstrated O
that O
LOC100287225 B-RNA
misregulation O
couldbe O
a O
potential O
target O
for O
gene O
therapy O
in O
colorectal B-Disease
cancer I-Disease
. O

Among O
the O
validated O
lncRNAs O
, O
H19 O
, O
MIR210HG B-RNA
, O
MEG9 B-RNA
, O
MALAT1 B-RNA
and O
MIR22HG O
were O
also O
induced O
in O
a O
mouse O
model O
of O
hindlimb B-Disease
ischemia I-Disease
. O

Down O
- O
regulation O
of O
HOTTIP B-RNA
and O
HOXA13 O
was O
associated O
with O
cell O
growth O
and O
cell O
cycle O
, O
and O
exerts O
tumor O
- O
suppressive O
functions O
in O
the O
genesis O
and O
progression O
of O
prostate B-Disease
cancer I-Disease
, O
providing O
a O
potential O
attractive O
therapeutic O
approach O
for O
this O
malignancy O
. O

Long O
non O
- O
coding O
RNA O
SNHG5 B-RNA
suppresses O
gastric B-Disease
cancer I-Disease
progression O
by O
trapping O
MTA2 O
in O
the O
cytosol O
. O

Here O
we O
report O
a O
novel O
LncRNA O
, O
Lnc34a B-RNA
, O
that O
is O
enriched O
in O
colon B-Disease
cancer I-Disease
stem O
cells O
( O
CCSCs O
) O
and O
initiates O
asymmetric O
division O
by O
directly O
targeting O
the O
microRNA O
miR O
- O
34a O
to O
cause O
its O
spatial O
imbalance O
. O

miR B-RNA
- I-RNA
143 I-RNA
inhibited O
the O
proliferation O
, O
migration O
and O
invasion O
of O
the O
glioblastoma B-Disease
cells O
. O

miR B-RNA
- I-RNA
138 I-RNA
inhibited O
cell O
proliferation O
and O
invasion O
, O
and O
promoted O
cell O
apoptosis O
of O
human O
osteosarcoma B-Disease
cells O
. O

LncRNA O
NEAT1 B-RNA
was O
overexpressed O
in O
gastric B-Disease
cancer I-Disease
tissues O
and O
cell O
lines O
and O
corrected O
with O
clinical O
stage O
, O
histological O
type O
, O
lymph O
node O
metastasis O
, O
and O
distant O
metastasis O
. O

LncRNA O
NEAT1 B-RNA
plays O
an O
important O
role O
on O
gastric B-Disease
cancer I-Disease
tumorigenesis O
and O
progression O
and O
may O
act O
as O
a O
potential O
biomarker O
for O
therapeutic O
strategy O
and O
prognostic O
prediction O
. O

MicroRNA B-RNA
- I-RNA
92b I-RNA
promotes O
hepatocellular B-Disease
carcinoma I-Disease
progression O
by O
targeting O
Smad7 O
and O
is O
mediated O
by O
long O
non O
- O
coding O
RNA O
XIST B-RNA
. O

. O
We O
found O
that O
HOTTIP B-RNA
was O
upregulated O
in O
gastric B-Disease
cancer I-Disease
cell O
lines O
. O

The O
expression O
levels O
of O
Lnc B-RNA
- I-RNA
34 I-RNA
were O
increased O
in O
83 O
. O
3 O
% O
( O
10 O
/ O
12 O
) O
of O
esophageal B-Disease
cancer I-Disease
samples O

We O
demonstrated O
that O
LOC572558 B-RNA
expression O
was O
markedly O
decreased O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
bladder B-Disease
cancer I-Disease
cell O
lines O
. O

We O
found O
that O
GHET1 B-RNA
expression O
was O
significantly O
increased O
in O
the O
CRC O
samples O
compared O
with O
adjacent O
tissues O
. O

we O
found O
that O
the O
expression O
of O
lncRNA O
MALAT1 B-RNA
was O
significantly O
increased O
in O
glioma B-Disease
tissues O
compared O
with O
that O
of O
paracancerous B-Disease
tissues O
. O

The O
results O
showed O
MALAT1 B-RNA
was O
overexpressed O
in O
PCa B-Disease
tissues O
and O
high O
expression O
of O
MALAT1 B-RNA
had O
close O
relationships O
with O
high O
Gleason O
score O
, O
prostate O
specific O
antigen O
( O
PSA O
) O
, O
and O
tumor O
- O
node O
- O
metastasis O
( O
TNM O
) O
stage O
. O

we O
identified O
a O
novel O
lncRNA O
, O
GClnc1 B-RNA
, O
which O
was O
upregulated O
and O
associated O
with O
tumorigenesis O
, O
tumor O
size O
, O
metastasis O
, O
and O
poor O
prognosis O
in O
gastric B-Disease
cancer I-Disease
. O

we O
demonstrated O
that O
downregulating O
the O
expression O
of O
the O
lncRNA O
nuclear O
paraspeckle O
assembly O
transcript O
1 O
( O
NEAT1 B-RNA
) O
in O
breast B-Disease
cancer I-Disease
cells O
inhibited O
cell O
growth O
and O
induced O
cell O
apoptosis O
. O

LOC100507661 B-RNA
, O
was O
strongly O
upregulated O
in O
thyroid B-Disease
cancer I-Disease
tissues O
relative O
to O
paired O
contralateral O
normal O
tissue O
. O

Targeting O
the O
lncRNA O
SAMMSON B-RNA
Reveals O
Metabolic O
Vulnerability O
in O
Melanoma B-Disease
. O

Long O
noncoding O
RNA O
MEG3 B-RNA
inhibits O
breast B-Disease
cancer I-Disease
growth O
via O
upregulating O
endoplasmic O
reticulum O
stress O
and O
activating O
NF O
- O
kB O
and O
p53 O
. O

We O
first O
evaluated O
the O
expression O
ZNRD1 B-RNA
- I-RNA
AS1 I-RNA
and O
ZNRD1 B-RNA
among O
lung B-Disease
cancer I-Disease
tissues O
and O
corresponding O
normal O
tissues O
, O
which O
showed O
higher O
expression O
of O
ZNRD1 B-RNA
- I-RNA
AS1 I-RNA
and O
lower O
expression O
of O
ZNRD1 B-RNA
. O

Higher O
level O
of O
miR B-RNA
- I-RNA
95 I-RNA
was O
detected O
in O
PCa B-Disease
than O
in O
NPT O
, O
but O
the O
difference O
was O
not O
statistically O
significant O
. O

MALAT1 B-RNA
was O
overexpressed O
in O
14 O
% O
( O
63 O
/ O
446 O
) O
of O
the O
breast B-Disease
tumours I-Disease
. O

We O
showed O
that O
lncRNA O
- O
ATB O
expression O
was O
significantly O
upregulated O
in O
tumor O
tissues O
in O
patients O
with O
prostate B-Disease
cancer I-Disease
in O
comparison O
with O
adjacent O
non O
- O
tumor O
tissues O
. O

We O
analyzed O
exosomal O
lncRNA O
levels O
in O
a O
cohort O
consisting O
of O
30 O
cervical B-Disease
cancer I-Disease
patients O
, O
30 O
cancer O
- O
free O
HPV O
- O
positive O
subjects O
and O
30 O
HPV O
- O
negative O
normal O
subjects O
by O
qRT O
- O
PCR O
. O

In O
this O
study O
, O
we O
show O
that O
Malat1 O
is O
overexpressed O
in O
gallbladder B-Disease
cancer I-Disease
( O
GBC O
) O
tissue O
and O
cells O
. O

we O
found O
the O
expression O
of O
DANCR B-RNA
increases O
in O
prostate B-Disease
cancer I-Disease
tissues O
and O
cells O
compared O
to O
normal O
prostate O
tissues O
and O
cells O
. O

RMRP B-RNA
levels O
in O
tissue O
, O
plasma O
and O
gastric O
juices O
from O
patients O
with O
gastric B-Disease
cancer I-Disease
were O
significantly O
different O
from O
those O
from O
controls O
. O

Knockdown O
of O
linc B-RNA
- I-RNA
UFC1 I-RNA
suppresses O
proliferation O
and O
induces O
apoptosis O
of O
colorectal B-Disease
cancer I-Disease
. O

One O
lncRNA O
, O
BCAR4 B-RNA
, O
could O
be O
potential O
candidates O
to O
detect O
colorectal B-Disease
cancer I-Disease
. O

We O
found O
that O
PANDAR B-RNA
was O
significantly O
up O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
with O
paired O
- O
adjacent O
nontumorous O
tissues O
in O
a O
cohort O
of O
55 O
bladder B-Disease
cancer I-Disease
patients O
. O

MiR O
- O
153 O
as O
a O
Tumor O
Suppressor O
in O
Glioblastoma B-Disease
Multiforme O
is O
Downregulated O
by O
DNA O
Methylation O
. O

Expression O
quantitative O
trait O
loci O
in O
long O
non O
- O
coding O
RNA O
PAX8 B-RNA
- I-RNA
AS1 I-RNA
are O
associated O
with O
decreased O
risk O
of O
cervical B-Disease
cancer I-Disease
. O

The O
Long O
Noncoding O
RNA O
MALAT O
- O
1 O
Is O
Highly O
Expressed O
in O
Ovarian B-Disease
Cancer I-Disease
and O
Induces O
Cell O
Growth O
and O
Migration O
. O

The O
lincRNA O
- O
APOC1P1 B-RNA
- I-RNA
3 I-RNA
was O
overexpressed O
in O
breast B-Disease
cancer I-Disease
, O
which O
was O
related O
to O
tumor O
size O
and O
hypomethylation O
in O
its O
promoter O
region O
. O

Together O
, O
these O
results O
indicate O
that O
miR B-RNA
- I-RNA
23b I-RNA
- I-RNA
3p I-RNA
plays O
a O
crucial O
role O
in O
suppressing O
seizure O
formation O
in O
experimental O
models O
of O
epilepsy O
and O
that O
miR B-RNA
- I-RNA
23b I-RNA
- I-RNA
3p I-RNA
supplement O
may O
be O
a O
potential O
anabolic O
strategy O
for O
ameliorating O
seizure O
. O

In O
prostate B-Disease
cancer I-Disease
tissues O
, O
Her B-RNA
- I-RNA
2 I-RNA
and O
PlncRNA B-RNA
- I-RNA
1 I-RNA
were O
highly O
expressed O
and O
significantly O
correlated O
. O

SPRY4 B-RNA
- I-RNA
IT1 I-RNA
expression O
is O
high O
in O
melanoma B-Disease
patients O
but O
low O
in O
healthy O
controls O
, O
and O
is O
closely O
associated O
with O
tumor O
site O
and O
tumor O
stage O
. O

In O
conclusion O
, O
our O
study O
showed O
for O
the O
first O
time O
that O
lncRNA O
ZFAS1 B-RNA
expression O
is O
up O
- O
regulated O
in O
gastric O
cancer O
tissues O
and O
cells O
, O
and O
its O
overexpression O
is O
associated O
with O
poor O
prognosis O
and O
may O
be O
a O
negative O
prognostic O
factor O
for O
gastric O
cancer O
patients O
. O

Long O
noncoding O
RNA O
H19 B-RNA
is O
up O
- O
regulated O
in O
esophageal O
squamous O
cell O
carcinoma O
and O
promotes O
cell O
proliferation O
and O
metastasis O
. O

Here O
, O
we O
show O
that O
Xist O
expression O
is O
significantly O
reduced O
in O
breast B-Disease
tumor I-Disease
samples O
and O
cancer O
cell O
lines O
. O

Thus O
, O
lncRNA O
CASC8 B-RNA
rs10505477 O
could O
serve O
as O
a O
possible O
risk O
marker O
for O
diagnosing O
lung B-Disease
cancer I-Disease
, O
and O
could O
be O
used O
to O
forecast O
the O
response O
and O
toxicity O
of O
platinum O
- O
based O
treatment O
in O
lung B-Disease
cancer I-Disease
patients O
. O

Overexpressed O
MALAT1 B-RNA
promotes O
invasion O
and O
metastasis O
of O
gastric B-Disease
cancer I-Disease
cells O
via O
increasing O
EGFL7 O
expression O
. O

The O
expression O
level O
of O
lncRNA B-RNA
- I-RNA
UNMIBC I-RNA
was O
up O
- O
regulated O
in O
the O
tissues O
of O
45 O
cases O
of O
primary O
nonmuscle O
invasive O
bladder B-Disease
cancer I-Disease
compared O
with O
normal O
mucosa O
. O

MiR O
- O
205 O
and O
MiR O
- O
373 O
Are O
Associated O
with O
Aggressive O
Human O
Mucinous O
Colorectal B-Disease
Cancer I-Disease
. O

Our O
results O
revealed O
that O
PVT1 B-RNA
is O
upregulated O
in O
cervical B-Disease
cancer I-Disease
tissues O
. O

In O
this O
study O
, O
we O
show O
that O
BC200 B-RNA
is O
upregulated O
in O
breast B-Disease
cancer I-Disease
; O
among O
breast O
tumor O
specimens O
there O
is O
a O
higher O
level O
of O
BC200 B-RNA
in O
estrogen O
receptor O
( O
ER O
) O
positive O
than O
in O
ER O
- O
negative O
tumors O
. O

Expression O
levels O
of O
the O
lncRNA O
CCAT2 B-RNA
in O
ovarian B-Disease
cancer I-Disease
tissues O
and O
cell O
linewere O
significantly O
higher O
compared O
with O
values O
obtained O
for O
adjacent O
non O
- O
tumor O
tissues O
and O
normal O
ovarian O
epithelial O
cells O
. O

The O
expression O
of O
HOTAIR B-RNA
was O
significantly O
higher O
in O
colon B-Disease
cancer I-Disease
tissues O
than O
in O
matched O
tumor O
- O
adjacent O
normal O
colon O
tissues O
( O
P O
< O
0 O
. O
5 O
) O
. O

Here O
, O
we O
found O
that O
expression O
of O
HOTAIRM1 B-RNA
was O
reduced O
in O
colorectal B-Disease
cancer I-Disease
( O
CRC O
) O
tissues O
compared O
with O
matched O
normal O
tissues O
, O
and O
plasma O
HOTAIRM1 B-RNA
levels O
in O
CRC O
patients O
were O
less O
than O
in O
controls O
. O

HOTAIR B-RNA
expression O
was O
significantly O
greater O
in O
the O
serum O
of O
cervical B-Disease
cancer I-Disease
patients O
( O
P O
< O
0 O
. O
1 O
) O
. O

We O
found O
that O
the O
expression O
level O
of O
HOXD B-RNA
- I-RNA
AS1 I-RNA
was O
significantly O
increased O
in O
bladder B-Disease
cancer I-Disease
tissues O
and O
cells O
. O

Significant O
associations O
between O
the O
HOTAIR B-RNA
rs920778 O
polymorphism O
and O
cancer O
risk O
were O
observed O
( O
T O
vs O
C O
: O
OR O
= O
1 O
. O
33 O
, O
95 O
% O
CI O
= O
1 O
. O
17 O
- O
1 O
. O
53 O
; O
TT O
vs O
TC O
+ O
CC O
: O
OR O
= O
1 O
. O
55 O
, O
95 O
% O
CI O
= O
1 O
. O
21 O
- O
2 O
. O
0 O
; O
TC O
+ O
TT O
vs O
CC O
: O
OR O
= O
1 O
. O
33 O
, O
95 O
% O
CI O
= O
1 O
. O
11 O
- O
1 O
. O
59 O
; O
TT O
vs O
CC O
: O
OR O
= O
2 O
. O
2 O
, O
95 O
% O
CI O
= O
1 O
. O
31 O
- O
3 O
. O
10 O
) O
in O
the O
total O
population O
, O
as O
well O
as O
in O
subgroup O
analysis O
. O

We O
found O
that O
lncRNA B-RNA
- I-RNA
UCA1 I-RNA
expression O
was O
upregulated O
in O
osteosarcoma B-Disease
tissues O
and O
cell O
lines O
. O

MiR B-RNA
- I-RNA
18a I-RNA
upregulation O
decreases O
Dicer O
expression O
and O
confers O
paclitaxel O
resistance O
in O
triple O
negative O
breast B-Disease
cancer I-Disease
. O

Here O
we O
demonstrated O
that O
TUG1 B-RNA
was O
up O
- O
expressed O
in O
human O
glioblastoma B-Disease
tissues O
and O
glioblastoma B-Disease
cell O
lines O
. O

Deregulation O
of O
a O
number O
of O
lncRNAs O
, O
such O
as O
HOTAIR B-RNA
, O
XIST B-RNA
, O
MALAT B-RNA
, O
and O
H19 B-RNA
has O
been O
detected O
in O
breast B-Disease
cancer I-Disease
samples O
and O
cell O
lines O
. O

We O
show O
that O
TUG1 B-RNA
is O
significantly O
upregulated O
in O
human O
hepatoblastoma B-Disease
specimens O
and O
metastatic O
hepatoblastoma B-Disease
cell O
lines O
. O

TUG1 B-RNA
expression O
was O
confirmed O
to O
be O
upregulated O
in O
glioma B-Disease
tissues O
, O
and O
showed O
an O
inverse O
correlation O
with O
downregulated O
miR B-RNA
- I-RNA
26a I-RNA
. O

Our O
study O
discloses O
the O
role O
of O
PVT1 B-RNA
as O
a O
novel O
prognostic O
factor O
and O
as O
a O
molecular O
target O
for O
novel O
therapeutic O
interventions O
in O
renal B-Disease
carcinoma I-Disease
. O

Long O
noncoding O
RNA O
GIHCG B-RNA
promotes O
hepatocellular B-Disease
carcinoma I-Disease
progression O
through O
epigenetically O
regulating O
miR B-RNA
- I-RNA
200b I-RNA
/ I-RNA
a I-RNA
/ I-RNA
429 I-RNA
. O

LncRNA O
FER1L4 B-RNA
suppresses O
cancer O
cell O
proliferation O
and O
cycle O
by O
regulating O
PTEN O
expression O
in O
endometrial B-Disease
carcinoma I-Disease
. O

Long O
non O
- O
coding O
RNA O
CRNDE B-RNA
promotes O
tumor O
growth O
in O
medulloblastoma B-Disease
. O

In O
the O
current O
study O
, O
we O
firstly O
reported O
that O
NEAT1 B-RNA
was O
consistently O
up O
- O
regulated O
in O
bladder B-Disease
cancer I-Disease
tissues O
compared O
to O
the O
matched O
tissues O
and O
bladder B-Disease
cancer I-Disease
cell O
lines O
compared O
to O
the O
normal O
bladder O
epithelial O
cell O
and O
the O
expression O
level O
of O
the O
NEAT1 B-RNA
in O
bladder B-Disease
cancer I-Disease
tissues O
is O
closely O
related O
to O
its O
clinical O
pathologic O
grade O
and O
TNM O
phase O
. O

In O
this O
study O
, O
we O
demonstrate O
that O
lncRNA B-RNA
- I-RNA
CLMAT3 I-RNA
expression O
was O
significantly O
increased O
in O
colorectal B-Disease
cancer I-Disease
cells O
compared O
with O
a O
normal O
intestinal O
mucous O
cell O
line O
and O
that O
inhibition O
of O
lncRNA B-RNA
- I-RNA
CLMAT3 I-RNA
suppressed O
colorectal B-Disease
cancer I-Disease
cell O
proliferation O
in O
vitro O
. O
. O

It O
was O
detected O
that O
the O
piR B-RNA
- I-RNA
651 I-RNA
expression O
increased O
in O
MCF O
- O
7 O
and O
MDA O
- O
MB O
- O
231 O
breast B-Disease
cancer I-Disease
cells O
treated O
with O
estrogen O

It O
was O
detected O
that O
the O
piR B-RNA
- I-RNA
651 I-RNA
expression O
increased O
in O
LNCaP O
and O
PC O
- O
3 O
prostate B-Disease
cancer I-Disease
cells O
treated O
with O
androgen O

After O
estrogen O
treatment O
, O
piR B-RNA
- I-RNA
823 I-RNA
expressions O
decreased O
in O
MCF O
breast B-Disease
cancer I-Disease
cells O
line O
which O
were O
malignant O

The O
lncRNA O
MALAT1 B-RNA
functions O
as O
a O
competing O
endogenous O
RNA O
to O
regulate O
MCL B-RNA
- I-RNA
1 I-RNA
expression O
by O
sponging O
miR O
- O
363 O
- O
3p O
in O
gallbladder B-Disease
cancer I-Disease
. O

uc004cov B-RNA
. I-RNA
4 I-RNA
is O
highly O
upregulated O
in O
blood O
of O
hypertrophic B-Disease
cardiomyopathy I-Disease
patients O

This O
study O
identifiedGAS5 O
as O
a O
critical O
regulator O
in O
hypertension B-Disease
and O
demonstrated O
the O
potential O
of O
gene O
therapy O
and O
drug O
development O
for O
treating O
hypertension B-Disease
. O

Decreased O
expression O
of O
the O
long O
noncoding O
RNA O
LINC00261 B-RNA
indicate O
poor O
prognosis O
in O
gastric B-Disease
cancer I-Disease
and O
suppress O
gastric B-Disease
cancer I-Disease
metastasis O
by O
affecting O
the O
epithelial O
- O
mesenchymal O
transition O
. O

Long O
non O
- O
coding O
RNA O
LINC01133 B-RNA
inhibits O
epithelial O
- O
mesenchymal O
transition O
and O
metastasis O
in O
colorectal B-Disease
cancer I-Disease
by O
interacting O
with O
SRSF6 O
. O

The O
results O
confirmed O
that O
HOTAIR B-RNA
mRNA O
expression O
was O
inversely O
correlated O
with O
miR O
- O
148b O
- O
3p O
expression O
in O
A172 O
glioma B-Disease
cells O
. O

NEAT1 B-RNA
messenger O
RNA O
( O
mRNA O
) O
expression O
levels O
were O
significantly O
downregulated O
in O
leukemia B-Disease
patient O
samples O
compared O
with O
those O
from O
healthy O
donors O
. O

ZFP91 B-RNA
- I-RNA
P I-RNA
expression O
was O
initially O
detected O
in O
two O
pancreatic B-Disease
cancer I-Disease
cell O
lines O
by O
reverse O
transcription O
- O
quantitative O
polymerase O
chain O
reaction O
( O
RT O
- O
qPCR O
) O
and O
the O
highest O
expression O
of O
ZFP91 B-RNA
- I-RNA
P I-RNA
was O
found O
in O
the O
BXPC O
- O
3 O
- O
H O
cell O
line O
. O

We O
found O
that O
overexpression O
of O
one O
specific O
T O
- O
UCRs O
named O
uc B-RNA
. I-RNA
63 I-RNA
is O
associated O
with O
bad O
outcome O
in O
luminal O
A O
subtype O
of O
breast B-Disease
cancer I-Disease
patients O
. O

GCASPC B-RNA
was O
overexpressed O
or O
silenced O
in O
several O
gallbladder B-Disease
cancer I-Disease
cell O
lines O
where O
molecular O
and O
biological O
analysis O
were O
performed O

Upregulated O
long O
noncoding O
RNA O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
contributes O
to O
increased O
cell O
viability O
by O
activating O
zinc O
finger O
703 O
expression O
in O
esophageal O
squamous O
cell O
carcinoma O
. O

Knockdown O
of O
Long O
Noncoding O
RNA O
PCAT6 B-RNA
Inhibits O
Proliferation O
and O
Invasion O
in O
Lung B-Disease
Cancer I-Disease
Cells O
. O

MALAT1 B-RNA
promotes O
osteosarcoma B-Disease
development O
by O
targeting O
TGFA O
via O
MIR376A O
. O

The O
expression O
levels O
of O
AK001091 B-RNA
and O
AK024171 B-RNA
in O
gastric O
cancerous O
tissues O
were O
lower O
than O
those O
in O
non O
- O
cancerous O
gastric O
tissues O
, O
while O
the O
expression O
levels O
of O
AK093735 O
, O
BC003519 O
and O
NR O
_ O
3573 O
in O
gastric O
cancerous O
tissues O
were O
higher O
than O
those O
in O
non O
- O
cancerous O
gastric O
tissues O
. O

miR B-RNA
- I-RNA
326 I-RNA
reverses O
chemoresistance O
in O
human O
lung B-Disease
adenocarcinoma I-Disease
cells O
by O
targeting O
specificity O
protein O
1 O

Long O
noncoding O
RNA O
BCAR4 B-RNA
promotes O
osteosarcoma B-Disease
progression O
through O
activating O
GLI2 O
- O
dependent O
gene O
transcription O
. O

The O
expression O
level O
of O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
was O
significantly O
higher O
in O
glioma B-Disease
in O
comparison O
to O
normal O
matched O
tissue O
. O

Real O
- O
time O
polymerase O
chain O
reaction O
( O
PCR O
) O
results O
indicated O
that O
ANRIL B-RNA
expression O
is O
upregulated O
in O
the O
two O
melanoma B-Disease
cell O
lines O
. O

Long O
non O
- O
coding O
RNA O
XIST B-RNA
exerts O
oncogenic O
functions O
in O
human O
nasopharyngeal B-Disease
carcinoma I-Disease
by O
targeting O
miR B-RNA
- I-RNA
34a I-RNA
- I-RNA
5p I-RNA
. O

Characterization O
of O
global O
microRNA O
expression O
reveals O
oncogenic O
potential O
of O
miR B-RNA
- I-RNA
145 I-RNA
in O
metastatic O
colorectal B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
203 I-RNA
: O
miR B-RNA
- I-RNA
124 I-RNA
and O
miR B-RNA
- I-RNA
203 I-RNA
are O
epigenetically O
silenced O
tumor O
- O
suppressive O
microRNAs O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

Selective O
blockade O
of O
microRNA B-RNA
( I-RNA
miR I-RNA
) I-RNA
- I-RNA
126 I-RNA
suppressed O
the O
asthmatic B-Disease
phenotype O
. O

Recently O
, O
the O
SNPs O
rs11614913 O
in O
hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
196a2 I-RNA
and O
rs3746444 O
in O
hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
499 I-RNA
were O
reported O
to O
be O
associated O
with O
increased O
breast B-Disease
cancer I-Disease
risk O
, O
and O
the O
SNP O
rs2910164 O
in O
hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
146a I-RNA
was O
shown O
to O
have O
an O
effect O
on O
age O
of O
breast B-Disease
cancer I-Disease
diagnosis O
. O

miR O
- O
143 O
is O
as O
a O
new O
target O
for O
prostate B-Disease
cancer I-Disease
treatment O
. O

MicroRNA B-RNA
- I-RNA
214 I-RNA
is O
aberrantly O
expressed O
in O
cervical B-Disease
cancers I-Disease
and O
inhibits O
the O
growth O
of O
HeLa O
cells O
. O

Our O
findings O
reveal O
that O
diverse O
changes O
of O
miRNAs O
occur O
during O
liver O
development O
and O
, O
one O
of O
these O
, O
miR B-RNA
- I-RNA
500 I-RNA
is O
an O
oncofetal O
miRNA O
relevant O
to O
the O
diagnosis O
of O
human O
HCC B-Disease
. O

MicroRNA B-RNA
- I-RNA
125a I-RNA
represses O
cell O
growth O
by O
targeting O
HuR O
in O
breast B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
222 I-RNA
( O
p O
= O
0 O
. O
23 O
) O
and O
miR B-RNA
- I-RNA
181a I-RNA
( O
p O
= O
0 O
. O
14 O
) O
expression O
was O
higher O
in O
AML B-Disease
than O
in O
MDS O
. O

Involvement O
of O
miR B-RNA
- I-RNA
326 I-RNA
in O
chemotherapy O
resistance O
of O
breast B-Disease
cancer I-Disease
through O
modulating O
expression O
of O
multidrug O
resistance O
- O
associated O
protein O
1 O
. O

miR B-RNA
- I-RNA
218 I-RNA
expression O
was O
reduced O
significantly O
in O
gastric B-Disease
cancer I-Disease
tissues O
, O
in O
H O
. O
pylori O
- O
infected O
gastric O
mucosa O
, O
and O
in O
H O
. O
pylori O
- O
infected O
AGS O
cells O
. O

Pcgem1 B-RNA
, O
a O
patented O
prostatespecific O
non O
- O
coding O
rna O
gene O
with O
an O
upregulated O
transcription O
in O
African O
American O
malignancy O
will O
be O
discussed O
in O
relationship O
to O
the O
etiology O
of O
prostate B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
138 I-RNA
: O
miR B-RNA
- I-RNA
138 I-RNA
might O
reverse O
multidrug O
resistance O
of O
leukemia B-Disease
cells O
. O

These O
findings O
suggest O
the O
development O
of O
therapeutic O
strategies O
by O
restoring O
miR B-RNA
- I-RNA
15a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
expression O
in O
ovarian B-Disease
cancer I-Disease
and O
in O
other O
cancers O
that O
involve O
upregulation O
of O
Bmi O
- O
1 O
. O

Our O
data O
indicate O
that O
reduction O
in O
miR B-RNA
- I-RNA
145 I-RNA
expression O
may O
provide O
bladder B-Disease
cancer I-Disease
cells O
with O
a O
selective O
advantage O
by O
inhibition O
of O
cell O
death O
otherwise O
triggered O
in O
malignant O
cells O
. O

We O
hypothesize O
that O
the O
G O
- O
variant O
of O
rs895819 O
might O
impair O
the O
maturation O
of O
the O
oncogenic O
miR B-RNA
- I-RNA
27a I-RNA
and O
thus O
, O
is O
associated O
with O
familial O
breast B-Disease
cancer I-Disease
risk O
. O

miR O
- O
34a O
: O
MicroRNA B-RNA
- I-RNA
34a I-RNA
is O
an O
important O
component O
of O
PRIMA O
- O
1 O
- O
induced O
apoptotic O
network O
in O
human O
lung B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
223 I-RNA
is O
overexpressed O
in O
T O
- O
lymphocytes O
of O
patients O
affected O
by O
rheumatoid B-Disease
arthritis I-Disease
. O

As O
compared O
to O
NEC O
, O
miRNAs O
signi O
fi O
cantly O
upregulated O
in O
AD B-Disease
subjects O
and O
confi O
rmed O
by O
qPCR O
were O
miR B-RNA
- I-RNA
34a I-RNA
and O
181b O
. O

Both O
glioma B-Disease
and O
glioblastoma B-Disease
multiforme I-Disease
( O
GBM O
) O
cell O
lines O
exhibited O
a O
significant O
down O
- O
regulation O
of O
miRNA B-RNA
- I-RNA
128 I-RNA
ranging O
from O
an O
average O
of O
0 O
. O
24 O
- O
to O
0 O
. O
54 O
- O
fold O
compared O
to O
primary O
human O
neural O
cell O
controls O
. O

miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
: O
the O
detection O
of O
upregulation O
of O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
and O
miR B-RNA
- I-RNA
181a I-RNA
in O
B O
- O
and O
T B-Disease
- I-Disease
cell I-Disease
lymphomas I-Disease
respectively O
. O

We O
investigated O
whether O
two O
highly O
predicted O
microRNAs O
( O
miRNAs O
) O
, O
miR B-RNA
- I-RNA
140 I-RNA
and O
miR B-RNA
- I-RNA
27a I-RNA
, O
regulate O
these O
two O
genes O
in O
human O
OA B-Disease
chondrocytes O
. O

miR O
- O
29a O
: O
MicroRNA B-RNA
- I-RNA
29a I-RNA
regulates O
intestinal O
membrane O
permeability O
in O
patients O
with O
irritable B-Disease
bowel I-Disease
syndrome I-Disease
. O

Up O
- O
regulation O
of O
p27 O
( O
kip1 O
) O
by O
miR B-RNA
- I-RNA
221 I-RNA
/ O
222 O
antisense O
oligonucleotides O
enhances O
the O
radiosensitivity O
of O
U251 O
glioblastoma B-Disease
. O

miR B-RNA
- I-RNA
27a I-RNA
: O
Down O
- O
regulation O
of O
miR B-RNA
- I-RNA
27a I-RNA
might O
reverse O
multidrug O
resistance O
of O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
335 I-RNA
and O
miR B-RNA
- I-RNA
195 I-RNA
were O
significantly O
downregulated O
in O
adrenocortical B-Disease
carcinomas I-Disease
. O

miR B-RNA
- I-RNA
311 I-RNA
- I-RNA
3p I-RNA
regulate O
ERBB O
- O
2 O
expression O
and O
androgen O
receptor O
signaling O
in O
prostate B-Disease
cancer I-Disease
. O

Correlation O
of O
overexpression O
of O
HMGA1 B-RNA
and O
HMGA2 B-RNA
with O
poor O
tumor O
differentiation O
, O
invasion O
, O
and O
proliferation O
associated O
with O
let B-RNA
- I-RNA
7 I-RNA
down O
- O
regulation O
in O
retinoblastomas B-Disease
. O

miR B-RNA
- I-RNA
24 I-RNA
, O
miR B-RNA
- I-RNA
149 I-RNA
, O
miR B-RNA
- I-RNA
638 I-RNA
and O
miR B-RNA
- I-RNA
1181 I-RNA
were O
identified O
to O
be O
involved O
in O
HCV B-Disease
entry O
, O
replication O
and O
propagation O
. O

MicroRNA B-RNA
- I-RNA
206 I-RNA
delays O
ALS B-Disease
progression O
and O
promotes O
regeneration O
of O
neuromuscular O
synapses O
in O
mice O
. O

miR B-RNA
- I-RNA
206 I-RNA
slows O
ALS B-Disease
progression O
by O
sensing O
motor O
neuron O
injury O
and O
promoting O
the O
compensatory O
regeneration O
of O
neuromuscular O
synapses O
. O

STAT5 O
requires O
the O
N O
- O
domain O
for O
suppression O
of O
miR15 B-RNA
/ O
16 O
, O
induction O
of O
bcl O
- O
2 O
, O
and O
survival O
signaling O
in O
myeloproliferative B-Disease
disease O
. O

MiR B-RNA
- I-RNA
221 I-RNA
and O
miR B-RNA
- I-RNA
222 I-RNA
were O
upregulated O
in O
ATRT B-Disease
and O
their O
expression O
inversely O
correlated O
with O
p27Kip1 B-RNA
mRNA O
expression O
. O

miR133a B-RNA
regulates O
cardiomyocyte B-Disease
hypertrophy I-Disease
in O
diabetes O
. O

Taken O
together O
, O
the O
murine O
and O
human O
data O
indicate O
an O
inverse O
correlation O
between O
miR B-RNA
- I-RNA
133 I-RNA
and O
miR B-RNA
- I-RNA
1 I-RNA
expression O
and O
myocardial B-Disease
hypertrophy I-Disease
. O

POU5F1P1 B-RNA
was O
found O
to O
be O
the O
only O
member O
of O
the O
POU5F1 O
family O
to O
be O
expressed O
in O
prostate O
with O
over O
- O
expression O
in O
prostatic B-Disease
carcinoma I-Disease
compared O
to O
surrounding O
prostatic O
tissue O
probably O
because O
of O
an O
increased O
density O
of O
expressing O
cells O
. O

miR B-RNA
- I-RNA
223 I-RNA
: O
miR B-RNA
- I-RNA
223 I-RNA
suppression O
in O
AML B-Disease
is O
caused O
by O
impaired O
miR B-RNA
- I-RNA
223 I-RNA
upstream O
factors O
. O

A O
set O
of O
12 O
miRNAs O
( O
including O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
, O
miR B-RNA
- I-RNA
34a I-RNA
, O
miR B-RNA
- I-RNA
519a I-RNA
, O
miR B-RNA
- I-RNA
93 I-RNA
, O
miR B-RNA
- I-RNA
96 I-RNA
, O
and O
let B-RNA
- I-RNA
7c I-RNA
) O
was O
linked O
to O
disease O
progression O
from O
normal O
liver O
through O
cirrhosis O
to O
full O
- O
blown O
HCC B-Disease
. O

miRNA O
profiling O
of O
these O
tumors O
identified O
members O
of O
the O
let B-RNA
- I-RNA
7 I-RNA
and I-RNA
miR I-RNA
- I-RNA
34 I-RNA
( O
34b O
, O
34c O
) O
families O
as O
candidate O
tumor O
suppressors O
in O
retinoblastoma B-Disease
. O

miR O
- O
15a O
: O
Micro B-RNA
- I-RNA
RNA I-RNA
- I-RNA
15a I-RNA
and O
micro B-RNA
- I-RNA
RNA I-RNA
- I-RNA
16 I-RNA
expression O
and O
chromosome O
13 O
deletions O
in O
multiple B-Disease
myeloma I-Disease
. O

let B-RNA
- I-RNA
7a I-RNA
: O
The O
let B-RNA
- I-RNA
7a I-RNA
microRNA O
protects O
from O
growth O
of O
lung B-Disease
carcinoma I-Disease
by O
suppression O
of O
k O
- O
Ras O
and O
c O
- O
Myc O
in O
nude O
mice O
. O

miR B-RNA
- I-RNA
491 I-RNA
: O
Functional O
screening O
identifies O
a O
microRNA O
, O
miR B-RNA
- I-RNA
491 I-RNA
that O
induces O
apoptosis O
by O
targeting O
Bcl O
- O
X O
( O
L O
) O
in O
colorectal B-Disease
cancer I-Disease
cells O
. O

miR O
- O
1 O
: O
miRNA B-RNA
- I-RNA
1 I-RNA
may O
have O
a O
functional O
effect O
on O
chordoma B-Disease
tumor O
pathogenesis O
. O

H19 B-RNA
expression O
was O
lower O
in O
the O
infertility B-Disease
group O
as O
compared O
to O
the O
control O
group O
. O

We O
propose O
that O
miR B-RNA
- I-RNA
141 I-RNA
- O
and O
tumor O
- O
related O
genes O
c O
- O
MYC O
, O
SPLUNC1 O
, O
BRD3 O
, O
UBAP1 O
and O
PTEN O
may O
constitute O
a O
gene O
- O
miRNA O
network O
to O
contribute O
to O
NPC B-Disease
development O
. O

ANRIL B-RNA
expression O
is O
associated O
with O
atherosclerosis B-Disease
risk O
. O

Expression O
of O
ANRIL B-RNA
transcripts O
was O
directly O
correlated O
with O
severity O
of O
atherosclerosis B-Disease
. O

Together O
, O
these O
results O
suggest O
that O
miR B-RNA
- I-RNA
27a I-RNA
would O
suppress O
adipocyte O
differentiation O
through O
targeting O
PPARgamma O
and O
thereby O
down O
- O
regulation O
of O
miR B-RNA
- I-RNA
27a I-RNA
might O
be O
associated O
with O
adipose O
tissue O
dysregulation O
in O
obesity B-Disease
. O

These O
findings O
establish O
a O
novel O
regulation O
of O
miR B-RNA
- I-RNA
24 I-RNA
- O
related O
AE1 B-RNA
expression O
in O
gastric B-Disease
carcinogenesis I-Disease
and O
erythropoiesis O
. O

hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
205 I-RNA
is O
a O
miRNA O
that O
is O
highly O
expressed O
in O
lung B-Disease
squamous I-Disease
cell I-Disease
carcinomas I-Disease
( O
SqCC O
) O
but O
not O
in O
lung O
adenocarcinomas O
. O

miR B-RNA
- I-RNA
193b I-RNA
: O
miR B-RNA
- I-RNA
193b I-RNA
is O
an O
epigenetically O
regulated O
putative O
tumor O
suppressor O
in O
prostate B-Disease
cancer I-Disease
. O

Disturbance O
of O
the O
balance O
between O
SRAP1 B-RNA
- O
coding O
and O
non O
- O
coding O
SRA1 B-RNA
RNAs O
in O
breast B-Disease
tumor I-Disease
tissues O
might O
be O
involved O
in O
breast O
tumorigenesis O
. O

Overexpression O
of O
miR B-RNA
- I-RNA
26a I-RNA
in O
PTEN O
- O
competent O
and O
PTEN O
- O
deficient O
glioblastoma B-Disease
cells O
promoted O
tumor O
growth O
in O
vivo O
, O
and O
it O
further O
increased O
growth O
in O
cells O
overexpressing O
CDK4 B-RNA
or O
CENTG1 B-RNA
. O

miR O
- O
181c O
: O
Involvement O
of O
epigenetically O
silenced O
microRNA B-RNA
- I-RNA
181c I-RNA
in O
gastric B-Disease
carcinogenesis I-Disease
. O

our O
results O
in O
primary O
MCL B-Disease
cells O
indicate O
that O
down O
- O
regulation O
of O
miR B-RNA
- I-RNA
29 I-RNA
could O
cooperate O
with O
cyclin O
D1 O
in O
MCL B-Disease
pathogenesis O
. O

overexpression O
of O
miR B-RNA
- I-RNA
34a I-RNA
in O
primary O
B B-Disease
- I-Disease
CLL I-Disease
cells O
induced O
apoptosis O
. O

Our O
findings O
indicate O
that O
miR B-RNA
- I-RNA
21 I-RNA
warrants O
further O
investigation O
as O
a O
marker O
for O
early O
detection O
of O
PDAC B-Disease
. O

miR B-RNA
- I-RNA
143 I-RNA
: O
miR B-RNA
- I-RNA
143 I-RNA
and O
- O
145 O
are O
important O
onco O
- O
related O
genes O
for O
the O
initiation O
step O
of O
colorectal B-Disease
tumor I-Disease
development O
. O

MicroRNA B-RNA
- I-RNA
145 I-RNA
targets O
YES O
and O
STAT1 O
in O
colon B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
9 I-RNA
targets O
NF O
- O
kappaB1 O
and O
regulates O
gastric B-Disease
cancer I-Disease
cell O
growth O
. O

What O
disclosed O
that O
PCA3 B-RNA
mRNA O
is O
prostate B-Disease
cancer I-Disease
specific O
and O
shows O
increased O
expression O
in O
prostate B-Disease
cancer I-Disease
. O

UCA1 B-RNA
mRNA O
was O
not O
detected O
in O
normal O
bladder O
, O
normal O
kidney O
, O
renal O
cancer O
or O
hyperplastic O
prostate O
tissues O
, O
but O
highly O
expressed O
in O
cancerous O
bladder O
tissues O
. O

UCA1 B-RNA
gene O
locates O
in O
the O
cytoplasm O
, O
and O
its O
mRNA O
expression O
level O
is O
closely O
corrrelated O
to O
the O
progression O
of O
bladder B-Disease
cancer I-Disease
, O
indication O
its O
potential O
as O
a O
specific O
molecular O
marker O
of O
bladder B-Disease
cancer I-Disease
. O

Increased O
lncRNA O
Gas5 B-RNA
activity O
in O
immune O
cells O
could O
suppress O
GR O
- O
induced O
transcriptional O
activity O
and O
contribute O
to O
the O
development O
of O
autoimmune B-Disease
disease I-Disease
. O

miR B-RNA
- I-RNA
15a I-RNA
and I-RNA
miR I-RNA
- I-RNA
16 I-RNA
- I-RNA
1 I-RNA
were O
the O
first O
microRNAs O
linked O
to O
cancer O
because O
their O
genes O
are O
commonly O
deleted O
in O
human O
chronic B-Disease
lymphocytic I-Disease
leukemia I-Disease
( O
CLL O
) O
. O

miR O
- O
27b O
: O
MicroRNA B-RNA
- I-RNA
27b I-RNA
regulates O
the O
expression O
of O
matrix O
metalloproteinase O
13 O
in O
human O
osteoarthritis B-Disease
chondrocytes O
. O

miR B-RNA
- I-RNA
31 I-RNA
ablates O
expression O
of O
the O
HIF O
regulatory O
factor O
FIH O
to O
activate O
the O
HIF O
pathway O
in O
head B-Disease
and I-Disease
neck I-Disease
carcinoma I-Disease
. O

The O
expression O
of O
the O
tumor O
marker O
MALAT1 B-RNA
ncRNA O
is O
sensitive O
to O
cell O
surface O
receptor O
activation O
by O
oxytocin O
in O
a O
neuroblastoma B-Disease
cell O
line O
. O

miR O
- O
125b O
: O
miRNA125b B-RNA
may O
be O
involved O
in O
the O
regulation O
of O
VDR O
expression O
and O
in O
the O
resistance O
against O
1 O
, O
25 O
( O
OH O
) O
( O
2 O
) O
D O
( O
3 O
) O
in O
melanoma B-Disease
cells O
. O

Elevated O
cardiac O
- O
specific O
miR B-RNA
- I-RNA
208a I-RNA
in O
plasma O
may O
be O
a O
novel O
biomarker O
for O
early O
detection O
of O
myocardial B-Disease
injury I-Disease
in O
humans O
. O

The O
transcriptional O
regulation O
of O
miR B-RNA
- I-RNA
21 I-RNA
, O
its O
multiple O
transcripts O
, O
and O
their O
implication O
in O
prostate B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
34c I-RNA
is O
down O
regulated O
in O
prostate B-Disease
cancer I-Disease
and O
exerts O
tumor O
suppressive O
functions O
. O

miR B-RNA
- I-RNA
218 I-RNA
: O
Polymorphisms O
involved O
in O
the O
miR B-RNA
- I-RNA
218 I-RNA
- O
LAMB3 O
pathway O
and O
susceptibility O
of O
cervical B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
133a I-RNA
: O
NFATc4 O
is O
negatively O
regulated O
in O
miR B-RNA
- I-RNA
133a I-RNA
- O
mediated O
cardiomyocyte B-Disease
hypertrophic I-Disease
repression O
. O

Here O
we O
show O
that O
miR B-RNA
- I-RNA
9 I-RNA
, O
which O
is O
upregulated O
in O
breast B-Disease
cancer I-Disease
cells O
, O
directly O
targets O
CDH1 O
, O
the O
E O
- O
cadherin O
- O
encoding O
messenger O
RNA O
, O
leading O
to O
increased O
cell O
motility O
and O
invasiveness O
. O

miR O
- O
130b O
: O
MicroRNA B-RNA
- I-RNA
130b I-RNA
regulates O
the O
tumour O
suppressor O
RUNX3 O
in O
gastric B-Disease
cancer I-Disease
. O

Our O
data O
show O
that O
reciprocal O
repression O
between O
miR B-RNA
- I-RNA
133 I-RNA
and O
calcineurin O
regulates O
cardiac B-Disease
hypertrophy I-Disease
. O

miR O
- O
9 O
and O
NFATc3 O
regulate O
myocardin O
in O
cardiac O
hypertrophy O

Most O
of O
the O
differentially O
expressed O
miRNAs O
were O
downregulated O
in O
germinomas B-Disease
, O
but O
miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
5p I-RNA
and O
miR B-RNA
- I-RNA
146a I-RNA
were O
upregulated O
. O

Consistent O
with O
other O
REST O
target O
genes O
, O
HAR1 B-RNA
levels O
are O
significantly O
lower O
in O
the O
striatum O
of O
HD B-Disease
patients O
compared O
to O
unaffected O
individuals O
. O

Therefore O
, O
these O
data O
are O
consistent O
with O
the O
hypothesis O
that O
MEG3 B-RNA
, O
which O
encodes O
a O
noncoding O
RNA O
, O
may O
be O
a O
tumor O
suppressor O
gene O
at O
chromosome O
14q32 O
involved O
in O
meningioma B-Disease
progression O
via O
a O
novel O
mechanism O
. O

miR B-RNA
- I-RNA
31 I-RNA
is O
associated O
with O
defects O
in O
the O
p53 O
pathway O
and O
functions O
in O
serous O
ovarian B-Disease
cancer I-Disease
and O
other O
cancers O
. O

A O
luciferase O
assay O
demonstrated O
that O
hsa B-RNA
- I-RNA
let I-RNA
- I-RNA
7f I-RNA
can O
target O
KLK10 O
in O
the O
RCC B-Disease
cell O
line O
ACHN O
. O

miR O
- O
433 O
: O
A O
mutation O
in O
the O
3 O
' O
- O
UTR O
of O
the O
HDAC6 B-RNA
gene O
abolishing O
the O
post O
- O
transcriptional O
regulation O
mediated O
by O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
433 I-RNA
is O
linked O
to O
a O
new O
form O
of O
dominant B-Disease
X I-Disease
- I-Disease
linked I-Disease
chondrodysplasia I-Disease
. O

Expression O
of O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
210 I-RNA
in O
head B-Disease
and I-Disease
neck I-Disease
cancer I-Disease
correlates O
with O
other O
approaches O
for O
assessing O
hypoxia O
and O
is O
associated O
with O
prognosis O
. O

Serum O
miR B-RNA
- I-RNA
146a I-RNA
and O
miR B-RNA
- I-RNA
223 I-RNA
as O
potential O
new O
biomarkers O
for O
sepsis B-Disease
. O

miR O
- O
196a2 O
: O
MIR196A2 B-RNA
polymorphism O
was O
associated O
with O
susceptibility O
to O
HBV O
- O
related O
HCC B-Disease
in O
a O
maleChinese O
population O
. O

microRNA B-RNA
- I-RNA
34a I-RNA
is O
tumor O
suppressive O
in O
brain B-Disease
tumors I-Disease
and O
glioma B-Disease
stem O
cells O
. O

miR B-RNA
- I-RNA
146a I-RNA
in O
PBMCs O
modulates O
Th1 O
function O
in O
patients O
with O
acute B-Disease
coronary I-Disease
syndrome I-Disease
. O

miR O
- O
137 O
: O
MicroRNA B-RNA
- I-RNA
137 I-RNA
promoter O
methylation O
in O
oral O
rinses O
from O
patients O
with O
squamous B-Disease
cell I-Disease
carcinoma I-Disease
of I-Disease
the I-Disease
head I-Disease
and I-Disease
neck I-Disease
is O
associated O
with O
gender O
and O
body O
mass O
index O
. O

Specifically O
, O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
, O
which O
is O
involved O
in O
autoimmunity O
, O
is O
upregulated O
in O
CD4 O
( O
+ O
) O
cells O
from O
MS B-Disease
patients O
. O

miR B-RNA
- I-RNA
29a I-RNA
decreased O
in O
Alzheimer B-Disease
disease I-Disease
brains O
targets O
neuron O
navigator O
- O
3 O
. O

By O
microarray O
analysis O
, O
we O
identified O
up O
- O
regulation O
of O
miR B-RNA
- I-RNA
29a I-RNA
, O
miR B-RNA
- I-RNA
29b I-RNA
and O
miR B-RNA
- I-RNA
338 I-RNA
- I-RNA
3p I-RNA
in O
amyotrophic B-Disease
lateral I-Disease
sclerosis I-Disease
brains O
. O

miR B-RNA
- I-RNA
222 I-RNA
: O
miR B-RNA
- I-RNA
221 I-RNA
/ O
222 O
and O
p27 O
may O
represent O
a O
regulatory O
loop O
that O
helps O
maintaining O
CLL B-Disease
cells O
in O
a O
resting O
condition O
. O

MicroRNA B-RNA
- I-RNA
181a I-RNA
sensitizes O
human O
malignant O
glioma O
U87MG O
cells O
to O
radiation O
by O
targeting O
Bcl O
- O
2 O
. O

Increased O
miR B-RNA
- I-RNA
146a I-RNA
expression O
was O
also O
observed O
in O
human O
temporal B-Disease
lobe I-Disease
epilepsy I-Disease
hippocampus O
specimens O
compared O
with O
control O
hippocampus O
. O

MicroRNA B-RNA
- I-RNA
375 I-RNA
is O
downregulated O
in O
gastric B-Disease
carcinomas I-Disease
. O

MicroRNA B-RNA
- I-RNA
21 I-RNA
( O
miR O
- O
21 O
) O
represses O
tumor O
suppressor O
PTEN O
and O
promotes O
growth O
and O
invasion O
in O
non B-Disease
- I-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
( O
NSCLC O
) O
. O

MicroRNA B-RNA
- I-RNA
375 I-RNA
targets O
Hippo O
- O
signaling O
effector O
YAP O
in O
liver B-Disease
cancer I-Disease
and O
inhibits O
tumor O
properties O
. O

A O
polymorphism O
of O
microRNA196a B-RNA
genome O
region O
was O
associated O
with O
decreased O
risk O
of O
glioma B-Disease
in O
Chinese O
population O
. O

a O
cluster O
of O
three O
microRNAs O
including O
miR B-RNA
- I-RNA
134 I-RNA
, O
miR B-RNA
- I-RNA
198 I-RNA
, O
and O
miR B-RNA
- I-RNA
370 I-RNA
, O
suggesting O
that O
the O
microRNA O
signatures O
can O
be O
used O
to O
identify O
patients O
at O
risk O
for O
acute B-Disease
coronary I-Disease
syndromes I-Disease
. O

miR B-RNA
- I-RNA
20b I-RNA
modulates O
VEGF O
expression O
by O
targeting O
HIF O
- O
1alpha O
and O
STAT3 O
in O
MCF O
- O
7 O
breast B-Disease
cancer I-Disease
cells O
. O

we O
demonstrate O
that O
miR B-RNA
- I-RNA
138 I-RNA
suppresses O
TSCC B-Disease
cell O
migration O
and O
invasion O
by O
regulating O
two O
key O
genes O
in O
the O
Rho O
GTPase O
signaling O
pathway O
. O

Together O
, O
these O
data O
demonstrate O
that O
elevated O
expression O
levels O
of O
Dicer B-RNA
in O
oral B-Disease
cancer I-Disease
cells O
correlate O
with O
downregulation O
of O
let B-RNA
- I-RNA
7b I-RNA
and O
increased O
cell O
proliferation O
. O

let B-RNA
- I-RNA
7b I-RNA
, O
but O
not O
let B-RNA
- I-RNA
7a I-RNA
, O
was O
significantly O
reduced O
in O
the O
HNSCC B-Disease
cell O
lines O
compared O
to O
control O
cells O
. O

miR B-RNA
- I-RNA
31 I-RNA
: O
Increase O
of O
microRNA O
miR B-RNA
- I-RNA
31 I-RNA
level O
in O
plasma O
could O
be O
a O
potential O
marker O
of O
oral B-Disease
cancer I-Disease
. O

plasma O
miR B-RNA
- I-RNA
31 I-RNA
could O
be O
validated O
a O
marker O
of O
OSCC B-Disease
for O
diagnostic O
uses O
. O

the O
plasma O
concentrations O
of O
miRNAs O
( O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
5p I-RNA
, O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
106a I-RNA
, O
miR B-RNA
- I-RNA
106b I-RNA
) O
were O
significantly O
higher O
in O
GC B-Disease
patients O
than O
controls O
. O

A O
novel O
mutation O
in O
the O
miR B-RNA
- I-RNA
128b I-RNA
gene O
reduces O
miRNA O
processing O
and O
leads O
to O
glucocorticoid O
resistance O
of O
MLL O
- O
AF4 O
acute O
lymphocytic O
leukemia O
cells O
. O

MiR B-RNA
- I-RNA
218 I-RNA
inhibits O
invasion O
and O
metastasis O
of O
gastric B-Disease
cancer I-Disease
by O
targeting O
the O
Robo1 O
receptor O
. O

miR B-RNA
- I-RNA
21 I-RNA
acts O
as O
an O
oncogene O
and O
miR O
- O
30b O
a O
tumor O
suppressor O
gene O
in O
MM B-Disease
. O

miR O
- O
21 O
acts O
as O
an O
oncogene O
and O
miR B-RNA
- I-RNA
30b I-RNA
a O
tumor O
suppressor O
gene O
in O
MM B-Disease
. O

MicroRNA B-RNA
- I-RNA
193b I-RNA
Represses O
Cell O
Proliferationand O
Regulates O
Cyclin O
D1 O
in O
Melanoma B-Disease
. O

significantly O
increases O
HCC B-Disease
cell O
migration O
and O
invasion O
in O
vitro O
and O
in O
vivo O
, O
mainly O
through O
miR B-RNA
- I-RNA
151 I-RNA
- I-RNA
5p I-RNA
, O
but O
not O
through O
miR O
- O
151 O
- O
3p O
. O

Hsa B-RNA
- I-RNA
let I-RNA
- I-RNA
7g I-RNA
inhibits O
proliferation O
of O
hepatocellular B-Disease
carcinoma I-Disease
Cells O
by O
down O
- O
regulation O
of O
c O
- O
Myc O
and O
Up O
- O
regulation O
of O
p16 O
( O
INK4A O
) O
. O

MicroRNA145 B-RNA
targets O
BNIP3 O
and O
suppresses O
prostate B-Disease
cancer I-Disease
progression O
. O

Aberrant O
MicroRNA B-RNA
- I-RNA
155 I-RNA
expression O
is O
an O
early O
event O
in O
the O
multistep O
progression O
of O
pancreatic B-Disease
adenocarcinoma I-Disease
. O

Expression O
of O
microRNA B-RNA
- I-RNA
21 I-RNA
in O
ovarian O
epithelial B-Disease
carcinoma I-Disease
and O
its O
clinical O
significance O
. O

Let B-RNA
- I-RNA
7g I-RNA
targets O
collagen O
type O
I O
alpha2 O
and O
inhibits O
cell O
migration O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

hsa O
- O
let O
- O
7a O
: O
The O
let B-RNA
- I-RNA
7 I-RNA
family O
of O
microRNAs O
inhibits O
Bcl O
- O
xL O
expression O
and O
potentiates O
sorafenib O
- O
induced O
apoptosis O
in O
human O
hepatocellular B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
17 I-RNA
: O
detection O
of O
miRNA O
in O
peripheral O
blood O
may O
be O
a O
novel O
tool O
for O
monitoring O
circulating O
tumor O
cells O
in O
patients O
with O
gastric B-Disease
cancers I-Disease
. O

miR O
- O
34a O
: O
MicroRNA B-RNA
- I-RNA
34a I-RNA
suppresses O
invasion O
through O
downregulation O
of O
Notch1 O
and O
Jagged1 O
in O
cervical B-Disease
carcinoma I-Disease
and O
choriocarcinoma B-Disease
cells O
. O

Therapeutic O
silencing O
of O
miR B-RNA
- I-RNA
10b I-RNA
inhibits O
metastasis O
in O
a O
mouse O
mammary B-Disease
tumor I-Disease
model O
. O

Our O
data O
indicate O
that O
miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
are O
involved O
in O
the O
regulation O
of O
MYO6 O
expression O
and O
possibly O
in O
the O
development O
of O
prostate B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
21 I-RNA
: O
Deregulated O
expression O
of O
miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
181a I-RNA
in O
non B-Disease
small I-Disease
cell I-Disease
lung I-Disease
cancer I-Disease
is O
related O
to O
clinicopathologic O
characteristics O
or O
patient O
prognosis O
. O

MicroRNA B-RNA
- I-RNA
602 I-RNA
regulating O
tumor O
suppressive O
gene O
RASSF1A O
is O
overexpressed O
in O
hepatitis O
B O
virus O
- O
infected O
liver O
and O
hepatocellular B-Disease
carcinoma I-Disease
. O

Network O
modeling O
identifies O
molecular O
functions O
targeted O
by O
miR B-RNA
- I-RNA
204 I-RNA
to O
suppress O
head B-Disease
and I-Disease
neck I-Disease
tumor I-Disease
metastasis O
. O

Specifically O
, O
the O
disruption O
of O
the O
DISC O
genomic O
locus O
, O
which O
encodes O
both O
the O
DISC1 O
protein O
- O
coding O
gene O
and O
the O
DISC2 B-RNA
lncRNA O
, O
has O
been O
linked O
in O
a O
number O
of O
genetic O
analysis O
to O
the O
risk O
of O
developing O
schizophrenia B-Disease
, O
schizoaffective B-Disease
disorder I-Disease
, O
bipolar B-Disease
disorder I-Disease
, O
major O
depression O
, O
and O
autistic O
spectrum O
disorders O
. O

we O
show O
that O
miR B-RNA
- I-RNA
650 I-RNA
is O
involved O
in O
lymphatic O
and O
distant O
metastasis O
in O
human O
gastric B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
27a I-RNA
: O
MicroRNA B-RNA
- I-RNA
27a I-RNA
Indirectly O
Regulates O
Estrogen O
Receptor O
{ O
alpha O
} O
Expression O
and O
Hormone O
Responsiveness O
in O
MCF O
- O
7 O
Breast O
Cancer O
Cells O
. O

EWS O
- O
FLI O
- O
1 O
modulates O
miRNA145 B-RNA
and O
SOX2 B-RNA
expression O
to O
initiate O
mesenchymal O
stem O
cell O
reprogramming O
toward O
Ewing B-Disease
sarcoma I-Disease
cancer I-Disease
stem O
cells O
. O

In O
particular O
, O
changes O
in O
this O
pathway O
have O
been O
observed O
in O
clinically O
nonfunctioning O
pituitary B-Disease
adenomas I-Disease
, O
which O
do O
not O
express O
MEG3 O
, O
compared O
with O
normal O
tissue O
and O
hormone O
- O
secreting O
tumors O
, O
which O
express O
MEG3 O
. O

mir B-RNA
- I-RNA
182 I-RNA
: O
Hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
182 I-RNA
suppresses O
lung B-Disease
tumorigenesis I-Disease
through O
down O
regulation O
of O
RGS17 O
expression O
in O
vitro O
. O

The O
study O
elucidates O
that O
fine O
tuning O
of O
HULC B-RNA
expression O
is O
part O
of O
an O
auto O
- O
regulatory O
loop O
in O
which O
it O
' O
s O
inhibitory O
to O
expression O
and O
activity O
of O
miR B-RNA
- I-RNA
372 I-RNA
allows O
lncRNA O
up O
- O
regulated O
expression O
in O
liver B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
148a I-RNA
: O
The O
silencing O
of O
microRNA B-RNA
148a I-RNA
production O
by O
DNA O
hypermethylation O
is O
an O
early O
event O
in O
pancreatic B-Disease
carcinogenesis I-Disease
. O

We O
find O
that O
the O
rs7536540 O
polymorphism O
in O
miR O
- O
101 O
- O
1 O
is O
significantly O
associated O
with O
development O
of O
liver B-Disease
cirrhosis I-Disease
and O
hepatocellular B-Disease
carcinoma I-Disease
occurrence O
. O

miR B-RNA
- I-RNA
155 I-RNA
: O
MicroRNA B-RNA
- I-RNA
155 I-RNA
contributes O
to O
preeclampsia B-Disease
by O
down O
- O
regulating O
CYR61 B-RNA
. O

MiR O
- O
222 O
: O
MiR O
- O
221 O
and O
MiR O
- O
222 O
alterations O
in O
sporadic B-Disease
ovarian I-Disease
carcinoma I-Disease

miR B-RNA
- I-RNA
31 I-RNA
: O
Pro O
- O
tumorigenic O
effects O
of O
miR B-RNA
- I-RNA
31 I-RNA
loss O
in O
mesothelioma B-Disease
. O

MiR B-RNA
- I-RNA
133b I-RNA
has O
been O
implicated O
in O
Parkinson B-Disease
' I-Disease
s I-Disease
disease I-Disease
( O
PD O
) O
by O
a O
mechanism O
that O
involves O
the O
regulation O
of O
the O
transcription O
factor O
PITX3 O
. O

Our O
results O
demonstrate O
that O
miR B-RNA
- I-RNA
34a I-RNA
acts O
as O
a O
tumor O
suppressor O
in O
p53 O
- O
mutant O
glioma B-Disease
cells O
U251 O
, O
partially O
through O
regulating O
SIRT1 O
. O

Taken O
together O
, O
our O
results O
suggest O
that O
miR B-RNA
- I-RNA
182 I-RNA
could O
be O
a O
valuable O
marker O
of O
glioma B-Disease
progression O
and O
that O
high O
miR B-RNA
- I-RNA
182 I-RNA
expression O
is O
associated O
with O
poor O
overall O
survival O
in O
patients O
with O
malignant O
glioma B-Disease
. O

miR B-RNA
- I-RNA
196a I-RNA
: O
MicroRNA O
miR B-RNA
- I-RNA
196a I-RNA
is O
a O
central O
regulator O
of O
HOX O
- O
B7 O
and O
BMP4 O
expression O
in O
malignant B-Disease
melanoma I-Disease
. O

Although O
the O
IGF2 B-RNA
and O
H19 B-RNA
genotypes O
/ O
haplotypes O
were O
not O
significantly O
associated O
with O
melanoma B-Disease
, O
two O
of O
the O
most O
severe O
cases O
( O
very O
early O
onset O
or O
multiple O
melanomas O
) O
showed O
to O
be O
heterozygous O
for O
both O
genes O
. O

miR B-RNA
- I-RNA
200b I-RNA
: O
Downregulation O
of O
microRNA B-RNA
- I-RNA
200 I-RNA
in O
EBV B-Disease
- I-Disease
associated I-Disease
gastric I-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
200c I-RNA
: O
Downregulation O
of O
microRNA B-RNA
- I-RNA
200 I-RNA
in O
EBV B-Disease
- I-Disease
associated I-Disease
gastric I-Disease
carcinoma I-Disease
. O

miR O
- O
1224 O
- O
3P O
: O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
371 I-RNA
- I-RNA
5P I-RNA
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
423 I-RNA
- I-RNA
5P I-RNA
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
638 I-RNA
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
1224 I-RNA
- I-RNA
3P I-RNA
and O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
663 I-RNA
that O
were O
differentially O
expressed O
in O
lupus B-Disease
nephritis I-Disease
across O
different O
racial O
groups O
and O
all O
specimen O
types O
tested O
. O

miR B-RNA
- I-RNA
192 I-RNA
: O
miR B-RNA
- I-RNA
192 I-RNA
mediates O
TGF O
- O
beta O
/ O
Smad3 O
- O
driven O
renal B-Disease
fibrosis I-Disease
. O

we O
identified O
miRNAs O
that O
are O
up O
- O
and O
down O
- O
regulated O
in O
melanoma B-Disease
cells O
exposed O
to O
a O
hESC O
microenvironment O
, O
such O
as O
miR B-RNA
- I-RNA
302a I-RNA
and O
miR B-RNA
- I-RNA
27b I-RNA
, O
respectively O
. O

Mir B-RNA
- I-RNA
30 I-RNA
: O
Mir B-RNA
- I-RNA
30 I-RNA
reduction O
maintains O
self O
- O
renewal O
and O
inhibits O
apoptosis O
in O
breast B-Disease
tumor I-Disease
- O
initiating O
cells O
. O

miR B-RNA
- I-RNA
146a I-RNA
: O
The O
role O
of O
microRNA B-RNA
- I-RNA
146a I-RNA
( O
miR B-RNA
- I-RNA
146a I-RNA
) O
and O
its O
target O
IL O
- O
1R O
- O
associated O
kinase O
( O
IRAK1 O
) O
in O
psoriatic B-Disease
arthritis I-Disease
susceptibility O
. O

We O
found O
that O
the O
expression O
of O
BACE1 B-RNA
- O
antisense O
as O
well O
as O
miR B-RNA
- I-RNA
485 I-RNA
- I-RNA
5p I-RNA
are O
dysregulated O
in O
RNA O
samples O
from O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
subjects O
compared O
to O
control O
individuals O
. O

miRNA B-RNA
- I-RNA
331 I-RNA
- I-RNA
3p I-RNA
: O
miRNA B-RNA
- I-RNA
331 I-RNA
- I-RNA
3p I-RNA
directly O
targets O
E2F1 O
and O
induces O
growth O
arrest O
in O
human O
gastric B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
92a I-RNA
: O
Deregulation O
of O
miR B-RNA
- I-RNA
92a I-RNA
expression O
is O
implicated O
in O
hepatocellular B-Disease
carcinoma I-Disease
development O
. O

miR O
- O
206 O
: O
Waldenstrom B-Disease
macroglobulinemia I-Disease
( O
WM O
) O
cells O
present O
with O
increased O
expression O
of O
microRNA B-RNA
- I-RNA
206 I-RNA
( O
miRNA B-RNA
- I-RNA
206 I-RNA
) O
and O
reduced O
expression O
of O
miRNA O
- O
9 O
. O

miR O
- O
206 O
: O
Waldenstrom B-Disease
macroglobulinemia I-Disease
( O
WM O
) O
cells O
present O
with O
increased O
expression O
of O
microRNA O
- O
206 O
( O
miRNA O
- O
206 O
) O
and O
reduced O
expression O
of O
miRNA B-RNA
- I-RNA
9 I-RNA
. O

miR B-RNA
- I-RNA
122 I-RNA
: O
Small O
molecule O
modifiers O
of O
microRNA O
miR B-RNA
- I-RNA
122 I-RNA
function O
for O
the O
treatment O
of O
hepatitis B-Disease
C I-Disease
virus O
infection O
and O
hepatocellular B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
200b I-RNA
: O
The O
elevated O
serum O
levels O
of O
miR B-RNA
- I-RNA
200a I-RNA
and O
miR B-RNA
- I-RNA
200b I-RNA
in O
most O
patients O
with O
pancreatic B-Disease
cancer I-Disease
could O
have O
diagnostic O
utility O
. O

miR B-RNA
- I-RNA
21 I-RNA
: O
miR B-RNA
- I-RNA
21 I-RNA
might O
be O
a O
novel O
therapeutic O
target O
in O
cardiovascular O
diseases O
. O

The O
7SL B-RNA
RNA O
PCR O
has O
proven O
useful O
for O
direct O
diagnosis O
of O
Old O
World O
leishmaniasis B-Disease
, O
especially O
when O
combined O
with O
the O
RBD O
assay O
for O
species O
identification O
. O

miR B-RNA
- I-RNA
23b I-RNA
: O
miR B-RNA
- I-RNA
23b I-RNA
targets O
proline O
oxidase O
, O
a O
novel O
tumor O
suppressor O
protein O
in O
renal B-Disease
cancer I-Disease
. O

our O
results O
identify O
miR B-RNA
- I-RNA
196a I-RNA
and O
miR B-RNA
- I-RNA
196b I-RNA
as O
ERG O
regulators O
and O
implicate O
a O
potential O
role O
for O
these O
miRNAs O
in O
acute O
leukemia B-Disease
. O

miR B-RNA
- I-RNA
34a I-RNA
: O
Development O
of O
a O
lung B-Disease
cancer I-Disease
therapeutic O
based O
on O
the O
tumor O
suppressor O
microRNA B-RNA
- I-RNA
34 I-RNA
. O

Our O
results O
suggest O
that O
miR B-RNA
- I-RNA
196 I-RNA
may O
play O
a O
role O
in O
the O
malignant O
progression O
of O
gliomas B-Disease
and O
may O
be O
a O
prognostic O
predictor O
in O
glioblastomas B-Disease
. O

miRNA B-RNA
- I-RNA
106b I-RNA
: O
Expression O
of O
miRNA B-RNA
- I-RNA
106b I-RNA
in O
conventional O
renal B-Disease
cell I-Disease
carcinoma I-Disease
is O
a O
potential O
marker O
for O
prediction O
of O
early O
metastasis O
after O
nephrectomy O
. O

miRNA B-RNA
- I-RNA
96 I-RNA
: O
miRNA B-RNA
- I-RNA
96 I-RNA
suppresses O
KRAS O
and O
functions O
as O
a O
tumor O
suppressor O
gene O
in O
pancreatic B-Disease
cancer I-Disease
. O

let B-RNA
- I-RNA
7a I-RNA
: O
Gastric B-Disease
carcinoma I-Disease
has O
relatively O
lower O
expression O
of O
let B-RNA
- I-RNA
7a I-RNA
. O

let B-RNA
- I-RNA
7a I-RNA
: O
The O
let B-RNA
- I-RNA
7a I-RNA
microRNA O
protects O
from O
growth O
of O
lung B-Disease
carcinoma I-Disease
by O
suppression O
of O
k O
- O
Ras O
and O
c O
- O
Myc O
in O
nude O
mice O
. O

Down O
- O
regulation O
of O
miR B-RNA
- I-RNA
1 I-RNA
/ O
miR B-RNA
- I-RNA
133 I-RNA
contributes O
to O
re O
- O
expression O
of O
pacemaker O
channel O
genes O
HCN2 B-RNA
and O
HCN4 B-RNA
in O
hypertrophic B-Disease
heart I-Disease
. O

Relevance O
of O
miR B-RNA
- I-RNA
21 I-RNA
and O
miR B-RNA
- I-RNA
143 I-RNA
Expression O
in O
Tissue O
Samples O
of O
Colorectal O
Carcinoma O
and O
Its O
Liver O
Metastases O
. O

miR O
- O
149 O
: O
miR O
- O
149 O
* O
induces O
apoptosis O
by O
inhibiting O
Akt1 O
and O
E2F1 O
in O
human O
cancer O
cells O
. O

miR B-RNA
- I-RNA
338 I-RNA
: O
we O
found O
significant O
overexpression O
of O
miR B-RNA
- I-RNA
103 I-RNA
, O
miR B-RNA
- I-RNA
107 I-RNA
, O
miR B-RNA
- I-RNA
301 I-RNA
and O
miR B-RNA
- I-RNA
338 I-RNA
in O
lung B-Disease
cancer I-Disease
cells O
as O
compared O
to O
HBECs O
. O

miR O
- O
186 O
: O
miR B-RNA
- I-RNA
186 I-RNA
* I-RNA
may O
serve O
as O
a O
potential O
gene O
therapy O
target O
for O
refractory O
lung B-Disease
cancer I-Disease
that O
is O
sensitive O
to O
curcumin O
. O

let O
- O
7e O
: O
Proinflammatory O
role O
for O
let B-RNA
- I-RNA
7 I-RNA
microRNAS O
in O
experimental O
asthma B-Disease
. O

miR B-RNA
- I-RNA
21 I-RNA
could O
protect O
human O
glioblastoma B-Disease
U87MG O
cells O
from O
TMZ O
induced O
apoptosis O
. O

miR B-RNA
- I-RNA
21 I-RNA
: O
These O
experiments O
demonstrate O
an O
important O
role O
for O
miR B-RNA
- I-RNA
21 I-RNA
in O
fibrotic B-Disease
lung I-Disease
diseases O
. O

miR B-RNA
- I-RNA
137 I-RNA
: O
Our O
data O
show O
that O
miR B-RNA
- I-RNA
148 I-RNA
and O
miR B-RNA
- I-RNA
137 I-RNA
present O
an O
additional O
level O
of O
regulating O
Mitf O
expression O
in O
melanocytes O
and O
melanoma B-Disease
cells O
. O

miR B-RNA
- I-RNA
203 I-RNA
expression O
is O
a O
new O
prognostic O
marker O
in O
pancreatic B-Disease
adenocarcinoma I-Disease
patients O
. O

mir B-RNA
- I-RNA
27a I-RNA
: O
mir B-RNA
- I-RNA
27a I-RNA
genetic O
variant O
contributes O
to O
gastric B-Disease
cancer I-Disease
susceptibility O
. O

Gas5 B-RNA
has O
also O
been O
linked O
with O
breast B-Disease
cancer I-Disease
because O
Gas5 B-RNA
transcript O
levels O
are O
significantly O
reduced O
compared O
to O
unaffected O
normal O
breast O
epithelia O
. O

miR B-RNA
- I-RNA
489 I-RNA
: O
miR B-RNA
- I-RNA
489 I-RNA
is O
a O
tumour O
- O
suppressive O
miRNA O
target O
PTPN11 O
in O
hypopharyngeal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

Thus O
, O
both O
miR B-RNA
- I-RNA
144 I-RNA
and O
miR B-RNA
- I-RNA
451 I-RNA
may O
represent O
new O
therapeutic O
agents O
for O
the O
treatment O
of O
ischemic B-Disease
heart I-Disease
disease I-Disease
. O

miR B-RNA
- I-RNA
106b I-RNA
aberrantly O
expressed O
in O
a O
double O
transgenic O
mouse O
model O
for O
Alzheimer B-Disease
' I-Disease
s I-Disease
disease I-Disease
targets O
TGF O
- O
 O
type O
II O
receptor O
. O

The O
expression O
of O
the O
long O
ncRNA O
MALAT1 B-RNA
correlates O
with O
tumor O
development O
, O
progression O
or O
survival O
in O
lung O
, O
liver O
and O
breast B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
195 I-RNA
: O
microRNA B-RNA
- I-RNA
195 I-RNA
promotes O
apoptosis O
and O
suppresses O
tumorigenicity O
of O
human O
colorectal B-Disease
cancer I-Disease
cells O
. O

These O
preliminary O
findings O
point O
to O
the O
possibility O
that O
disease O
- O
related O
changes O
in O
the O
expression O
of O
small O
noncoding O
RNAs O
such O
as O
miR B-RNA
- I-RNA
30b I-RNA
in O
schizophrenia B-Disease
could O
be O
influenced O
by O
gender O
and O
potentially O
regulated O
by O
estrogen O
signaling O
. O

down O
- O
regulated O
of O
miR B-RNA
- I-RNA
451 I-RNA
in O
A172 O
, O
LN229 O
and O
U251 O
human O
glioblastoma B-Disease
cells O
. O

miR B-RNA
- I-RNA
24 I-RNA
: O
MicroRNA B-RNA
- I-RNA
24 I-RNA
targeting O
RNA O
- O
binding O
protein O
DND1 O
in O
tongue B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
21 I-RNA
and O
miR B-RNA
- I-RNA
31 I-RNA
converge O
on O
TIAM1 O
to O
regulate O
migration O
and O
invasion O
of O
colon B-Disease
carcinoma I-Disease
cells O
. O

Downregulation O
of O
miR B-RNA
- I-RNA
125b I-RNA
in O
metastatic O
cutaneous O
malignant O
melanoma B-Disease
. O

Programmed O
cell O
death O
4 O
loss O
increases O
tumor O
cell O
invasion O
and O
is O
regulated O
by O
miR B-RNA
- I-RNA
21 I-RNA
in O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
122a I-RNA
: O
microRNA B-RNA
- I-RNA
122a I-RNA
( O
miR B-RNA
- I-RNA
122a I-RNA
) O
is O
a O
liver O
- O
specific O
miRNA O
that O
is O
frequently O
downregulated O
in O
hepatocellular B-Disease
carcinoma I-Disease
( O
HCC O
) O
. O

miR B-RNA
- I-RNA
155 I-RNA
: O
Human O
SMG O
- O
1 O
is O
Involved O
in O
Gemcitabine O
- O
Induced O
Primary O
microRNA B-RNA
- I-RNA
155 I-RNA
/ O
BIC B-RNA
Up O
- O
Regulation O
in O
Human O
Pancreatic B-Disease
Cancer I-Disease
PANC O
- O
1 O
Cells O
. O

In O
vivo O
delivery O
of O
a O
miR B-RNA
- I-RNA
380 I-RNA
- I-RNA
5p I-RNA
antagonist O
decreases O
tumor O
size O
in O
an O
orthotopic O
mouse O
model O
of O
neuroblastoma B-Disease
. O

PRNCR1 B-RNA
expression O
was O
upregulated O
in O
some O
of O
the O
PC O
cells O
as O
well O
as O
precursor O
lesion O
prostatic B-Disease
intraepithelial I-Disease
neoplasia I-Disease
. O

miRs B-RNA
- I-RNA
208b I-RNA
and O
- O
499 O
were O
highly O
elevated O
in O
acute B-Disease
myocardial I-Disease
infarction I-Disease
plasma O
. O

MALAT O
- O
1 O
enhances O
cell O
motility O
of O
lung B-Disease
adenocarcinoma I-Disease
cells O
by O
influencing O
the O
expression O
of O
motility O
- O
related O
genes O
. O

Osteosarcoma B-Disease
patients O
' O
survival O
is O
significantly O
associated O
with O
MALAT O
- O
1 O
expression O
levels O
. O

In O
a O
finding O
of O
relevance O
to O
breast B-Disease
cancer I-Disease
pathogenesis O
, O
the O
mammary O
gland O
lncRNA O
PINC B-RNA
, O
whose O
genomic O
structure O
is O
substantially O
different O
between O
primates O
and O
rodents O
has O
been O
shown O
to O
function O
in O
both O
cell O
survival O
and O
cell O
cycle O
progression O
. O

As O
evidence O
that O
this O
subset O
of O
miRNAs O
is O
relevant O
to O
leukemia B-Disease
, O
we O
show O
that O
loss O
of O
2 O
miRNAs O
identified O
in O
our O
analysis O
, O
miR B-RNA
- I-RNA
145 I-RNA
and O
miR B-RNA
- I-RNA
146a I-RNA
, O
results O
in O
leukemia B-Disease
in O
a O
mouse O
model O
. O

The O
clinical O
usefulness O
of O
the O
PCA3 B-RNA
/ O
PSA B-RNA
mRNA O
of O
urine O
sediments O
after O
DRE O
as O
a O
molecular O
marker O
in O
the O
early O
diagnosis O
of O
prostate B-Disease
cancer I-Disease
. O

The O
observation O
that O
miR B-RNA
- I-RNA
34a I-RNA
and O
miR B-RNA
- I-RNA
195 I-RNA
levels O
were O
increased O
in O
the O
RISC O
of O
U O
- O
87 O
astrocytoma B-Disease
cells O
suggests O
an O
oncogenic O
role O
for O
these O
miRNAs O
. O

The O
authors O
' O
previous O
studies O
on O
miR B-RNA
- I-RNA
34a I-RNA
showed O
that O
miRNA O
can O
influence O
the O
growth O
of O
uveal O
melanoma B-Disease
cells O
. O

Interestingly O
, O
HOXD10 O
is O
not O
only O
targeted O
by O
the O
miR B-RNA
- I-RNA
10b I-RNA
miRNA O
, O
but O
also O
targeted O
by O
a O
long O
noncoding O
RNA O
termed O
HOTAIR B-RNA
, O
which O
has O
also O
been O
shown O
to O
promote O
breast B-Disease
cancer I-Disease
metastasis O
. O

In O
hilar B-Disease
cholangiocarcinoma I-Disease
, O
down O
- O
expression O
of O
miR B-RNA
- I-RNA
373 I-RNA
leads O
to O
increase O
of O
MBD2 O
, O
which O
in O
turn O
suppresses O
the O
methylation O
- O
mediated O
gene O
such O
as O
RASSF1A O
. O

Taken O
together O
, O
the O
present O
study O
identifies O
let B-RNA
- I-RNA
7b I-RNA
as O
a O
tumor O
suppressor O
that O
represses O
cancer O
cell O
proliferation O
and O
migration O
as O
well O
as O
tumor O
metastasis O
in O
mouse O
melanoma B-Disease
cells O
. O

PCA3 B-RNA
is O
a O
noncoding O
RNA O
that O
is O
highly O
over O
- O
expressed O
in O
prostate B-Disease
cancer I-Disease
tissue O
compared O
to O
benign O
tissue O
. O

MiR B-RNA
- I-RNA
184 I-RNA
significantly O
reduces O
tumour O
growth O
and O
increases O
overall O
survival O
in O
an O
orthotopic O
murine O
model O
of O
neuroblastoma B-Disease
through O
assessment O
of O
tumour O
growth O
and O
moribundity O
relative O
to O
control O
miRNA O
- O
treated O
cohorts O
. O

Thus O
, O
we O
show O
that O
overexpression O
of O
miR B-RNA
- I-RNA
125b I-RNA
is O
sufficient O
both O
to O
shorten O
the O
latency O
of O
BCR O
- O
ABL O
- O
induced O
leukemia O
and O
to O
independently O
induce O
leukemia O
in O
a O
mouse O
model O
. O

Circulating O
miR B-RNA
- I-RNA
29a I-RNA
levels O
in O
patients O
with O
scleroderma B-Disease
spectrum I-Disease
disorder I-Disease
. O

Induction O
of O
MIR B-RNA
- I-RNA
21 I-RNA
by O
retinoic O
acid O
in O
estrogen O
- O
receptor O
- O
positive O
breast B-Disease
carcinoma I-Disease
cells O
: O
biological O
correlates O
and O
molecular O
targets O
. O

The O
miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
MicroRNA O
Cluster O
Regulates O
Multiple O
Components O
of O
the O
TGF O
- O
beta O
Pathway O
in O
Neuroblastoma B-Disease
. O

MicroRNA B-RNA
- I-RNA
129 I-RNA
, O
miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
5p I-RNA
, O
and O
miR B-RNA
- I-RNA
25 I-RNA
were O
differentially O
expressed O
in O
every O
pediatric O
brain B-Disease
tumor I-Disease
type O
compared O
to O
normal O
tissue O
controls O
as O
measured O
by O
microarray O
. O
When O
further O
examined O
by O
qRT O
- O
PCR O
, O
these O
miRNAs O
demonstrated O
differential O
expression O
that O
significantly O
correlated O
with O
the O
microarray O
findings O
. O

Papillary B-Disease
Thyroid I-Disease
Carcinoma I-Disease
( O
PTC O
) O
. O

Direct O
interaction O
with O
THRB O
was O
shown O
for O
miR B-RNA
- I-RNA
21 I-RNA
and O
miR B-RNA
- I-RNA
146a I-RNA
. O

Nearly O
100 O
% O
of O
TCC B-Disease
patients O
highly O
expressed O
IGF2 B-RNA
- I-RNA
P4 I-RNA
and O
H19 B-RNA
, O
as O
determined O
by O
ISH O
and O
by O
qPCR O
. O

Methyl O
- O
CpG O
binding O
protein O
MBD2 O
is O
implicated O
in O
methylation O
- O
mediated O
suppression O
of O
miR B-RNA
- I-RNA
373 I-RNA
in O
hilar B-Disease
Cholangiocarcinoma I-Disease
. O

The O
microRNA O
molecular O
signature O
of O
atypic O
and O
common O
acquired O
melanocytic B-Disease
nevi I-Disease
: O
differential O
expression O
of O
miR B-RNA
- I-RNA
125b I-RNA
and O
let B-RNA
- I-RNA
7c I-RNA
. O

miR B-RNA
- I-RNA
181a I-RNA
shows O
tumor O
suppressive O
effect O
against O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
cells O
by O
downregulating O
K O
- O
ras O
. O

Human O
microRNAs O
miR B-RNA
- I-RNA
22 I-RNA
, O
miR B-RNA
- I-RNA
138 I-RNA
- I-RNA
2 I-RNA
, O
miR B-RNA
- I-RNA
148a I-RNA
, O
and O
miR B-RNA
- I-RNA
488 I-RNA
Are O
Associated O
with O
Panic B-Disease
Disorder I-Disease
and O
Regulate O
Several O
Anxiety O
Candidate O
Genes O
and O
Related O
Pathways O
. O

The O
metastasis O
associated O
microRNA O
miR B-RNA
- I-RNA
516a I-RNA
- I-RNA
3p I-RNA
is O
a O
novel O
therapeutic O
target O
for O
inhibiting O
peritoneal O
dissemination O
of O
human O
scirrhous B-Disease
gastric I-Disease
cancer I-Disease
. O

Polo O
- O
like O
kinase O
1 O
regulates O
cell O
proliferation O
and O
is O
targeted O
by O
miR B-RNA
- I-RNA
593 I-RNA
* I-RNA
in O
esophageal B-Disease
cancer I-Disease
. O

down O
- O
regulated O
of O
miR B-RNA
- I-RNA
342 I-RNA
is O
Associated O
with O
Tamoxifen O
Resistant O
Breast O
Tumors O
. O

miR B-RNA
- I-RNA
150 I-RNA
* I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
- I-RNA
2 I-RNA
* I-RNA
, O
miR B-RNA
- I-RNA
1179 I-RNA
and O
miR B-RNA
- I-RNA
139 I-RNA
- I-RNA
3p I-RNA
were O
up O
- O
regulated O
in O
colorectal O
cancers O
with O
liver O
metastasis O
. O

Hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
155 I-RNA
may O
play O
an O
important O
role O
in O
the O
proliferation O
, O
and O
metastasis O
of O
endometrial B-Disease
cancer I-Disease
, O
which O
may O
be O
a O
indicator O
in O
the O
diagnosis O
and O
prognosis O
of O
endometrial B-Disease
cancer I-Disease
and O
may O
be O
used O
as O
a O
predictive O
biomarker O
. O

Down O
- O
Regulation O
of O
mir B-RNA
- I-RNA
424 I-RNA
Contributes O
to O
the O
Abnormal O
Angiogenesis O
via O
MEK1 O
and O
Cyclin O
E1 O
in O
Senile B-Disease
Hemangioma I-Disease
: O
Its O
Implications O
to O
Therapy O
. O

The O
miR B-RNA
- I-RNA
92a I-RNA
expression O
in O
leukemia B-Disease
cells O
could O
be O
a O
prognostic O
factor O
in O
ALL O
patients O
. O

Here O
we O
report O
that O
modulation O
of O
microRNA B-RNA
- I-RNA
499 I-RNA
( O
miR B-RNA
- I-RNA
499 I-RNA
) O
levels O
affects O
apoptosis O
and O
the O
severity O
of O
myocardial B-Disease
infarction I-Disease
and O
cardiac O
dysfunction O
induced O
by O
ischemia O
- O
reperfusion O
. O

Involvement O
of O
miR B-RNA
- I-RNA
21 I-RNA
in O
resistance O
to O
daunorubicin O
by O
regulating O
PTEN O
expression O
in O
the O
leukaemia O
K562 O
cell O
line O
. O

MiR B-RNA
- I-RNA
26a I-RNA
Inhibits O
Cell O
Growth O
and O
Tumorigenesis O
of O
Nasopharyngeal B-Disease
Carcinoma I-Disease
through O
Repression O
of O
EZH2 O
. O

Disruption O
of O
telomerase O
trafficking O
by O
WRAP53 B-RNA
mutation O
causes O
dyskeratosis B-Disease
congenita I-Disease
. O

upstream O
CpG O
- O
rich O
regions O
of O
mir B-RNA
- I-RNA
34b I-RNA
and O
mir B-RNA
- I-RNA
129 I-RNA
- I-RNA
2 I-RNA
are O
frequently O
methylated O
in O
gastric B-Disease
cancer I-Disease
tissues O
compared O
with O
adjacent O
normal O
tissues O
, O
and O
their O
methylation O
status O
correlated O
inversely O
with O
their O
expression O
patterns O
. O

Hsa B-RNA
- I-RNA
mir I-RNA
- I-RNA
145 I-RNA
is O
the O
top O
EWS O
- O
FLI1 O
- O
repressed O
microRNA O
involved O
in O
a O
positive O
feedback O
loop O
in O
Ewing B-Disease
' I-Disease
s I-Disease
sarcoma I-Disease
. O

Knockdown O
of O
miR B-RNA
- I-RNA
21 I-RNA
in O
human O
breast B-Disease
cancer I-Disease
cell O
lines O
inhibits O
proliferation O
, O
in O
vitro O
migration O
and O
in O
vivo O
tumor O
growth O
. O

MiR B-RNA
- I-RNA
9 I-RNA
down O
- O
regulates O
CDX2 O
expression O
in O
gastric B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
340 I-RNA
inhibition O
of O
breast B-Disease
cancer I-Disease
cell O
migration O
and O
invasion O
through O
targeting O
of O
oncoprotein O
c O
- O
Met O
. O

our O
work O
demonstrating O
that O
inhibition O
of O
miR B-RNA
- I-RNA
17 I-RNA
 I-RNA
92 I-RNA
increases O
lucocorticoid O
- O
induced O
apoptosis O
highlights O
the O
potential O
importance O
of O
miR B-RNA
- I-RNA
17 I-RNA
 I-RNA
92 I-RNA
as O
a O
therapeutic O
target O
in O
leukemias B-Disease
and O
lymphomas O
. O

miR B-RNA
- I-RNA
20a I-RNA
targets O
BNIP2 O
and O
contributes O
chemotherapeutic O
resistance O
in O
colorectal B-Disease
adenocarcinoma I-Disease
SW480 O
and O
SW620 O
cell O
lines O
. O

NF O
- O
kB O
and O
c O
- O
Jun O
induce O
the O
expression O
of O
the O
oncogenic O
miR B-RNA
- I-RNA
221 I-RNA
and O
miR B-RNA
- I-RNA
222 I-RNA
in O
prostate B-Disease
carcinoma I-Disease
and O
glioblastoma B-Disease
cells O
. O

Endothelial O
- O
specific O
intron O
- O
derived O
miR B-RNA
- I-RNA
126 I-RNA
is O
down O
- O
regulated O
in O
human O
breast B-Disease
cancer I-Disease
and O
targets O
both O
VEGFA O
and O
PIK3R2 O
. O

Novel O
regulation O
of O
NF O
- O
YB O
by O
miR B-RNA
- I-RNA
485 I-RNA
- I-RNA
3p I-RNA
affects O
expression O
of O
DNA O
topoisomerase O
II O
{ O
alpha O
} O
and O
drug O
responsiveness O
in O
human O
lymphoblastic O
leukemia B-Disease
CEM O
cells O
. O

miR B-RNA
- I-RNA
495 I-RNA
is O
upregulated O
by O
E12 O
/ O
E47 O
in O
breast B-Disease
cancer I-Disease
stem O
cells O
, O
and O
promotes O
oncogenesis O
and O
hypoxia O
resistance O
via O
down O
- O
regulated O
of O
E B-RNA
- I-RNA
cadherin I-RNA
and O
REDD1 B-RNA
. O

Polymicrobial O
Infection O
with O
Periodontal O
Pathogens O
Specifically O
enhances O
miR B-RNA
- I-RNA
146a I-RNA
in O
ApoE O
- O
/ O
- O
Mice O
during O
Experimental O
Periodontal B-Disease
Disease I-Disease
. O

miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
210 I-RNA
and O
miR B-RNA
- I-RNA
221 I-RNA
were O
significantly O
overexpressed O
, O
whereas O
miR O
- O
10b O
, O
miR O
- O
145 O
, O
miR O
- O
205 O
, O
miR O
- O
122a O
were O
significantly O
underexpressed O
in O
the O
triple O
- O
negative O
primary O
breast O
cancers O
. O

miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
210 I-RNA
and O
miR B-RNA
- I-RNA
221 I-RNA
were O
significantly O
overexpressed O
, O
whereas O
miR O
- O
10b O
, O
miR O
- O
145 O
, O
miR O
- O
205 O
, O
miR O
- O
122a O
were O
significantly O
underexpressed O
in O
the O
triple O
- O
negative O
primary O
breast O
cancers O
. O

miR B-RNA
- I-RNA
373 I-RNA
was O
found O
to O
be O
capable O
of O
promoting O
breast B-Disease
cancer I-Disease
invasion O
and O
metastasis O

Malignant O
melanoma B-Disease
patients O
had O
significantly O
higher O
miR B-RNA
- I-RNA
221 I-RNA
levels O
than O
healthy O
controls O
in O
serum O
. O

miR O
- O
181a O
shows O
tumor O
suppressive O
effect O
against O
oral B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
cells O
by O
downregulating O
K O
- O
ras O
. O

PDCD4 O
nuclear O
loss O
inversely O
correlates O
with O
miR O
- O
21 O
levels O
in O
colon B-Disease
carcinogenesis I-Disease
. O

Elevated O
miR B-RNA
- I-RNA
155 I-RNA
promotes O
inflammation B-Disease
in O
cystic B-Disease
fibrosis I-Disease
by O
driving O
hyper O
- O
expression O
of O
interleukin O
- O
8 O
. O

In O
both O
the O
mouse O
and O
human O
studies O
, O
the O
expression O
levels O
of O
miR B-RNA
- I-RNA
199a I-RNA
, O
199a O
* O
, O
200a O
, O
and O
200b O
were O
positively O
and O
significantly O
correlated O
to O
the O
progressed O
liver B-Disease
fibrosis I-Disease
. O

miR O
- O
33 O
reduces O
RIP140 O
coactivator O
activity O
for O
NF O
- O
kB O
, O
which O
is O
supported O
by O
the O
reduction O
in O
NF O
- O
kB O
reporter O
activity O
and O
the O
inflammatory B-Disease
potential O
in O
macrophages O
. O

MiR B-RNA
- I-RNA
145 I-RNA
inhibits O
cell O
proliferation O
of O
human O
lung B-Disease
adenocarcinoma I-Disease
by O
targeting O
EGFR O
and O
NUDT1 O
. O

MYB O
transcriptionally O
regulates O
the O
miR B-RNA
- I-RNA
155 I-RNA
host O
gene O
in O
chronic B-Disease
lymphocytic I-Disease
leukemia I-Disease
. O

expression O
of O
the O
imprinted O
gene O
CDKN1C B-RNA
is O
suppressed O
by O
ER O
 O
signaling O
in O
hormone O
- O
responsive O
breast O
cancer O
cells O
through O
epigenetic O
mechanisms O
probably O
involving O
the O
chromatin O
- O
interacting O
ncRNA O
KCNQ1OT1 B-RNA
and O
the O
chromatin O
- O
dependent O
transcriptional O
regulator O
CTCF O
. O

Inverse O
correlation O
with O
the O
expression O
of O
potential O
mRNA O
targets O
identified O
mmu B-RNA
- I-RNA
miR I-RNA
- I-RNA
146b I-RNA
, O
- O
223 O
, O
- O
29b O
, O
- O
29c O
, O
- O
483 O
, O
- O
574 O
- O
5p O
, O
- O
672 O
and O
- O
690 O
as O
the O
best O
candidates O
for O
an O
active O
implication O
in O
asthma O
pathogenesis O
. O

Six O
miRNAs O
were O
more O
than O
2 O
- O
fold O
over O
- O
expressed O
in O
severe O
preeclampsia B-Disease
: O
let B-RNA
- I-RNA
7b I-RNA
, O
miRNA B-RNA
- I-RNA
302 I-RNA
* I-RNA
, O
miRNA B-RNA
- I-RNA
104 I-RNA
, O
miRNA B-RNA
- I-RNA
128a I-RNA
, O
miRNA B-RNA
- I-RNA
182 I-RNA
* I-RNA
and O
miRNA B-RNA
- I-RNA
133b I-RNA
. O

Genetic O
variants O
( O
SNP O
rs1042538 O
A O
/ O
T O
) O
at O
the O
miR B-RNA
- I-RNA
124 I-RNA
binding O
site O
on O
the O
cytoskeleton O
- O
organizing O
IQGAP1 O
gene O
confer O
differential O
predisposition O
to O
breast B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
101 I-RNA
is O
down O
- O
regulated O
in O
glioblastoma B-Disease
resulting O
in O
EZH2 O
- O
induced O
proliferation O
, O
migration O
, O
and O
angiogenesis O
. O

miR B-RNA
- I-RNA
21 I-RNA
Expression O
in O
Pregnancy O
- O
Associated O
Breast B-Disease
Cancer I-Disease
: O
A O
Possible O
Marker O
of O
Poor O
Prognosis O
. O

Over O
- O
expression O
of O
miR B-RNA
- I-RNA
146a I-RNA
may O
be O
useful O
in O
the O
prevention O
and O
treatment O
of O
atherosclerosis B-Disease
. O

Highly O
increased O
maspin O
expression O
corresponds O
with O
up O
- O
regulation O
of O
miR B-RNA
- I-RNA
21 I-RNA
in O
endometrial B-Disease
cancer I-Disease
. O

A O
microRNA O
, O
miR B-RNA
- I-RNA
34b I-RNA
, O
that O
suppresses O
the O
expression O
of O
alpha4 O
through O
specific O
binding O
to O
the O
3 O
' O
- O
untranslated O
region O
of O
alpha4 O
is O
downregulated O
in O
transformed O
or O
human O
lung B-Disease
tumors I-Disease
. O

miR B-RNA
- I-RNA
520b I-RNA
regulates O
migration O
of O
breast B-Disease
cancer I-Disease
cells O
through O
targeting O
hepatitis O
B O
X O
- O
interacting O
protein O
and O
interleukin O
- O
8 O
. O

both O
miR B-RNA
- I-RNA
195 I-RNA
and O
miR B-RNA
- I-RNA
497 I-RNA
play O
important O
inhibitory O
roles O
in O
breast B-Disease
cancer I-Disease
malignancy O
and O
may O
be O
the O
potential O
therapeutic O
and O
diagnostic O
targets O
. O

miR B-RNA
- I-RNA
145 I-RNA
, O
miR B-RNA
- I-RNA
133a I-RNA
and O
miR B-RNA
- I-RNA
133b I-RNA
: O
Tumor O
- O
suppressive O
miRNAs O
target O
FSCN1 O
in O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

Our O
analysis O
predicted O
a O
significant O
association O
between O
miR B-RNA
- I-RNA
128 I-RNA
and O
the O
protein O
kinase O
WEE1 O
, O
which O
we O
subsequently O
validated O
experimentally O
by O
showing O
that O
the O
over O
- O
expression O
of O
the O
naturally O
under O
- O
expressed O
miR B-RNA
- I-RNA
128 I-RNA
in O
glioma O
cells O
resulted O
in O
the O
inhibition O
of O
WEE1 O
in O
glioblastoma B-Disease
cells O
. O

Our O
analysis O
predicted O
a O
significant O
association O
between O
miR B-RNA
- I-RNA
128 I-RNA
and O
the O
protein O
kinase O
WEE1 O
, O
which O
we O
subsequently O
validated O
experimentally O
by O
showing O
that O
the O
over O
- O
expression O
of O
the O
naturally O
under O
- O
expressed O
miR B-RNA
- I-RNA
128 I-RNA
in O
glioma B-Disease
cells O
resulted O
in O
the O
inhibition O
of O
WEE1 O
in O
glioblastoma O
cells O
. O

Modulation O
of O
T O
cell O
cytokine O
production O
by O
miR B-RNA
- I-RNA
144 I-RNA
* I-RNA
with O
elevated O
expression O
in O
patients O
with O
pulmonary B-Disease
tuberculosis I-Disease
. O

let B-RNA
- I-RNA
7a I-RNA
- I-RNA
2 I-RNA
, O
7a O
- O
3 O
, O
7d O
, O
7f O
- O
2 O
downregulated O
in O
breast B-Disease
cancer I-Disease
. O

Enhancer O
of O
Zeste O
homolog O
2 O
( O
EZH2 O
) O
is O
overexpressed O
in O
recurrent O
nasopharyngeal B-Disease
carcinoma I-Disease
and O
is O
regulated O
by O
miR B-RNA
- I-RNA
26a I-RNA
, O
miR B-RNA
- I-RNA
101 I-RNA
, O
and O
miR B-RNA
- I-RNA
98 I-RNA
. O

We O
identified O
a O
cluster O
of O
miRNAs O
that O
includes O
miR B-RNA
- I-RNA
181b I-RNA
, O
miR B-RNA
- I-RNA
125a I-RNA
- I-RNA
3p I-RNA
, O
miR B-RNA
- I-RNA
30c I-RNA
- I-RNA
2 I-RNA
, O
miR B-RNA
- I-RNA
497 I-RNA
and O
miR B-RNA
- I-RNA
491 I-RNA
- I-RNA
3p I-RNA
as O
hypoxia O
- O
regulated O
miRNAs O
( O
HRMs O
) O
in O
retinoblastoma B-Disease
cells O
, O
of O
which O
miR B-RNA
- I-RNA
181b I-RNA
was O
the O
most O
typically O
differentially O
expressed O
miRNA O
under O
hypoxic O
conditions O
. O

Bcl B-RNA
- I-RNA
2 I-RNA
up O
- O
regulated O
Induced O
by O
miR B-RNA
- I-RNA
21 I-RNA
Via O
a O
Direct O
Interaction O
Is O
Associated O
with O
Apoptosis O
and O
Chemoresistance O
in O
MIA O
PaCa O
- O
2 O
Pancreatic B-Disease
Cancer I-Disease
Cells O
. O

miR B-RNA
- I-RNA
1 I-RNA
as O
a O
tumor O
suppressive O
microRNA O
targeting O
TAGLN2 O
in O
head B-Disease
and I-Disease
neck I-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
. O

Down O
- O
Regulated O
Plasma O
miR B-RNA
- I-RNA
92a I-RNA
Levels O
in O
Non O
- O
Hodgkin O
' O
s O
Lymphoma B-Disease
. O

miR B-RNA
- I-RNA
9 I-RNA
suppresses O
mesenchymal O
differentiation O
in O
glioblastoma B-Disease
by O
downregulating O
expression O
of O
JAK O
kinases O
and O
inhibiting O
activation O
of O
STAT3 O
. O

down O
- O
regulated O
of O
miR B-RNA
- I-RNA
195 I-RNA
correlates O
with O
lymph O
node O
metastasis O
and O
poor O
prognosis O
in O
colorectal B-Disease
cancer I-Disease
. O

miR O
- O
301 O
as O
a O
crucial O
oncogene O
in O
human O
breast B-Disease
cancer I-Disease
that O
acts O
through O
multiple O
pathways O
and O
mechanisms O
to O
promote O
nodal O
or O
distant O
relapses O
. O

MiR O
- O
133a O
induces O
apoptosis O
through O
direct O
regulation O
of O
GSTP1 O
in O
bladder B-Disease
cancer I-Disease
cell O
lines O
. O

Hence O
, O
miR B-RNA
- I-RNA
146a I-RNA
may O
be O
useful O
for O
the O
treatment O
of O
both O
cartilage B-Disease
regeneration I-Disease
and O
pain O
symptoms O
caused O
by O
OA B-Disease
( I-Disease
osteoarthritis I-Disease
) I-Disease
. O

miR O
- O
125b O
is O
directly O
involved O
in O
cancer O
progression O
and O
is O
associated O
with O
poor O
prognosis O
in O
human O
colorectal O
cancer O
. O

Our O
findings O
suggest O
that O
miR O
- O
125b O
could O
be O
an O
important O
prognostic O
indicator O
for O
colorectal O
cancer O
patients O
. O

miR O
- O
125b O
is O
directly O
involved O
in O
cancer O
progression O
and O
is O
associated O
with O
poor O
prognosis O
in O
human O
colorectal B-Disease
cancer I-Disease
. O

increased O
expression O
of O
miR B-RNA
- I-RNA
34a I-RNA
in O
an O
acquired O
model O
of O
docetaxel O
resistance O
in O
breast B-Disease
cancer I-Disease
. O

Expression O
of O
CD19 O
and O
lack O
of O
miR B-RNA
- I-RNA
223 I-RNA
distinguish O
extramedullary O
plasmacytoma O
from O
multiple B-Disease
myeloma I-Disease
. O

The O
Notch O
ligand O
Jagged2 O
promotes O
lung B-Disease
adenocarcinoma I-Disease
metastasis O
through O
a O
miR B-RNA
- I-RNA
200 I-RNA
- O
dependent O
pathway O
in O
mice O
. O

Prostate O
cancer O
gene O
3 O
( O
PCA3 B-RNA
or O
DD3 O
) O
is O
a O
promising O
urinary O
biomarker O
of O
prostate B-Disease
cancer I-Disease
. O

Let B-RNA
- I-RNA
7 I-RNA
MicroRNA O
and O
HMGA2 B-RNA
levels O
of O
expression O
are O
not O
inversely O
linked O
in O
adipocytic B-Disease
tumors I-Disease
: O
Analysis O
of O
56 O
lipomas B-Disease
and O
liposarcomas B-Disease
with O
molecular O
cytogenetic O
data O
. O

Genomic O
Loss O
of O
miR B-RNA
- I-RNA
486 I-RNA
Regulates O
Tumor O
Progression O
and O
the O
OLFM4 O
Anti O
- O
apoptotic O
Factor O
in O
Gastric B-Disease
Cancer I-Disease
. O

MiR B-RNA
- I-RNA
204 I-RNA
, O
which O
was O
predicted O
to O
target O
ezrin O
, O
was O
downregulated O
in O
gastric B-Disease
cancer I-Disease
cells O
and O
gastric B-Disease
carcinomas I-Disease
. O

Down O
- O
regulation O
of O
miR B-RNA
- I-RNA
1 I-RNA
/ O
miR B-RNA
- I-RNA
133 I-RNA
contributes O
to O
re O
- O
expression O
of O
pacemaker O
channel O
genes O
HCN2 O
and O
HCN4 O
in O
hypertrophic B-Disease
heart I-Disease
. O

miR B-RNA
- I-RNA
449 I-RNA
inhibits O
cell O
proliferation O
and O
is O
down O
- O
regulated O
in O
gastric B-Disease
cancer I-Disease
. O

MiRNA B-RNA
- I-RNA
205 I-RNA
modulates O
cellular O
invasion O
and O
migration O
via O
regulating O
zinc O
finger O
E O
- O
box O
binding O
homeobox O
2 O
expression O
in O
esophageal B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
cells O
. O

mir B-RNA
- I-RNA
21 I-RNA
is O
up O
- O
regulated O
in O
subcutaneous O
adipose O
tissue O
in O
human O
obesity B-Disease
. O

Anti O
- O
sense O
miRNA B-RNA
- I-RNA
21 I-RNA
oligonucleotide O
inhibits O
Tb O
3 O
. O
1 O
human O
tongue B-Disease
squamous I-Disease
cell I-Disease
carcinoma I-Disease
growth O
in O
vitro O
. O

In O
this O
study O
, O
we O
demonstrated O
that O
a O
small O
regulatory O
microRNA O
, O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
381 I-RNA
, O
an O
 O
oncomir O
 O
, O
had O
a O
major O
role O
in O
glioma B-Disease
progression O
and O
that O
LRRC4 O
was O
a O
target O
of O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
381 I-RNA
. O

miR B-RNA
- I-RNA
223 I-RNA
regulates O
migration O
and O
invasion O
by O
targeting O
Artemin O
in O
human O
esophageal B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
205 I-RNA
suppresses O
melanoma B-Disease
cell O
proliferation O
and O
induces O
senescence O
via O
regulation O
of O
E2F1 O
. O

MiR B-RNA
- I-RNA
148a I-RNA
promotes O
apoptosis O
by O
targeting O
Bcl O
- O
2 O
in O
colorectal B-Disease
cancer I-Disease
. O

Methylation O
of O
H19 B-RNA
and O
its O
imprinted O
control O
region O
( O
H19 B-RNA
ICR1 O
) O
in O
Mullerian B-Disease
aplasia I-Disease
. O

Human O
ZFAS1 B-RNA
levels O
are O
reduced O
in O
ductal O
carcinoma O
relative O
to O
normal O
breast B-Disease
tissue I-Disease
. O

our O
results O
elucidate O
a O
novel O
Myc O
- O
and O
FoxP1 O
- O
dependent O
pathway O
of O
malignant O
transformation O
and O
suggest O
miR B-RNA
- I-RNA
34a I-RNA
replacement O
therapy O
as O
a O
promising O
strategy O
in O
lymphoma B-Disease
treatment O
. O

Overexpression O
of O
miR B-RNA
- I-RNA
210 I-RNA
, O
a O
downstream O
target O
of O
HIF1 O
, O
causes O
centrosome O
amplification O
in O
renal B-Disease
carcinoma I-Disease
cells O
. O

miR B-RNA
- I-RNA
214 I-RNA
is O
highly O
expressed O
in O
human O
melanomas O
and O
contributes O
to O
melanoma B-Disease
tumour O
progression O
through O
suppression O
of O
TFAP2C O
. O

Altered O
miR B-RNA
- I-RNA
146a I-RNA
expression O
in O
Sjogren B-Disease
' I-Disease
s I-Disease
syndrome I-Disease
. O

ACCs O
( O
adrenocortical O
carcinomas O
) O
exhibited O
significantly O
lower O
levels O
of O
miR B-RNA
- I-RNA
139 I-RNA
- I-RNA
3p I-RNA
( O
up O
to O
8 O
. O
49 O
- O
fold O
, O
p O
< O
0 O
. O
1 O
) O
, O
miR B-RNA
- I-RNA
675 I-RNA
( O
up O
to O
23 O
. O
25 O
- O
fold O
, O
p O
< O
0 O
. O
1 O
) O
and O
miR B-RNA
- I-RNA
335 I-RNA
( O
up O
to O
5 O
. O
25 O
- O
fold O
, O
p O
< O
0 O
. O
1 O
) O
. O

up O
- O
regulated O
of O
MIR B-RNA
- I-RNA
21 I-RNA
mediates O
resistance O
to O
trastuzumab O
therapy O
for O
breast B-Disease
cancer I-Disease
. O

Hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
100 I-RNA
was O
significantly O
down O
- O
regulated O
in O
the O
estrogen O
- O
dependent O
endometrial B-Disease
cancer I-Disease
samples O
as O
compared O
to O
the O
estrogen O
- O
independent O
samples O
and O
thus O
has O
the O
potential O
to O
target O
ESR1 O
. O

Down O
- O
regulation O
of O
BRCA1 B-RNA
expression O
by O
miR B-RNA
- I-RNA
146a I-RNA
and O
miR B-RNA
- I-RNA
146b I-RNA
- I-RNA
5p I-RNA
in O
triple O
negative O
sporadic O
breast O
cancers O
. O

Restoration O
of O
miR B-RNA
- I-RNA
517a I-RNA
expression O
induces O
cell O
apoptosis O
in O
bladder B-Disease
cancer I-Disease
cell O
lines O
. O

Restoration O
of O
miR O
- O
517a O
expression O
induces O
cell O
apoptosis O
in O
bladder B-Disease
cancer I-Disease
cell O
lines O
. O

Levels O
of O
miR B-RNA
- I-RNA
126 I-RNA
in O
serum O
, O
and O
its O
levels O
in O
patients O
' O
serum O
in O
association O
with O
a O
specific O
marker O
of O
MPM O
, O
SMRPs O
, O
correlate O
with O
subjects O
at O
high O
risk O
to O
develop O
malignant B-Disease
pleural I-Disease
mesothelioma I-Disease
( O
MPM O
) O
. O

miR B-RNA
- I-RNA
221 I-RNA
downregulated O
in O
Glioblastoma B-Disease
vs O
Normal O
. O

H19 B-RNA
has O
been O
implicated O
as O
having O
both O
oncogenic O
and O
tumor O
suppression O
properties O
in O
cancer O
. O

H19 B-RNA
is O
upregulated O
in O
a O
number O
of O
human O
cancers O
, O
including O
hepatocellular O
, O
bladder O
and O
breast B-Disease
carcinomas I-Disease
, O
suggesting O
an O
oncogenic O
function O
for O
this O
lncRNA O
. O

HULC B-RNA
- O
Highly O
Upregulated O
in O
Liver B-Disease
Cancer I-Disease
. O

Once O
activated O
, O
the O
CREB O
protein O
was O
able O
to O
promote O
HULC B-RNA
transcription O
by O
maintaining O
an O
open O
chromatin O
structure O
at O
the O
HULC B-RNA
promoter O
resulting O
in O
increased O
HULC B-RNA
transcription O
. O

H19 B-RNA
has O
been O
implicated O
as O
having O
both O
oncogenic O
and O
tumor O
suppression O
properties O
in O
cancer O
. O

H19 B-RNA
is O
upregulated O
in O
a O
number O
of O
human O
cancers O
, O
including O
hepatocellular O
, O
bladder O
and O
breast B-Disease
carcinomas I-Disease
, O
suggesting O
an O
oncogenic O
function O
for O
this O
lncRNA O
. O

miR B-RNA
- I-RNA
145 I-RNA
Inhibits O
Lung B-Disease
Adenocarcinoma I-Disease
Stem O
Cells O
Proliferation O
by O
Targeting O
4-Oct O
Gene O
. O

Forced O
expression O
of O
BCAR4 B-RNA
in O
human O
ZR O
- O
75 O
- O
1 O
and O
MCF7 O
breast B-Disease
cancer I-Disease
cells O
resulted O
in O
cell O
proliferation O
in O
the O
absence O
of O
estrogen O
and O
in O
the O
presence O
of O
various O
antiestrogens O
. O

High O
expression O
of O
serum O
miR B-RNA
- I-RNA
21 I-RNA
and O
tumor O
miR B-RNA
- I-RNA
200c I-RNA
associated O
with O
poor O
prognosis O
in O
patients O
with O
lung B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
218 I-RNA
on O
the O
genomic O
loss O
region O
of O
chromosome O
4p15 O
. O
31 O
functions O
as O
a O
tumor O
suppressor O
in O
bladder O
cancer O
. O

PVT1 B-RNA
may O
mediate O
the O
development O
and O
progression O
of O
diabetic B-Disease
nephropathy I-Disease
through O
mechanisms O
involving O
ECM O
accumulation O
. O

Lsinct5 B-RNA
is O
overexpressed O
in O
breast O
and O
ovarian B-Disease
cancer I-Disease
cell O
lineand O
tumor O
tissues O
, O
relative O
to O
their O
normal O
counterpart O
. O

MicroRNA O
Let B-RNA
- I-RNA
7f I-RNA
Inhibits O
Tumor O
Invasion O
and O
Metastasis O
by O
Targeting O
MYH9 O
in O
Human O
Gastric B-Disease
Cancer I-Disease
. O

Upregulation O
of O
MiR B-RNA
- I-RNA
155 I-RNA
in O
Nasopharyngeal B-Disease
Carcinoma I-Disease
is O
Partly O
Driven O
by O
LMP1 O
and O
LMP2A O
and O
Downregulates O
a O
Negative O
Prognostic O
Marker O
JMJD1A O
. O

miR B-RNA
- I-RNA
137 I-RNA
under O
expression O
was O
significantly O
associated O
with O
melanomas B-Disease
with O
the O
KRAS O
- O
variant O
. O

miR B-RNA
- I-RNA
29c I-RNA
induces O
cell O
cycle O
arrest O
in O
Esophageal B-Disease
Squamous I-Disease
Cell I-Disease
Carcinoma I-Disease
by O
modulating O
Cyclin O
E O
expression O
. O

miR B-RNA
- I-RNA
143 I-RNA
and O
miR B-RNA
- I-RNA
145 I-RNA
are O
downregulated O
in O
ulcerative B-Disease
colitis I-Disease
. O

A O
common O
genetic O
variant O
( O
rs938671 O
) O
in O
the O
3 O
' O
- O
UTR O
of O
Vacuolar O
H O
+ O
- O
ATPase O
ATP6V0A1 O
creates O
a O
micro O
- O
RNA O
( O
hsa B-RNA
- I-RNA
miR I-RNA
- I-RNA
637 I-RNA
) O
motif O
to O
alter O
Chromogranin O
A O
( O
CHGA O
) O
processing O
and O
hypertension B-Disease
risk O
. O

The O
elevated O
expression O
of O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
in O
melanoma B-Disease
cells O
compared O
to O
melanocytes O
, O
its O
accumulation O
in O
cell O
cytoplasm O
, O
and O
effects O
on O
cell O
dynamics O
, O
including O
increased O
rate O
of O
wound O
closure O
on O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
overexpression O
, O
suggest O
that O
the O
higher O
expression O
of O
SPRY4 B-RNA
- I-RNA
IT1 I-RNA
may O
have O
an O
important O
role O
in O
the O
molecular O
etiology O
of O
human O
melanoma B-Disease
. O

miR B-RNA
- I-RNA
10b I-RNA
methylation O
may O
be O
a O
useful O
molecular O
biomarker O
for O
assessing O
the O
risk O
of O
gastric B-Disease
cancer I-Disease
development O
, O
and O
modulation O
of O
miR B-RNA
- I-RNA
10b I-RNA
may O
represent O
a O
therapeutic O
approach O
for O
treating O
gastric B-Disease
cancer I-Disease
. O

The O
gene O
encoding O
the O
miR B-RNA
- I-RNA
34a I-RNA
microRNA O
is O
a O
transcriptional O
target O
of O
the O
p53 O
tumor O
suppressor O
protein O
and O
subject O
to O
epigenetic O
inactivation O
in O
colorectal B-Disease
cancer I-Disease
and O
numerous O
other O
tumor O
types O
. O

Down O
- O
regulation O
of O
miR B-RNA
- I-RNA
27a I-RNA
might O
inhibit O
proliferation O
and O
drug O
resistance O
of O
gastric B-Disease
cancer I-Disease
cells O
. O

Targeting O
oncogenic O
miR B-RNA
- I-RNA
335 I-RNA
inhibits O
growth O
and O
invasion O
of O
malignant O
astrocytoma B-Disease
cells O
. O

miR B-RNA
- I-RNA
214 I-RNA
drives O
melanoma B-Disease
metastasis O
. O

Circulating O
microRNAs O
let B-RNA
- I-RNA
7a I-RNA
and O
miR B-RNA
- I-RNA
16 I-RNA
predict O
progression O
- O
free O
survival O
and O
overall O
survival O
in O
patients O
with O
myelodysplastic B-Disease
syndrome I-Disease
. O

Hepatitis B-Disease
C I-Disease
Virus O
Infection O
and O
Hepatic O
Stellate O
Cell O
Activation O
Downregulate O
miR B-RNA
- I-RNA
29 I-RNA
: O
miR B-RNA
- I-RNA
29 I-RNA
Overexpression O
Reduces O
Hepatitis B-Disease
C I-Disease
Viral O
Abundance O
in O
Culture O
. O

Epigenetically O
silenced O
miR B-RNA
- I-RNA
34b I-RNA
/ I-RNA
c I-RNA
as O
a O
novel O
faecal O
- O
based O
screening O
marker O
for O
colorectal B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
346 I-RNA
Controls O
Release O
of O
TNF O
- O
a O
Protein O
and O
Stability O
of O
Its O
mRNA O
in O
Rheumatoid B-Disease
Arthritis I-Disease
via O
Tristetraprolin O
Stabilization O
. O

The O
level O
of O
expression O
of O
piR B-RNA
- I-RNA
651 I-RNA
was O
higher O
in O
gastric B-Disease
tumour I-Disease
tissues O
and O
cell O
lines O
compared O
to O
normal O
tissues O
and O
the O
levels O
of O
piR B-RNA
- I-RNA
651 I-RNA
were O
associated O
with O
TNM O
stages O
. O

The O
peripheral O
blood O
levels O
of O
piR O
- O
651 O
and O
piR B-RNA
- I-RNA
823 I-RNA
in O
the O
patients O
with O
gastric B-Disease
cancer I-Disease
were O
significantly O
lower O
than O
those O
from O
controls O
, O
pirnas O
may O
be O
valuable O
biomarkers O
for O
detecting O
circulating O
gastric B-Disease
cancer I-Disease
cells O
. O

The O
expression O
of O
piR B-RNA
- I-RNA
651 I-RNA
in O
gastric O
, O
colon O
, O
lung O
, O
and O
breast B-Disease
cancer I-Disease
tissues O
was O
higher O
than O
that O
in O
paired O
non O
- O
cancerous O
tissues O
. O

Let B-RNA
- I-RNA
7 I-RNA
microRNAs O
inhibit O
IL B-RNA
- I-RNA
13 I-RNA
expression O
and O
represent O
a O
major O
regulatory O
mechanism O
for O
modulating O
IL B-RNA
- I-RNA
13 I-RNA
secretion O
in O
IL B-RNA
- I-RNA
13 I-RNA
- O
producing O
cell O
types O
and O
thereby O
T O
( O
H O
) O
2 O
inflammation O
. O

A O
miR B-RNA
- I-RNA
21 I-RNA
inhibitor O
enhances O
apoptosis O
and O
reduces O
G O
( O
2 O
) O
- O
M O
accumulation O
induced O
by O
ionizing O
radiation O
in O
human O
glioblastoma B-Disease
U251 O
cells O
. O

Downregulation O
of O
Pdcd4 B-RNA
by O
mir B-RNA
- I-RNA
21 I-RNA
facilitates O
glioblastoma B-Disease
proliferation O
in O
vivo O
. O

p53 B-RNA
downregulates O
Down B-Disease
syndrome I-Disease
- O
associated O
DYRK1A B-RNA
through O
miR B-RNA
- I-RNA
1246 I-RNA
. O

MiR B-RNA
- I-RNA
100 I-RNA
regulates O
cell O
differentiation O
and O
survival O
by O
targeting O
RBSP3 O
, O
a O
phosphatase O
- O
like O
tumor O
suppressor O
in O
acute B-Disease
myeloid I-Disease
leukemia I-Disease
. O

miR B-RNA
- I-RNA
122 I-RNA
activates O
hepatitis O
C O
virus O
translation O
by O
a O
specialized O
mechanism O
requiring O
particular O
RNA O
components O
. O

The O
presence O
of O
the O
( O
TAAA O
) O
n O
short O
tandem O
repeat O
polymorphisms O
in O
the O
PCA3 B-RNA
promoter O
region O
may O
be O
a O
risk O
factor O
for O
prostate O
cancer O
in O
the O
Chinese O
population O
. O

The O
rs8259 O
T O
allele O
was O
associated O
with O
significantly O
decreased O
psoriasis B-Disease
susceptibility O
( O
OR O
= O
0 O
. O
758 O
, O
95 O
% O
CI O
0 O
. O
638 O
- O
0 O
. O
901 O
, O
p O
= O
0 O
. O
2 O
) O
compared O
to O
A O
allele O
. O
the O
rs8259 O
polymorphism O
was O
located O
in O
a O
seed O
region O
for O
miR B-RNA
- I-RNA
492 I-RNA
binding O
. O

High O
- O
mobility O
group O
A1 O
proteins O
enhance O
the O
expression O
of O
the O
oncogenic O
miR B-RNA
- I-RNA
222 I-RNA
in O
lung B-Disease
cancer I-Disease
cells O
. O

miR B-RNA
- I-RNA
198 I-RNA
inhibits O
migration O
and O
invasion O
of O
hepatocellular B-Disease
carcinoma I-Disease
cells O
by O
targeting O
the O
HGF O
/ O
c O
- O
MET O
pathway O
. O

miR B-RNA
- I-RNA
17 I-RNA
- I-RNA
92 I-RNA
cluster O
microRNAs O
confers O
tumorigenicity O
in O
multiple B-Disease
myeloma I-Disease
. O

down O
- O
regulated O
of O
miR B-RNA
- I-RNA
132 I-RNA
by O
promoter O
methylation O
contributes O
to O
pancreatic B-Disease
cancer I-Disease
development O
. O

Tamoxifen O
down O
- O
regulated O
of O
miR B-RNA
- I-RNA
451 I-RNA
increases O
14 O
- O
3 O
- O
3 O
and O
promotes O
breast B-Disease
cancer I-Disease
cell O
survival O
and O
endocrine O
resistance O
. O

TRPS1 O
targeting O
by O
miR B-RNA
- I-RNA
221 I-RNA
/ I-RNA
222 I-RNA
promotes O
the O
epithelial O
- O
to O
- O
mesenchymal O
transition O
in O
breast B-Disease
cancer I-Disease
. O

miR B-RNA
- I-RNA
29a I-RNA
and O
miR B-RNA
- I-RNA
142 I-RNA
- I-RNA
3p I-RNA
show O
downregulation O
and O
diagnostic O
implication O
in O
human O
acute B-Disease
myeloid I-Disease
leukemia I-Disease
. O

Down O
- O
Regulated O
miRNA B-RNA
- I-RNA
214 I-RNA
Induces O
a O
Cell O
Cycle O
G1 O
Arrest O
in O
Gastric B-Disease
Cancer I-Disease
Cells O
by O
Up O
- O
Regulating O
the O
PTEN O
Protein O
. O

miR B-RNA
- I-RNA
340 I-RNA
inhibites O
breast B-Disease
cancer I-Disease
cell O
migration O
and O
invasion O
through O
targeting O
of O
oncoprotein O
c O
- O
Met O
. O

The O
expression O
levels O
of O
miR B-RNA
- I-RNA
122 I-RNA
and O
miR B-RNA
- I-RNA
194 I-RNA
correlated O
negatively O
with O
the O
age O
of O
patients O
with O
CHB O
( O
chronic O
hepatitis O
B O
) O
or O
ACLF B-Disease
( O
acute O
- O
on O
- O
chronic O
liver O
failure O
) O
. O

The O
expression O
levels O
of O
miR O
- O
122 O
and O
miR O
- O
194 O
correlated O
negatively O
with O
the O
age O
of O
patients O
with O
CHB O
( O
chronic O
hepatitis O
B O
) O
or O
ACLF O
( O
acute O
- O
on O
- O
chronic O
liver O
failure O
) O
. O

Circulating O
miR B-RNA
- I-RNA
210 I-RNA
predicts O
survival O
in O
critically O
ill O
patients O
with O
acute O
kidney O
injury O
. O

miR B-RNA
- I-RNA
148a I-RNA
could O
reduce O
the O
invasiveness O
, O
migratory O
and O
adhesive O
activities O
of O
gastric B-Disease
tumor I-Disease
cells O
. O

Most O
importantly O
, O
elevated O
miR B-RNA
- I-RNA
148a I-RNA
level O
in O
gastric O
cancer O
tissues O
was O
strongly O
correlated O
with O
distant O
metastasis O
, O
organ O
and O
peritoneal O
invasion O
and O
reduced O
survival O
rate O
. O

ROC O
curve O
analyses O
revealed O
that O
both O
peripheral O
blood O
piR B-RNA
- I-RNA
651 I-RNA
and O
piR B-RNA
- I-RNA
823 I-RNA
were O
valuable O
biomarkers O
for O
differentiating O
gastric B-Disease
cancer I-Disease
from O
controls O
with O
AUC O
of O
0 O
. O
841 O
and O
0 O
. O
822 O
. O

Deregulated O
miR B-RNA
- I-RNA
155 I-RNA
promotes O
Fas O
- O
mediated O
apoptosis O
in O
human O
intervertebral B-Disease
disc I-Disease
degeneration I-Disease
by O
targeting O
FADD O
and O
caspase O
- O
3 O
. O

MIR203 B-RNA
is O
epigeneticlly O
silenced O
in O
multiple B-Disease
myeloma I-Disease
. O

miR B-RNA
- I-RNA
23a I-RNA
regulation O
of O
X O
- O
linked O
inhibitor O
of O
apoptosis O
( O
XIAP O
) O
contributes O
to O
sex O
differences O
in O
the O
response O
to O
cerebral B-Disease
ischemia I-Disease
. O

Ectopic O
expression O
of O
miR B-RNA
- I-RNA
375 I-RNA
inhibited O
melanoma B-Disease
cell O
proliferation O
, O
invasion O
, O
and O
cell O
motility O
, O
and O
induced O
cell O
shape O
changes O
, O
strongly O
suggesting O
that O
miR B-RNA
- I-RNA
375 I-RNA
may O
have O
an O
important O
function O
in O
the O
development O
and O
progression O
of O
human O
melanomas O
. O

MiR B-RNA
- I-RNA
200b I-RNA
and O
miR B-RNA
- I-RNA
15b I-RNA
regulate O
chemotherapy O
- O
induced O
epithelial O
- O
mesenchymal O
transition O
in O
human O
tongue B-Disease
cancer I-Disease
cells O
by O
targeting O
BMI1 O
. O

miR B-RNA
- I-RNA
122 I-RNA
inhibits O
viral O
replication O
and O
cell O
proliferation O
in O
hepatitis O
B O
virus O
- O
related O
hepatocellular B-Disease
carcinoma I-Disease
and O
targets O
NDRG3 O
. O

Reduction O
in O
miR B-RNA
- I-RNA
141 I-RNA
is O
induced O
by O
leukemia O
inhibitory O
factor O
and O
inhibits O
proliferation O
in O
choriocarcinoma B-Disease
cell O
line O
JEG O
- O
3 O
. O

miR B-RNA
- I-RNA
22 I-RNA
promotes O
HBV O
related O
hepatocellular B-Disease
carcinoma I-Disease
development O
in O
males O
. O

Coordinated O
increase O
of O
miRNA B-RNA
- I-RNA
155 I-RNA
and O
miRNA B-RNA
- I-RNA
196b I-RNA
expression O
correlates O
with O
the O
detection O
of O
the O
antigenomic O
strand O
of O
hepatitis B-Disease
C I-Disease
virus O
in O
peripheral O
blood O
mononuclear O
cells O
. O

miR B-RNA
- I-RNA
215 I-RNA
has O
a O
unique O
potential O
as O
a O
prognostic O
biomarker O
in O
stage O
II O
and O
III O
colon B-Disease
cancer I-Disease
. O

Elevated O
microRNA O
miR B-RNA
- I-RNA
21 I-RNA
Levels O
in O
Pancreatic O
Cyst O
Fluid O
Are O
Predictive O
of O
Mucinous O
Precursor O
Lesions O
of O
Ductal B-Disease
Adenocarcinoma I-Disease
. O

3 O
, O
3 O
' O
- O
Diindolylmethane O
inhibits O
breast B-Disease
cancer I-Disease
cell O
growth O
via O
miR B-RNA
- I-RNA
21 I-RNA
- O
mediated O
Cdc25A O
degradation O
. O

miR B-RNA
- I-RNA
155 I-RNA
could O
significantly O
inhibit O
the O
growth O
of O
human O
lung B-Disease
cancer I-Disease
95D O
cells O
in O
vitro O
, O
which O
might O
be O
closely O
related O
to O
miR B-RNA
- I-RNA
155 I-RNA
induced O
G0 O
/ O
G1 O
phase O
arrest O
. O

miR B-RNA
- I-RNA
29c I-RNA
targets O
TNFAIP3 O
, O
inhibits O
cell O
proliferation O
and O
induces O
apoptosis O
in O
hepatitis O
B O
virus O
- O
related O
hepatocellular B-Disease
carcinoma I-Disease
. O

Circulating O
miR B-RNA
- I-RNA
26a I-RNA
is O
a O
potential O
predictors O
and O
therapeutic O
targets O
for O
non O
- O
hypertensive O
ICH O
( O
intracerebral B-Disease
hemorrhage I-Disease
) O
. O

MiR B-RNA
- I-RNA
133a I-RNA
regulates O
collagen O
1A1 O
, O
which O
has O
potential O
role O
in O
myocardial O
fibrosis O
in O
angiotensin O
II O
dependent O
hypertension B-Disease
. O

miR B-RNA
- I-RNA
21 I-RNA
expression O
was O
upregulated O
in O
response O
to O
treatment O
with O
TGF O
- O
beta1 O
or O
TNF O
- O
alpha O
in O
human B-Disease
renal I-Disease
tubular I-Disease
epithelial I-Disease
cells O
in O
vitro O
. O

MicroRNA O
HSA B-RNA
- I-RNA
miR I-RNA
- I-RNA
125a I-RNA
- I-RNA
5p I-RNA
induces O
apoptosis O
by O
activating O
p53 O
in O
lung B-Disease
cancer I-Disease
cells O
. O

Up O
- O
regulation O
of O
miR B-RNA
- I-RNA
122 I-RNA
negatively O
regulates O
ADAM O
- O
17 O
, O
a O
known O
downstream O
target O
, O
in O
thyroid O
cells O
, O
suggesting O
an O
antiangiogenic O
mechanism O
in O
thyroid B-Disease
carcinoma I-Disease
. O

miR B-RNA
- I-RNA
10a I-RNA
overexpression O
is O
associated O
with O
NPM1 O
mutations O
and O
MDM4 O
downregulation O
in O
intermediate O
- O
risk O
acute B-Disease
myeloid I-Disease
leukemia I-Disease
. O

TGF O
- O
{ O
beta O
} O
/ O
Smad3 O
Signaling O
Promotes O
Renal B-Disease
Fibrosis I-Disease
by O
Inhibiting O
miR O
- O
29 O
. O

Differentially O
expressed O
miRNAs O
including O
miR B-RNA
- I-RNA
99a I-RNA
, O
miR B-RNA
- I-RNA
100 I-RNA
, O
miR B-RNA
- I-RNA
125b I-RNA
, O
miR B-RNA
- I-RNA
192 I-RNA
, O
and O
miR B-RNA
- I-RNA
429 I-RNA
were O
detected O
in O
pancreatic B-Disease
cancer I-Disease
stem O
cells O
. O

miR B-RNA
- I-RNA
203 I-RNA
expression O
predicts O
outcome O
after O
liver O
transplantation O
for O
hepatocellular B-Disease
carcinoma I-Disease
in O
cirrhotic O
liver O
. O

Two O
common O
SNPs O
( O
rs41275794 O
, O
rs12976445 O
) O
in O
pri B-RNA
- I-RNA
miR I-RNA
- I-RNA
125a I-RNA
alter O
the O
mature O
miRNA O
expression O
and O
associate O
with O
Abortion O
, O
Habitual O
in O
a O
Han O
- O
Chinese O
population O
. O

Overexpression O
of O
the O
Lung B-Disease
Cancer I-Disease
- O
Prognostic O
miR O
- O
146b O
MicroRNAs O
Has O
a O
Minimal O
and O
Negative O
Effect O
on O
the O
Malignant O
Phenotype O
of O
A549 O
Lung B-Disease
Cancer I-Disease
Cells O
. O

The O
lncRNA O
HULC B-RNA
is O
one O
of O
the O
most O
upregulated O
of O
all O
genes O
in O
hepatocellular B-Disease
carcinoma I-Disease
. O

Primate O
- O
specific O
miRNA B-RNA
- I-RNA
637 I-RNA
inhibits O
tumorigenesis O
in O
hepatocellular B-Disease
carcinoma I-Disease
by O
disrupting O
stat3 O
signaling O
. O

Lower O
miR B-RNA
- I-RNA
29a I-RNA
expression O
was O
mainly O
observed O
in O
MLL O
- O
rearranged O
pediatric O
acute B-Disease
myeloid I-Disease
leukemia I-Disease
, O
specifically O
in O
cases O
carrying O
t O
( O
10 O
; O
11 O
) O
. O

miR B-RNA
- I-RNA
21 I-RNA
, O
miR B-RNA
- I-RNA
210 I-RNA
, O
miR B-RNA
- I-RNA
34a I-RNA
, O
and O
miR B-RNA
- I-RNA
146a I-RNA
/ I-RNA
b I-RNA
are O
up O
- O
regulated O
in O
human O
atherosclerotic O
plaques O
( O
compared O
to O
non O
- O
atherosclerotic O
left O
internal O
thoracic O
arteries O
( O
LITA O
) O
) O
in O
the O
Tampere O
Vascular O
Study O
. O

Overexpression O
of O
miR B-RNA
- I-RNA
335 I-RNA
suppressed O
gastric B-Disease
cancer I-Disease
cell O
invasion O
and O
metastasis O
in O
vitro O
and O
in O
vivo O
, O
but O
has O
no O
significant O
effects O
on O
cell O
proliferation O
. O

Recently O
, O
it O
has O
been O
described O
that O
overexpression O
of O
HOTAIR B-RNA
is O
able O
to O
accumulate O
the O
PRC2 O
complex O
to O
execute O
gene O
silencing O
, O
alternate O
genome O
- O
wide O
H3K27me3 O
patterns O
, O
reset O
global O
gene O
expression O
profiles O
, O
activate O
metastasis O
- O
associated O
genes O
, O
and O
promote O
breast B-Disease
cancer I-Disease
metastasis O
. O

MiR O
- O
145 O
was O
significantly O
down O
- O
regulated O
in O
canine O
malignant O
melanoma B-Disease
tissues O
. O

These O
data O
indicate O
that O
miR B-RNA
- I-RNA
15a I-RNA
/ I-RNA
16 I-RNA
- I-RNA
1 I-RNA
plays O
an O
important O
role O
in O
the O
ATRA O
- O
induced O
differentiation O
of O
leukemic O
and O
primary O
AML B-Disease
cells O
. O

There O
is O
an O
inverse O
Association O
between O
miR B-RNA
- I-RNA
194 I-RNA
Expression O
and O
Tumor O
Invasion O
in O
Gastric B-Disease
Cancer I-Disease
. O

Smad3 O
- O
Mediated O
Upregulation O
of O
miR B-RNA
- I-RNA
21 I-RNA
Promotes O
Renal B-Disease
Fibrosis I-Disease
. O

MicroRNA B-RNA
- I-RNA
194 I-RNA
inhibits O
epithelial O
to O
mesenchymal O
transition O
of O
endometrial B-Disease
cancer I-Disease
cells O
by O
targeting O
oncogene O
BMI O
- O
1 O
. O

Let B-RNA
- I-RNA
7a I-RNA
Is O
a O
Direct O
EWS O
- O
FLI O
- O
1 O
Target O
Implicated O
in O
Ewing O
' O
s O
Sarcoma O
Development O
. O

CAMTA1 O
is O
a O
novel O
tumour O
suppressor O
regulated O
by O
miR B-RNA
- I-RNA
9 I-RNA
/ I-RNA
9 I-RNA
( I-RNA
* I-RNA
) I-RNA
in O
glioblastoma B-Disease
stem O
cells O
. O

miR B-RNA
- I-RNA
506 I-RNA
- I-RNA
514 I-RNA
cluster O
was O
consistently O
overexpressed O
in O
nearly O
all O
melanomas O
tested O
( O
30 O
- O
60 O
fold O
, O
P O
< O
0 O
. O
1 O
) O
, O
regardless O
of O
mutations O
in O
N O
- O
ras O
or O
B O
- O
raf O
. O
